CIRSE 2016 Pocket Guide

Barcelona, Spain terialASeptember 10-14 CIRSE 2016y BiliarPOCKET GUIDE

ANNUAL MEETING AND POSTGRADUATE COURSE nousOF THE V CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGICAL SOCIETY OF EUROPE Aortiincluding c IDEAS Interdisciplinary Endovascular PainPAortic Symposium a oNeuro yOnco Scientific & Educational Programme * Corporate Activities

2General Information from A to Z 12 Session Types, 14 Posters on Stage, 16 Super Endo Tuesday, 18 Film Interpretation Quiz, 19 Opening Ceremony, 20 Hands-on Workshops

32 Saturday – Scientiﬁc Programme SAT

50 Sunday – Scientiﬁc Programme SUN

69 Monday – Scientiﬁc Programme MON

87 Tuesday – Scientiﬁc Programme TUE

106 Wednesday – Scientiﬁc Programme WED

109 Poster Exhibition

POSTERS

193 Corporate Activities 195 Satellite Symposia, 220 Learning Centres, 230 IDEAS Training Village, 236 Hands-on Workshop Sponsors

242 Technical Exhibition 242 Alphabetical & Numerical List, 248 Exhibitors Guide, 298 Radiation Protection Pavilion, 306 Societies, 318 Floor Plans

* advertisement-free section in accordance with the document UEMS 2012/30 – the Accreditation of Live Educational Events of the EACCME® (article 33/34) 2 CIRSE 2016 Pocket Guide

General Information from A to Z

App Let the CIRSE app take care of your congress planning. New- comers, please download the CIRSE society app which is available for iPhone, iPad and Android (www.cirse.org/app) and install the CIRSE/IDEAS 2016 event. If the CIRSE society app is already on your smartphone, please just install the CIRSE/IDEAS 2016 event and have the best toolkit to plan your personal congress programme, evaluate sessions, browse the exhibition, take part in votings and submit questions to the moderator in selected sessions.

• browse the programme • complete the paperless session evaluation • search for exhibitors by product category • and much more...

Badges Your personalised badge is your admission card to the congress. For organisational and security reasons, badges must be worn at the congress venue at all times. A lanyard will be given to you with the congress bag. Identity checks in the congress centre may occur at any time. In case of loss, a replacement badge will be provided at an administrative charge of €80.

Certificate of Attendance To obtain your certificate of attendance, you can choose one of the following options:

Print your certificate onsite at the congress From 14:00 on Monday, September 12, you can use one of the dedicated workstations in the registration area to print your certificate. All you need is your congress badge.

Print your certificate at home After the congress you will be able to print your certificate of attendance at www.cirse.org. All you need is your last name and badge number. Alternatively, you could log into your personal CIRSE account at www.cirse.org with your personal log-in details. C RSE General Information 3

Credit Allowance The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) is accredited by the European Accredita- tion Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

CIRSE 2016 is designated for a maximum of 26 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Disclaimer CIRSE cannot accept any liability for the acts of the suppliers to this meeting or the attendees’ safety while travelling to or from the congress. All participants are strongly advised to carry adequate travel and health insurance, as CIRSE cannot accept liability for accidents or injuries that may occur.

Disclosures For financial disclosures and conflict of interest statements, please refer to www.cirse.org. 4 4 CIRSE 2016 Pocket2016 Guide ETF European Trainee Forum The European Trainee Forum

To make sure IR will continue its success story in the next decades, CIRSE is currently expanding its eﬀorts to support young IRs and those still in training. In early 2016, CIRSE established the Eu- ropean Trainee Forum (ETF) with the purpose to create a community within CIRSE dedicated to the training, educational and networking needs of IR trainees across EU, as well as to promote IR among peers and students. This year, CIRSE will include special features for young IRs, trainees and residents:

IR Trainee Session: building an IR career Tuesday, September 13 11:30-12:30, Room 133

• G. Makris: Welcome and introduction to ETF • A. Adam: Developing your academic career as an IR • D. Vorwerk: Publishing and CVIR • O.M. van Delden: The EBIR Exam • C.A. Binkert: Establishing private clinics and clinical entrepreneurship

Lounge of the European Trainee Forum CIRSE 2016 will oﬀer a new feature for Resident IRs: The Lounge of the European Trainee Forum will be a designated area for young interventional radiologists to relax, meet peers, create contacts to leading European IRs and help build a professional network. It will be located directly next to the Members’ Lounge.

Cardiovascular and Interventional Radiological Society of Europe General Information 5

Evaluation To complete the session evaluation and obtain credits for your attendance at CIRSE and IDEAS 2016 sessions, please use the online evaluation system, accessible through the CIRSE mobile app (please see page 2) and at https://cslide.ctimeetingtech.com/cirse2016/myevaluations/login.

Hotels | Social Events | City Information For information regarding hotels, transfers, restaurants and excursions, please ask our official travel partner, Kuoni, whose information desk is located in the entrance hall of the congress centre. Kuoni will be pleased to help you with all matters relating to your stay in Barcelona.

Opening Hours Friday, September 9 16:00-18:00 Saturday, September 10 07:00-18:00 Sunday, September 11 07:30-18:00 Monday, September 12 07:30-18:00 Tuesday, September 13 07:30-18:00 Wednesday, September 14 07:30-11:00

Internet/Wifi A free wireless service is available to all delegates throughout the congress centre.

Network: CIRSE 2016 Password: Barcelona16

Lounge of the European Trainee Forum CIRSE 2016 will offer a new feature for resident IRs: the Lounge of the European Trainee Forum will be a designated area for young interventional radiologists to relax, meet peers, create contacts to leading European IRs and facilitate building a lasting professional network. It will be located directly next to the Members’ Lounge. 6 CIRSE 2016 Pocket Guide

Main Programme & Abstract Book elbaliava si "kooB tcartsbA & emmargorP niaM" eht fo ypoc A ypoc fo eht niaM" emmargorP & tcartsbA "kooB si elbaliava for every scienti c delegate at the registration desk and express lane.

Members’ Lounge All members are invited to relax and enjoy a snack in the Members’ Lounge which is located in the exhibition hall.

Mobile Phones Please do not forget to turn your mobile phone to silent mode during the sessions.

Photographs and Video Recording Please note that any form of recording, lming or photo- graphing of presentation material during the session is strictly forbidden. Subject to the authors’ consent, all presentation material will be made available online on CIRSE’s educational platform ESIR.org.

Poster Area All accepted scienti c and educational posters as well as case reports will be presented electronically through CIRSE’s Electronic Poster Online System. For a detailed list of all posters, please refer to pages 109-192.

The Poster Area is located in the exhibition hall of the congress centre (please see the oorplan on the inside back cover). 32 computers will be available to view the CIRSE 2016 posters.

Opening Hours Saturday, September 10 07:30-18:30 Sunday, September 11 07:30-18:30 Monday, September 12 07:30-18:30 Tuesday, September 13 07:30-18:30

Onsite sta will be glad to assist you during these hours.

C RSE General Information 7

Publication in CVIR Meeting abstracts are published by Springer in an electronic supplementary issue of the official CIRSE journal CVIR and are therefore citable publications (Online Publication Number: 10.1007/s00270-016-1405-3).

We strongly encourage submission of the complete manu- script of any oral or poster presentation for publication in the journal, preferably in an electronic version through the CVIR submission website www.editorialmanager.com/cvir. Please note that submissions have to comply with the "Guidelines for Authors" specified on the CVIR submission website.

Radiation Protection Pavilion The Radiation Protection Pavilion (RPP) is CIRSE’s interactive awareness campaign for radiation protection and dose management and is located in the exhibition hall. Services offered in the RPP include free eye-checks, short talks on radiation safety, take-home information material and a radiation safety simulator. Please find a detailed description of the initiative and its sponsors on pages 298-305. For more information visit www.cirse.org/rpp.

Registration Desk – Opening Hours Friday, September 9 16:00-18:00 Saturday, September 10 07:00-18:00 Sunday, September 11 07:30-18:00 Monday, September 12 07:30-18:00 Tuesday, September 13 08:00-18:00 Wednesday, September 14 08:00-11:00

Smoking The CIRSE Annual Meeting is a non-smoking congress. Smok- ing is permitted outside the congress centre only. 8 CIRSE 2016 Pocket Guide

Speaker Centre The Speaker Centre is located in the mezzanine of the congress centre. Please note that only digital material will be allowed for oral presentations. All material must be in English and provided on a CD-ROM, DVD-ROM or USB flash drive (which is preferred) to be placed on the central server onsite. All presentation files must be uploaded at least 3 hours prior to the beginning of the corresponding session.

Computers connected to the central server allowing access to the speakers’ presentations are available in every lecture room. These computers are equipped with Microsoft Win- dows 7 Professional and Microsoft Office 2013 Professional. Please note that speakers are not allowed to use their own laptops for their presentations.

Opening Hours Friday, September 9 16:00-18:30 Saturday, September 10 07:30-18:30 Sunday, September 11 07:30-18:30 Monday, September 12 07:30-18:30 Tuesday, September 13 07:30-18:30 Wednesday, September 14 07:30-12:00

Students‘ Lounge The Students’ Lounge, located in the entrance hall of the congress centre, welcomes all participants of the CIRSE 2016 Student Programme.

Students can meet, have lunch and find out more about interventional radiology and CIRSE in a relaxed and comfortable environment.

Technical Exhibition The CIRSE Technical Exhibition is located on the entrance level. Please find a floor plan of the exhibition on the inside back cover and a detailed list of all exhibitors on pages 242-297.

Opening Hours Saturday, September 10 09:00-18:00 Sunday, September 11 09:00-18:00 Monday, September 12 09:00-18:00 Tuesday, September 13 09:00-19:00

C RSE General Information 9

Transportation in Barcelona

Public transportation The Centre de Convencions Internacional de Barcelona "CCIB" can be reached with Metro line "L4" – exit "El Maresme | Forum".

All CIRSE 2016 delegates with a full congress registration (scientific badges) will receive a complimentary "Hola BCN 5-day" travel card. This card allows delegates to travel on 5 consecutive days within Zone 1, making the congress centre easily accessible during the congress dates.

You will receive your personal ticket upon checking in to the congress at the express lane or when collecting your congress material at one of our onsite registration counters.

Taxis Taxis will be available in front of the congress centre. The cost to go to the city centre is between €15 - €20. 10INNOVATIONCIRSE 2016 Pocket | EDUCATION Guide | INTERVENTION

CIRSE 2016 LIVE AND ON DEMAND

LIVE

CIRSE 2016

CIRSE 2016 ON DEMAND

Can’t make it to the congress? No problem, you can watch all sessions in HD quality via our livestream!

Can’t decide which session to go to? No problem, just watch the other presentations in our On Demand area!

Did you miss any other presentations from past CIRSE congresses? No problem, just go to ESIRonline, our online congress presentation platform at www.esir.org FREE ACCESS for 11 CIRSE members and CONGRESS attendees

A WEALTH OF IR LEARNING

Over 9,000 recorded presentations from all congresses since 2006 are waiting to be watched.

ESIRonline is free for CIRSE members year- round, and all other congress attendees have free access for one year!

www.esir.org

Cardiovascular and Interventional Radiological Society of Europe 12 CIRSE 2016 Pocket Guide

Session Types

Amazing Interventions The aim of this session is to present examples of unusual and difficult interventional procedures. Acclaimed experts in interventional radiology will present brief cases of their most unusual and challenging procedures. The emphasis of the session will be to highlight innovative ways that interventional radiologists can solve difficult problems and get out of trouble. It is envisaged that the session will be both educational and entertaining.

Aortic Complications This new session format features case presentations of major complications and/or unsuccessful interventions. Key opinion leaders will present aortic cases that were either originally complicated or became difficult to deal with during the procedure. This session provides a valuable learning opportunity by showing how to avoid unpleasant conditions in the daily clinical practice and how to find solutions to serious unex- pected events.

"CIRSE meets…" Session The "CIRSE meets…" programme proved to be an important platform for establishing and strengthening the relations between CIRSE and other societies in the field of interventional and vascular therapy. At CIRSE 2016, CIRSE’s guest will be the European Association of Urology (EAU).

Expert Case Discussions The Expert Case Discussions are divided into several topics. This format is designed to provide a platform for experts with different skills and views, who can each present their unique approach. Interesting cases, where different treatment options seem possible, will be presented, followed by a lively discussion involving the speakers and the audience. These interactive sessions provide an excellent learning experience on how to approach and work through difficult cases.

C RSE Session Types 13

Expert Round Tables The Expert Round Table sessions facilitate addressing important aspects of interventional radiology in an informal setting. Key opinion leaders will outline their views and preferred therapy options regarding select "hot topics", and then engage in lively discussions thereof with both their fellow speakers and the audience.

Film Interpretation Quiz The Film Interpretation Quiz is one of CIRSE’s most popular sessions and will be run as a "last man standing" quiz. The Quiz Master will present the audience with three possible answers to each case – those choosing incorrectly will be eliminated and must sit down, while those who get the answer right will continue to the next case. The last few contestants left stan ding will be invited onstage for a head- to-head finale. Those eliminated at the very beginning will get a second chance to put their skills to the test.

Free Paper Sessions Researchers will present original papers on new and original aspects of cardiovascular and interventional radiology. Se lected papers will be gathered into sessions, each dealing with a homogenous topic. There will be time for discussion between researchers and attendees after each presentation.

Featured Papers: In order to achieve a more interactive format to the Free Paper Sessions, one paper per session will be highlighted. More time will be dedicated to this featured paper by means of further questions prepared prior to the meeting by the moderator. This will ensure a more structured and thorough discussion of the topic.

Fundamental Courses Fundamental Courses cover a specific area of interventional radiology, focusing on basic principles and illustrating the procedure in a step-by-step fashion. They are designed for radiologists-in-training and new consultants, as well as for experienced consultants who require a refresher course on the subject. There will be plenty of time for questions and dis cussion. Each session will last one hour. 14 CIRSE 2016 Pocket Guide NEW Posters on Stage In order to enhance the appreciation of the poster presen- i Artertations at CIRSE Annual Meetings, Posters on Stage will be introduced as a new session format at CIRSE 2016. Selected posters and their presenting authors will take centre stage in these sessions. The posters will be displayed and navigated on terminals which are speciﬁcally designed for poster discussions in small groups. B BAll Postersiliary on Stage discussions will take place in the Poster Area located in the exhibition hall.

Saturday, September 10, 13:30-14:15 PS 404 Endovascular interventions Veno For the detailed programme, please refer to page 39. u

Sunday, September 11, 13:30-14:15 PS 1204 Embolisation A orticFor the detailed programme, please refer to page 58. A Monday, September 12, 13:30-14:15 PS 2004 Non-vascular interventions For the detailed programme, please refer to page 76. P n Pain Tuesday, September 13, 13:30-14:15 PS 2804 Interventional oncology

For the detailed programme, please refer to page 96.

Come and meet authors of top-rated posters in an informal N Nand euroopen setting, join in lively debates and ask questions! Oncolo Session Types 15

Hands-on Workshops The participants of Hands-on Workshops can follow live demonstrations of interventional techniques and practice certain procedures under the guidance of a technician and/or instructor.

Hot Topic Symposia The Hot Topic Symposia aim to address controversial IR topics in the setting of a plenary session. Invited speakers will give brief lectures on important aspects of the subject under Bdiscussion. A major feature of these sessions will be a round- table discussion involving the speakers and the audience.

Lecture Sessions Lecture Sessions feature targeted presentations addressing diverse issues in minimally invasive aortic aneurysm repair. Each session concludes with a lively debate of the particular utopic’s most controversial aspects. Morbidity & Mortality Conference The Morbidity and Mortality Conference will analyse interventional radiology cases which led to complications and/or deaths that could have been avoided. This session provides a valuable learning experience for everyone involved in interventional radiology. The session will be dedicated to vascular Aand non-vascular cases. Posters on Stage Selected posters and their presenting authors will take centre stage in these sessions. The posters will be displayed and navigated on terminals which are specifically designed for poster discussions in small groups.

Satellite Symposia PSatellite Symposia are organised by companies and take place at lunchtime as well as in the morning and in the evening. During these sessions cutting-edge information on inter- Nventional equipment and techniques is provided. o 16 CIRSE 2016 Pocket Guide

Super Endo Tuesday Free Paper Sessions feature the presentation of original i Arterpapers on new and impactful aspects of cardiovascular and interventional radiology.

This year, an exclusive Free Paper slot called Super Endo Tuesday will take place, showcasing high-class research and up-to-the-minute trial results which all interventional radiologists should be aware of. The goal of this session is to B Bmakeiliary real science more popular and increase the importance of the scientiﬁc work in IR.

Tuesday, September 13, 16:15-17:15, Room 115 FP 3005 Super Endo Tuesday u Veno For the detailed programme, please refer to page 100.

This session is geared toward everyone, IRs young and old, Aand is notortic to be missed! A nPainP NeuroN OncolC RSE o Session Types 17

Special Sessions Special Sessions are designed to impart the latest knowledge on topics of interest to interventional specialists. These sessions are the backbone of the CIRSE meeting and are spe cifically chosen by the programme planning committee because of their importance in daily practice.

Workshops During Workshops you will have the chance to learn from your colleagues’ expertise in an informal, interactive manner. BWorkshops will entail individual cases and discussion points with regard to the particular interventional topic. Atten dees can contribute their opinions and ask questions in small groups.

Workshop for Radiographers This well-established interactive workshop, organised by CIRSE and the European Federation of Radiographer Societies u(EFRS), is especially designed for radiographers and nurses working in the field of interventional radiology. It caters to the fact that optimal patient care can only be delivered if the physician and the other team members, such as radiographers, are well trained and highly professional in what Athey do. P N o 18 CIRSE 2016 Pocket Guide

Film Interpretation Quiz

Monday, September 12 14:30-15:15 Auditorium 1

Co-ordinators: I.J. McCaﬀerty (Birmingham/GB), A.F. Watkinson (Exeter/GB)

The Film Interpretation Quiz is one of CIRSE’s most popular sessions and will be run as a "last man standing" quiz.

The Quiz Master will present the audience with three possible answers to each case – those choosing incorrectly will be eliminated and must sit down, while those who get the answer right will continue to the next case. The last few contestants left standing will be invited onstage for a head-to-

head ﬁnale. Those eliminated at the very beginning will get a second chance to put their skills to the test. Be part of this year’s most interactive session? and win free registration to CIRSE 2017 in Copenhagen! ?? ? CIRSE Opening and Awards Ceremony 19

CIRSE Opening and Awards Ceremony

Saturday, September 10 14:30-16:00 Auditorium 1

Chairperson: E. Brountzos (Athens/GR)

Welcome Addresses

CVIR Editor’s Medal Award

The Award of Excellence and Innovation in IR (R.W. Günther Foundation Award)

Distinguished Fellow: P.A. Gaines (Sheﬃeld/GB) Laudation: A.F. Watkinson (Exeter/GB)

Distinguished Fellow: L.M. Kenny (Brisbane, QLD/AU) Laudation: A. Adam (London/GB)

Distinguished Fellow: M. Maynar (Santa Cruz de Tenerife/ES) Laudation: J.I. Bilbao (Pamplona/ES)

Gold Medal: M.J. Lee (Dublin/IE) Laudation: R.A. Morgan (London/GB) 20 CIRSE 2016 Pocket Guide

Hands-on Workshops

The participants of hands-on workshops may follow live demonstrations of interventional techniques and practise certain procedures under the guidance of a technician and/or instructor.

Due to limited space and high demand, participants are advised to register for the hands-on workshops in advance. Should you not have pre-registered but are interested in participating, please arrive at the respective workshop rooms well in advance to check availability.

A closer look at closure devices

Co-ordinators: J.P. Schaefer (Kiel/DE), R. Uberoi (Oxford/GB)

Vascular closure devices (VCDs) are commonly used for the management of arterial puncture sites after therapeutic arterial interventions.

This hands-on workshop will introduce the VCDs currently available on the market. The main focus will be on the hands- on experience, with the opportunity to deploy devices and discuss the pros and cons of using closure devices in diﬀerent settings with experts. Furthermore, many tips and tricks for the proper use of closure devices in daily practice will be shared during the hands-on part. The course will include a dedicated tutorial of the "pre-close" technique for closing large arterial punctures for total percutaneous aortic repair.

Thanks to the opportunity to try currently available closure devices ﬁrst hand, the workshop should enable all participants to understand their various principles and indications.

C RSE Hands-on Workshops 21

Learning objectives – To become familiar with the currently available vascular closure devices for peripheral and aortic interventions – To understand when and how to successfully use a vascular closure device – To know when not to use a vascular closure device and how to avoid complications – To gain experience with the "pre-close" technique required for total percutaneous treatment of aortic aneurysms

Saturday, September 10 CD-HoW 1 12:30-14:00

Monday, September 12 CD-HoW 2 09:30-11:00

Instructors: R. Patel (Oxford/GB), P. Vilares Morgado (Porto/PT)

Location Room 132

Please note that participants need to register in advance at an extra cost of €75 per session. 22 CIRSE 2016 Pocket Guide

Embolisation: materials and tools

Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES), J.V. Patel (Leeds/GB)

This series of hands-on workshops provides an overview of current embolisation materials and techniques.

In each session, a brief introduction is followed by participants rotating between various table-top demonstrations. The workshops may be attended as a series or individually. Participants will engage informally with instructors and try out various embolic materials on anatomical and ﬂow models. The emphasis of the sessions is a practical hands-on approach. Participants can handle and/or deliver mechanical, liquid or particulate embolic agents (depending on the session). This course is intended for IRs with limited embolisation experience or those wishing to refresh their knowledge.

Learning objectives – To understand the basic principles of embolisation – To become familiar with common embolic agents – To be able to choose an appropriate embolic agent – To know how to correctly prepare and deliver the chosen agent – To understand how to avoid non-target embolisation and other complications

Saturday, September 10 EMT-HoW 1 – Coils & plugs 09:30-11:00 EMT-HoW 2 – Coils & plugs 12:30-14:00

Instructors: P.E. Huppert (Darmstadt/DE), G. Maleux (Leuven/BE), L.P. Moramarco (Pavia/IT), M. Pech (Magdeburg/DE), J.-P. Pelage (Caen/FR), H. Rio Tinto (Lisbon/PT), M. Wojtaszek (Warsaw/PL)

C RSE Hands-on Workshops 23

Sunday, September 11 EMT-HoW 3 – Liquid agents 09:30-11:00 EMT-HoW 4 – Liquid agents 12:30-14:00

Instructors: A. Alonso-Burgos (Madrid/ES), H. Lindgren (Helsingborg/SE), R. Loﬀroy (Dijon/FR), I.J. McCaﬀerty (Birmingham/GB)

Monday, September 12 EMT-HoW 5 – Particulate agents 09:30-11:00

Tuesday, September 13 EMT-HoW 6 – Particulate agents 09:30-11:00

Instructors: M. Koehler (Münster/DE), R. Lopez-Benitez (Luzern/CH), B.A. Radeleﬀ (Heidelberg/DE), G.J. Robinson (Hull/GB)

Location Room 130

Please note that participants need to register in advance at an extra cost of €75 per session. 24 CIRSE 2016 Pocket Guide

Principles to practice: education and simulation skills training

Co-ordinators: M. Midulla (Valenciennes/FR), J.C. van den Berg (Lugano/CH)

This popular series of workshops comprises a one-hour round-table discussion with experts in the ﬁeld, delivering key knowledge and practical tips, followed by one hour of hands-on experience using high-ﬁdelity simulators.

Each session is aimed at delegates with a specific level of experience (core, intermediate or advanced). The round-table discussions are themed around learning objectives which relate to a specific clinical or procedural topic.

The delivery of each session is adaptable to respond to the delegates’ interests, and emphasis is placed on small group teaching, allowing close interaction with the expert faculty. Equipment and devices will be available to demonstrate deployment technique.

Saturday, September 10 8:30-13:00 PTP-HoW 1 – Basic embolisation techniques (core level)

Session Organiser: J.C. van den Berg (Lugano/CH) Instructors: A. Holden (Auckland/NZ), H. Hoppe (Bern/CH), R.G. McWilliams (Liverpool/GB), M. Midulla (Valenciennes/FR)

PTP 1.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 1.2 (group 2): 09:40-10:40 discussion 10:50-11:50 simulation

PTP 1.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation

C RSE Hands-on Workshops 25

Learning objectives – To gather insights on the management, assessment and imaging of patients prior to embolisation – To learn about treatment options for embolisation of solid organs, the gastro-intestinal tract and blood vessels – To become familiar with patient selection, equipment and approach for embolisation – To discover how to improve outcomes in embolisation – To perform coil/particulate embolisation on a simulator

Sunday, September 11 08:30-13:00 PTP-HoW 2 – Acute aortic syndromes and emergency EVAR (intermediate level)

Session organiser: T.J. Cleveland (Sheﬃeld/GB) Instructors: S.D. Goode (Sheﬃeld/GB), N. Kakani (Manchester/GB), M. Taudorf (Copenhagen/DK), R.P. Yadavali (Aberdeen/GB)

PTP 2.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 2.2 (group 2): 09:40-10:40 discussion 10:50-11:50 simulation

PTP 2.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation

Learning objectives – To understand the presentation, diagnosis and management strategies of acute aortic syndromes, traumatic aortic injury and aortic rupture – To gain new perspectives on patient assessment, graft selection, the role of aortic occlusion balloons and the co-ordi- nation of the anaesthetic, surgical and radiological teams – To develop a thorough understanding of the sequence of events in performing eEVAR – To deploy a thoracic or abdominal stent graft on a simulator 26 CIRSE 2016 Pocket Guide

Monday, September 12 08:30-13:00 PTP-HoW 3 – The role of endovascular treatment in the diabetic foot (advanced level)

Session Organiser: to be announced Instructors: D.-D. Do (Bern/CH), E. Pampana (Rome/IT)

PTP 3.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 3.2 (group 2): 09:40-10:40 discussion 10:50-11:50 simulation

PTP 3.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation

Learning objectives – To ﬁnd out the principles behind the management of an ulcerated, ischaemic diabetic foot – To determine relevant indications and utilise strategies for identifying the target vessel, as well as when to use unconventional access – To become familiar with the equipment and pharmaco- therapy currently used in BTK interventions – To acquire skills on how to manage complications resulting from interventions

C RSE Hands-on Workshops 27

Tuesday, September 13 08:30-13:00 PTP-HoW 4 – Handling complications in iliac and femoral interventions (core level)

Session organiser: J.A. Vos (Nieuwegein/NL) Instructors: G.S. Goh (Melbourne, VIC/AU), F.G. Irani (Singapore/SG), R. Lely (Amsterdam/NL), G.J. Munneke (London/GB)

PTP 4.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 4.2 (group 2): 09:40-10:40 discussion 10:50-11:50 simulation

PTP 4.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation

Learning objectives – To recognise the potential complications in iliac and femoral interventions – To learn the treatment options available to manage complications – To determine how to prevent complications – To perform a rescue procedure on a simulator

Location Simulator Gallery

Please note that participants need to register in advance at an extra cost of €75 per session. 28 CIRSE 2016 Pocket Guide

Tumour ablation: tips and tricks

Co-ordinators: L. Crocetti (Pisa/IT), L. Hechelhammer (St. Gallen/CH)

Each of these six hands-on workshops includes a brief introduction and practical training in the basic principles of various currently available ablation systems.

Participants will have the opportunity to become familiar with ablation equipment and to practice respective procedures under in-vitro conditions using various systems. Moreover, international experts will share their experience and insights in an intimate atmosphere.

The latest 3D navigation systems will be available in a dedicated area. Participants will have the possibility to test them in conjunction with available ablation systems to understand how to optimise image-guidance and improve ablation results.

By the end of the workshop participants, including those with little or no experience in tumour ablation, will be familiar with a range of ablation techniques and will have learned tips and tricks for a safe and eﬃcacious clinical application.

Learning objectives – To understand the most appropriate indications for ablation of hepatic, renal, lung, thyroid, bone or soft tissue tumours according to present guidelines – To know how to choose the right ablation technique for each lesion – To understand when and how 3D navigation systems can improve image-guidance and ablation results – To understand the contraindications for local ablation techniques – To understand how to enhance the eﬃcacy of a speciﬁc ablation technique with adjuvant techniques and how to minimise or avoid the most commonly encountered complications

C RSE Hands-on Workshops 29

Saturday, September 10 TA-HoW 1 09:30-11:00

Sunday, September 11 TA-HoW 2 09:30-11:00 TA-HoW 3 12:30-14:00

Instructors: R. Bale (Innsbruck/AT), D.J. Breen (Southampton/GB), M. Meijerink (Amsterdam/NL), G. Tsoumakidou (Strasbourg/FR), A. Veltri (Orbassano/IT)

Monday, September 12 TA-HoW 4 12:30-14:00

Tuesday, September 13 TA-HoW 5 09:30-11:00 TA-HoW 6 12:30-14:00

Instructors: J. Garnon (Strasbourg/FR), B. Gonçalves (Porto/PT), M. Meijerink (Amsterdam/NL), W. Prevoo (Amsterdam/NL), P. Wiggermann (Regensburg/DE)

Location Room 111

Please note that participants need to register in advance at an extra cost of €75 per session. 30 CIRSE 2016 Pocket Guide

Varicose veins

Co-ordinators: J.A. Brookes (London/GB), L. Oguzkurt (Istanbul/TR)

Over the past 15 years, ultrasound-guided endovenous thermal ablation has replaced ‘high tie and strip’ surgery to become the gold standard for symptomatic truncal saphenous vein reflux (NICE guidelines UK 2013). As this treatment continues to gain popularity, more IR practices are considering offering a clinical service for chronic venous insufficiency. Familiarisation with the procedural techniques and clinical context is essential in developing a successful service.

This CIRSE Hands-on Workshop has grown in popularity over the past four years and provides an opportunity to learn the most commonly used techniques and compare and contrast the available devices for endovenous therapy through handling diﬀerent ﬁbres and systems and the corresponding generators. Participants will learn how to access the vein with ultrasound guidance, how to apply tumescent anaesthesia and how to use the appropriate devices. Techniques of duplex assessment of the legs will also be demonstrated. Throughout the workshop, participants will be given insightful advice from experts.

Learning objectives – To learn the different methods for endovenous treatment – To gain awareness of the clinical context and assessment of chronic venous insufficiency, with particular regard to varicose veins – To obtain practical experience with different devices – To receive hands-on training in ultrasound-guided venous access – To develop familiarity with the technique of tumescent anaesthesia

C RSE Hands-on Workshops 31

Monday, September 12 VV-HoW 1 12:30-14:00

Tuesday, September 13 VV-HoW 2 12:30-14:00

Instructors: D. Greenstein (Harrow/GB), B. Gumus (Istanbul/TR), A. Komarek (Ried im Innkreis/AT), C. Lebard (Paris/FR), M. Tal (Tel Aviv/IL)

Location Room 132

Please note that participants need to register in advance at an extra cost of €75 per session. 32 CIRSE 2016 Pocket Guide

Saturday, September 10

08:30-09:30, Room 112 Fundamental Course FC 101 Patient assessment before endovascular therapy SAT Moderators: J.H. Peregrin (Prague/CZ), D. Vorwerk (Ingolstadt/DE)

101.1 Protocols and pathways R. Uberoi (Oxford/GB) 101.2 Imaging and procedure planning D.K. Tsetis (Iraklion/GR) 101.3 Patient preparation M. Černá (Olomouc/CZ) 101.4 Consultation and consent B. Gonçalves (Porto/PT)

08:30-09:30, Auditorium 2 Special Session SS 102 Thyroid ablation

Moderators: G. Carraﬁello (Varese/IT), C.G. Trumm (Munich/DE)

102.1 Treatment of benign nodules: thermal ablation vs. surgery F. Stacul (Trieste/IT) 102.2 The role of thermal ablation in malignant thyroid disease J.H. Baek (Seoul/KR) 102.3 HIFU for benign nodules R. Kovatcheva (Soﬁa/BG) 102.4 Irreversible electroporation: what is the advantage? to be announced

C RSE Scientific Programme 33

08:30-09:30, Room 116 Special Session SS 103 Intraprocedural radiation dose management

Moderators: W. Jaschke (Innsbruck/AT), SAT E. Vano (Madrid/ES)

103.1 Occupational dosimetry in the interventional laboratory: dose limits and risk estimation G. Bartal (Kfar-Saba/IL) 103.2 Radiation protection tools: shielding and personal protective devices N. Rathmann (Mannheim/DE) 103.3 Real-time dosimetry in IR L. Tselikas (Villejuif/FR) 103.4 Patient dose reduction technologies W. Jaschke (Innsbruck/AT)

08:30-09:30, Room 117 Special Session SS 104 Prostate embolisation

Moderators: J.M. Pisco (Lisbon/PT), M.R. Sapoval (Paris/FR)

104.1 Patient selection D. Abt (St. Gallen/CH) 104.2 Anatomical variants F.C. Carnevale (São Paulo/BR) 104.3 CBCT-guided embolisation H. Kobeiter (Créteil/FR) 104.4 Evidence M. Grosso (Cuneo/IT) 34 CIRSE 2016 Pocket Guide

08:30-13:00, Simulator Gallery Hands-on Workshop PTP-HoW 1 Principles to practice: education and simulation skills training - Basic embolisation techniques

SAT Co-ordinators: M. Midulla (Valenciennes/FR), J.C. van den Berg (Lugano/CH)

Session Organiser: J.C. van den Berg (Lugano/CH) Instructors: A. Holden (Auckland/NZ), H. Hoppe (Bern/CH), R.G. McWilliams (Liverpool/GB), M. Midulla (Valenciennes/FR)

PTP 1.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 1.2 (group 2): 09:40-10:40 discussion 10:50-11:50 simulation

PTP 1.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation

09:30-11:00, Room 130 Hands-on Workshop EMT-HoW 1 Embolisation: materials and tools – Coils & plugs

Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES), J.V. Patel (Leeds/GB)

Instructors: P.E. Huppert (Darmstadt/DE), G. Maleux (Leuven/BE), L.P. Moramarco (Pavia/IT), M. Pech (Magdeburg/DE), J.-P. Pelage (Caen/FR), M. Wojtaszek (Warsaw/PL)

C RSE Scientific Programme 35

09:30-11:00, Room 111 Hands-on Workshop TA-HoW 1 Tumour ablation: tips and tricks

Co-ordinators: L. Crocetti (Pisa/IT), L. Hechelhammer (St. Gallen/CH)

Instructors: R. Bale (Innsbruck/AT), D.J. Breen SAT (Southampton/GB), A. Veltri (Orbassano/IT)

10:00-11:00, Auditorium 1 Expert Round Table e-voting ERT 201 Therapy of long SFA lesions

Moderator: K.N. Katsanos (London/GB)

Panellists: F. Fanelli (Rome/IT) H. Zayed (London/GB) A. Diamantopoulos (London/GB) S. Müller-Hülsbeck (Flensburg/DE)

10:00-11:00, Room 116 Special Session SS 202 Safe and eﬀective practice in interventional oncology

Moderators: A. Adam (London/GB), C.A. Binkert (Winterthur/CH)

202.1 Safety in interventional radiology: the essential steps M.J. Lee (Dublin/IE) 202.2 Registries and trials in interventional oncology: how its evidence base is being established P.L. Pereira (Heilbronn/DE) 202.3 A curriculum for interventional oncology: why is it necessary and what will it teach? A. Gangi (Strasbourg/FR) 202.4 The CIRSE Quality Assurance framework for interventional oncology: an essential tool for eﬀective cancer care L.M. Kenny (Brisbane, QLD/AU) 36 CIRSE 2016 Pocket Guide

10:00-11:00, Room 112 Fundamental Course FC 203 Venous stenting

Moderators: M. Bratby (Oxford/GB), C. Lebard (Paris/FR) SAT 203.1 Recanalisation of deep venous obstructions: current status R. de Graaf (Maastricht/NL) 203.2 Decision-making in deep venous interventions: from imaging to follow-up L. Oguzkurt (Istanbul/TR) 203.3 Technical aspects of deep venous interventions, tips and tricks G.J. O‘Sullivan (Galway/IE) 203.4 Prevention of PTS, eliminating the cause of DVT J.A. Vos (Nieuwegein/NL)

10:00-11:00, Room 117 Special Session SS 204 Special indications and their outcome for UFE

Moderators: A. Laborda (Zaragoza /ES), A.C. Roberts (La Jolla, CA/US)

204.1 Fertility A.-M. Belli (London/GB) 204.2 Large and subserosal ﬁbroids P.M. Crowe (Birmingham/GB) 204.3 Adenomyosis P.N.M. Lohle (Tilburg/NL) 204.4 Post-menopausal UFE J.B. Spies (Washington, DC/US)

C RSE Scientific Programme 37

11:30-12:30, Auditorium 1 Expert Case Discussion e-voting ECD 301 Arterial thrombectomy

Moderator: T. Rand (Vienna/AT)

301.1 L. Hechelhammer (St. Gallen/CH)

301.2 D. Karnabatidis (Patras/GR) SAT

11:30-12:30, Auditorium 2 Expert Round Table e-voting ERT 302 Therapy of lung metastasis

Moderator: T. de Baère (Villejuif/FR)

Panellists: A. Gillams (London/GB) L.M. Kenny (Brisbane, QLD/AU) E. Van Cutsem (Leuven/BE) J. Palussière (Bordeaux/FR) L. Molins (Barcelona/ES)

11:30-12:30, Room 117 Special Session SS 303 Dialysis access

Moderators: A. Diamantopoulos (London/GB), F.G. Irani (Singapore/SG)

303.1 Clinical assessment and imaging for failing ﬁstulas to be announced 303.2 Current status of stent grafts Z.J. Haskal (Charlottesville, VA/US) 303.3 Current status on drug-eluting devices in dialysis access M. Das (Maastricht/NL) 303.4 Treatment of chronic central venous obstructions J.H. Peregrin (Prague/CZ) 38 CIRSE 2016 Pocket Guide

11:30-12:30, Room 112 Special Session SS 304 Embolisation for lower GI bleeding

Moderators: R.W. Günther (Berlin/DE), M. Rossi (Rome/IT) SAT 304.1 Patient preparation and imaging J. Urbano (Madrid/ES) 304.2 Optimal angiographic techniques M.D. Darcy (St. Louis, MO/US) 304.3 The role of liquid agents R. Loﬀroy (Dijon/FR) 304.4 The role of particles B.S. Funaki (Chicago, IL/US)

12:30-14:00, Room 132 Hands-on Workshop CD-HoW 1 A closer look at closure devices

Co-ordinators: J.P. Schaefer (Kiel/DE), R. Uberoi (Oxford/GB)

Instructors: R. Patel (Oxford/GB), P. Vilares Morgado (Porto/PT)

12:30-14:00, Room 130 Hands-on Workshop EMT-HoW 2 Embolisation: materials and tools – Coils & plugs

Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES), J.V. Patel (Leeds/GB)

Instructors: P.E. Huppert (Darmstadt/DE), L.P. Moramarco (Pavia/IT), M. Pech (Magdeburg/DE), J.-P. Pelage (Caen/FR), H. Rio Tinto (Lisbon/PT), M. Wojtaszek (Warsaw/PL)

C RSE Scientific Programme 39

13:00-14:00 Satellite Symposia

For the detailed programmes, please refer to pages 195-196.

13:30-14:15, Poster Area SAT Posters on Stage PS 404 Endovascular interventions

Moderators: A. Diamantopoulos (London/GB), F. Fanelli (Rome/IT)

P-476 A comparison of clinical outcomes for diabetic and non-diabetic patients following Misago Rx nitinol stent implantation in the e-MISAGO registry S. Müller-Hülsbeck (Flensburg/DE) P-520 Long-term results of percutaneous endovascular treatment in patients with mesenteric ischaemia: bypass postponement... or renouncement? T. Bulut (Enschede/NL) P-529 Endovascular management of renovascular hypertension in a paediatric population: a 12-year single-centre experience N. Thulasidasan (London/GB) P-465 Predictors of clinical outcome following endovascular treatment of infrapopliteal disease in patients with critical limb ischaemia L. Biasi (London/GB) P-292 Learning curve of the transradial approach of percutaneous carotid intervention E.M. Végh (Budapest/HU) 40 CIRSE 2016 Pocket Guide

14:30-16:00, Auditorium 1 OP 501 CIRSE Opening and Award Ceremony

Chairperson: E. Brountzos (Athens/GR)

Welcome Addresses SAT CVIR Editor’s Medal Award

The Award of Excellence and Innovation in IR (R.W. Günther Foundation Award)

Distinguished Fellow: P.A. Gaines (Sheﬃeld/GB) Laudation: A.F. Watkinson (Exeter/GB)

Distinguished Fellow: L.M. Kenny (Brisbane, QLD/AU) Laudation: A. Adam (London/GB)

Distinguished Fellow: M. Maynar (Santa Cruz de Tenerife/ES) Laudation: J.I. Bilbao (Pamplona/ES)

Gold Medal: M.J. Lee (Dublin/IE) Laudation: R.A. Morgan (London/GB)

16:15-17:15, Room 117 Workshop WS 601 BTK and pedal

601.1 M.G. Manzi (Abano Terme/IT) 601.2 T. Rand (Vienna/AT)

16:15-17:15, Room 112 Workshop WS 602 IR after abdominal surgery

602.1 P. Lucatelli (Siena/IT) 602.2 S. Spiliopoulos (Patras/GR)

C RSE Scientific Programme 41

16:15-17:15, Room 133 Workshop WS 603 Cancer pain management

603.1 D.K. Filippiadis (Athens/GR) 603.2 G.C. Anselmetti (Turin/IT) SAT 16:15-17:15, Room 116 Workshop WS 604 Percutaneous fracture management

604.1 J. Garnon (Strasbourg/FR) 604.2 R.-T. Hoﬀmann (Dresden/DE)

16:15-17:15, Room 134 Workshop WS 605 Paediatric radiation protection: keep the kids safe – intervene gently

605.1 G. Bartal (Kfar-Saba/IL) 605.2 E. Vano (Madrid/ES)

16:15-17:15, Room 114 Free Paper Session FP 606 Dialysis intervention

Moderators: J. Kettenbach (St. Pölten/AT), J.M. Lozano (Bogota/CO)

606.1 Does technical success of angioplasty in dysfunctional hemodialysis accesses correlate with access patency? D.K. Rajan1, A. Sidhu2; 1Toronto, ON/CA, 2Southﬁeld, MI/US 606.2 Time-extended lyse-and-wait technique for thrombosed hemodialysis access S. Regus, W. Lang, M. Heinz, M. Uder, A. Schmid; Erlangen/DE 606.3 Long-term local thrombolysis using rtPA for acute thrombosed hemodialysis access S. Regus, W. Lang, M. Heinz, M. Uder, A. Schmid; Erlangen/DE 42 CIRSE 2016 Pocket Guide

featured 606.4 Creation of a percutaneous arteriovenous paper ﬁstula (pAVF) for hemodialysis access C.G. Radosa1, N. Weiss1, T. Hofmockel1, J.C. Radosa2, M. Laniado1, C. Gatzweiler1, R.-T. Hoﬀmann1; 1Dresden/DE, 2Homburg/DE 606.5 Endexo: superb technology for hemodialysis

SAT catheter? Data analysis from pre-clinical trials E.W. Lee1, K. LeBlanc2, S. Kee1; 1Los Angeles, CA/US, 2Latham, NY/US 606.6 Novel use of a pneumatic compression device for haemostasis of haemodialysis ﬁstula access catheterisation sites D.T. Ryan, M.K. O‘Reilly, G. Sugrue, C. Farrelly; Dublin/IE

16:15-17:15, Room 113 Free Paper Session FP 607 Biliary intervention

Moderators: M. Casares Santiago (Palma de Mallorca/ES), A. Hatzidakis (Iraklion/GR)

607.1 Percutaneous transhepatic biliary drainage (PTBD) for obstructive jaundice: right or left approach? External or internal/external drain? S.H. Hyon, J. Montagne, L. Boccalatte, M.E. Fratantoni, C. Abuawad, V.M. Cano, P. Huespe, E. de Santibanes, J. Pekolj; Buenos Aires/AR 607.2 Bacterial isolates from biliary cultures obtained during percutaneous biliary intervention: a multicentre review. Are we prescribing the right antibiotics? P.S. Najran1, F. Babatola2, J. Bell1, D. Mullan1, H.-U. Laasch1; 1Manchester/GB, 2Stoke/GB 607.3 Treatment of benign bile leaks by placing transparietohepatic self-expanding metal covered stents M. Páramo1, P. García-Barquín1, M. Carrillo2, M. Millor1, I. Vivas1, J.I. Bilbao1; 1Pamplona/ES, 2Murcia/ES

C RSE Scientific Programme 43

607.4 Biodegradable biliary stents: a single- featured paper center experience in the treatment of benign biliary strictures Q. Ordi i Camprubi, I. Diez-Miranda, M. Perez Lafuente, C. Gonzalez-Junyent, D. Hernandez Morales, C. Parra-Fariñas, X. Merino-Casabiel, A. Segarra Medrano; Barcelona/ES

607.5 Irreversible electroporation with SAT endoluminal balloon catheter in perihilar region: preliminary results T. Andrašina, J. Pánek, D. Červinka, I. Svobodova, M.J. Arbet, J. Husty, V. Válek; Brno/CZ 607.6 Liver tract closure for transhepatic percutaneous interventions: presentation of the ﬁrst-in-man case and initial evaluation of the HEP-plug device F. Sakhinia, R. Peck; Sheﬃeld/GB

16:15-16:55, Auditorium 2 Satellite Symposium

For the detailed programme, please refer to page 197.

17:30-18:30, Room 112 Workshop WS 701 Recanalisation techniques: skill and technology

701.1 M.A. Ruﬃno (Turin/IT) 701.2 J.M. Abadal (Madrid/ES)

17:30-18:30, Room 117 Workshop WS 702 Abdominal and pelvic trauma

702.1 O.M. van Delden (Amsterdam/NL) 702.2 J. Golzarian (Minneapolis, MN/US) 44 CIRSE 2016 Pocket Guide

17:30-18:30, Room 115 Workshop WS 703 Transarterial and combined treatment of HCC

703.1 J. Urbano (Madrid/ES)

SAT 703.2 I. Bargellini (Pisa/IT)

17:30-18:30, Auditorium 2 Workshop WS 704 Benign biliary disease

704.1 A. Hatzidakis (Iraklion/GR) 704.2 P.A.M.S. Almeida (Viseu/PT)

17:30-18:30, Room 133 Free Paper Session FP 705 Experimental work in IR

Moderators: M.E. Krokidis (Cambridge/GB), M. Szczerbo-Trojanowska (Lublin/PL)

705.1 Large degradable starch microspheres to induce tissue necrosis after transarterial embolization of the kidney C.M. Sommer1, T. Mokry1, T.L. Gockner2, T.D. Do1, C. Schlett1, P. Flechsig1, D. Gnutzmann1, B.A. Radeleﬀ1, U. Stampﬂ1, P.L. Pereira3, H.U. Kauczor1, S. Macher-Göppinger2; 1Heidelberg/DE, 2Mainz/DE, 3Heilbronn/DE 705.2 Development of an atrophy–hypertrophy animal model after partial liver radioembolization M. Páramo, J.I. Bilbao, E. Santa María, A. Benito, M. Rodríguez-Fraile, M. Iñarrairaegui; Pamplona/ES

C RSE Scientific Programme 45

705.3 In vivo realtime interventional MR featured paper elastography (MRE) and thermometry (MRT) during percutaneous thermal ablation of liver: a proof of concept P.P. Rao, N. Corbin, J. Vappou, B. Elodie, B. Wach, M. De Mathelin, A. Gangi; Strasbourg/FR

705.4 A novel radiopaque and colored PEG SAT microsphere for embolization and chemoembolization E. Servais1, L. Moine2, A. Beilvert1, L. Bédouet1, D. Labarre2, A. Laurent3; 1Jouy en Josas/FR, 2Châtenay-Malabry/FR, 3Paris/FR 705.5 First in vivo evaluation of the tissue- engineered BioStent S. Ichihashi1, L. Rongen1, A.H. Mahnken2, T. Schmitz-Rode1, P. Mela1, S. Jockenhoevel1; 1Aachen/DE, 2Marburg/DE 705.6 Systemic hypotension following intravenous administration of non-ionic contrast medium during computed tomography-guided interventions: a randomized, placebo- controlled, double-blinded phase IV clinical trial G. Widmann, R. Bale, H. Ulmer, D. Putzer, P. Schullian, F. Wiedermann, W. Lederer; Innsbruck/AT

17:30-18:30, Room 114 Free Paper Session FP 706 All about veins

Moderators: P.E. Andersen (Odense/DK), G.J. O‘Sullivan (Galway/IE)

706.1 Clinical outcomes following percutaneous cyanoacrylate embolisation (using VenaSeal) in treating venous disease of the legs K. James, S. Porcherot, S. Ray; Kingston/GB 706.2 Novel biomatrix sclerofoam compared to endovenous laser: initial results and 1-year follow-up J.C. Ragg; Berlin/DE 46 CIRSE 2016 Pocket Guide

706.3 Adrenal venous sampling in primary aldosteronism: comparison of contralateral suppression index and multinomial regression modelling to detect lateralization of aldosterone hypersecretion when the right adrenal vein sampling is missing

SAT F. Perrault, G. Soulez, M. Chagnon, P. Gilbert, M.-F. Giroux, P. Perreault, L. Bouchard, V.L. Oliva, I. Bourdeau, A. Lacroix, E. Therasse; Montreal, QC/CA 706.4 Results from VIVO-EU, a prospective study of the Zilver Vena venous stent in featured paper the treatment of symptomatic iliofemoral venous outflow obstruction: on behalf of the VIVO-EU investigators G.J. O‘Sullivan1, J.A. McCann-Brown2; 1Galway/IE, 2West Lafayette, IN/US 706.5 Alginate–foam-combined dressing application in hemostasis after central venous catheter insertion in the intervention room S.-Y. Chun, J.H. Shin; Seoul/KR 706.6 Variables associated with reduced radiation exposure, cost, and technical difficulty of IVC filter placement and retrieval M. Neill, H.W. Charles, S. Kovacs, E. Aaltonen, A.R. Deipolyi; New York, NY/US

C RSE Scientific Programme 47

17:30-18:30, Room 116 Free Paper Session FP 707 Prostate embolisation and IRE

Moderators: F.C. Carnevale (São Paulo/BR), N. Hacking (Southampton/GB)

707.1 Prostatic artery embolisation for benign SAT prostatic hyperplasia: anatomical factors aﬀecting the procedure performance A. Cannavale1, B. Maher2, T.J. Bryant2, M. Santoni3, N. Hacking2; 1Canterbury/GB, 2Southampton/GB, 3Rome/IT 707.2 Clinical results after prostatic artery embolization (PAE): a single-center study of 68 patients G. Amouyal, O. Pellerin, N. Thiounn, C. Del Giudice, C. Déan, M.R. Sapoval; Paris/FR 707.3 First experiences of prostatic artery embolization for large, benign prostatic hyperplasia ahead of a randomized controlled trial A. Massmann, M. Saar, G.K. Schneider, M. Stöckle, S. Siemer, C. Niklas, A. Buecker; Homburg/DE

featured 707.4 Prostate cancer treatment with paper irreversible electroporation (IRE): efficacy and safety in 300 patients over 5 years M. Stehling1, N. Klein1, E. Guenther1, S. Zapf1, R. El Idrissi1, B. Rubinsky2; 1Offenbach Am Main/ DE, 2Berkeley, CA/US 707.5 UK-ROPE: preliminary findings S. Modi1, T.J. Bryant1, A.F. Ray2, N. Hacking1; 1Southampton/GB, 2Cardiff/GB 707.6 Prostatic artery embolization (PAE) in patients with spinal injury to reduce the prostatic volume and facilitate intermittent catheterization: a new indication? A.G. Rampoldi, F. Barbosa, S. Secco, C. Migliorisi, R. Vercelli, M. Solcia, A. Galfano, A. Bocciardi, M. Spinelli; Milan/IT 48 CIRSE 2016 Pocket Guide

17:30-18:30, Room 134 Free Paper Session FP 708 Imaging

Moderators: O. Akhan (Ankara/TR), A.G. Ryan (Waterford City/IE) SAT 708.1 Extravascular incidental malignant findings in follow-up CT angiograms in patients post- endovascular aneurysm repair P.S. Dhillon, M.W. Butt, J.E. Kirk, G. Pollock, P.M. Bungay, C. Squirrell, M. De Nunzio, P.D. Thurley; Derby/GB 708.2 Profile of secondary interventions and triggering surveillance imaging after EVAR I.N. Roy, S.R. Vallabhaneni; Liverpool/GB 708.3 Diagnostic performance of iodine quantification in distinguishing benign from neoplastic portal vein thrombosis on dual- energy CT in patients with hepatocellular carcinoma C. Sofia, S. Silipigni, M.A. Marino, G. Ascenti; Messina/IT 708.4 A 3-dimensional (3D) printed endovascular simulation model: technique and initial data 1 1 1 1 featured S. Mafeld , C. Nesbitt , J. McCaslin , A. Bagnall , paper P. Davey2, P. Bose3, R. Williams1; 1Newcastle-upon-Tyne/GB, 2Durham/GB, 3Essex/GB 708.5 Efficacy of CT in diagnosing non-variceal gastrointestinal bleeding prior to transarterial embolization after endoscopic failure in managing acute gastrointestinal bleeding A. Wadhwani, P. Beck, E. Herget; Calgary, AB/CA

C RSE Scientific Programme 49

708.6 Medium range CT follow-up of imageable iodinated microspheres after embolization of liver tumors E. Levy1, K. Sharma2, A. Lewis3, V. Krishnasamy1, S. Willis3, V. Anderson1, C. Macfarlane3, A. Radaelli4, M. van der Bom4, W. Pritchard1, J.-F.H. Geschwind5, B.J. Wood1; 1Bethesda, 2 3

MD/US, Washington, DC/US, Camberley/GB, SAT 4Eindhoven/NL, 5New Haven, CT/US

17:30-17:50, Room 113 Satellite Symposium

For the detailed programme, please refer to page 197. 50 CIRSE 2016 Pocket Guide

Sunday, September 11

08:00-08:20 Satellite Symposia

For the detailed programmes, please refer to page 198.

08:30-09:30, Room 112 Fundamental Course SUN FC 901 Thermal liver ablation

Moderators: J.L. del Cura-Rodriguez (Bilbao/ES), J. Ricke (Magdeburg/DE)

901.1 HCC: patient selection T. de Baère (Villejuif/FR) 901.2 HCC: ablation techniques T. Bilhim (Lisbon/PT) 901.3 Colorectal metastases: patient selection W. Prevoo (Amsterdam/NL) 901.4 Colorectal metastases: ablation techniques R. Bale (Innsbruck/AT)

08:30-09:30, Room 115 Special Session SS 902 Biopsy: new developments

Moderators: L.E. Derchi (Genoa/IT), R.F. Grasso (Rome/IT)

902.1 Preprocedural work-up including coagulation M.C. Burgmans (Leiden/NL) 902.2 Optimal biopsy C.J. Zech (Basel/CH) 902.3 New techniques in biopsies L. Tselikas (Villejuif/FR) 902.4 Tricky biopsies J. Kettenbach (St. Pölten/AT)

C RSE Scientific Programme 51

08:30-09:30, Room 117 Special Session SS 903 Calcium burden and treatment solutions in modern endovascular practice

Moderators: P. Krishnan (New York, NY/US), T. Rand (Vienna/AT)

903.1 Peripheral arterial calciﬁcation: mechanism of action, detection, classiﬁcation and clinical

implications SUN F. Fanelli (Rome/IT) 903.2 Rotational vs. directional vs. orbital vs. photoablation: which atherectomy for heavy calciﬁed lesions? U. Teichgräber (Jena/DE) 903.3 Scoring balloons: an alternative method for "vessel preparation" E. Blessing (Karlsbad/DE) 903.4 Lithoplasty: last frontier in calcium modulation A. Holden (Auckland/NZ)

08:30-09:30, Auditorium 1 Special Session Controversy e-voting SS 904 Controversies in new ﬁelds of embolisation

Moderators: F.S. Keller (Portland, OH/US), J.-P. Pelage (Caen/FR)

904.1 Bariatric embolisation: con P. Vorwald (Madrid/ES) 904.2 Bariatric embolisation: pro C.R. Weiss (Baltimore, MD/US) 904.3 Haemorrhoid embolisation: con P. Vavra (Ostrava/CZ) 904.4 Haemorrhoid embolisation: pro V. Vidal (Marseille/FR) 904.5 Transradial approach for visceral interventions: con A. Buecker (Homburg/DE) 904.6 Transradial approach for visceral interventions: pro A. Fischman (New York, NY/US) 52 CIRSE 2016 Pocket Guide

08:30-09:30, Auditorium 2 Lecture Session LS 905 Thoracic dissections

Moderators: R.G. McWilliams (Liverpool/GB), C. Nienaber (London/GB)

905.1 Do we need a new classiﬁcation for type B dissection? M.D. Dake (Stanford, CA/US) 905.2 Ancilliary techniques in complicated type B SUN dissections D.M. Williams (Ann Arbor, MI/US) 905.3 Update on fenestrated and branched grafts in post-dissection aneurysms W. Ritter (Nuremberg/DE) 905.4 Complications of stent-grafting C. Nienaber (London/GB) Debate: 905.5 TEVAR for type B dissection - percutaneous approach: pro L.B. Lönn (Copenhagen/DK) 905.6 TEVAR for type B dissection - percutaneous approach: con V. Riambau (Barcelona/ES)

08:30-13:00, Simulator Gallery Hands-on Workshop PTP-HoW 2 Principles to practice: education and simulation skills training - Acute aortic syndromes and emergency EVAR

Co-ordinators: M. Midulla (Valenciennes/FR), J.C. van den Berg (Lugano/CH)

Session Organiser: T.J. Cleveland (Sheﬃeld/GB) Instructors: S.D. Goode (Sheﬃeld/GB), N. Kakani (Manchester/GB), M. Taudorf (Copenhagen/DK), R.P. Yadavali (Aberdeen/GB)

C RSE Scientific Programme 53

PTP 2.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 2.2 (group 2): 09:40-10:40 discussion 10:50-11:50 simulation

PTP 2.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation SUN 09:30-11:00, Room 130 Hands-on Workshop EMT-HoW 3 Embolisation: materials and tools - Liquid agents

Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES), J.V. Patel (Leeds/GB)

Instructors: A. Alonso-Burgos (Madrid/ES), H. Lindgren (Helsingborg/SE), R. Loﬀroy (Dijon/FR), I.J. McCaﬀerty (Birmingham/GB)

09:30 -11:00, Room 111 Hands-on Workshop TA-HoW 2 Tumour ablation: tips and tricks

Co-ordinators: L. Crocetti (Pisa/IT), L. Hechelhammer (St. Gallen/CH)

Instructors: R. Bale (Innsbruck/AT), M. Meijerink (Amsterdam/NL), G. Tsoumakidou (Strasbourg/FR), A. Veltri (Orbassano/IT) 54 CIRSE 2016 Pocket Guide

10:00-11:00, Room 117 Fundamental Course FC 1001 Lung ablation

Moderators: G. Carraﬁello (Varese/IT), J. Tacke (Passau/DE)

1001.1 Techniques, imaging guidance and follow-up protocols: ten-year update R. Cioni (Pisa/IT) SUN 1001.2 Indications and results in NSCLC J. Palussière (Bordeaux/FR) 1001.3 Indications and results in colorectal cancer metastases A. Gillams (London/GB) 1001.4 Role of SBRT and ablation C.T. Sofocleous (New York, NY/US)

10:00-11:00, Room 112 Expert Round Table e-voting ERT 1002 Therapy of biliary obstructions

Moderator: O.M. van Delden (Amsterdam/NL)

Panellists: J.E. van Hooft (Amsterdam/NL) O.R.C. Busch (Amsterdam/NL) H.-U. Laasch (Manchester/GB)

10:00-11:00, Auditorium 1 Expert Round Table e-voting ERT 1003 Therapy of chronic limb ischaemia

Moderator: L.M. Palena (Abano Terme/IT)

Panellists: K.N. Katsanos (London/GB) M. Brodmann (Graz/AT) M. Montero-Baker (Houston, TX/US) L.J. Diaz-Sandoval (Wyoming, MI/US)

C RSE Scientific Programme 55

10:00-11:00, Room 115 Special Session SS 1004 Intra-arterial therapies in the liver: the evidence

Moderators: J.I. Bilbao (Pamplona/ES), J.-F.H. Geschwind (New Haven, CT/US),

1004.1 Bland embolisation G.M. Varano (Milan/IT) 1004.2 Conventional TACE T. de Baère (Villejuif/FR)

1004.3 Drug-eluting beads (DEB) – TACE SUN K. Malagari (Athens/GR) 1004.4 Radioembolisation (TARE) A. Denys (Lausanne/CH)

10:00-11:00, Auditorium 2 Expert Round Table ERT 1005 Thoracic aorta – uncomplicated acute type B dissections

Moderators: G.M. Richter (Stuttgart/DE), E. Verhoeven (Nuremberg/DE)

1005.1 Is there a role for medical therapy? C. Nienaber (London/GB) 1005.2 Risk factors for late complications M.D. Dake (Stanford, CA/US) 1005.3 Is coverage of the entry tear enough? F.E. Vermassen (Ghent/BE) 1005.4 Is the petticoat technique useful? E. Ducasse (Bordeaux/FR) 56 CIRSE 2016 Pocket Guide

11:30-12:30, Room 116 Special Session SS 1101 Anaesthesia and interventional radiology: time to face reality?

Moderators: E. Brountzos (Athens/GR), M.J. Lee (Dublin/IE)

1101.1 Anaesthesia and interventional radiology: best friends or worst enemies? A. Gangi (Strasbourg/FR) SUN 1101.2 Which anaesthesia in percutaneous hepatobiliary procedures: sedation M. Bezzi (Rome/IT) 1101.3 Which anaesthesia in percutaneous hepatobiliary procedures: general A.H. Mahnken (Marburg/DE) 1101.4 Propofol given by non-anaesthiologists: the Swiss GI experience L.T. Heuss (Zollikerberg/CH) 1101.5 The CIRSE Survey on Anaesthetic Practices for Interventional Radiology in Europe A. Vari (Rome/IT)

11:30-12:30, Room 115 EFRS Workshop e-voting RWS 1102 Radiation dose management in IR suites

1102.1 G. Paulo (Coimbra/PT) 1102.2 S. Foley (Dublin/IE) 1102.3 L. O’Hora (Dublin/IE)

11:30-12:30 Satellite Symposia

For the detailed programmes, please refer to pages 199-202.

C RSE Scientific Programme 57

12:30-14:00, Room 130 Hands-on Workshop EMT-HoW 4 Embolisation: materials and tools – Liquid agents

Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES), J.V. Patel (Leeds/GB)

Instructors: A. Alonso-Burgos (Madrid/ES), H. Lindgren (Helsingborg/SE), R. Loﬀroy (Dijon/FR), I.J. McCaﬀerty (Birmingham/GB) SUN 12:30-14:00, Room 111 Hands-on Workshop TA-HoW 3 Tumour ablation: tips and tricks

Co-ordinators: L. Crocetti (Pisa/IT), L. Hechelhammer (St. Gallen/CH)

Instructors: R. Bale (Innsbruck/AT), M. Mejerink (Amsterdam/NL), G. Tsoumakidou (Strasbourg/FR), A. Veltri (Orbassano/IT)

13:00-14:00 Satellite Symposia

For the detailed programmes, please refer to pages 202-206. 58 CIRSE 2016 Pocket Guide

13:30-14:15, Poster Area Posters on Stage PS 1204 Embolisation

Moderators: C.A. Binkert (Winterthur/CH), F. Wolf (Vienna/AT)

P-456 Endovenous radiofrequency-powered thermal ablation of the marginal venous system W. Uller (Regensburg/DE) P-93 The role of pre-operative bilateral internal iliac SUN artery balloon occlusion in patients with abnormally invasive placenta (accreta, increta, percreta) I.S. Al Salmi (Muscat/OM) P-308 First human experience with directly imageable iodinated embolization microbeads E. Levy (Bethesda, MD/US) P-300 Preoperative devascularization of juvenile nasopharyngeal angioﬁbromas: direct percutaneous tumoral injection with cyanoacrylate glue in conjunction with particulate endovascular embolization M.A.O. Kasem (Cairo/EG) P-602 Embolization for erectile dysfunction due to venous leakage R. Aschenbach (Jena/DE)

14:30-16:00, Auditorium 1 Honorary Lecture / Hot Topic Symposium

14:30-15:00, Auditorium 1 Honorary Lecture HL 1301 Andreas Gruentzig Lecture

Moderator: E. Brountzos (Athens/GR) Laudation: J.A. Reekers (Amsterdam/NL)

1301.1 Vascular IR and sailing the ocean J. Lammer (Vienna/AT)

C RSE Scientific Programme 59

15:00-16:00, Auditorium 1 Hot Topic Symposium HTS 1302 Aortic emergencies

Moderators: C.A. Binkert (Winterthur/CH), F. Fanelli (Rome/IT)

1302.1 Death and secondary aortic rupture risk 15 years after EVAR or open repair R.M. Greenhalgh (London/GB) 1302.2 Acute TEVAR for ruptured aneurysm and dissection

A. Chavan (Oldenburg/DE) SUN 1302.3 Traumatic rupture of the thoracic aorta M.D. Dake (Stanford, CA/US) 1302.4 Intramural haematoma and penetrating ulcer F.E. Vermassen (Ghent/BE)

14:30-15:30 Satellite Symposia

For the detailed programmes, please refer to pages 206-207.

16:15-17:15, Room 115 Workshop WS 1401 Varicocele and ovarian vein embolisation

1401.1 A. Basile (Catania/IT) 1401.2 A.C. Roberts (La Jolla, CA/US)

16:15-17:15, Room 117 Workshop WS 1402 Varicose veins: ablation and ancillary therapies

1402.1 J.M. Pulido-Duque (Las Palmas de Gran Canaria/ES) 1402.2 M. Åkesson (Malmo/SE) 60 CIRSE 2016 Pocket Guide

16:15-17:15, Room 134 Workshop WS 1403 Preparation for EBIR and the use of ESIRonline

1403.1 O.M. van Delden (Amsterdam/NL) 1403.2 M. Bezzi (Rome/IT)

16:15-17:15, Auditorium 1 AI 1405 Amazing Interventions SUN

Co-ordinator: P. Haage (Wuppertal/DE)

Case presenters: R. Bale (Innsbruck/AT), L. Crocetti (Pisa/IT), B. Gonçalves (Porto/PT), F.G. Irani (Singapore/SG), A. Krajina (Hradec Králové/CZ), P. Minko (Homburg/DE), O. Pellerin (Paris/FR), P. Reimer (Karlsruhe/DE), M. Szczerbo-Trojanowska (Lublin/PL), S.O. Trerotola (Philadelphia, PA/US)

16:15-17:15, Auditorium 2 Lecture Session LS 1406 Arch and ascending thoracic aorta

Moderators: C. Ferro (Genoa/IT), C. Nienaber (London/GB)

1406.1 Update on surgical techniques and outcomes A.L. Nobre (Lisbon/PT) 1406.2 Overview of endovascular techniques in the arch H. Rousseau (Toulouse/FR) 1406.3 Stroke: the big enemy M.P. Jenkins (London/GB) 1406.4 Stent graft in the ascending aorta: where are we? T. Kölbel (Hamburg/DE)

C RSE Scientific Programme 61

Debate: 1406.5 When to use a total endovascular approach for arch management S. Haulon (Lille/FR) 1406.6 When to use a hybrid approach for arch management S. Trimarchi (San Donato Milanese/IT)

16:15-17:15, Room 133 Free Paper Session FP 1407 Non-vascular IR: biopsies and drainages SUN Moderators: D.K. Tsetis (Iraklion/GR), C.J. Zech (Basel/CH)

1407.1 Performance of percutaneous CT-guided lung biopsy with an augmented reality navigation system (SIRIO) on 450 lung lesions G. Frauenfelder, E. Faiella, G. Luppi, F. Giurazza, B. Beomonte Zobel, R.F. Grasso; Rome/IT 1407.2 Postbiopsy pneumothorax reduction using a hydrogel tract sealant system after percutaneous CT and infrared optical- guided lung biopsy with a 17-gauge coaxial needle E. Faiella, G. Frauenfelder, G. Luppi, S. Della Sala, B. Beomonte Zobel, R.F. Grasso; Rome/IT featured 1407.3 Free-hand vs. instrument-guided needle paper puncture using CT imaging and optical navigation in vitro J. Kettenbach1, G. Toporek2, L. Kara3, S. Weber2; 1St. Pölten/AT, 2Bern/CH, 3Zurich/CH 1407.4 Transperineal prostate biopsy: a comparison between two techniques A. Babaei Jandaghi1, H. Habibzadeh1, S. Falahatkar1, A. Heidarzadeh1, R. Pourghorban2; 1Rasht/IR, 2Tehran/IR 1407.5 Transjugular renal biopsy in high-risk patients J. Kettenbach1, H. Mueller2; 1St. Pölten/AT, 2Hamburg/DE 1407.6 Directional atherectomy for endovascular tissue sampling A. Massmann, P. Fries, G.K. Schneider, A. Buecker; Homburg/DE 62 CIRSE 2016 Pocket Guide

16:15-17:15, Room 116 Free Paper Session FP 1408 Peripheral 1

Moderators: H. Lindgren (Helsingborg/SE), M. Schoder (Vienna/AT)

1408.1 Early results of the endovascular femoropopliteal artery bypass (EFAB) study using the PQ Bypass system P. Szopinski1, G. Halena2, G. Oszkinis3; SUN 1Warsaw/PL, 2Gdansk/PL, 3Poznan/PL 1408.2 One-year outcome of subintimal revascularization with Supera® stenting of long femoropopliteal occlusions in critical limb ischemia: the “Supersub” study L.M. Palena1, L.J. Diaz-Sandoval2, E. Sultato1, C. Brigato1, A. Candeo1, M.G. Manzi1; 1Abano Terme/IT, 2Wyoming, MI/US 1408.3 Lithoplasty for the treatment of calciﬁed featured paper SFA lesions: the DISRUPT PAD study program T.J. Brinton1, U. Illindala2, M. Brodmann3, M. Werner4, G. Tepe5, A. Holden6, D. Scheinert7, G. Torsello8, F. Wolf4, T. Zeller9; 1Stanford, CA/US, 2Fremont, CA/US, 3Graz/AT, 4Vienna/ AT, 5Rosenheim/DE, 6Auckland/NZ, 7Leipzig/DE, 8Münster/DE, 9Bad Krozingen/DE 1408.4 Drug-eluting balloon angioplasty of femo- ropo pliteal arterial disease: a real world experience P. Drescher, C.O. Hampson, P. Zalog; Milwaukee, WI/US 1408.5 Mechanical thrombectomy to treat intraprocedural distal embolization occurring during lower limb revascularization R. Gandini, S. Merolla, M. Stefanini, F. De Crescenzo, E. Pampana, A. D‘Onofrio; Rome/IT 1408.6 DEB and stents: what we have learnt from the Freeway Stent Study and the PACUBA Trial J. Lammer1, J. Tacke2; 1Vienna/AT, 2Passau/DE

C RSE Scientific Programme 63

16:15-17:00 Satellite Symposia

For the detailed programmes, please refer to pages 207-208.

17:30-18:30, Room 117 Workshop WS 1501 Obstetric haemorrhage

1501.1 J.-P. Pelage (Caen/FR)

1501.2 A.-M. Belli (London/GB) SUN

17:30-18:30, Room 115 Workshop WS 1502 Pulmonary artery intervention

1502.1 V. Pedicini (Milan/IT) 1502.2 B.C. Meyer (Hannover/DE)

17:30-18:30, Room 116 Workshop WS 1503 Translational research and clinical trials in IR

1503.1 T.J. Vogl (Frankfurt/DE) 1503.2 M.E. Krokidis (Cambridge/GB) 64 CIRSE 2016 Pocket Guide

17:30-18:30, Auditorium 2 Lecture Session LS 1505 Endoleaks/complications

Moderators: L. di Marzo (Rome/IT), R.A. Morgan (London/GB)

1505.1 Hypogastric preservation with EVAR: a must for most F. Verzini (Perugia/IT) 1505.2 Is aortic neck dilatation a problem? SUN J.P.P.M. de Vries (Nieuwegein/NL) 1505.3 Prediction and prevention of type II endoleak G.M. Richter (Stuttgart/DE) 1505.4 Iliac limb occlusion: how to prevent, how to manage E. Brountzos (Athens/GR) Debate: 1505.5 Endovascular management of type I endoleaks J.F. Benenati (Miami, FL/US) 1505.6 Surgical management of type I endoleaks R.G.J. Gibbs (London/GB)

C RSE Scientific Programme 65

17:30-18:30, Room 133 Free Paper Session FP 1506 Bone and spine

Moderators: J. Egge (Haugesund/NO), F. Florio (San Giovanni Rotondo/IT)

1506.1 A randomised sham-controlled trial of vertebroplasty for painful chronic osteoporotic vertebral fractures D. Carli1, P.N.M. Lohle2; 1Veldhoven/NL, 2Tilburg/NL

1506.2 Percutaneous pulsed radiofrequency neurolysis SUN in knee osteoarthritis: evaluation of pain reduction in chronic refractory cases D.K. Filippiadis, G. Velonakis, L. Reppas, A. Mazioti, E. Brountzos, N.L. Kelekis, A.D. Kelekis; Athens/GR featured 1506.3 Percutaneous internal ﬁxation to prevent paper impeding pathological hip fractures: a 1-year follow-up study F. Deschamps1, T. Carteret2, L. Tselikas1, B. Lapuyade2, T. de Baère1, F. Cornelis2; 1Villejuif/FR, 2Bordeaux/FR 1506.4 Percutaneous MR-guided cryoablation of Morton’s neuroma: rationale and technical details after the ﬁrst 20 patients R.L. Cazzato, J. Garnon, G. Tsoumakidou, J. Caudrelier, P.P. Rao, G. Koch, A. Gangi; Strasbourg/ FR 1506.5 Osteoid osteoma and more: MRgFUS in the treatment of benign and painful bone lesions F. Arrigoni, L. Zugaro, A. Barile, C. Masciocchi; L‘Aquila/IT 1506.6 Pain palliation and local control of musculoskeletal metastases with percutaneous cryoablation A.N. Wallace, S. Connolly, J. Symanski, D. Vaswani, R. Vyhmeister, S. McWilliam, A. Lee, T. Hillen, M. Friedman, J. Jennings; Saint Louis, MO/US 66 CIRSE 2016 Pocket Guide

17:30-18:30, Room 114 Free Paper Session FP 1507 Dialysis: what‘s new

Moderators: G.S. Goh (Melbourne, VIC/AU), D. Karnabatidis (Patras/GR)

1507.1 Can paclitaxel-coated balloons be beneﬁcial in preventing restenosis in haemodialysis access? A randomised clinical trial L.J. Roosen; Dordrecht/NL SUN 1507.2 Paclitaxel-coated balloon versus plain balloon angioplasty for the treatment of symptomatic central venous stenosis in dialysis access: results from a prospective randomized controlled trial P.M. Kitrou, P. Papadimatos, S. Spiliopoulos, K.N. Katsanos, S. Sourouni, N. Christeas, D. Karnabatidis; Patras/GR 1507.3 Primary patency of drug-eluting balloon angioplasty in hemodialysis patients with arteriovenous ﬁstula stenosis B.M. Çildağ, K.Ö.F. Köseoğlu; Aydin/TR

featured 1507.4 Pilot randomized trial of conventional paper balloon angioplasty vs. drug coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae W. Vander Mijnsbrugge1, N. Verbeeck2, D. Henroteaux3, A. Laenen1, S. Cornelissen1, S. Heye1, G. Maleux1; 1Leuven/BE, 2Luxembourg/ LU, 3Liège/BE 1507.5 Our experience in the treatment of failing distal radiocephalic arteriovenous fistulas: two different brands of paclitaxel-eluting balloons for juxta-anastomotic stenoses compared with standard angioplasty (PTA) G. Coniglio, S. Santonocito, S. Giuffrida, G. Calcara, P. Malfa, P. Bisceglie, D. Patanè; Catania/IT 1507.6 Comparing secondary patency of covered and bare stents in hemodialysis patients: a 2-year study A. Masrani, J. Soni, U.C. Turba, J. Tasse, S. Madassery, O. Ahmed, B. Arslan; Chicago, IL/US

C RSE Scientific Programme 67

17:30-18:30, Room 113 Free Paper Session FP 1508 Oncology: liver

Moderators: M. Barrufet (Barcelona/ES), J. Ricke (Magdeburg/DE)

1508.1 Novel non-iodinated radiopaque microbeads for transarterial embolization and transarterial radioembolization of liver tumors V.H. Somasundaram, A. Ashokan, N.K. Puthukudiyil, A.K.K. Unni,

P. Shanmugasundaram, S. Nair, K. Manzoor; SUN Kochi/IN 1508.2 Radiofrequency versus microwave liver ablation: preliminary results of a randomized clinical trial R. Quesada, A. Radosevic, J. Sanchez, A. Agustí, F. Burdío; Barcelona/ES featured 1508.3 New drug-eluting beads for sorafenib paper delivery in HCC embolization L. Bédouet1, L. Moine2, E. Servais1, A. Beilvert1, F. Pascale1, D. Labarre2, A. Laurent3; 1Jouy en Josas/FR, 2Châtenay-Malabry/FR, 3Paris/FR 1508.4 Percutaneous electrochemotherapy of malignant main portal vein thrombosis: a prospective case series L. Tarantino1, G. Busto1, A. Nasto1, R. Fristachi1, L. Cacace1, M. Talamo1, P. Ambrosino2, P. Gallo3, P. Tarantino2, C. Accardo1; 1Pagani/IT, 2Naples/ IT, 3Rome/IT 1508.5 Hypervascular HCC TACE performed with M1 DC Bead: ﬁrst long-term follow-up results P. Lucatelli, R. Argiro‘, M. Corona, F. Fanelli, M. Bezzi, C. Cirelli, S.G. Corradini, C. Catalano; Rome/IT 1508.6 Feasibility, safety and early eﬃcacy of 70–150- μm drug-eluting beads loaded with irinotecan (M1-DEBIRI) for the treatment of unresectable hepatic colorectal metastases O. Akinwande1, R.C.G. Martin2; 1Baltimore, MD/US, 2Louisville, KY/US 68 CIRSE 2016 Pocket Guide

17:30-18:30, Room 134 Free Paper Session FP 1509 TIPS, portal vein intervention and BRTO

Moderators: J.I. Bilbao (Pamplona/ES), S. Punamiya (Singapore/SG)

1509.1 Integrated stent graft for non-invasive pressure monitoring after transjugular intrahepatic portosystemic shunt (TIPS) implantation C. Spink1, W. Krautschneider1, J. Bibin1, SUN D. Schröder1, R. Fischbach2, M. Braunschweig2, J.-H. Buhk1, G. Adam1, A. Koops3; 1Hamburg/DE, 2Dresden/DE, 3Berlin/DE 1509.2 TIPS: is the underdilation of nitinol stents an illusion? A. Mollaiyan, M. Rössle, D. Bettinger; Freiburg/DE 1509.3 Three-dimensional image fusion guidance featured paper for transjugular intrahepatic portosystemic shunt in cirrhotic patients H. Derbel, V. Tacher, A. Petit, M. Chiaradia, F. Ridouani, D. Azoulay, C. Duvoux, H. Kobeiter; Créteil/FR 1509.4 Plug-assisted retrograde transvenous obliteration (PARTO) for gastric variceal bleeding: comparison of its eﬃcacy with balloon-occluded retrograde transvenous obliteration (BRTO) U.B. Jeon, J.Y. Jang, J.H. Park; Yangsan/KR 1509.5 Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique B. Guiu1, P. Chevallier2, A. Denys3, M.-A. Pierredon1, L. Escal1, V. Schembri1, J. Ramos1; 1Montpellier/FR, 2Nice/FR, 3Lausanne/CH 1509.6 Prospective comparative study of diﬀerent strategies to induce future liver remnant (FLR) hypertrophy in 118 cases of major hepatic resection P. Marra, M. Venturini, C. Sallemi, F. Ratti, L. Aldrighetti, A. Del Maschio, F. De Cobelli; Milan/IT

C RSE Scientific Programme 69

Monday, September 12

07:40-08:20 Satellite Symposia

For the detailed programmes, please refer to pages 209-210.

08:30-09:30, Room 112 Fundamental Course FC 1701 Radioembolisation

Moderators: C.A. Binkert (Winterthur/CH), J. Ricke (Magdeburg/DE)

1701.1 Dose calculation for IRs

E.G. Santos Martín (Pittsburgh, PA/US) MON 1701.2 Embolisation principles: preparation for radioembolisation R.J. Lewandowski (Chicago, IL/US) 1701.3 Patient care: outpatient setup, special precautions W.S. Rilling (Milwaukee, WI/US) 1701.4 Overview of recent trials J.I. Bilbao (Pamplona/ES)

08:30-09:30, Room 116 Special Session SS 1702 Robotic interventions: which patients; is it worth it?

Moderators: M. Guimaraes (Charleston, SC/US), L.B. Lönn (Copenhagen/DK)

1702.1 Carotid stenting J.F. Benenati (Miami, FL/US) 1702.2 Prostate embolisation M.R. Sapoval (Paris/FR) 1702.3 Fibroid embolisation M.S. Hamady (London/GB) 1702.4 Visceral arterial interventions D. Kuhelj (Ljubljana/SI) 70 CIRSE 2016 Pocket Guide

08:30-09:30, Room 117 Special Session SS 1703 Musculoskeletal embolisation

Moderators: A. Gangi (Strasbourg/FR), A.G. Ryan (Waterford City/IE)

1703.1 Pre-operative embolisation R. Marcello (Rome/IT) 1703.2 Palliative embolisation: alone and in combination with ablation R.F. Grasso (Rome/IT) 1703.3 Inﬂammatory and degenerative disease Y. Okuno (Tokyo/JP) 1703.4 Malformations

MON I.J. McCaﬀerty (Birmingham/GB)

08:30-09:30, Room 115 Special Session SS 1704 The role of IR in inﬂammatory pancreatic disease

Moderators: S. Stojanovic (Novi Sad/RS), M. Szczerbo-Trojanowska (Lublin/PL)

1704.1 Clinical overview of pancreatitis G. Carraﬁello (Varese/IT) 1704.2 Imaging of pancreatitis W. Schima (Vienna/AT) 1704.3 Endoscopic treatments J. Phillips-Hughes (Oxford/GB) 1704.4 Percutaneous treatments O. Akhan (Ankara/TR)

C RSE Scientific Programme 71

08:30-09:30, Auditorium 2 Lecture Session LS 1705 Abdominal aorta 1

Moderator: R. Uberoi (Oxford/GB)

1705.1 Four-year results of the comparative French trial of fenestrated and branched graft versus open surgery J.-P. Becquemin (Créteil/FR) 1705.2 The PERICLES registry K.P. Donas (Münster/DE) 1705.3 Contrast-free EVAR: when and how F. Fanelli (Rome/IT) 1705.4 3D printing for complex EVAR A. Hoﬀman (Haifa/IL) Debate:

1705.5 Standard EVAR outside IFU – yes MON J.P.P.M. de Vries (Nieuwegein/NL) 1705.6 Standard EVAR outside IFU – no J. Lammer (Vienna/AT)

08:30-13:00, Simulator Gallery Hands-on Workshop PTP-HoW 3 Principles to practice: education and simulation skills training – The role of endovascular treatment in the diabetic foot

Co-ordinators: M. Midulla (Valenciennes/FR), J.C. van den Berg (Lugano/CH)

Session Organiser: to be announced Instructors: D.-D. Do (Bern/CH), E. Pampana (Rome/IT)

PTP 3.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 3.2 (group 2): 09:40-10:40 discussion 10:50-11:50 simulation

PTP 3.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation 72 CIRSE 2016 Pocket Guide

09:30-11:00, Room 132 Hands-on Workshop CD-HoW 2 A closer look at closure devices

Co-ordinators: J.P. Schaefer (Kiel/DE), R. Uberoi (Oxford/GB)

Instructors: R. Patel (Oxford/GB), P. Vilares Morgado (Porto/PT)

09:30-11:00, Room 130 Hands-on Workshop EMT-HoW 5 Embolisation: materials and tools – Particulate agents MON Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES), J.V. Patel (Leeds/GB)

Instructors: M. Koehler (Münster/DE), R. Lopez-Benitez (Luzern/CH), B.A. Radeleﬀ (Heidelberg/DE), G.J. Robinson (Hull/GB)

10:00-11:00, Auditorium 1 Expert Round Table e-voting ERT 1801 Therapy of small renal cancer

Moderator: L. Crocetti (Pisa/IT)

Panellists: D.J. Breen (Southampton/GB) T.K. Helmberger (Munich/DE) G. Tsoumakidou (Strasbourg/FR) A. Veltri (Orbassano/IT)

C RSE Scientific Programme 73

10:00-11:00, Room 112 Special Session SS 1802 Alternative arterial access

Moderators: P. Drescher (Hartland, WI/US), M. Maynar (Santa Cruz de Tenerife/ES)

1802.1 Direct SFA access F. Wolf (Vienna/AT) 1802.2 Retrograde access of the lower limb P.E. Huppert (Darmstadt/DE) 1802.3 Radial access C.A. Binkert (Winterthur/CH) 1802.4 Subclavian access G. Puippe (Zurich/CH)

10:00-11:00, Room 117 MON Fundamental Course FC 1803 Liquid embolic agents

Moderators: J. Golzarian (Minneapolis, MN/US), J. Urbano (Madrid/ES)

1803.1 Overview of liquid embolic agents M. Köcher (Olomouc/CZ) 1803.2 When and how to use glue H.J. Jae (Seoul/KR) 1803.3 When and how to use sclerosants W.A. Wohlgemuth (Regensburg/DE) 1803.4 When and how to use ethylene vinyl alcohol K. Zeleňák (Martin/SK) 74 CIRSE 2016 Pocket Guide

10:00-11:00, Room 115 Expert Case Discussion e-voting ECD 1804 Enteral feeding - gastrostomy, gastrojejunostomy, jejunostomy

Moderator: H. van Overhagen (The Hague/NL)

1804.1 H.-U. Laasch (Manchester/GB) 1804.2 M.J. Sousa (Porto/PT)

10:00-11:00, Auditorium 2 Expert Round Table ERT 1805 Abdominal aorta – challenging proximal neck MON Moderators: E.S. Debus (Hamburg/DE), J. Lammer (Vienna/AT)

1805.1 Standard EVAR J.F. Benenati (Miami, FL/US) 1805.2 Chimney technique P. Cao (Rome/IT) 1805.3 Fenestrated A. Holden (Auckland/NZ) 1805.4 Is there still a role for surgery in AAA? J. Schmidli (Bern/CH)

C RSE Scientific Programme 75

11:30-12:30, Room 115 Special Session SS 1901 How to handle the radiation risk

Moderators: E.P. Efstathopoulos (Athens/GR), W. Jaschke (Innsbruck/AT)

1901.1 Radiation Dose Structured Report (RDSR) of ﬂuoroscopy-guided interventions: do we get what we want? G. Bartal (Kfar-Saba/IL) 1901.2 How to identify high-risk procedures for operators R.W.R. Loose (Nuremberg/DE) 1901.3 How to identify high-risk procedures for patients G. Paulo (Coimbra/PT)

1901.4 Diagnostic reference levels (DRLs) – MON help or hindrance? E. Vano (Madrid/ES)

11:30-12:30 Satellite Symposia

For the detailed programmes, please refer to pages 210-211.

12:30-14:00, Room 111 Hands-on Workshop TA-HoW 4 Tumour ablation: tips and tricks

Co-ordinators: L. Crocetti (Pisa/IT), L. Hechelhammer (St. Gallen/CH)

Instructors: J. Garnon (Strasbourg/FR), B. Gonçalves (Porto/PT), W. Prevoo (Amsterdam/NL), P. Wiggermann (Regensburg/DE) 76 CIRSE 2016 Pocket Guide

12:30-14:00, Room 132 Hands-on Workshop VV-HoW 1 Varicose veins

Co-ordinators: J.A. Brookes (London/GB), L. Oguzkurt (Istanbul/TR)

Instructors: D. Greenstein (Harrow/GB), B. Gumus (Istanbul/TR), A. Komarek (Ried im Innkreis/AT), C. Lebard (Paris/FR), M. Tal (Tel Aviv/IL)

13:00-14:00 Satellite Symposia

MON For the detailed programmes, please refer to pages 212-214.

13:30-14:15, Poster Area Posters on Stage PS 2004 Non-vascular interventions

Moderators: K.A. Hausegger (Klagenfurt/AT), O.M. van Delden (Amsterdam/NL)

P-225 Pancreatic duct percutaneous image-guided drainage: what for and how? M. Mizandari (Tbilisi/GE) P-207 Monitoring thermal-induced changes of liver stiﬀness by real-time point shear wave elastography (pSWE) in ex-vivo bovine liver tissue F. Calcagni (Pisa/IT) P-30 Local biliary temperature and bile duct damage in catheter radiofrequency ablation of ex vivo porcine liver W. Lu (Beijing/CN) P-423 Radiofrequency ablation of benign thyroid nodules: a prospective multicenter study S.L. Jung (Seoul/KR) P-76 Percutaneous CT-guided sympathicolisis with radiofrequency for the treatment of palmar hyperhidrosis J.M. Madrid (Pamplona/ES) C RSE Scientific Programme 77

14:30-15:15, Auditorium 1 FI 2101 Film Interpretation Quiz

Co-ordinators: I.J. McCaﬀerty (Birmingham/GB), A.F. Watkinson (Exeter/GB)

15:15-16:00, Auditorium 1 Hot Topic Symposium HTS 2102 Paradigm shift: acute ischaemic stroke

Moderators: T. Andersson (Stockholm/SE), K.A. Hausegger (Klagenfurt/AT)

2102.1 Treatment of acute ischaemic stroke: what is the future role of intravenous thrombolysis? H. Mattle (Bern/CH)

2102.2 Selection of patients for mechanical MON thrombectomy: what is the role for advanced imaging? T. Engelhorn (Erlangen/DE) 2102.3 Organisation of future stroke care: who should treat and who should be responsible for the patients? P.A. Brouwer (Stockholm/SE)

14:30-15:30, Auditorium 2 Expert Case Discussion e-voting ECD 2103 Thoracic cases

Moderators: M.D. Dake (Stanford, CA/US), S. Haulon (Lille/FR)

2103.1 Multilayer case D. Palombo (Genoa/IT) 2103.2 T-branch for TAAA E. Verhoeven (Nuremberg/DE) 2103.3 False lumen occlusion in chronic dissection M.A. Funovics (Vienna/AT) 2103.4 Visceral ischaemia in dissection T. Kölbel (Hamburg/DE) 78 CIRSE 2016 Pocket Guide

14:30-15:30 Satellite Symposia

For the detailed programmes, please refer to pages 216-217.

16:15-17:15, Room 112 Workshop WS 2201 Acute arterial thrombosis

2201.1 S. Müller-Hülsbeck (Flensburg/DE) 2201.2 to be announced

MON 16:15-17:15, Room 117 Workshop WS 2202 Transradial visceral embolisation: advantages over femoral approach

2202.1 M. Guimaraes (Charleston, SC/US) 2202.2 A. Fischman (New York, NY/US)

16:15-17:15, Room 113 Workshop WS 2203 Revascularisation in acute ischaemic stroke

2203.1 R. Barranco Pons (Barcelona/ES) 2203.2 H. van Overhagen (The Hague/NL)

16:15-17:15, Room 116 Workshop WS 2204 Urogenital interventions including renal transplant

2204.1 P.J. Haslam (Newcastle-upon-Tyne/GB) 2204.2 J.H. Peregrin (Prague/CZ)

C RSE Scientific Programme 79

16:15-17:15, Auditorium 2 Lecture Session LS 2205 Thoraco-abdominal aortic disease

Moderators: A. Holden (Auckland/NZ), F.E. Vermassen (Ghent/BE)

2205.1 Role of surgery in 2016 J. Schmidli (Bern/CH) 2205.2 Technical challenges in endovascular TAAA procedures S. Haulon (Lille/FR) 2205.3 Sandwich grafts: how far can we go? T. Pfammatter (Zurich/CH) 2205.4 Incidence and prevention of spinal cord ischaemia in TAAA branched grafting E.S. Debus (Hamburg/DE)

Debate: MON 2205.5 Hybrid repair is the best option R.G.J. Gibbs (London/GB) 2205.6 Total endovascular repair is the best option R.A. Morgan (London/GB)

16:15-17:15, Room 133 Free Paper Session FP 2206 Abdominal aorta

Moderators: M. Cariati (Milan/IT), V. Vidjak (Zagreb/HR)

2206.1 A single-centre experience of the Nellix endovascular aneurysm sealing (EVAS) in patients with challenging aortic anatomy P. Szopinski, E. Pleban, T. Dobrowolski, J. Iwanowski; Warsaw/PL 2206.2 Clinical outcome after endovascular aneurysm sealing of abdominal aortic aneurysms (EVAS): a retrospective cohort study M. Karouki1, C. Swaelens1, L. Iazzolino1, R.G. McWilliams1, R. Fisher1, A. England2, F. Torella1; 1Liverpool/GB, 2Manchester/GB 80 CIRSE 2016 Pocket Guide

2206.3 Monocentric evaluation of home-made featured paper versus standard renal fenestrations in endovascular aortic repair for juxtarenal aortic aneurysms C. Caradu, J. Morin, D. Midy, E. Ducasse; Bordeaux/FR 2206.4 Percutaneous EVAR: what mortality and morbidity should we quote our patients as the standard for minimally invasive aneurysm repair? A. Mathew, F. Sakhinia, S.M. Thomas, D. Kusumawidjaja, J.M. Regi, D. Turner, T.J. Cleveland, S.D. Goode; Sheﬃeld/GB 2206.5 Three-dimensional image fusion guidance for type II endoleaks treatment after EVAR:

MON with Onyx F. Ridouani, V. Tacher, K. You, P. Desgranges, J.F. Deux, H. Kobeiter; Créteil/FR 2206.6 Human Thiel-embalmed cadaveric aortic model with perfusion for aortic stent graft training and device development J.G. Houston, H.M. McLeod, J. Robertson, J. Anwar, R. Bhat, A. Melzer, T. Wilkinson; Dundee/GB

16:15-17:15, Room 134 Free Paper Session FP 2207 Gynaecological intervention

Moderators: A. Laborda (Zaragoza/ES), J.-P. Pelage (Caen/FR)

2207.1 Tunable delivery of niflumic acid from resorbable embolization microspheres for uterine fibroid embolization L. Bédouet1, L. Moine2, E. Servais1, A. Beilvert1, D. Labarre2, A. Laurent3; 1Jouy en Josas/FR, 2Châtenay-Malabry/FR, 3Paris/FR 2207.2 Uterine artery embolisation for adenomyosis: portending factors affecting the clinical outcome A. Cannavale1, D. Miligkos2, B. Karunyam2, B. Maher2, T.J. Bryant2, N. Hacking2; 1Canterbury/GB, 2Southampton/GB C RSE Scientific Programme 81

2207.3 Analysis of patient-controlled analgesia to define the time course of pain following uterine artery embolization S. Islam, S. Ameli-Renani, L. Ratnam, L. Mailli, A.-M. Belli, R. Das; London/GB 2207.4 Why gynecologists do not perceive any con- featured paper flict with IR over uterine fibroid treatments E.J. Keller, M. Crowley-Matoka, J.D. Collins, H.B. Chrisman, M.P. Milad, R.L. Vogelzang; Chicago, IL/US 2207.5 The impact of uterine artery embolization on nonenhancing fibroids G. Bao, L. Hu, H.W. Charles, A.R. Deipolyi; New York, NY/US 2207.6 Efficacy and safety of intrafetal radiofrequency ablation for twin-reversed arterial perfusion sequence: a single-center experience

P.P. Goﬀette, C. Hubinont, J.M. Biard, P. Bernard; MON Brussels/BE

16:15-17:15, Room 115 GA 2209 General Assembly

16:15-16:35 Satellite Symposium

For the detailed programme, please refer to page 217.

17:30-18:30, Room 116 Workshop WS 2301 Tips and tricks for femoro-popliteal CTO

2301.1 H. Kobeiter (Créteil/FR) 2301.2 P. Krishnan (New York, NY/US)

17:30-18:30, Room 115 Workshop WS 2302 Bronchial artery embolisation

2302.1 D.W. De Boo (Amsterdam/NL) 2302.2 M. Tsitskari (Athens/GR) 82 CIRSE 2016 Pocket Guide

17:30-18:30, Room 113 Workshop WS 2303 Carotid and intracranial stenting in stroke prevention

2303.1 S. Cekirge (Ankara/TR) 2303.2 I. Saatci (Ankara/TR)

17:30-18:30, Room 117 Free Paper Session FP 2304 Thoracic aorta

Moderators: E. Esteban Hernández (Valencia/ES), C. Ferro (Genoa/IT) MON 2304.1 An alternative approach for the intractable complication: trans-catheter closure of anastomotic leakage after ascending aortic surgery W. Wu, J. Pu, L. Huang; Beijing/CN 2304.2 Virtual stenting in EXTENTO: a tool for therapy planning for coarctation of the aorta (CoA) H. Mirzaee1, M. Neugebauer1, C. Schumann1, S. Nordmeyer2, M. Kelm2, L. Goubergrits2, T. Kuehne2, A. Hennemuth1; 1Bremen/DE, 2Berlin/DE 2304.3 Endovascular management of chronic featured paper symptomatic aortic dissection (CSAD) with the streamliner multilayer ﬂow modulator (SMFM): 12-month outcomes from the global registry S. Sultan1, E.P. Kavanagh1, F. Stefanov1, M. Sultan1, A. Elhelali1, V. Lundon1, V. Costache2, E.B. Diethrich3, N. Hynes1; 1Galway/IE, 2Sibiu/RO, 3Phoenix, AZ/US 2304.4 Endoleak complications of thoracic endovascular aortic repair (TEVAR): long-term outcomes and survival F. Barbosa, E. De Febis, M. Pegorer, P.M. Brambillasca, M. Solcia, R. Vercelli, C. Migliorisi, F. Romani, C. Russo, A.G. Rampoldi; Milan/IT

C RSE Scientific Programme 83

2304.5 Evaluation of multilayer ﬂow modulator in management of complex thoracoabdominal aortic pathology: a systematic review and meta-analysis N. Hynes1, A. Elhelali1, E.B. Diethrich2, E.P. Kavanagh1, P. Delassus1, L. Morris1, S. Sultan1; 1Galway/IE, 2Phoenix, AZ/US 2304.6 Endovascular treatment of thoracoabdominal aneurysm using the octopus technique M.-Y. Hsu, I.-H. Su, C.-M. Chen, S.-Y. Chu, S.-Y. Lin, Y.-H. Lee, P.-J. Ko, J.-H. Tseng, C.-F. Hung; Taoyuan/TW

17:30-18:30, Room 114 Free Paper Session FP 2305 Embolisation 1 MON Moderators: A.M. Al-Kutoubi (Beirut/LB), S.J. Park (Incheon/KR)

2305.1 Elution of vandetanib from radiopaque drug- eluting beads in vitro and pharmacokinetics of vandetanib in swine following administration in radiopaque drug-eluting beads P. Czuczman1, D. Grey1, Z. Bascal1, A. Denys2, A. Lewis1, J. John1, H. Kilpatrick1, R. Whomsley1, R. Holden1; 1Camberley/GB, 2Lausanne/CH 2305.2 Importance of collateral perfusion to the spleen following proximal/mid-splenic arterial embolization in adult patients with blunt trauma M. Groenwald, J. Pollak, T. Friedman, I. Latich, K.B. Quencer; New Haven, CT/US 2305.3 Transarterial embolization as a therapeutic option for focal nodular hyperplasia (FNH) J.-H. Sun, G.-H. Zhou, Y.-L. Zhang, C.-H. Nie; Hangzhou/CN 84 CIRSE 2016 Pocket Guide

2305.4 Usefulness of conebeam computed featured paper tomography and automatic vessel detection software in emergency transarterial embolization A.M. Ierardi1, P. Torcia2, U.G. Rossi2, E. Duka1, M. Cariati2, G. Carraﬁello1; 1Varese/IT, 2Milan/IT 2305.5 Safety and eﬃcacy of a new embolic device: initial single-center experience using the microvascular plug in routine clinical practice R. Corti, L.P. Moramarco, G. Leati, M. Maestri, P. Quaretti; Pavia/IT 2305.6 A single-centre experience in spontaneous portosystemic shunt embolisation: what do we know after a decade of work? C. Parra-Fariñas, M. Perez Lafuente, I. Diez-

MON Miranda, C. Gonzalez-Junyent, D. Hernandez Morales, Q. Ordi i Camprubi, S. Dyer Hartnett, A. Segarra Medrano; Barcelona/ES

17:30-18:30, Room 133 Free Paper Session FP 2306 Oncology: beyond the liver

Moderators: N. Goldberg (Jerusalem/IL), R.F. Grasso (Rome/IT)

2306.1 SIRFLOX study: a novel approach to deﬁne the depth of response (DpR) within a volumetric model in patients with metastatic colorectal cancer (mCRC) V. Heinemann1, J. Ricke2, N.K. Sharma3, M.P. Findlay4, M. Peeters5, V. Gebski6, M. Van Buskirk7, P. Gibbs8, G.A. van Hazel9; 1Munich/DE, 2Magdeburg/DE, 3Reading, PA/US, 4Auckland/NZ, 5Antwerp/BE, 6Camperdown, NSW/AU, 7Chester, NJ/US, 8Melbourne, VIC/AU, 9Perth, WA/AU 2306.2 Development and evaluation of a novel biodegradable embolic agent for transcatheter embolization in a rabbit kidney model: work in progress H. Wittgenstein, M. Stechele, J. Breinl, N. Stolzenburg, D. Geisel, J. Schnorr, B. Hamm, R.W. Günther, F. Streitparth; Berlin/DE C RSE Scientific Programme 85

2306.3 Endovascular denervation of the celiac featured paper or hypogastric arteries for management of refractory abdominal cancer pain B. Damascelli1, V. Tichà1, G. Patelli2, D. Miotti3, A. Prino4, S. Pasqua4, A. D’Alessio5; 1Milan/IT, 2Alzano Lombardo/IT, 3Pavia/IT, 4Novara/IT, 5Osio Sotto/IT 2306.4 Multi-center study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE): preliminary safety outcomes P.W. Eiken1, T. de Baère2, F. Deschamps2, J. Palussière3, X. Buy3, M.R. Callstrom1, D.A. Woodrum1, F. Abtin4, R.D. Suh4, B. Pua5, D.C. Madoﬀ5, D. Papadouris6, S. Bagla6, D.E. Dupuy 7, T. Healey 7, W. Moore8, S.B. Solomon5, H. Yarmohammadi5, H. Krebs9;

1Rochester, MN/US, 2Villejuif/FR, 3Bordeaux/FR, MON 4Los Angeles, CA/US, 5New York, NY/US, 6Alexandria, VA/US, 7Providence, RI/US, 8Stony Brook, NY/US, 9Newnan, GA/US 2306.5 Ten-year experience of thermal ablation of colorectal lung metastases: a retrospective series of 209 patients J.T. Perez, M. Fonck, X. Buy, D. Bechade, V. Catena, J. Palussière; Bordeaux/FR 2306.6 Multimodality treatment of 132 consecutive patients with locally advanced pancreatic cancer J.A. Vogel1, T. de Rooij1, K.P. van Lienden1, J.W. Wilmink1, H.W. van Laarhoven1, J.E. van Hooft1, O.M. van Delden1, M.G. Dijkgraaf1, R.C.G. Martin2, O.R.C. Busch1, M.G.H. Besselink1; 1Amsterdam/NL, 2Louisville, KY/US

17:30-18:30, Room 134 Free Paper Session FP 2307 Radiation protection

Moderators: C.M. Loewe (Vienna/AT), M.J.L. van Strijen (Nieuwegein/NL)

2307.1 Maximising dose reduction in patients undergoing endovascular aneurysm repair (EVAR) using current hybrid theatre technology A. Mayes, K.O. Bashaeb, G. Antoniou; Oldham/GB 86 CIRSE 2016 Pocket Guide

2307.2 New protocol to reduce fetal radiation dose during prophylactic balloon insertion in pregnant patients with abnormal placental adherence A. Barah, A. Abualruz, M.B. Gomaa, A. Almuzrakchi, V. Chavan, O. Almokdad, A. Omar; Doha/QA 2307.3 Real-time patient and staﬀ dose monitoring featured paper in IR practice A.M.H. Sailer, L. Paulis, L. Vergoossen, R. de Graaf, G.W. Schurink, C. van der Leij, M.W. de Haan, W.H. van Zwam, M. Das, J.E. Wildberger, C.R. Jeukens; Maastricht/NL 2307.4 CT-guided needle biopsy of lung lesions: is there the possibility of reducing the dose?

MON G. Coppola, R. Iezzi, A. Posa, E.G.M. Antonuccio, M.T. Congedo, L. Bonomo; Rome/IT 2307.5 Percutaneous transhepatic biliary drainage: evaluation of a sterile, lead-free, radiation- protection shield for reducing occupational exposure to scatter radiation A. Fohlen, Y. Tancray, M.-A. Jegonday, V. Le Pennec, J.-P. Pelage; Caen/FR 2307.6 Radiation doses to operators performing transjugular intrahepatic portosystemic shunt using a ﬂat-panel detector based system and real-time ultrasound guidance for portal vein targeting R. Miraglia, R. Gerasia, L. Maruzzelli, M. D’Amico, A. Luca; Palermo/IT

17:30-18:30, Auditorium 2 Workshop WS 2308 Thoracic aorta

2308.1 F. Wolf (Vienna/AT) 2308.2 V. Riambau (Barcelona/ES)

C RSE Scientific Programme 87

Tuesday, September 13

08:30-09:30, Room 115 Fundamental Course FC 2501 Basic acute ischaemic stroke intervention

Moderators: T. Andersson (Stockholm/SE), S. Cekirge (Ankara/TR)

2501.1 Overview of treatment options: neurologist’s view E.M. Arsava (Ankara/TR) 2501.2 Patient selection: optimal timing and imaging J. Weber (St. Gallen/CH) 2501.3 Current techniques in IA stroke intervention I.Q. Grunwald (Southend-on-Sea/GB) 2501.4 Trials update W.H. van Zwam (Maastricht/NL)

08:30-09:30, Room 117 Special Session TUE SS 2502 Treatment options for pancreatic cancer

Moderators: I. Bargellini (Pisa/IT), J. Tacke (Passau/DE)

2502.1 Expanding surgery of locally advanced pancreatic cancer P. Bachellier (Strasbourg/FR) 2502.2 Transarterial therapy T. Tanaka (Kashihara/JP) 2502.3 RFA and IRE K.P. van Lienden (Amsterdam/NL) 2502.4 HIFU F. Orsi (Milan/IT) 88 CIRSE 2016 Pocket Guide

08:30-09:30, Room 112 Special Session SS 2503 The patient’s perspective in PAD

Moderators: M.H.K. Hoﬀmann (Basel/CH), D. Vorwerk (Ingolstadt/DE)

2503.1 Patient-reported outcome measurements (PROMS) M.J.W. Koelemay (Amsterdam/NL) 2503.2 Shared decision making D.T. Ubbink (Amsterdam/NL) 2503.3 Supervised exercise training ﬁrst: pro/con J.A. Reekers (Amsterdam/NL) 2503.4 Primary PTA ﬁrst: pro/con A. Buecker (Homburg/DE)

08:30-09:30, Room 116 Special Session

TUE SS 2504 Bone ablation: current evidence and future frontiers

Moderators: T. de Baère (Villejuif/FR), S. Marcia (Cagliari/IT)

2504.1 Benign tumours D.K. Filippiadis (Athens/GR) 2504.2 Ablation of MSK oligometastatic disease M.R. Callstrom (Rochester, MN/US) 2504.3 Palliative therapies in malignant tumours G. Koch (Strasbourg/FR) 2504.4 HIFU: therapeutic and palliative applications A. Napoli (Rome/IT)

C RSE Scientific Programme 89

08:30-09:30, Auditorium 2 Lecture Session LS 2505 Abdominal aorta 2

Moderators: J.F. Benenati (Miami, FL/US), V. Riambau (Barcelona/ES)

2505.1 Tips and tricks for obtaining supraceliac aortic control for rAAA F.J. Veith (New York, NY/US) 2505.2 Update on fenestrated stent grafts G.M. Richter (Stuttgart/DE) 2505.3 Potential of inner branched grafts E. Verhoeven (Nuremberg/DE) 2505.4 The ongoing Achilles’ heel of EVAR: how to counter it G. Maleux (Leuven/BE) Debate: 2505.5 Conventional stent grafts are superior to new concepts: pro E.S. Debus (Hamburg/DE) 2505.6 Conventional stent grafts are superior to new TUE concepts: con R.A. Morgan (London/GB) 90 CIRSE 2016 Pocket Guide

08:30-13:00, Simulator Gallery Hands-on Workshop PTP-HoW 4 Principles to practice: education and simulation skills training - Handling complications in iliac and femoral interventions

Co-ordinators: M. Midulla (Valenciennes/FR), J.C. van den Berg (Lugano/CH)

Session Organiser: J.A. Vos (Nieuwegein/NL) Instructors: G.S. Goh (Melbourne, VIC/AU), F.G. Irani (Singapore/SG), R. Lely (Amsterdam/NL), G.J. Munneke (London/GB)

PTP 4.1 (group 1): 08:30-09:30 discussion 09:40-10:40 simulation

PTP 4.2 (group 2):

TUE 09:40-10:40 discussion 10:50-11:50 simulation

PTP 4.3 (group 3): 10:50-11:50 discussion 12:00-13:00 simulation

09:30-11:00, Room 130 Hands-on Workshop EMT-HoW 6 Embolisation: materials and tools – Particulate agents

Co-ordinators: A. Martínez de la Cuesta (Pamplona/ES), J.V. Patel (Leeds/GB)

Instructors: M. Koehler (Münster/DE), R. Lopez-Benitez (Luzern/CH), B.A. Radeleﬀ (Heidelberg/DE), G.J. Robinson (Hull/GB)

C RSE Scientific Programme 91

09:30 -11:00, Room 111 Hands-on Workshop TA-HoW 5 Tumour ablation: tips and tricks

Co-ordinators: L. Crocetti (Pisa/IT), L. Hechelhammer (St. Gallen/CH)

Instructors: J. Garnon (Strasbourg/FR), B. Gonçalves (Porto/PT), M. Meijerink (Amsterdam/NL), W. Prevoo (Amsterdam/NL), P. Wiggermann (Regensburg/DE)

10:00-11:00, Room 117 Special Session SS 2601 How to improve acute stroke management: present and future

Moderators: M. Das (Maastricht/NL), R. Gandini (Rome/IT)

2601.1 How to improve patient selection for TUE mechanical thrombectomy or IV thrombolysis C.P. Stracke (Essen/DE) 2601.2 Role of access/support devices to improve IA acute stroke treatment K.A. Hausegger (Klagenfurt/AT) 2601.3 Direct recanalisation with or without stent retrievers I.Q. Grunwald (Southend-on-Sea/GB) 2601.4 Clots: how to best manage a complex problem T. Andersson (Stockholm/SE)

10:00-11:00, Auditorium 1 Expert Round Table e-voting ERT 2602 Therapy of liver metastasis from colon cancer

Moderator: A. Denys (Lausanne/CH)

Panellists: N. Demartines (Lausanne/CH) B. Guiu (Montpellier/FR) F. Orsi (Milan/IT) E. Raymond (Paris/FR) R. Salem (Chicago, IL/US) 92 CIRSE 2016 Pocket Guide

10:00-11:00, Room 112 Fundamental Course FC 2603 Drug-eluting technologies

Moderators: E. Blessing (Karlsbad/DE), K.N. Katsanos (London/GB)

2603.1 The science behind drug-eluting balloon technology R. Virmani (Gaithersburg, MD/US) 2603.2 Clinical studies on drug-eluting balloons A. Cannavale (Canterbury/GB) 2603.3 Drug-eluting stents - new developments and established data S. Müller-Hülsbeck (Flensburg/DE) 2603.4 Drug-eluting balloons for AV ﬁstulas A. Massmann (Homburg/DE)

10:00-11:00, Room 115

TUE Special Session SS 2604 Vertebroplasty: new evidence

Moderators: G.C. Anselmetti (Turin/IT), A.G. Ryan (Waterford City/IE)

2604.1 Impact of sham-controlled trials on referral patterns K.F. Layton (Dallas, TX/US) 2604.2 Update on VERTOS IV P.N.M. Lohle (Tilburg/NL) 2604.3 Update on the VAPOR study W.A. Clark (Ramsgate, NSW/AU) 2604.4 Review of comparative studies: vertebroplasty vs. augmentation techniques F. Ruiz Santiago (Granada/ES)

C RSE Scientific Programme 93

10:00-11:00, Auditorium 2 Expert Case Discussion e-voting ECD 2605 Abdominal cases

Moderators: F. Fanelli (Rome/IT), F.J. Veith (New York, NY/US)

2605.1 Standard EVAR in short, angulated neck F. Verzini (Perugia/IT) 2605.2 Complex endoleak management C.A. Binkert (Winterthur/CH) 2605.3 Chimney technique K.P. Donas (Münster/DE) 2605.4 Fenestrated A. Chavan (Oldenburg/DE)

11:30-12:30, Room 112 CIRSE meets CM 2701 CIRSE meets EAU

Moderators: E. Brountzos (Athens/GR), TUE A. Stenzl (Tübingen/DE)

2701.1 Explanation of LUTS to interventional radiologists S.A. Gravas (Larissa/GR) 2701.2 Surgical and medical therapy for benign prostate hyperplasia S.A. Gravas (Larissa/GR) 2701.3 For which patient PAE is most feasible (the radiologist’s view) N. Hacking (Southampton/GB) 2701.4 For which patient PAE is most feasible (the urologist’s view) A. Stenzl (Tübingen/DE)

11:30-12:30, Auditorium 1 Expert Case Discussion e-voting ECD 2702 Diﬃcult and unusual tumour ablations

Moderator: A. Gangi (Strasbourg/FR)

2702.1 J. Garnon (Strasbourg/FR) 2702.2 R. Bale (Innsbruck/AT) 94 CIRSE 2016 Pocket Guide

11:30-12:30, Room 117 Special Session SS 2703 Portal hypertension

Moderators: G.M. Richter (Stuttgart/DE), P. Vilares Morgado (Porto/PT)

2703.1 TIPS in children O. Renc (Hradec Králové/CZ) 2703.2 Therapy options for gastric varices J.A. Kaufman (Portland, OR/US) 2703.3 TIPS in portal and hepatic vein thrombosis S. Punamiya (Singapore/SG) 2703.4 Management of procedural complications and encephalopathy G. Maleux (Leuven/BE)

11:30-12:30, Room 115 Special Session

TUE SS 2704 Interventional radiology: taking care of your own patient

Moderators: A.-M. Belli (London/GB), M.J. Lee (Dublin/IE)

2704.1 How to set up your own clinical department B. Gonçalves (Porto/PT) 2704.2 Infrastructural requirement for day-case procedures M.R. Sapoval (Paris/FR) 2704.3 Patient before and aftercare R. Patel (Oxford/GB) 2704.4 Economic case for in- and outpatient procedures J.P. Schaefer (Kiel/DE)

C RSE Scientific Programme 95

11:30-12:30, Auditorium 2 Aortic Complications e-voting AC 2705 A bad day in the angio-suite: case-based discussion

Moderators: J. Lammer (Vienna/AT) E. Verhoeven (Nuremberg/DE)

2705.1 M.P. Jenkins (London/GB) 2705.2 M.W. de Haan (Maastricht/NL) 2705.3 A. Holden (Auckland/NZ)

11:30-12:30, Room 133 ETF Session ETF 2706 IR trainee session: building an IR career

Moderator: G. Makris (Oxford/GB)

2706.1 Welcome and introduction to ETF G. Makris (Oxford/GB) 2706.2 Developing an academic career TUE A. Adam (London/GB) 2706.3 Publishing and CVIR D. Vorwerk (Ingolstadt/DE) 2706.4 EBIR O.M. van Delden (Amsterdam/NL) 2706.5 Establishing private clinics and clinical entrepreneurship C.A. Binkert (Winterthur/CH)

12:30-14:00, Room 111 Hands-on Workshop TA-HoW 6 Tumour ablation: tips and tricks

Co-ordinators: L. Crocetti (Pisa/IT), L. Hechelhammer (St. Gallen/CH)

Instructors: J. Garnon (Strasbourg/FR), B. Gonçalves (Porto/PT), M. Meijerink (Amsterdam/NL), P. Wiggermann (Regensburg/DE) 96 CIRSE 2016 Pocket Guide

12:30-14:00, Room 132 Hands-on Workshop VV-HoW 2 Varicose veins

Co-ordinators: J.A. Brookes (London/GB) L. Oguzkurt (Istanbul/TR)

Instructors: D. Greenstein (Harrow/GB), B. Gumus (Istanbul/TR), A. Komarek (Ried im Innkreis/AT), C. Lebard (Paris/FR), M. Tal (Tel Aviv/IL)

13:00-14:00 Satellite Symposia

For the detailed programmes, please refer to pages 218-219.

13:30-14:15, Poster Area

TUE Posters on Stage PS 2804 Interventional oncology

Moderators: M. Burrel (Barcelona/ES), T.K. Helmberger (Munich/DE)

P-337 Embolotherapy for neuroendocrine tumor liver metastases: prognostic factors for hepatic progression-free survival and overall survival J.X. Chen (Philadelphia, PA/US) P-366 Surgical resection versus radiofrequency ablation plus drug-eluting bead transcatheter arterial chemoembolisation in the treatment of single large hepatocellular carcinoma A. Posa (Rome/IT) P-344 Impact of diﬀerent embolic agents for TACE procedures on VEGF levels post-treatment P. Wiggermann (Regensburg/DE) P-361 Comparison of microwave vs. radiofrequency ablation of HCC when combined with DEB-TACE: progression-free and overall survival analysis E. Kim (New York, NY/US) P-324 Irreversible electroporation of the liver: is there a threshold for the volume of tissue to be ablated? F. Burdío (Barcelona/ES) C RSE Scientific Programme 97

14:30-16:00, Auditorium 1 Honorary Lecture / Hot Topic Symposium

14:30-15:00, Auditorium 1 Honorary Lecture HL 2901 Josef Roesch Lecture

Moderator: E. Brountzos (Athens/GR) Laudation: A. Gangi (Strasbourg/FR)

2901.1 The IR evolution in oncology: tools, treatments, guidelines T. de Baère (Villejuif/FR)

15:00-16:00, Auditorium 1 Hot Topic Symposium HTS 2902 Paradigm shift: liver colorectal metastases

Moderators: E. Brountzos (Athens/GR), T.K. Helmberger (Munich/DE) TUE

2902.1 The paradigm is shifting – the new ESMO guidelines for CRC and more E. Van Cutsem (Leuven/BE) 2902.2 The IO toolbox (eﬃcacy of IO tools) P.L. Pereira (Heilbronn/DE) 2902.3 Interdisciplinarity in MDT boards – proposal(s) for smart treatment pathways A. Adam (London/GB) 2902.4 Round-table discussion 98 CIRSE 2016 Pocket Guide

14:30-15:30, Auditorium 2 Lecture Session LS 2903 Tips and tricks

Moderators: R.G.J. Gibbs (London/GB), T. Kölbel (Hamburg/DE)

2903.1 Access route for thoracic stent-grafting V. Riambau (Barcelona/ES) 2903.2 Endograft sizing for type B dissection J.C. van den Berg (Lugano/CH) 2903.3 Identiﬁcation and navigation in the true lumen in aortic dissection R.G. McWilliams (Liverpool/GB) 2903.4 Post-stent graft infection and ﬁstulas J.-P. Beregi (Nîmes/FR) 2903.5 Value of procedure rehearsal of EVAR procedures L. Desender (Ghent/BE) 2903.6 How to simplify FEVAR

TUE M.S. Hamady (London/GB)

14:30-15:30 Satellite Symposium

For the detailed programme, please refer to page 219.

C RSE Scientific Programme 99

16:15-17:15, Room 116 Workshop WS 3001 Carotid stenting for stroke prevention: case-based discussion

3001.1 K. Mathias (Hamburg/DE) 3001.2 T.J. Cleveland (Sheﬃeld/GB)

16:15-17:15, Room 134 Workshop WS 3002 Kidney ablation

3002.1 R.F. Grasso (Rome/IT) 3002.2 A.H. Mahnken (Marburg/DE)

16:15-17:15, Room 114 Workshop WS 3003 Central venous access

3003.1 R. Kasthuri (Glasgow/GB) TUE 3003.2 B. Gebauer (Berlin/DE)

16:15-17:15, Room 113 Workshop WS 3004 Tips and tricks in UFE

3004.1 J.-P. Pelage (Caen/FR) 3004.2 N. Hacking (Southampton/GB) 100 CIRSE 2016 Pocket Guide

16:15-17:15, Room 115 Free Paper Session FP 3005 Super Endo Tuesday

Moderators: C.A. Binkert (Winterthur/CH), F. Fanelli (Rome/IT)

3005.1 Twenty-four-month results from the MAJESTIC trial of the Eluvia drug-eluting vascular stent system S. Müller-Hülsbeck1, K.F. Keirse2, T. Zeller3, H. Schroe4, J. Diaz-Cartelle5; 1Flensburg/DE, 2Tienen/BE, 3Bad Krozingen/DE, 4Genk/BE, 5Marlborough, MA/US 3005.2 Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femo ropo- pliteal artery disease in Japan: 3-year results K. Kichikawa1, H. Yokoi2, T. Ohki3, M. Nakamura3, K. Komori4, S. Nanto5, A.E. Lottes6, M.D. Dake7; 1Nara/JP, 2Fukuoka/JP, 3Tokyo/JP, 4Nagoya/JP, 5 6 TUE Osaka/JP, West Lafayette, IN/US, 7Stanford, CA/US 3005.3 Is DCB effective in diabetic patients P. Krishnan1, D. Scheinert2, J.R. Laird3, M. Brodmann4, G. Tepe5, T. Zeller6, C. Metzger7, P. Schneider8, A. Micari9, D.J. Cohen10, M.R. Jaff11; 1New York, NY/US, 2Leipzig/DE, 3Sacramento, CA/US, 4Graz/AT, 5Rosenheim/DE, 6Bad Krozingen/DE, 7Kingsport, TN/US, 8Honolulu, HI/US, 9Cotignola/IT, 10Kansas City, MO/US, 11Boston, MA/US presented by E. Blessing (Heidelberg/DE) 3005.4 10-years’ outcomes from the randomized EMMY trial A.M. de Bruijn, W.J.K. Hehenkamp, W.M. Ankum, J.A. Reekers; Amsterdam/NL 3005.5 Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the United Kingdom K.N. Katsanos1, B.P. Geisler2, A.M. Garner2, H. Zayed1, T.J. Cleveland3, J.B. Pietzsch2; 1London/GB, 2Menlo Park, CA/US, 3Sheffield/GB 3005.6 Novel aspiration thrombectomy for intervention of peripheral and visceral arterial occlusions: the PRISM trial results J.F. Benenati1, G.L. Adams2, R.R. Saxon3, L.E. Sewall4, C. Teigen5; 1Miami, FL/US, 2Raleigh, NC/US, 3Ocean- side, CA/US, 4La Grange, IL/US, 5Fargo, ND/US Scientific Programme 101

16:15-17:15, Auditorium 2 Workshop WS 3006 Abdominal aneurysm

3006.1 J.D. Kakisis (Athens/GR) 3006.2 M.A. Funovics (Vienna/AT)

17:30-18:30, Room 115 Workshop WS 3101 Acute mesenteric ischaemia

3101.1 J. Raupach (Hradec Králové/CZ) 3101.2 S.J. McPherson (Leeds/GB)

17:30-18:30, Room 113 Workshop WS 3102 Optimising liver remnant

3102.1 R. Salem (Chicago, IL/US) 3102.2 A. Denys (Lausanne/CH) TUE

17:30-18:30, Room 116 Workshop WS 3103 Diﬃcult central venous access

3103.1 D. Savio (Turin/IT) 3103.2 I. Robertson (Glasgow/GB) 102 CIRSE 2016 Pocket Guide

17:30-18:30, Room 134 Free Paper Session FP 3104 Neuro interventions and carotid stenting

Moderators: K.A. Hausegger (Klagenfurt/AT), J. Weber (St. Gallen/CH)

3104.1 Comparison between Solumbra and ADAPT: clinical outcomes of acute ischemic stroke therapy Y. Kayan, J.E. Delgado Almandoz, M.L. Young, J.L. Lease, J.M. Scholz, A.M. Milner, T.H. Hehr, P. Roohani, M. Mulder, R.M. Tarrel; Minneapolis, MN/US 3104.2 Equal technical success rates with TREVO® and Capture LP™: device selection may have a role in the prediction of clinical outcome S.M. Protto, J.-P. Pienimäki, J. Seppänen, I. Matkaselkä, J. Ollikainen, H. Numminen, N. Sillanpää; Tampere/FI

TUE 3104.3 RACER: a European registry in the featured treatment of AIS with the ACE64 paper reperfusion catheter used as first intention in real life A. Kowoll1, W. Weber1, C. Loehr2, A. Moreno3, J. Weber4, J. Masso Romero5, S. Peschillo6, A. Berlis7, G. Gál8, T. Lo9; 1Bochum/DE, 2Recklinghausen/DE, 3Murcia/ES, 4St. Gallen/CH, 5San Sebastian/ES, 6Rome/IT, 7Augsburg/DE, 8Odense/DK, 9Utrecht/NL 3104.4 Transverse sinus stenting for idiopathic intracranial hypertension A.K. Gupta, H.S. Penderkar, A.H. Gouda, C. Prasad, J. Saini, G. Medhi; Bangalore/IN 3104.5 Incidence and prognosis of plaque protrusion during carotid artery stenting K. Takayama1, K. Myouchin1, T. Wada2, K. Kichi kawa2, S. Kurokawa1; 1Yao City/JP, 2Nara/JP 3104.6 Carotid artery stenting using new generation micromesh dual-layer stent: the Italian experience from 3 high-volume centres R. Nerla1, F. Castriota1, A. Micari1, P. Sbarzaglia1, C. Setacci2, M.A. Ruﬃno3, A. Cremonesi1; 1Cotignola/IT, 2Siena/IT, 3Turin/IT

C RSE Scientific Programme 103

17:30-18:30, Room 133 Free Paper Session FP 3105 Embolisation 2

Moderators: B.A. Radeleﬀ (Heidelberg/DE), C.R. Weiss (Baltimore, MD/US)

3105.1 Superior rectal artery embolisation "EMBORRHOID" as the first line treatment in patients suffering from haemorrhoidal disease: final results V. Vidal, F. Tradi, D. Mege, J.-M. Bartoli, I. Sielezneff; Marseille/FR 3105.2 Safety and efficacy in embolotherapy of cecum hemorrhage in comparison to non- cecum lower gastrointestinal bleeding: is bowel ischemia a coming nightmare? S. Li, S. Sun, S. Wang, Y. Guo, L. Lenhart; Iowa City, IA/US 3105.3 Bariatric embolization of arteries for featured the treatment of obesity (BEAT obesity): paper 6-month safety and efficacy data TUE C.R. Weiss1, O. Akinwande1, K. Paudel1, L. Cheskin1, B. Holly1, K. Hong1, A. Fischman2, R. Patel2, E.J. Shin1, K. Steele1, T.H. Moran1, D.L. Kraitchman1, A. Arepally3; 1Baltimore, MD/US, 2New York, NY/US, 3Atlanta, GA/US 3105.4 Coil embolization of unligated side branches in the grafted left internal mammary artery causing myocardial ischemia O. Beton, M.B. Yilmaz; Sivas/TR 3105.5 Ethylene vinyl alcohol copolymer for treatment of high flow arteriovenous vascular malformations: long-term results and histology A.S. Gomes1, P.A. Monteleone1, A. Vasan2, J.W. Sayre1, S.V. Bukata3; 1Los Angeles, CA/US, 2Durham, NC/US, 3Santa Monica, CA/US 3105.6 Image-guided percutaneous treatment of chylous leaks: a single-center experience of 62 patients over 5 years M.P. Yannes, E.G. Santos Martín; Pittsburgh, PA/US 104 CIRSE 2016 Pocket Guide

17:30-18:30, Room 114 Free Paper Session FP 3106 Peripheral 2

Moderators: M.H.K. Hoﬀmann (Basel/CH), R.H. Portugaller (Graz/AT)

3106.1 Six-month results from the ﬁrst-in-human randomized study on the Ranger paclitaxel- coated balloon catheter D. Scheinert1, A. Willfort-Ehringer2, H. Sievert3, V. Geist4, M. Lichtenberg5, M.R. Sapoval6, A. Sauguet7; 1Leipzig/DE, 2Vienna/AT, 3Frankfurt/DE, 4Bad Segeberg/DE, 5Arnsberg/DE, 6Paris/FR, 7Toulouse/FR 3106.2 The Freeway Stent Study: the 6-month results favor the use of DEB in combination with stenting J. Tacke1, K.A. Hausegger2, H. Schröder3, S. Müller- Hülsbeck4, S. Stahnke5; 1Passau/DE, 2Klagenfurt/ 3 4 5 TUE AT, Berlin/DE, Flensburg/DE, Bonn/DE 3106.3 Relationship between albuminuria and featured renal artery stent outcomes: results of the paper cardiovascular outcomes with renal artery lesions (CORAL) randomized clinical trial T.P. Murphy1, C.J. Cooper2, K. Pencina3, R. D’Agostino3, J. Massaro3, D. Cutlip3, K. Jamerson4, A.H. Matsumoto5, W. Henrich6, J. Shapiro7, K. Tuttle8, D.J. Cohen9, M. Steﬀes10, Q. Gao3, C. Metzger11, W. Abernethy12, S.C. Textor13, J. Briguglio14, S. Tobe15, L. Dworkin1; 1Providence, RI/US, 2Toledo, OH/US, 3Boston, MA/US, 4Ann Arbor, MI/US, 5Charlottes- ville, VA/US, 6San Antonio, TX/US, 7Huntington, WV/US, 8Spokane, WA/US, 9Kansas City, MO/US, 10Minneapolis, MN/US, 11Kingsport, TN/US, 12Asheville, NC/US, 13Rochester, MN/US, 14Lancaster, PA/US, 15Toronto, ON/CA 3106.4 Characterization of atherectomy samples from long SFA CTOs in correlation with clinical outcomes J. George; Philadelphia, PA/US

C RSE Scientific Programme 105

3106.5 SUPERA stent versus standard nitinol stents for recanalization of chronic total occlusions of the femoropopliteal artery: the SUPERFAST study I. Paraskevopoulos, A. Diamantopoulos, S. Abisi, H. Zayed, P. Gkoutzios, V. Zymvragoudakis, K.N. Katsanos; London/GB 3106.6 Treating in-stent restenosis using ZERO ﬂuoroscopy: OCT-guided atherectomy case series A. Desai1, A.G. Schwindt2; 1Redwood City, CA/US, 2Münster/DE TUE 106 CIRSE 2016 Pocket Guide

Wednesday, September 14

08:30-09:30, Room 117 Special Session SS 3201 IR options for colon cancer at diﬀerent stages

Moderators: R. Lopez-Benitez (Luzern/CH), M.R. Meijerink (Amsterdam/NL)

3201.1 Colonic stenting T. Sabharwal (London/GB) 3201.2 Radioembolisation T.K. Helmberger (Munich/DE) 3201.3 TACE with DEBIRI P.E. Huppert (Darmstadt/DE) 3201.4 Multimodality treatment concept T. Ruers (Amsterdam/NL)

08:30-09:30, Room 112 Special Session SS 3202 IVC ﬁlters: reassessing the evidence

Moderators: O. Pellerin (Paris/FR), WED D.K. Tsetis (Iraklion/GR)

3202.1 Current status in the USA J.A. Kaufman (Portland, OR/US) 3202.2 Current status in Europe G.J. Robinson (Hull/GB) 3202.3 Post-procedural patient care S.D. Qanadli (Lausanne/CH) 3202.4 Factors aﬀecting ﬁlter retrieval O. Pellerin (Paris/FR)

C RSE Scientific Programme 107

10:00-11:00, Room 115 Special Session SS 3301 HCC: controversial issues (beyond guidelines)

Moderators: Y. Arai (Tokyo/JP), F. Orsi (Milan/IT)

3301.1 Is radiofrequency ablation still the standard of care? R. Lencioni (Miami, FL/US) 3301.2 What is the role of combined treatments? R. Iezzi (Rome/IT) 3301.3 Ready to include radioembolisation in guidelines? P.L. Pereira (Heilbronn/DE) 3301.4 How to manage patients after stage migration M. Burrel (Barcelona/ES)

10:00-11:00, Room 117 Special Session SS 3302 Pharmacomechanical thrombolysis for acute DVT WED Moderators: M.J. Garcia (Newark, DE/US), Z.J. Haskal (Charlottesville, VA/US)

3302.1 Patient selection and peri-interventional management S. Vedantham (St. Louis, MO/US) 3302.2 Thrombo-aspiration R. Uberoi (Oxford/GB) 3302.3 Thrombolysis M. Roček (Prague/CZ) 3302.4 Mechanical thrombectomy R.A. Lookstein (New York, NY/US) 108 CIRSE 2016 Pocket Guide

10:00-11:00, Room 112 Expert Case Discussion e-voting ECD 3303 Upper GI bleeding

Moderator: W.S. Rilling (Milwaukee, WI/US)

3303.1 F. Gundling (Munich/DE) 3303.2 T.K. Helmberger (Munich/DE)

11:30-12:30, Room 117 MM 3401 Morbidity & Mortality e-voting Conference

Co-ordinators: A. Hatzidakis (Iraklion/GR), R. Uberoi (Oxford/GB)

3401.1 Dislodgement of a coronary stent – the value of interdisciplinary cooperation S. Müller-Hülsbeck (Flensburg/DE) 3401.2 Free falling I. Bargellini (Pisa/IT) 3401.3 Sleeve on the run M.W. de Haan (Maastricht/NL) 3401.4 Haemoperitoneum after TIPS WED A. Krajina (Hradec Králové/CZ) 3401.5 Hero to zero A. Ryan (Waterford City/IE) 3401.6 Controlling uncontrollable bleeding T.-E.G. Vrachliotis (Athens/GR)

C RSE Posters 109

Posters

Aortic intervention

P-1 Fusion of CT angiography or MR angiography with unenhanced CBCT and fluoroscopy guidance in endovascular treatments of aorto-iliac steno- occlusion: preliminary experience A.M. Ierardi1, F. Fontana1, E. Duka1, F. Piacentino1, G. Piffaretti1, P. Torcia2, U.G. Rossi2, M. Cariati2, G. Carrafiello1; 1Varese/IT, 2Milan/IT

P-2 Usefulness of cone-beam computed tomography and automatic vessel detection software in the identification of type 2 lumbar endoleak A.M. Ierardi1, E. Duka1, C. Micieli1, G. Piffaretti1, P. Torcia2, U.G. Rossi2, N. Rivolta1, M. Cariati2, G. Carrafiello1; 1Varese/IT, 2Milan/IT

P-3 Transcaval embolization in the treatment of type II endoleaks R. Gandini, F. De Crescenzo, S. Merolla, D. Konda, F. Chegai, E. Pampana, S. Abrignani, M. Muto; Rome/IT

P-4 Safety and eﬃcacy of resuscitative endovascular balloon occlusion of the aorta using a 7-Fr sheath M. Narita, K. Idoguchi, R. Usui, S. Nakao, Y. Mizushima; WED Osaka/JP

P-5 Experimental X-ray microtomograph MARS as the future new tool for the evaluation of infrarenal aneurysms rupture risk A.V. Svetlikov1, A. Zhemchugov1, D. Kozhevnikov2, G. Shelkov2, V. Gurevitch1, G. Khubulava1; 1St. Petersburg/RU, 2Dubna/RU

P-6 Image fusion for endovascular repair of complex aortic aneurysm P.-A. Barral, M. Gaudry, M. De Masi-Jacquier, P. Piquet, J.-M. Bartoli, A. Jacquier; Marseille/FR

P-7 Aorto-iliac TASC C and D lesions: outcome of ﬁrst endovascular approach T. Donati, S. Patel, G. Santoro, L. Biasi, P. Saha, K.N. Katsanos, H. Zayed; London/GB 110 CIRSE 2016 Pocket Guide

P-8 Endovascular repair of focal thoracic aortic aneurysms following aortic coarctation patch repair A. Alfahad, J. Thomson, M. Troxler, S.J. McPherson; Leeds/GB

P-9 Malperfusion syndromes in aortic dissection: what are their possible treatments? U.G. Rossi1, P. Torcia1, P. Rigamonti1, F. Petrocelli2, G. Mauri3, A.M. Ierardi4, G. Carraﬁello4, M. Cariati1; 1Milan/IT, 2Genoa/IT, 3San Donato Milanese/IT, 4Varese/IT

P-10 Cardiatis stent graft in a symptomatic type IV thoracoabdominal aortic aneurysm U.G. Rossi, P. Rigamonti, P. Torcia, D. Santuari, A. Settembrini, R. Dallatana, M. Cariati; Milan/IT

P-11 All in one: EVAR, chimney, iliac side branch, and internal iliac embolization U.G. Rossi, P. Torcia, P. Rigamonti, D. Santuari, R. Dallatana, M. Cariati; Milan/IT

P-12 Endovascular treatment of three aortoenteric ﬁstula cases N. Hosaka, S. Sai, N. Seino, R. Abe, N. Mizobuchi, T. Gokan, Y. Nakajima, K. Maruta, A. Aoki; Tokyo/JP

P-13 Transrenal E-XL stenting to prevent type Ia endoleak in the case of nonoptimal proximal neck during endovascular abdominal aortic aneurysm repair POSTERS M.I. Generalov, D.N. Maystrenko, A.N. Oleschuk, A.S. Ivanov; Saint Petersburg/RU

P-14 A novel use of the Gore® Excluder® iliac branch endoprosthesis A.H. Shah, J. Hopkins, M.J. Duddy; Birmingham/GB

P-15 Endovascular repair for severe graft kinking after total aortic arch replacement (TAR) J.-I. Nishimura, S. Fuwa, M. Yamazaki, T. Nakagawa, F. Saito, S. Hase; Kawasaki/JP

P-16 Late-stage Dacron graft aneurysm 28 years after extraanatomical bypass treated by endovascular stent graft T. Oda, N. Sakamoto, T. Taniguchi, H. Tomimatsu, T. Kadoba, S. Noguchi, M. Nishioka, Y. Nakashima, T. Suga, M. Nobuhara, S. Noma; Tenri-shi/JP Posters 111

P-17 Treatment of infrarenal aortic stenosis: our case series B. Lukić, V.Z. Cvetic, M. Colic, D. Masulovic; Belgrade/RS

P-18 Direct puncture and embolization with coils and Onyx of a ruptured aneurysm sac due to a type 2 endoleak A. Masrani, U.C. Turba, B. Arslan; Chicago, IL/US

P-19 Two cases of tracheocarotid ﬁstula after tracheostomy: endovascular management with covered stent placement R. Woodhams1, T. Yamane1, K. Fujii1, H. Nishimaki2, Y. Inoue1; 1Sagamihara/JP, 2Kawasaki/JP

P-20 Type A aortic dissection occurring after EVAR for abdominal aortic aneurysm in a patient with Marfan syndrome: management by combined surgery and endovascular treatment J.H. Won, J.J. Shim; Suwon/KR

P-21 Type I endoleak after TEVAR for traumatic aortic aneurysm owing to undersizing of the stent-graft during hypovolemia: treatment by percutaneous NBCA injection J.H. Won, J.J. Shim; Suwon/KR

P-22 Type IB thoracic endoleak successfully sealed with Onyx: the technique and mid-term follow-up J. Urbano, M. Tomas, M. Cabrera-Gónzalez, A. Alonso-Burgos, L. Paul-Ferrer; Madrid/ES

P-23 Endovascular repair of chronic type A aortic dissection with disseminated intravascular coagulation (DIC)

A.S. Jo, M. Khaja, D. Williams; Ann Arbor, MI/US POSTERS

P-24 Abdominal aortic aneurysm with a ﬁstula to IVC C.L. Martinez Higueros, J. Pereda Rodriguez, C. Fernández Rey; Segovia/ES

P-25 Percutaneous transarterial repair of visceral branches after surgical implantation of multibranched thoracoabdominal aortic stent graft for aortic aneurysm exclusion E. Paci, E. Gatta, M. Rosati, C. Mincarelli, M. Fichetti, P. Boscarato, R. Candelari; Ancona/IT 112 CIRSE 2016 Pocket Guide

Biliary intervention

P-26 Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth type III and IV hilar cholangiocarcinoma W. Yu, C. Wei, F. Wenzhe, Z. Ying Qiang, L. Mingjian, Y. Wang, L. Jiaping; Guangzhou/CN

P-27 Percutaneous management of inoperable intrahepatic CCC by drainage and subsequent percutaneous biliary recanalization by endoluminal RFA and stenting M. Mizandari1, N. Habib2, T. Azrumelashvili1; 1Tbilisi/GE, 2London/GB

P-28 Predicting success in percutaneous transhepatic biliary drainage A. Khosla, Y. Xi, S. Toomay; Dallas, TX/US

P-29 Concordance between planned vs. actually performed percutaneous biliary procedures: quality improvement metrics from the CIRSE IR Patient Safety Checklist S.H. Hyon, O. Mazza, M.E. Fratantoni, R. Sanchez-Claria, M. de Santibanes, M. Ciardullo, J. Pekolj, E. de Santibanes; Buenos Aires/AR

P-30 Local biliary temperature and bile duct damage in catheter radiofrequency ablation of ex vivo porcine liver POSTERS W. Lu; Beijing/CN

P-31 Percutaneous treatment of biliary stenosis after liver transplantation in children: 10-year experience of a single center in Cali, Colombia S.Y. Rodriguez-Takeuchi, A.J. Holguín, J.S. Toro, V. Botero; Cali/CO

P-32 Outcome of percutaneous transhepatic biliary stenting (PTBS) for bile duct obstruction caused by metastatic disease L. Vandenabeele, E. Dhondt, F. Van Den Bergh, P. Vanlangenhove, K. Geboes, L. Defreyne; Ghent/BE

P-33 Ultrasound-guided percutaneous cholecystostomy drains in children: a case series R. Gnannt, D.A. Parra, B. Connolly; Toronto, ON/CA Posters 113

P-34 Management of percutaneous catheter drainage of pyogenic liver abscesses: Factors contributing to success S. Haider, M. Tarulli, E.K. Hoﬀer, N.J. McNulty; Lebanon, NH/US

P-35 The safety and eﬃcacy of percutaneous transhepatic removal in elderly patients with bile duct stones M.H. Rho, H.P. Hong, K.H. Lee; Seoul/KR

P-36 Long-term results of percutaneous treatment for anastomotic biliary stricture after living-donor liver transplantation S. Nakatsuka, M. Inoue, M. Tamura, S. Oguro, Y. Suyama, N. Ito, M. Jinzaki; Tokyo/JP

P-37 Percutaneous extraction of biliary plastic stents L. Pancione, K. Novacic, I. Syed, A.R.J. Alvi, M. Elsayad; Romford/GB

P-38 Pediatric liver transplant complications: a time for interventional radiology S. Dyer Hartnett, M. Perez Lafuente, I. Diez-Miranda, C. Gonzalez-Junyent, D. Hernandez Morales, Q. Ordi i Camprubi, C. Parra-Fariñas, A. Segarra Medrano; Barcelona/ES

P-39 Stent-in-stent (Y and T shaped) as palliative treatment in malignant hilar biliary obstruction patients P. Rigamonti1, U.G. Rossi1, P. Torcia1, G. Rubis Passonia1, A.M. Ierardi2, G. Carraﬁello2, M. Cariati1; 1Milan/IT, 2Varese/IT POSTERS P-40 Changes in total serum bilirubin after percutaneous biliary drainage in malignant bile duct obstructions A. Rodriguez, S. Pereyra, J. Garcìa, F. Borges, M. Langleib; Montevideo/UY

P-41 Recurrent pyogenic cholangitis: imaging and intervention K.M. Gummalla, S. Punamiya; Singapore/SG

P-42 Percutaneous approaches to complex biliary lesions: a pictorial essay I.M. Kably, G. Narayanan, J. Yrizarry; Miami, FL/US 114 CIRSE 2016 Pocket Guide

P-43 Dual-use endobiliary radiofrequency U.G. Rossi1, P. Rigamonti1, P. Torcia1, G. Mauri2, V. Pedicini1, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT

P-44 Bile duct embolization after surgical unrooﬁng for recurrent huge hepatic cyst C.H. Kang1, H. Kim2, J.M. Lee3, W.-H. Lee4, J. Ohm2; 1Gangneung/KR, 2Daejeon/KR, 3Bucheon/KR, 4Cheonan/KR

P-45 Iatrogenic occlusion of the common bile duct (CBD) with spontaneous recanalization: when the bile corrodes good F. Melchiorre, C. Luigiano, F. Morelli, E. Fumarola, F. Balestra, G. Cornalba; Milan/IT

P-46 Percutaneous transhepatic cholangioscopic laser lithotripsy K. Akkan1, M. Yazol1, E. Yaltırık2, İ. Sen1, M. Onaran1, B. Önal1, E.T. Ilgit1; 1Ankara/TR, 2Zonguldak/TR

P-47 Percutaneous retrieval of a 10-F endoscopic plastic biliary stent that could not be retrieved by endoscopy M. Leyva Vásquez-Caicedo, J.E. Armijo Astrain, J. González Nieto, J.V. Méndez Montero; Madrid/ES

P-48 Percutaneous cholangioscopy-guided laser lithotripsy C. Ferro, F. Petrocelli, F. Camerano, G. Bovio, A. Utili, G. Salsano; Genoa/IT POSTERS Biopsy and drainage

P-49 MRI-guided percutaneous biopsy of adrenal masses using a large-bore magnet: technical feasibility G. Koch, J. Caudrelier, R.L. Cazzato, P.P. Rao, G. Tsoumakidou, M.-A. Thenint, J. Garnon, A. Gangi; Strasbourg/FR

P-50 Performance evaluation of a novel tablet ultrasound during routine interventional procedures A.M. Ierardi1, E. Duka1, C. Micieli1, P. Torcia2, U.G. Rossi2, M. Cariati2, G. Carraﬁello1; 1Varese/IT, 2Milan/IT

P-51 Preclinical evaluation of a bioresorbable device facilitates biopsy tract sealing J.D. Carey1, J.C. Isenburg1, L.M. Pook2, S. Beam1, S.A. Penegor1; 1Minneapolis, MN/US, 2Northwood, OH/US Posters 115

P-52 CT ﬂuoroscopy-guided core biopsy of pancreatic lesions: technical and clinical outcomes of 104 procedures during a 10-year period F.F. Strobl, J.B. Schwarz, P.M. Paprottka, M.F. Reiser, C.G. Trumm; Munich/DE WITHDRAWN

P-53 CT ﬂuoroscopy-guided percutaneous core needle biopsy of mediastinal masses: technical outcome and complications C.A. Burgard, M.F. Reiser, C.G. Trumm; Munich/DE

P-54 Relationship of ascites volume with risk of spontaneous bacterial peritonitis A. Sideris, P. Patel, H.W. Charles, J. Park, D. Feldman, L. Teperman, A.R. Deipolyi; New York, NY/US

P-55 Accuracy of correct histopathologic tumor detection: comparison between 10-G and 18-G biopsy samples J.C. Apitzsch, S. Viniol, A.H. Mahnken; Marburg/DE

P-56 The role of interventional radiology in the management of vascular complications after percutaneous tissue biopsy S.A.R. Mustafa, J. Evans, A.C. Gordon, A.M. Wood, R.D. White; Cardiﬀ/GB

P-57 How to use your smartphone to assist CT-guided puncture M. Hirata, R. Watanabe; Matsuyama Ehime/JP

P-58 MDCT-guided transthoracic needle biopsy of the lung

using the transscapular approach POSTERS U.G. Rossi1, P. Torcia1, P. Rigamonti1, G. Mauri2, A.M. Ierardi3, G. Carraﬁello3, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT, 3Varese/IT

P-59 Fine-needle aspiration of the pediatric thyroid M.D. Hermann1, R. Vellody2; 1Ann Arbor, MI/US, 2Washington, DC/US

P-60 Targeted prostate biopsies using MRI/ultrasound fusion technique C. O’Brien, E. O’Dwyer, M. O’Sullivan, E. Ward, R. Browne, W. Torreggiani; Dublin/IE 116 CIRSE 2016 Pocket Guide

P-61 Bedside ultrasound-guidance for interventional procedures in intensive care unit patients: how to do it and what is needed? G. Sempere-Campello, M.D. Ferrer-Puchol, R. Ramiro Gandia, E. Esteban Hernández, A. Llavata; Alzira/ES

P-62 Percutaneous MR-guided biopsy of intra-orbital retro- globular masses R.L. Cazzato, J. Garnon, G. Koch, P.P. Rao, J. Caudrelier, G. Tsoumakidou, A. Gangi; Strasbourg/FR

P-63 Super-rapid multi-planar reconstruction facilitates real-time oblique CT-guided puncture R. Sato, T. Aramaki, E. Bekku, K. Yoza, M. Moriguchi, T. Ito; Shizuoka/JP

P-64 Paediatric traumatic urinoma: percutaneous drainage allowing conservative management P. Douglas, A. Tan, S. Goodwin, S. Cascio; Glasgow/GB

Bone, spine and soft tissue intervention

P-65 Cryoablation of primary soft-tissue tumors: experience in 39 patients X. Buy, M. Kind, E. Stoeckle, V. Catena, J. Palussière; Bordeaux/FR

P-66 Percutaneous vertebroplasty in multiple myeloma: long-term outcome in a patient series POSTERS F. Fasoli, F. Vecchietti, A. Siniscalchi, T. Caravita, P. de Fabritiis, M. Guazzaroni; Rome/IT

P-67 Internally cooled radiofrequency ablation of the vertebral body with a novel bipolar device: imaging and pathological ﬁndings S. Bagla1, M.R. Callstrom2; 1Woodbridge, VA/US, 2Rochester, MN/US

P-68 Percutaneous cryoablation of extra-abdominal desmoid tumors J.J. Schmitz, A.N. Kurup, G.D. Schmit, T.D. Atwell, A.J. Weisbrod, S.H. Okuno, S.I. Robinson, P.S. Rose, M.R. Callstrom, J.M. Morris; Rochester, MN/US

C RSE Posters 117

P-69 Early results of low back pain treatment using percutaneous thermal disc decompression-like minimally invasive outpatient procedure F. Vecchietti, F. Fasoli, R. Cancellieri, M. Guazzaroni; Rome/IT

P-70 Percutaneous thermal disc decompression versus percutaneous disc decompression-like minimally invasive outpatient procedure of low back pain treatment: 1-year single-center experience F. Fasoli, F. Vecchietti, R. Cancellieri, M. Guazzaroni; Rome/IT

P-71 Reinforced cementoplasty for lytic malignant lesions of the hip joint: preliminary results of 10 cases J. Chiras, E. Cormier, F. Clarençon; Paris/FR

P-72 Percutaneous radiofrequency ablation of osteoid osteoma in the spine, feet, and hands: can it be performed safely? A.A. Nassef, H.G. Khira, W.A. Ebeid; Cairo/EG WITHDRAWN

P-73 SAFIR: a software tool supporting clinical ablation procedure studies C. Rieder, C. Schumann, H. Ballhausen, T. Pätz, T. Preusser; Bremen/DE

P-74 Correlation of height restoration and kyphosis with clinical outcome after percutaneous vertebroplasty in patients with vertebral compression fractures T. Pan, S.-C. He, H.-D. Zhu, J.-H. Guo, G.-J. Teng;

Nanjing/CN POSTERS

P-75 Phantom study on accuracy and radiation dose of cone beam CT-guided percutaneous vertebroplasty compared with accuracy and dose of conventional ﬂuoroscopy-guided percutaneous vertebroplasty T. Yamamoto, A. Kitagawa, T. Ishiguti; Nagakute/JP

P-76 Percutaneous CT-guided sympathicolysis with radiofrequency for the treatment of palmar hyperhidrosis J.M. Madrid, P. García-Barquín, J.M. Bondía, A. España, J.J. Perez Cajaraville, J.D. Aquerreta Beola; Pamplona/ES 118 CIRSE 2016 Pocket Guide

P-77 Transforaminal balloon decompression using dilating working cannula in patients with lumbar foraminal stenosis H.-Y. Kang1, S.-H. Lee2, S.-Y. Moon1; 1Busan/KR, 2Seoul/KR

P-78 Eﬃcacy of bone remodelling system in the treatment of painful vertebral compressive fractures: a preliminary experience S. Marcia, E. Piras, S. Marini, A. Spinelli, L. Saba; Cagliari/IT

P-79 Percutaneous vertebral augmentation for malignant lesions in the thoracic spine: an 18-month follow-up on pain reduction and mobility improvement G. Velonakis, D.K. Filippiadis, C. Konstantos, K. Palialexis, E. Alexopoulou, N.L. Kelekis, A.D. Kelekis; Athens/GR

P-80 Computed tomography-guided radiofrequency ablation of intra-articular osteoid osteoma: clinical application of extra-articular access D.K. Filippiadis, G. Velonakis, S. Grigoriadis, L. Reppas, E. Brountzos, N.L. Kelekis, A.D. Kelekis; Athens/GR

P-81 Ultrasound-guided vs. CT-guided approach for the sacroiliac joint steroid injection in young women: main aspects, advantages and clinical response F. Smaldone, F. Arrigoni, A. Mancini, L. Zugaro, A. Barile, C. Masciocchi; L’Aquila/IT

POSTERS P-82 Aspiration of symptomatic Baker’s cysts under ultrasound and ﬂuoroscopic guidance followed by therapeutic injection leads to a durable reduction in pain symptoms in the majority of patients A.G. Ryan1, J. Laurinkiene1, K. Courtney1, H.K. Moriarty2, I.P. Kelly1; 1Waterford/IE, 2Dublin/IE

P-83 Cryotherapy for ﬁbroadipose vascular anomaly (FAVA) N. Dasgupta, C. Guevara, M.D. Darcy; St. Louis, MO/US

P-84 Top 10 spine-related pain clinical diagnoses: evidence- based management algorithms, interventional procedures and recommendations H. Brat1, T. Bouziane2, D. Fournier1; 1Sion/CH, 2Tournai/BE

C RSE Posters 119

P-85 To review diﬀerent vertebral interventional techniques R.S. Chivate, S.S. Kulkarni, N.S. Shetty, A.M. Polnaya, K.B. Gala, S. Panbude; Mumbai/IN

P-86 Vertebroplasty for cervical lesions J. Chiras, F. Clarençon, E. Cormier; Paris/FR

P-87 Lumbar artery pseudoaneurysm embolization after vertebral cryoablation and cementoplasty S. Quarchioni, F. Bruno, F. Arrigoni, M. Varrassi, S. Carducci, A.V. Giordano, C. Masciocchi; L’Aquila/IT

P-88 Combination of embolization, cementoplasty, and percutaneous screw ﬁxation for major acetabular destruction due to kidney cancer metastasis: mid-term outcome X. Buy, V. Catena, M. Gross-Goupil, J. Palussière; Bordeaux/FR

P-89 Percutaneous cryoablation of sclerotic metastasis of the femoral diaphysis: a technical report R.M.C. Freitas, M.C.B.V. Fragoso, B.B. Mendonça, A.M. Lerario, M.Q. Almeida, J.E.B. Neto, A.O. Hoﬀ, R.N. Sawaia, L.A. Buendia; São Paulo/BR

P-90 Combination therapy using denosumab and transarterial embolization for symptomatic sacral giant cell tumor R. Tani, T. Okada, T. Gentsu, N. Katayama, E. Ueshima, Y. Koide, K. Sofue, M. Yamaguchi, K. Sugimoto; Kobe/JP

P-91 Hypogastric plexus block

F.L. Moreno, R.S. Gonzalez Toranzo, C. Villa, POSTERS M. Caracoche, F.J. Suarez Anzorena Rosasco; Buenos Aires/AR

P-92 Cement nonunion after percutaneous vertebral kyphoplasty: treatment and discussion F. Ahmed, M. Jesse; Aurora, CO/US

Clinical practice development

P-93 The role of pre-operative bilateral internal iliac artery balloon occlusion in patients with abnormally invasive placenta (accreta, increta, percreta) I.S. Al Salmi, M. Al Hajeri, T. Al Rawahi, A. Zutshi, H.A. Al Ghaithi, M. Madhavan; Muscat/OM 120 CIRSE 2016 Pocket Guide

P-94 Current trends in interventional radiology literature A. Sidhu1, M. Syed2, R. Bashiti1, J. Liu3, L. Vance1, A. Bourgeois3; 1Southﬁeld, MI/US, 2Knoxville, TN/US, 3Charleston, SC/US

P-95 Presurgical right portal vein embolization with Onyx: an initial experience J. Urbano, A. Celdran, V. Castellano, M. Cabrera-Gónzalez, A. Alonso-Burgos, S. González-Ayora, L. Paul-Ferrer; Madrid/ES

P-96 Development of the steering microcatheter Y. Inaba1, Y. Arai2, M. Sone2, T. Aramaki3, K. Osuga4; 1Nagoya/JP, 2Tokyo/JP, 3Shizuoka/JP, 4Suita, Osaka/JP

P-97 Radiofrequency ablation combined with hypertonic saline injection allows creation of coagulation zones similar to those created by microwave ablation R. Quesada1, A. Radosevic1, A. Agustí1, J. Sanchez1, M. Trujillo2, E. Berjano2, F. Burdío1; 1Barcelona/ES, 2Valencia/ES

P-98 Monitoring liver function in patients undergoing transarterial chemoembolization (TACE) by a 13C-breath test (LiMAx) M.F. Schulze-Hagen, E. Barzakova, M. Zimmermann, M. Liebl, F. Pedersoli, P. Isfort, C. Kuhl, P. Bruners; Aachen/DE

POSTERS P-99 24/7 interventional radiology in a new acute hospital R. Chung, A. Chawla, S. Babu; Singapore/SG

P-100 Interventional radiology in marine animals: new horizons for interventional radiologists and veterinarians R. García Marcos1, D. García Párraga1, J. León Rafael1, J. Martínez Rodrigo1, F.M. Gómez2, J.L. Crespo Picazo1, L. Martí-Bonmatí1; 1Valencia/ES, 2Barcelona/ES

P-101 Sole use of dexmedetomidine for sedation and analgesia in patients undergoing endovenous thermal ablation for incompetent saphenous veins: a prospective observational study J.H. Hwang, S.W. Park, I.S. Chang; Seoul/KR

C RSE Posters 121

P-102 Radiofrequency ablation for uncontrolled hepatic echinococcosis despite initial surgery and puncture, aspiration, injection, and reaspiration (PAIR) Y.S. Jeon; Gunpo-si, Gyeonggi-do/KR

P-103 Variables decreasing tip movement of peripherally inserted central catheters (PICCs) in pediatric patients R. Gnannt, B. Connolly, D.A. Parra, J. Amaral, R. Moineddin, A. Thakor; Toronto, ON/CA

P-104 Development of micro-balloon catheter as a game- changing tool: for what and how can we use it? K. Yamada1, M. Yamamoto1, M. Horikawa2, H. Shinmoto1, T. Kaji1; 1Tokorozawa/JP, 2Portland, OR/US

P-105 NCI cancer center designation: implications for interventional radiologists R. Schwind, R.C. Gaba, L. Rund, L. Schook, C.E. Ray, Jr.; Chicago, IL/US

P-106 What to expect if you are setting up an out-of-hours interventional radiology service: lessons from Glasgow M. Hennessy, I. Robertson; Glasgow/GB

P-107 Safe and eﬀective sedation practice in interventional radiology: current trends and challenges A. Khankan1, S. Alshehri1, M. Arabi1, T. Al-Hazmi2, M. Al-Moaiqel1; 1Riyadh/SA, 2Makkah/SA

P-108 The environmental impact of interventional radiology M.P. Bolger, M.K. O’Reilly, G. Sugrue, L.P. Lawler;

Dublin/IE POSTERS

P-109 Initial experience of embolization for renal AVM with 4D DSA H. Ashida, K. Enoki; Tokyo/JP

P-110 Successful endovascular obliteration with a micro- balloon catheter: 2 case reports N. Ito; Tokyo/JP

P-111 Splenic cyst radiofrequency ablation: a case report D.K. Filippiadis, S. Grigoriadis, L. Reppas, A. Mazioti, E. Brountzos, N.L. Kelekis, A.D. Kelekis; Athens/GR

122 CIRSE 2016 Pocket Guide

Dialysis intervention and venous access

P-112 Polyurethane versus silicone catheters for central venous port devices implanted at the forearm M. Wildgruber1, C. Lueg1, S. Borgmeyer1, R. Meier2, M. Koehler3, J. Ettl1, H. Berger1; 1Munich/DE, 2Ulm/DE, 3Münster/DE

P-113 Dysfunctional hemodialysis arteriovenous ﬁstula: correlation between physical examination, dialysis ﬂow measurements, duplex ultrasound, and digital subtraction angiography J.A. Camacho Oviedo, J.M. Abadal, E. Gálvez Gonzalez, M.J. Alvarez; Madrid/ES

P-114 Comparison of sedoanalgesia versus ultrasound- guided supraclavicular brachial plexus block for analgesia during treatment of failed hemodialysis ﬁstulas by interventional radiology M. Gedikoglu1, C. Andic1, I. Guzelmansur2, H.E. Eker1, C. Bolgen1; 1Adana/TR, 2Hatay/TR

P-115 Patients with thrombocytopenia requiring venous access devices: re-evaluating the platelet threshold guidelines B. Patel, J. Tirado, P. Lombardi, M. Al-Roubaie, C. Greben; Manhasset, NY/US

P-116 Initial experience of revascularization of occluded POSTERS arteriovenous ﬁstulas (AVF) with a thromboectomy device (ASPIREX) M.A. Al-Toki, M. Almoaiqel, N. Guzaia; Riyadh/SA

P-117 Combination of endovascular techniques for treatment of thrombosed hemodialysis grafts: 6-year experience L. Paul-Ferrer, D. Gomez Campos, M. Cabrera-Gónzalez, A. Alonso-Burgos, J. Urbano; Madrid/ES

P-118 Comparing success of percutaneous declotting of thrombosed arteriovenous ﬁstulae (AVF) and arteriovenous graft (AVG): a retrospective review H. Shi, N.K.K. Venkatanarasimha, K. Damodharan, A. Gogna, S. Leong, T.A.J. Urlings, C.W. Too, F.G. Irani, A. Patel, J.M. Chan, H.G.R. Lo, K.-H. Tay, B.S. Tan; Singapore/SG Posters 123

P-119 Sharp recanalization of chronic total benign occlusions of the superior vena cava at the cavoatrial junction: feasibility of the endovascular SVC conduit M. Arabi, S. Alammari, S. Alshehri; Riyadh/SA

P-120 AngioJet™ thrombectomy of thrombosed hemodialysis ﬁstulas M.E. Perez Montilla, S. Lombardo Galera, J.J. Espejo Herrero, J. Garcia Revillo, L.J. Zurera Tendero; Cordoba/ES

P-121 Do right arm PICC lines have fewer complications than left arm PICC lines? A randomised controlled trial R. Lindsay, F. Paquet, L.-M.N.J. Boucher, M. Renzullo, D.A. Valenti; Montreal, QC/CA

P-122 Endoluminal dilatation to remove stuck central venous devices: a safe and reliable method for interventional radiologists I. Fiorina, L.P. Moramarco, M. Torresi, R. Corti, G. Leati, P. Quaretti; Pavia/IT

P-123 Percutaneous placement of the peritoneal dialysis catheter: an educational poster S. Alammari, T. Alanazi, A. Alharbi, M. Arabi; Riyadh/SA

P-124 The eﬀectiveness of transhepatic hemodialysis catheter in chronic hemodialysis patients: is it safe and functional? B. Sanal1, O.F. Nas2, N. Dogan2, M. Korkmaz1, K. Hacikurt2, A. Yildiz2, I.I.K. Aytac2, B. Hakyemez2, C. Erdoğan2; 1Kutahya/TR, 2Bursa/TR POSTERS P-125 Central venous catheter tip malposition: percutaneous tricks for its correct re-placement U.G. Rossi1, P. Torcia1, P. Rigamonti1, G. Mauri2, V. Pedicini1, D. Poretti1, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT

P-126 Percutaneous dialysis arteriovenous ﬁstula banding: technical review H.K. Kok, E. Ryan, M.J. Lee; Dublin/IE

P-127 Budd-Chiari syndrome: complication of a dialysis line and our subsequent management A. Tan, N. Mathias; Glasgow/GB 124 CIRSE 2016 Pocket Guide

P-128 Zero to HeRO: a savior graft for patients reaching end of their haemodialysis life M.A. Ghouri, C. Ratcliﬀ, C. Nesbitt, M. Thomas, A. Kaabneh, S. Milburn, M. Hansrani; Middlesbrough/GB

Embolotherapy (excluding oncology)

P-129 Ethanol sclerotherapy for venous malformations: clinical outcomes and patient satisfaction – a tertiary center experience O. Komisar, U. Rimon; Ramat-Gan/IL

P-130 Super-selective arterial embolization with n-butyl cyanoacrylate (NBCA) for colonic diverticular hemorrhage S. Fuwa1, S. Hase2, T. Nakagawa2, J.-I. Nishimura2; 1Tokyo/JP, 2Kawasaki-city, Kanagawa/JP

P-131 Volumetric ﬁlling density of coil embolization for pulmonary arteriovenous malformation and its relationship with reperfusion M. Shimohira, T. Hashizume, T. Kawai, K. Ohta, K. Suzuki, Y. Shibamoto; Nagoya/JP

P-132 Combination of balloon-remodeling and double microcatheter technique for embolization of wide- neck visceral artery aneurysms: a review of 11 consecutive cases M. Inoue, S. Nakatsuka, M. Tamura, S. Oguro, M. Jinzaki; POSTERS Tokyo/JP

P-133 Preliminary experience with Onyx embolisation in 21 patients with renal angiomyolipoma L. Paul-Ferrer, D. Gomez Campos, M. Cabrera-Gónzalez, A. Alonso-Burgos, J. Urbano; Madrid/ES

P-134 Safety and eﬃcacy of pre-operative tumour embolisation in combination with percutaneous direct puncture technique for juvenile nasopharyngeal angioﬁbromas (JNA) with impact on intra-operative blood loss R.S. Chivate, S.S. Kulkarni, N.S. Shetty, A.M. Polnaya, K.B. Gala; Mumbai/IN

C RSE Posters 125

P-135 Dyna-CT during prostate artery embolisation D.F.W. Maclean, B. Maher, A. Cannavale, J. Dyer, M.R. Harris, S. Modi, N. Hacking, T.J. Bryant; Southampton/GB

P-136 Digital subtraction cone-beam CT in preoperative embolization for pelvic bone tumor H.-C. Kim, G.M. Kim; Seoul/KR

P-137 Analysis of radiation dose in varicocele embolization using thermo-luminescence dosimeter (TLD): what risk for hereditary line? F. Melchiorre, R. Azzeroni, M. Mancini, E.M. Fumarola, F. Pelliccione, F. Morelli, A. Gioppo, M. Nichelatti, A. Vella, G. Cornalba; Milan/IT

P-138 Arterial embolization of rectus sheath hemorrhage secondary to anticoagulant therapy J.M. Jimenez Perez, G. Rodriguez-Rosales, M. González Leyte, A. Alvarez Luque, M. Echenagusia Boyra, E. Calleja Cartón; Madrid/ES

P-139 Varicocele treated by coils or a combination of coils and sclerosant therapy J. Egge1, I.K. Tesdal2; 1Haugesund/NO, 2Friedrichshafen/DE

P-140 Empirical embolization of the arterial stump for postoperative hemorrhage without a definite bleeding focus on radiographs after gastrointestinal surgery: radiologic findings and outcomes E.H. Kim, J.S. Oh, H.J. Chun, H.G. Lee, B.G. Choi; Seoul/KR POSTERS P-141 Identification of hemoptysis-responsible arteries prior to bronchial artery embolization: is there an added value of conventional aortography compared with CT angiography? C.J. Yoon, C.H. Jeon, H. Lee, Y.-J. Kim, S.W. An, Y.N. Woo; Seongnam/KR

P-142 Coronary stent-graft implantation for the management of acute visceral arterial bleeding P.P. Goﬀette, X. Wittebole, P. Laterre, O. Ciccarelli; Brussels/BE 126 CIRSE 2016 Pocket Guide

P-143 Evaluation criteria in patients with hemodynamically stable pelvic fracture: should angiography be performed or not? K. Shibuya, M. Aoki, S. Hirasawa, H. Tokue, M. Miyazaki, Y. Koyama, K. Oshima, Y. Tsushima; Maebashi/JP

P-144 Fusion imaging of dual arterial phase CT during angiography for hepatocellular carcinoma: usefulness for undetectable lesions at an early arterial phase K. Ohta, M. Shimohira, T. Hashizume, Y. Shibamoto; Nagoya/JP

P-145 Does reduction in prostate volume post-embolisation correlate with symptomatic relief? D.F.W. Maclean, M.R. Harris, J. Dyer, S. Modi, N. Hacking, T.J. Bryant; Southampton/GB

P-146 Embolization of pulmonary MAV in patients aﬀected by HHT: comparison of results between coils and plugs M. Grosso, D. Sortino, F. Pedrazzini, I. Baralis, C. Vinay, E. Peano, S. Bongiovanni, A. Balderi; Cuneo/IT

P-147 Imaging spectrum and management of spontaneous hepatic haemorrhage F. Corvino1, E. Cavaglia’1, M. Silvestre1, A. Cervo1, F. Giurazza2, A. Corvino1, F. Maglione1; 1Naples/IT, 2Rome/IT

P-148 Eﬃcacy of concurrent blood ﬂow control on POSTERS percutaneous sclerotherapy for soft tissue venous malformation K. Azama, F. Ganaha, Y. Iraha, J. Heianna, R. Kinoshita, W. Makino, S. Murayama; Okinawa/JP

P-149 Unusual causes of upper gastrointestinal bleeding E. Lake, G. Ananthakrishnan; Manchester/GB

P-150 Endovascular management of intractable postpartum hemorrhage caused by vaginal laceration A. Kuhara, M. Koganemaru, T. Kugiyama, M. Nabeta, N. Tanaka, T. Abe; Kurume/JP

P-151 Imaging spectrum and endovascular management of vascular steal syndromes R. Suri; San Antonio, TX/US C RSE Posters 127

P-152 Superior mesenteric vein–inferior vena cava shunt: amplatzer vascular plug embolization U.G. Rossi1, P. Torcia1, P. Rigamonti1, F. Petrocelli2, M. Cariati1; 1Milan/IT, 2Genoa/IT

P-153 Dysautonomia secondary to Guillain–Barré syndrome during prostate artery embolisation P. Kumar, S. Srinivasan, R. Ravi, S. Amin, E.A. O’Grady, A. Baird; Liverpool/GB

P-154 Endovascular embolization of anomalous systemic arterial supply to the left lower lung via the left brachial artery J.M. Lee1, J. Ohm2; 1Bucheon/KR, 2Daejeon/KR

P-155 Percutaneous transhepatic obliteration for superior mesenteric vein aneurysm rupture after transcatheter arterial chemoembolization for huge hepatocellular carcinoma: a case report and review of the literature H. Nagayama, T. Fukuda; Nagasaki/JP WITHDRAWN

P-156 Successful retrieval of an amplatzer vascular plug II (AVPII) used for embolization of pelvic arteriovenous malformation that migrated to the pulmonary artery M. Inoue, M. Tamura, S. Oguro, S. Nakatsuka, M. Jinzaki; Tokyo/JP

P-157 Recovery from a critical complication: successful removal of a thoracic drainage catheter penetrating through a bronchus and pulmonary artery with transcatheter embolization under proximal balloon

occlusion POSTERS T. Moriya, T. Saguchi, D. Yunaiyama, K. Saito, K. Tokuuye, J. Yamashita, A. Yamashina, N. Ikeda; Tokyo/JP

P-158 Successful treatment of terminal ileum arteriovenous malformation by balloon-occlusion arterial embolization using n-butyl-2-cyanoacrylate-lipiodol M. Eguchi, O. Ikeda, Y. Nakasone, Y. Yamashita; Kumamoto/JP

P-159 Balloon-assisted double-barrel catheter technique for glue embolization of a ruptured traumatic anterior tibial artery pseudoaneurysm K. Idoguchi, R. Usui, M. Narita, S. Nakao, Y. Mizushima; Osaka/JP 128 CIRSE 2016 Pocket Guide

P-160 Successful superselective glue embolization for a ruptured omental artery aneurysm in a patient with ﬁbromuscular dysplasia K. Idoguchi, M. Yamada, R. Usui, M. Narita, S. Nakao, Y. Mizushima; Osaka/JP WITHDRAWN

P-161 Selective endovascular embolization of pulmonary artery in blunt polytrauma: a report of 2 cases K. Idoguchi, R. Usui, M. Narita, S. Nakao, Y. Mizushima; Osaka/JP

P-162 Embolization of posttraumatic celiac trunk pseudoaneurysm M. González Leyte, M. Echenagusia Boyra, A. Alvarez Luque, G. Rodriguez-Rosales, J.M. Jimenez Perez, E. Calleja Cartón; Madrid/ES

P-163 An unusual right varicocele due to postraumatic arteriovenous ﬁstula in a young man F. Petrocelli, F. Camerano, G. Bovio, A. Utili, G. Salsano, C. Ferro; Genoa/IT

P-164 Successful transarterial coil embolization of coronary artery-pulmonary artery shunts: three cases T. Sato, H. Ota, H. Sakakibara, H. Takagi, T. Hasegawa, K. Seiji, K. Takase; Sendai, Miyagi/JP

P-165 Transcatheter arterial embolization of a Rasmussen POSTERS aneurysm with histoacryl glue injection under proximal balloon occlusion Y. Tanahashi1, H. Kondo1, S. Goshima2, M. Osawa1, H. Kawada2, T. Yamamoto1, M. Matsuo2, S. Furui1; 1Tokyo/JP, 2Gifu/JP

P-166 Emballoonisation: an useful alternative when the edge is too close M. González Leyte, M. Echenagusia Boyra, A. Alvarez Luque, G. Rodriguez-Rosales, J.M. Jimenez Perez, E. Calleja Cartón; Madrid/ES

P-167 Coil embolization with combination of micro-balloon assistance and double-catheter technique for a huge superior mesenteric artery pseudoaneurysm secondary to acute pancreatitis H. Yamaguchi, S. Murata, H. Saitou, S. Onozawa, T. Ueda, F. Sugihara, D. Yasui, I. Miki, S.-I. Kumita; Tokyo/JP Posters 129

P-168 Posttraumatic high-ﬂow priapism: endovascular embolization with n-butyl-2-cyanoacrylate M. Langleib, E. Squarza, M. Alvez, A. Icasuriaga, A. Esperon; Montevideo/UY

P-169 Urgent treatment of lower gastointestinal bleeding secondary to hepatic artery pseudoaneurysm: transcatheter embolization with NBCA and hepatic artery ﬂow preservation M. Langleib, E. Squarza; Montevideo/UY

P-170 Endovascular treatment for severe hematuria caused by radiation cystitis M. Leyva Vásquez-Caicedo, J. González Nieto, J.E. Armijo Astrain, J.V. Méndez Montero; Madrid/ES

P-171 Combined transpulmonary arterial embolization and retrograde transpulmonary venous embolization for pulmonary arteriovenous malformation H. Tanaka1, T. Tsuda2, T. Mochizuki2; 1Matsuyama Ehime/JP, 2Toon Ehime/JP

P-172 An amazing splenic aneurysm! K.R. Hamza1, R. Abid2; 1Tunis/TN, 2Sfax/TN

P-173 BRTO for SMV-IVC shunt with gastro-renal shunt M. Nakamura, T. Matsumura, T. Nakamura; Izumo Shimane/JP

P-174 The use of PHIL, a novel embolic agent in the management of type II endoleaks N. Shaida; Cambridge/GB

WITHDRAWN POSTERS

P-175 Transcatheter Amplatzer plugs and sodium tetradecyl sulfate "burger" technique for varicocele embolization S.R. Alharbi; Riyadh/SA

P-176 Inferior mesenteric arteriovenous malformation successfully treated with a combination of transarterial and transvenous embolization M. Kamo, K. Yagihashi; Tokyo/JP 130 CIRSE 2016 Pocket Guide

P-177 A novel technique of retrograde transvenous embolization with balloon-assisted arterial aspiration for peripheral arterio-venous malformation (AVM) with a dominant outﬂow vein A. Kuhara, N. Tanaka, T. Kugiyama, M. Nabeta, M. Koganemaru, T. Abe; Kurume/JP

P-178 Hybrid procedure for multiple pancreaticoduodenal artery aneurysms associated with superior mesenteric artery (SMA) occlusion K. Seiji, H. Sakakibara, T. Hasegawa, H. Ota, T. Shimizu, H. Goto, K. Takase; Sendai, Miyagi/JP

EVAR and TEVAR

P-179 Embolization of type II endoleaks after endovascular aortic repair (EVAR) of abdominal aortic aneurysms (AAA) using ethylene–vinyl alcohol copolymer (EVOH, Onyx®) A.Z. Vance, A. Graif, R. Patel, M. McGarry, M.J. Garcia, C.J. Grilli, G. Kimbiris, D. Leung; Newark, DE/US

P-180 ECG-gating magnetic resonance quantiﬁcation of aortic distensibility for the prediction of aortic aneurysmal growth rate H. Kawada1, S. Goshima1, Y. Tanahashi2, K. Kajita1, Y. Noda1, N. Kawai1, H. Koyasu1, H. Kondo2, M. Matsuo1; 1Gifu/JP, 2Tokyo/JP

POSTERS P-181 EVAR: type Ia endoleak treated with balloon- expandable stents P. Rigamonti, U.G. Rossi, P. Torcia, D. Santuari, M. Carmo, R. Dallatana, M. Cariati; Milan/IT

P-182 Balloon-assisted embolization of the celiac trunk prior to endovascular repair of thoracoabdominal aortic aneurysm for the prevention of type II endoleak Y. Ishizaka1, M. Yabuta2, K. Sawada1, A. Okumura1, T. Koyama1; 1Okayama/JP, 2Tokyo/JP

P-183 Justifying the role of multiple CT-A examinations in post-EVAR surveillance H. Joshi, V. Shrivastava, R. Alchanan; Hull/GB

C RSE Posters 131

P-184 Rationalising EVAR follow-up for an evolving centralised service A.L. Stimpson, C. Davies; Swansea/GB

P-185 Is automated EVAR planning accurate? C. Miller1, J.V. Patel1, K. Flood1, C.J. Hammond1, S.J. McPherson1, P. Walker1, D.R. Shaw2, J. Lenton2, D.O. Kessel1, J. Scott1, S. Puppala1; 1Leeds/GB, 2Wakeﬁeld/GB

P-186 Remodelling of aortic type B dissections in 12 patients treated using the streamliner multilayer ﬂow modulator: primary versus secondary intervention F. Stefanov, L. Morris, E.P. Kavanagh, A. Helali, V. Lundon, N. Hynes, S. Sultan; Galway/IE

P-187 Outpatient percutaneous endovascular aortic aneurysm repair: single-center experience with simple and complex aortic anatomy C.-M. Chen, S.-Y. Chu, P.-J. Ko; Taoyuan/TW

P-188 Clinical outcomes of thoracic endovascular aneurysm repair using commercially available fenestrated stent graft (Najuta endograft) S. Iwakoshi1, S. Ichihashi1, S. Sakaguchi2, K. Kichikawa1; 1Kashihara/JP, 2Matsubara, Osaka/JP

P-189 TEVAR planning and simulation training improves trainee confidence A. Alsafi, Z. Alsafi, M.S. Hamady; London/GB

P-190 Findings of aneurysm sac digital subtraction

angiography (DSA) during transarterial embolization POSTERS of type II endoleaks and its outcomes N. Hongo1, H. Kiyosue2, N. Kamei2, K. Oji2, R. Shuto1, S. Matsumoto1, H. Mori1; 1Oita/JP, 2Yufu/JP

P-191 Cerebral embolic protection in thoracic endovascular aortic repair (TEVAR): a pilot study G. Grover, N. Rudarakanchana, A. Perera, M. Hamady, R.G.J. Gibbs; London/GB

P-192 Post-EVAR type II endoleak: endovascular embolisation with Onyx P. Torcia, U.G. Rossi, P. Rigamonti, D. Santuari, M. Carmo, R. Dallatana, M. Cariati; Milan/IT 132 CIRSE 2016 Pocket Guide

P-193 Two-year follow-up of patients treated with EMBO- EVAR for prevention of type II endoleak M. Natrella, A. Rapellino, G. Lunardi, M. Cristoferi, G. Fanelli, A. Depaoli, C. Bogetti, T. Meloni; Aosta/IT WITHDRAWN

P-194 Stanford type B dissection managed by thoracic stent graft and "zipper" fenestration: case report and review of fenestration techniques T. Raudsepp, K. Daly, I. Robertson; Glasgow/GB

P-195 Aortitis post-EVAR: imaging and management approach C.L. Martinez Higueros; Madrid/ES

P-196 Imaging features and treatment of EVAR endoleaks D. Brennan, D. Herlihy, J. Duignan, H.K. Kok, M.F. Given; Dublin/IE

P-197 Eﬃcacy of aortic balloon occlusion at sac embolization using NBCA for type 2 endoleak after EVAR H. Nishimaki, K. Chiba, Y. Ogawa, Y. Sakurai, K. Murakami, J.-I. Nishimura, H. Ono, M. Chikada, T. Miyairi; Kawasaki/JP

P-198 A case of endovascular aneurysm repair of a dilated aortic diverticulum in a patient with a mirror-image right aortic arch S. Ono, T. Ichikawa, T. Hara, T. Sekiguchi, J. Koizumi, POSTERS Y. Imai, S. Shimura; Kanagawa/JP

P-199 Transcaval embolization for type II endoleak W.-H. Lee1, C.H. Kang2, S.B. Yang3, J.M. Lee4, J. Ohm5; 1Cheonan/KR, 2Gangneung/KR, 3Gumi/KR, 4Bucheon/KR, 5Daejeon/KR

Experimental work in IR

P-200 An experimental study of the anti-tumor eﬀect of a suspension of TR ﬂuid and cisplatin S. Watanabe1, N. Nitta1, S. Ota1, A. Sonoda1, Y. Tomozawa1, K. Murata1, R. Nakano2, S. Yao2; 1Otsu/JP, 2Fukuoka/JP

C RSE Posters 133

P-201 Can irreversible electroporation (IRE) be done in the presence of metal biliary stents? E.M.M. Yu, H. Kavnoudias, K.R. Thomson; Melbourne, VIC/AU

P-202 Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1 alpha for hepatocellular carcinoma: a preliminary study of a rat model J.Y. Ni, L.F. Xu; Guangzhou/CN

P-203 Comparison between tumor vascularity and hemodynamics in three rat hepatoma models H.-C. Kim; Seoul/KR

P-204 Short-, medium- and long-term follow-up for percutaneous, minimally invasive irreversible electroporation (IRE) of renal tumours: a prospective single-centre study H. Kavnoudias, E.M.M. Yu, R.E. Neal II, W. Cheung, S. Ellis, K.R. Thomson; Melbourne, VIC/AU

P-205 Real-time thermosensitive MR imaging during microwave ablation B. Kaltenbach, A. Roman, K. Eichler, N.-E.A. Nour-Eldin, T.J. Vogl, S. Zangos; Frankfurt/DE WITHDRAWN

P-206 Magnetic resonance-guided focused ultrasound surgery (MRgFUS) for primary pancreatic and hepatic cancer: a preliminary experience of tumor control H.-P. Erasmus, M. Anzidei, S. Dababou, C. Marrocchio,

M. Bezzi, C. Catalano, A. Napoli; Rome/IT POSTERS

P-207 Monitoring thermal-induced changes of liver stiﬀness by real-time point shear wave elastography (pSWE) in ex-vivo bovine liver tissue F. Calcagni1, L. Crocetti1, N. Tosoratti2, C. Amabile2, S. Cassarino2, F.P. Tarantino1, R. Cioni1; 1Pisa/IT, 2Aprilia/IT

P-208 Preclinical testing for the safety of a new prototype coaxial needle in a mimic iatrogenic vascular trauma animal model P.P. Rao, G. Tsoumakidou, B. Elodie, J. Garnon, G. Koch, J. Caudrelier, R.L. Cazzato, M.-A. Thenint, A. Gangi; Strasbourg/FR 134 CIRSE 2016 Pocket Guide

P-209 Robotic device for needle orientation and insertion under image guidance: initial preclinical experience P.P. Rao, A. Bruyas, L. Barbe, P. Renaud, F. Geiskopf, B. Wach, J. Garnon, A. Ricoeur, M. De Mathelin, A. Gangi; Strasbourg/FR

P-210 Percutaneous valvuloplasty of proximal GSV valves: comparison of two hyaluronan gels J.C. Ragg; Berlin/DE

P-211 Impact of crimping and balloon dilatation on endothelialized covered stents S. Ichihashi1, F. Wolf2, T. Schmitz-Rode2, K. Kichikawa1, S. Jockenhoevel2, P. Mela2; 1Kashihara, Nara/JP, 2Aachen/DE

P-212 Construction of a ‘hybrid’ stent graft using a novel ‘in situ welding’ technique: initial animal experience A.I. Bloom, F. Widlan, M. Zarek, Y. Kalish, V. Doviner, D. Cohn; Jerusalem/IL WITHDRAWN

P-213 Renal sympathicolysis by transaortic periarterial injection of ethanol in pigs with use of an experimental injection catheter P. Freyhardt, J. Schütze, R. Donners, J. Schnorr, N. Stolzenburg, J. Rinnenthal, R.W. Günther, B. Hamm, F. Streitparth; Berlin/DE

POSTERS P-214 3D printing for pre-/intra-procedural planning in interventional radiology A. Ghodadra1, R. Varma1, M. Rabinovitz1, N. Mani2, E.G. Santos Martín1; 1Pittsburgh, PA/US, 2St. Louis, MO/US

P-215 Simulation of embolization of visceral aneurysms with 3D-printed hollow models E. Shibata, T. Hidemasa, S. Amemiya, K. Ohtomo; Tokyo/JP

GI tract intervention

P-216 The safety and eﬃcacy of embolisation in the treatment of post-gastrectomy haemorrhages B.M. Ahmed, M.D. Kim, J.H. Kwon, G. Kim, M. Shin, W. Shin, S.I. Park, D.Y. Lee, J.Y. Won; Seoul/KR C RSE Posters 135

P-217 Provision of interventional radiology, endoscopy and surgery for acute lower gastrointestinal bleeding in the United Kingdom: preliminary results of a national comparative audit K. Oakland1, J. Grant-Casey1, V. Jairath2, R. Guy1, N. Mortensen1, M. Murphy1, R. Uberoi1; 1Oxford/GB, 2London, ON/CA

P-218 Onyx embolic liquid in the treatment of acute gastrointestinal hemorrhage P. Rabuﬃ, S. Vagnarelli, A. Bruni, D. Morosetti, C. Ambrogi; Rome/IT WITHDRAWN

P-219 Evaluating the accuracy of CT angiography in the diagnosis of upper and lower gastrointestinal hemorrhages: a systematic review and meta-analysis A. Wadhwani, R. Leigh, P. Beck, E. Herget; Calgary, AB/CA

P-220 Radiofrequency ablation (RFA) with a multiple- electrode switching system for >3.0-<6-cm nodules of hepatocellular carcinoma (HCC): a preliminary experience G. Francica1, A. Ragozzino2, C. Giardiello1, F. Romano1, M. Scaglione1; 1Castel Volturno/IT, 2Pozzuoli/IT WITHDRAWN

P-221 Percutaneous management of inoperable malignant biliary and pancreatic duct stricture by endoluminal RFA and stenting M. Mizandari1, N. Habib2, T. Azrumelashvili1; 1Tbilisi/GE, 2London/GB POSTERS P-222 Yttrium-90 radioembolization for unresectable intrahepatic cholangiocarcinoma: survival, eﬃcacy, and safety study C. Mosconi, A. Cappelli, M. Renzulli, A. Gramenzi, S. Ascanio, F. Modestino, R. Golﬁeri; Bologna/IT

P-223 Relationship between applied energy and ablation volume for diﬀerent ablation techniques: comparison between colorectal liver metastases and hepatocellular carcinoma W.J. Heerink, M. Solouki, R. Vliegenthart, M. Oudkerk, G. Sieders, K.P. de Jong; Groningen/NL 136 CIRSE 2016 Pocket Guide

P-224 Self-expanding colonic stent implantation in acute intestinal occlusion: our experience A.M. Fernández Martínez1, J.D. Samper Wamba2, L.A. Domitrovic1, J. Valdivia Ruiz1, O. Balboa Arregui1; 1Leon/ES, 2Elda/ES

P-225 Pancreatic duct percutaneous image-guided drainage: what for and how? M. Mizandari; Tbilisi/GE

P-226 Safety of percutaneous transesophageal gastrotubing (PTEG): comparison between the procedures and puncture routes Y. Arai1, T. Haraguchi1, Y. Himeno2, M. Sone2, Y. Arai2, H. Mimura1, Y. Nakajima1; 1Kanagawa/JP, 2Tokyo/JP

P-227 Radiologic percutaneous gastrostomy in nondistended stomach: a modiﬁed approach F. Petrocelli, G. Salsano, G. Bovio, F. Camerano, A. Utili, C. Ferro; Genoa/IT

P-228 Percutaneous approach and management of postoperative gastro-intestinal ﬁstulas G. Di Costanzo, R. Inchingolo, M. Nestola, M. Nardella; Matera/IT

P-229 Endovascular thrombolysis and angioplasty for the management of early hepatic artery thrombosis after living-donor liver transplantation: our experience of POSTERS 570 cases O. Abdelaziz, M. Mostafa; Cairo/EG

P-230 Acute gastrointestinal bleeding after endoscopic polypectomy: super-selective endovascular embolization with n-butyl-2-cyanoacrylate in clinically unstable patients P. Rigamonti1, U.G. Rossi1, G. Rubis Passonia1, P. Torcia1, V. Pedicini1, D. Poretti1, G. Carraﬁello2, M. Cariati1; 1Milan/IT, 2Varese/IT

P-231 Rotational angiography C-arm CT: an added value in super-selective TACE for HCC U.G. Rossi1, P. Rigamonti1, P. Torcia1, G. Mauri2, F. Petrocelli3, A.M. Ierardi4, G. Carraﬁello4, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT, 3Genoa/IT, 4Varese/IT C RSE Posters 137

P-232 Interventional radiology and esophagogastric surgery E. Lonjedo, J. Gomez, J. Salvador, E. Casula, A. Ruiz, J.A. Aguilar Gutierrez; Valencia/ES

P-233 Fluoroscopy-guided preoperative colonic stenting for malignant colonic obstruction S.H. Kwon, J.H. Oh; Seoul/KR

P-234 Spontaneous isolated superior mesenteric artery dissection: from diagnosis to therapy U.G. Rossi1, P. Rigamonti1, P. Torcia1, G. Mauri2, D. Poretti1, A.M. Ierardi3, G. Carraﬁello3, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT, 3Varese/IT

P-235 Role of interventional radiology in Budd-Chiari syndrome V. Rachapalli1, N. Kundaragi1, D. Thiruchunapalli2, S. Inuganti2, S. Chappiidi3, M. Uthappa1; 1Bangalore/IN, 2Chennai/IN, 3Hyderabad/IN

P-236 Back to the gelatin sponge: temporal haemostatic embolisation for massive upper GI bleeding A. Alonso-Burgos, M. Cabrera-Gónzalez, L. Paul-Ferrer, J. Urbano; Madrid/ES

P-237 Percutaneous embolization of rectal ﬁstula using NBCA in patients with supralevator and translevator perianal ﬁstula: a technical case report Y. Yamamoto1, M. Yabuta2, S. Kubo1; 1Kyoto/JP, 2Tokyo/JP

P-238 Upper gastrointestinal haemorrhage arising from an aberrant left gastric artery

V.G. Helyar1, A. Shaw2, K.N. Katsanos1, POSTERS A. Diamantopoulos1; 1London/GB, 2Kent/GB

P-239 Percutaneous embolisation with histoacryl of an enteric ﬁstula: a case report C.H.N. Bezerra1, T.F. Nunes2, R. Magnani2; 1Fortaleza/BR, 2Campo Grande Ms/BR

P-240 Eﬃcacy of coil embolization of superior rectal arteries (SRAs) in the treatment of hemorrhoids associated with rectal bleeding F. Melchiorre, M. Rovati, P. De Nardi, F. Morelli, P. Marra, A. Giori, M. Venturini; Milan/IT 138 CIRSE 2016 Pocket Guide

P-241 Ultraselective intrasaccular embolization of a jejunal artery branch aneurysm in a complex patient N. Marotti, E. Laiolo, M. Pieraccini; Grosseto/IT

P-242 Percutaneous transperitoneal insertion of a colonic stent A. Shaw, J. Spiking, C. Wetton, N. Scully, C. Elwood, C. Wright, P. Ignotus; Kent/GB

P-243 Recanalization of subacute distal occlusion of the superior mesenteric artery using mechanical thrombectomy and stenting R. Salman1, N. Guzaiz2, A. Khankan1, M. Almoaiqel1, M. Al-Toki1; 1Riyadh/SA, 2Mecca/SA

Gynaecological intervention (including UFE)

P-244 Radiation exposure during uterine ﬁbroid embolization (UFE): a confounder-controlled comparison between a state-of-the-art angiography device and a conventional device M. Klapp Oliger1, C.M. Sommer1, A. Hatopp1, S. Erpenbach1, P. Kurz1, C. Schlett2, G.M. Richter1; 1Stuttgart/DE, 2Heidelberg/DE

P-245 Application of contrast-enhanced CT to the management of primary postpartum hemorrhage H. Kondo1, Y. Tanahashi1, S. Goshima2, H. Kawada2, M. Osawa1, T. Yamamoto1, M. Matsuo2, S. Furui1; POSTERS 1Tokyo/JP, 2Gifu/JP

P-246 Analysis of risk factors for the recanalization of gelatin sponge during transcatheter arterial embolization for primary postpartum hemorrhage R. Woodhams1, K. Fujii1, G. Ogasawara1, T. Yamane1, H. Sugawara1, K. Matusnaga1, H. Nishimaki2, Y. Inoue1; 1Sagamihara/JP, 2Kawasaki/JP

P-247 Transcatheter arterial embolization for primary postpartum hemorrhage: predictive factors for embolic material conversion of gelatin sponge particles to n-butyl cyanoacrylate Y. Tanahashi1, H. Kondo1, S. Goshima2, M. Osawa1, H. Kawada2, T. Yamamoto1, M. Matsuo2, S. Furui1; 1Tokyo/JP, 2Gifu/JP C RSE Posters 139

P-248 Postpartum haemorrhage from nonuterine arteries: clinical importance of its detection and results of selective embolisation Y.H. So, Y.H. Choi, C.K. Sung, M.H. Moon; Seoul/KR

P-249 The interventional treatment of gestational trophoblastic tumor Z.J. Hao; Zhengzhou/CN WITHDRAWN

P-250 Secondary postpartum hemorrhage: clinical manifestations and angiographic ﬁndings S.H. Jeong, Y.H. Kim, Y.H.D. Kim, C.S. Kim, J.H. Kim, S.H. Kim, U.R. Kang; Daegu/KR

P-251 Transcatheter arterial embolization for acquired uterine arteriovenous malformation U.G. Rossi1, P. Rigamonti1, P. Torcia1, A.M. Ierardi2, G. Carraﬁello2, M. Cariati1; 1Milan/IT, 2Varese/IT

P-252 A case of round ligament artery embolization for atonic uterine bleeding H. Kawada1, S. Goshima1, Y. Noda1, N. Kawai1, H. Koyasu1, Y. Tanahashi2, H. Kondo2, M. Matsuo1; 1Gifu/JP, 2Tokyo/JP

P-253 Cervical ectopic pregnancy: management with uterine artery embolization F. Petrocelli, G. Bovio, F. Camerano, A. Utili, G. Salsano, C. Ferro; Genoa/IT

P-254 Bilateral uterine artery embolisation to treat a gigantic ﬁbroid: personal experience and literature review

G. Gabbani, C. Raspanti, M. Citone, F. Mondaini, POSTERS E. Mazza; Florence/IT

P-255 An unusual case of secondary postpartum haemorrhage T. Carlsson, G. Brehaut, F. Naaisa, N. Collin; Bristol/GB

P-256 Embolization of the uterine artery during caesarean hysterectomy in patients with total placenta previa and placenta accreta: a study of 2 cases R. Abe, S. Sai, N. Mizobuchi, N. Hosaka, N. Seino, T. Gokan; Tokyo/JP

140 CIRSE 2016 Pocket Guide

Imaging

P-257 Initial signs on prostate MRI after prostatic artery embolization in patients with symptomatic BPH T. Franiel, S. Trupp, M.-O. Grimm, U. Teichgräber, R. Aschenbach; Jena/DE

P-258 Is CT angiogram an essential investigation prior to prostate artery embolisation? D.F.W. Maclean, B. Maher, A. Cannavale, M.R. Harris, J. Dyer, S. Modi, N. Hacking, T.J. Bryant; Southampton/GB

P-259 Pulmonary lymphatic perfusion syndrome in patients with plastic bronchitis: diagnosis and embolization treatment M. Itkin1, Y. Dori1, F. McCormack2; 1Philadelphia, PA/US, 2Cincinnati, OH/US

P-260 CT during pancreatic arteriography for the localization of neuroendocrine tumors K. Kajiwara, M. Ishikawa, Y. Baba, W. Fukumoto, T. Fuji, K. Awai; Hiroshima/JP

P-261 US HCC screening behavior before and after implementation of a structured reporting initiative J. Wildenberg, T. Gade, S. Hunt, G.J. Nadolski, M.C. Soulen; Philadelphia, PA/US

P-262 Non-enhanced T1-weighted images acquired after POSTERS microwave ablation are useful in the accurate evaluation of coagulated necrosis Z. Jia, Z.-Q. Yang; Nanjing/CN WITHDRAWN

P-263 Novel 4D MRI-based splenic function index for predicting hypersplenism-associated thrombocytopenia E.J. Keller1, L. Kulik1, Z. Stankovic2, R.J. Lewandowski1, R. Salem1, J.C. Carr1, S. Schnell1, M. Markl1, J.D. Collins1; 1Chicago, IL/US, 2Freiburg/DE

C RSE Posters 141

P-264 Visualization of CTO micro-channels in PAD patients with contrast-enhanced ultrasound R. Allan, H.-Y. Tan, P. Puckridge, I. Spark; Bedford Park, SA/AU

P-265 C-arm computed tomography (CACT) adds diagnostic information in patients suﬀering from chronic thromboembolic pulmonary hypertension (CTEPH) with a positive V/Q SPECT mismatch pattern J. Hinrichs, T. Werncke, T. Kaireit, M.M. Hoeper, K.M. Olsson, F. Wacker, F. Bengel, I. Schatka, B.C. Meyer; Hannover/DE

P-266 Selective intra-arterial dual-energy CT angiography (s-CTA) in lower-extremity arterial occlusive disease J. Swanberg, A. Wanhainen; Uppsala/SE

P-267 Prospective intraindividual comparison of time- resolved peripheral MRA with continuous table movement and 64-section CT angiography in patients with critical limb ischemia S.S. Byun, J.W. Kim; Incheon/KR

P-268 The value of true-FISP sequences in the pancreas and renal transplantation: a comparison with vascular sequences with gadolinium A. Cervera Araez, P. Bermudez, M. Burrel, M. Barrufet, A. Sotomayor, F.M. Gómez; Barcelona/ES

P-269 Usefulness of MR angiography high temporal resolution (twist) in the assessment of peripheral artery disease of lower limbs

A. Alegre Castellanos1, M. Redondo Olmedilla1, J. Delgado POSTERS Escudero1, M.A. Garrido Collado1, J. Garcia Revillo2; 1Jaén/ES, 2Cordoba/ES

P-270 Go ballistic: gunshot trauma and the role of interventional radiology D. Ballah, M. Wilson, E. Velez, V. Kumar, S. Nanavati, E. Lehrman, M.B. Conrad; San Francisco, CA/US

P-271 Iodinated contrast media for junior interventionalists: a potpourri of safety issues A. Khankan1, S. Al-Shehri1, M. Arabi1, T. Al-Hazmi2, F. Aris3, M. Al-Moaiqel1; 1Riyadh/SA, 2Makkah/SA, 3Montreal, QC/CA 142 CIRSE 2016 Pocket Guide

P-272 Grading of diaphragmatic injuries in major thoracoabdominal trauma for planning interventional radiology management P. Torcia1, U.G. Rossi1, P. Rigamonti1, G. Mauri2, V. Pedicini1, D. Poretti1, A.M. Ierardi3, G. Carraﬁello3, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT, 3Varese/IT

P-273 Anatomic variations of renal arteries: what the interventional radiologist needs to know P. Torcia1, U.G. Rossi1, P. Rigamonti1, A.M. Ierardi2, G. Carraﬁello2, M. Cariati1; 1Milan/IT, 2Varese/IT

P-274 Abdominal visceral pseudoaneurysm: spectrum of MDCT ﬁndings N. Hosaka, S. Sai, N. Seino, R. Abe, N. Mizobuchi, T. Gokan; Tokyo/JP

P-275 The role of pulmonary angiography (PA) in the evaluation and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH) A.S. Jo, M. Khaja, J. Haft, V. Mclaughlin, D. Williams; Ann Arbor, MI/US

P-276 Delayed hemorrhage caused by biliary metallic stent placement for malignant bile duct obstruction: clinical manifestations and endovascular treatment S. Noguchi, N. Sakamoto, T. Taniguchi, Y. Nakashima, T. Oda, M. Nishioka, T. Kadoba, H. Tomimatsu; Tenri/JP

POSTERS P-277 Percutaneous transvenous embolization of the thoracic duct in the treatment of chylothorax E. Paci, M. Refai, C. Mincarelli, P. Boscarato, M. Fichetti, M. Rosati, R. Candelari; Ancona/IT

P-278 Diagnosis and treatment of iatrogenic vertebrobasilar insuﬃciency caused by screws of posterior cervical spinal fusion S. Yamazoe, M. Katayama, Y. Nozawa, A. Baba, S. Inoue, Y. Munetomo, Y. Kobashi, T. Mogami; Chiba/JP

P-279 Ergotism: a rare cause of peripheral vascular ischemia M. Leyva Vásquez-Caicedo, J. González Nieto, J.E. Armijo Astrain, J.V. Méndez Montero; Madrid/ES

C RSE Posters 143

Neuro and carotid intervention

P-280 Experience with pCONus bifurcation aneurysm implant for wide-neck intracranial aneurysm treatment E. Pampana, A. Bozzi, S. Abrignani, S. Merolla, F. Chegai, D. Konda, R. Gandini; Rome/IT

P-281 External carotid artery angioplasty and stenting for patients with ischemic events A. Dimitriade, A.C. Carp, A. Mergeani, B. Dorobat, F.A. Anochi, G. Iana; Bucharest/RO

P-282 Mechanical thrombectomy using a Solitaire AB stent for cerebral venous sinus thrombosis S. Shui, T.-F. Li, X.-W. Han, J. Ma; Zhengzhou/CN

P-283 Predictors of poor outcome in anterior circulation mechanical thrombectomy S.M. Protto, N. Sillanpää, J.-P. Pienimäki, I. Matkaselkä, H. Numminen, J. Seppänen; Tampere/FI

P-284 Mechanical thrombectomy is superior to intravenous thrombolysis only in the most proximal anterior circulation occlusions N. Sillanpää, S.M. Protto; Tampere/FI

P-285 Viabahn stent-graft placement for emergent/urgent innominate, carotid, or vertebral artery disease: a single-center experience of 21 cases M. Horikawa, B.D. Petersen, R. Priest, H. Bozorgchami, A. Dogan, G. Nesbit, J.A. Kaufman; Portland, OR/US POSTERS P-286 Endovascular recanalization for ICA occlusion at the subacute to chronic stage: results and follow-up of a single-center experience V. Mayoral Campos, A. Laborda, J.A. Guirola Ortíz, C. Tejero, M.J. Gimeno Peribáñez, M.A. de Gregorio; Zaragoza/ES

P-287 Association of brain venous drainage with cerebral aneurysm formation and aneurysm rupture E. Duman, I. Çöven, E. Yıldırım; Konya/TR 144 CIRSE 2016 Pocket Guide

P-288 Comparison of embolization protection devices with proximal balloon device and ﬁlter device: procedural complications and embolic infarctions on DWI M.H. Rho, H.P. Hong; Seoul/KR

P-289 Targeting microRNA for treating ischemic stroke L. Zhang, Y.-J. Li, W.-S. Wei; Shanghai/CN

P-290 Internal carotid artery stenting in patients with the carotid string sign and/or its segmental obstruction P. Myrcha, P. Ciostek; Warsaw/PL

P-291 MicroNet covered stent in the treatment of vulnerable carotid plaque: short- and mid-term results V. Gavrilovic, A. Vit, A. Pellegrin, P. Divis, S. Cannizzaro, M. Sponza; Udine/IT

P-292 Learning curve of the transradial approach of percutaneous carotid intervention E.M. Végh1, B. Nemes1, B. Teleki2, B. Merkely1, K. Hüttl1, Z. Ruzsa2; 1Budapest/HU, 2Kecskemét/HU

P-293 Initial clinical experience with the micromesh roadsaver carotid artery stent for the treatment of patients with symptomatic carotid artery disease R. Gandini, F. Chegai, E. Pampana, S. Merolla, M. Stefanini; Rome/IT

P-294 Endovascular embolization of a traumatic POSTERS pseudoaneurysm of the superﬁcial temporal artery V.Z. Cvetic, B. Lukić, M. Colic; Belgrade/RS

P-295 Spontaneous occlusion of cerebral arteriovenous malformation following partial embolization with Onyx O.F. Nas, K. Ozturk, G. Gokalp, B. Hakyemez; Bursa/TR

P-296 Preoperative embolization in patients with tympanic glomus tumor recurrence A. Montana, S. Bonomo, G. Coniglio, S. Santonocito, C. Tilocca, G. Petrillo, V. Magnano San Lio, G. Giordano; Catania/IT

C RSE Posters 145

Oncologic intervention

P-297 Validation of clinical scoring systems ART and ABCR after transarterial chemoembolization of hepatocellular carcinoma R. Kloeckner, M.B. Pitton, C. Düber, I. Schmidtmann, S. Koch, P.R. Galle, M.A. Wörns, A. Weinmann; Mainz/DE

P-298 Clinical value of transcatheter (chemo-) embolization for older patients with hepatocellular carcinoma T. Aramaki, E. Bekku, R. Sato, K. Yoza, M. Moriguchi, K. Asakura, M. Endo; Shizuoka/JP

P-299 Radial versus femoral access for peripheral artery embolization E. Khayrutdinov1, A. Arablinskiy1, V. Tsurkan1, I. Vorontsov2; 1Moscow/RU, 2Omsk/RU

P-300 Preoperative devascularization of juvenile nasopharyngeal angioﬁbromas: direct percutaneous tumoral injection with cyanoacrylate glue in conjunction with particulate endovascular embolization M.A.O. Kasem, A.S. Awad, H. El Bosraty, A. Ismail; Cairo/EG

P-301 Embolization for renal angiomyolipoma using a micro-balloon catheter and ethanol Y. Sawada, M. Shimohira, T. Hashizume, T. Kawai, K. Ohta, K. Suzuki, Y. Furuta, K. Nakayama, T. Naiki, T. Nagai, T. Yasui, Y. Shibamoto; Nagoya/JP

P-302 Preoperative embolization of metastatic vertebrae POSTERS tumors K. Karska, K. Wojtal, M. Miazga, M. Sojka, T. Roman, K. Pyra, M. Szczerbo-Trojanowska; Lublin/PL

P-303 Release of Yttrium 90 from resin or glass microsphere used in radioembolisation of hepatocellular carcinoma: an in vitro stability study V. Ardisson, N. Lepareur, E. Garin, Y. Rolland; Rennes/FR 146 CIRSE 2016 Pocket Guide

P-304 Evaluation of therapy response to transarterial embolization by hyperpolarized 13C magnetic resonance spectroscopic imaging in a rat model of HCC G. Kaissis1, S. Düwel2, M. Durst2, C. Gringeri1, Y. Kosanke1, C. Groß1, M. Janich2, A. Haase2, S. Glaser3, M. Schwaiger1, R. Schulte2, M. Menzel2, R.F. Braren1; 1Munich/DE, 2Garching/DE, 3Melbourne, VIC/AU

P-305 Transarterial chemoembolization using polyethylene glycol drug-eluting beads pre-charged with doxorubicin (LIFDOX®) for the treatment of primary liver cancer: preliminary results C. Aliberti1, R. Carandina1, D. Sarti2, V. Catalano2, L. Mulazzani2, A. Felicioli2, P. Coschiera2, G. Fiorentini2; 1Padova/IT, 2Pesaro/IT

P-306 Practical tips for hepatic transarterial embolization with LC LUMITM radiopaque microspheres E. Levy1, G. Narayanan2, V. Krishnasamy1, R. Lencioni2, S. Venkat2, K. Sharma3, A. Lewis4, B.J. Wood1; 1Bethesda, MD/ US, 2Miami, FL/US, 3Washington, DC/US, 4Surrey/GB

P-307 Carbon dioxide gas digital subtraction angiography under temporary microballoon occlusion during transcatheter arterial chemoembolisation for hepatocellular carcinoma J. Koizumi1, T. Hara2, T. Sekiguchi2; 1Kanagawa/JP, 2Isehara/JP POSTERS

P-308 First human experience with directly imageable iodinated embolization microbeads E. Levy1, V. Krishnasamy1, A. Lewis2, S. Willis3, C. Macfarlane2, V. Anderson1, M. van der Bom4, A. Radaelli4, M. Dreher3, K. Sharma5, A. Negussie1, A. Mikhail1, J.-F.H. Geschwind6, B.J. Wood1; 1Bethesda, MD/US, 2Camberley/GB, 3Surrey/GB, 4Eindhoven/NL, 5Washington, DC/US, 6New Haven, CT/US

P-309 Transarterial ethanol–lipiodol embolization (TAELE): our experience of TAELE for intermediate HCC F. Fiore, R. D’Angelo, F. Somma; Naples/IT

C RSE Posters 147

P-310 Technical complications of hepatic arterial infusion chemotherapy: retrospective comparison of the placement of the catheter tip in the proper hepatic artery and in the gastroduodenal artery R. Imamine, T. Shibata, K. Shinozuka, A. Furuta, S. Arizono, H. Isoda, K. Togashi; Kyoto/JP

P-311 Radiofrequency ablation with a switching controller system of medium and large hepatocellular carcinoma: 3-year follow-up L. Tarantino1, P. Ambrosino2, P. Gallo3, P. Tarantino2, A. Nasto1; 1Pagani/IT, 2Naples/IT, 3Rome/IT

P-312 Microwave ablation of large HCCs by simultaneous multiple antennae insertion: long-term follow-up L. Tarantino1, P. Ambrosino2, P. Gallo3, P. Tarantino2, A. Nasto1; 1Pagani/IT, 2Naples/IT, 3Rome/IT

P-313 Percutaneous ablation of small HCCs: comparison of three commercially available microwave devices L. Tarantino1, P. Ambrosino2, P. Gallo3, P. Tarantino2, A. Nasto1; 1Pagani/IT, 2Naples/IT, 3Rome/IT

P-314 Radiofrequency ablation of gas gangrene of the liver in a high-risk patient: a case report L. Tarantino1, V. Iovino1, A. Sullo2, F. De Marco1, P. Gallo3, A. Nasto1; 1Pagani/IT, 2Nocera/IT, 3Rome/IT

P-315 Survival beneﬁt of transarterial chemoembolization for hepatocellular carcinoma O. Majeed1, I. Rehman1, W. Ahmad1, A. Iqbal1, S. Khawar2, K. Aftab3, I. Niazi1; 1Lahore/PK, 2Warner Robons, GA/US,

3Abu Dhabi/AE POSTERS

P-316 Percutaneous isolated hepatic perfusion (chemosaturation) in patients with primary or secondary liver tumours: experience in 20 patients S. Marquardt, M. Peperhove, T. Rodt, A. Vogel, F. Wacker; Hannover/DE

P-317 Long-term survival following ablation of colorectal liver metastases I.R. Andersen, F. Rasmussen, F.V. Mortensen, D.T. Nielsen; Aarhus/DK 148 CIRSE 2016 Pocket Guide

P-318 IRE of malignant hepatic tumors: subacute and follow- up MRI appearance of ablation zone M. Dollinger1, P. Koch2, C. Niessen2, L.P. Beyer2, T. Bley1, C. Stroszczynski2, P. Wiggermann2; 1Würzburg/DE, 2Regensburg/DE

P-319 Feasibility and histopathological performance of postablative hepatocellular carcinoma biopsy: is preprocedure biopsy still needed? S.D. Hajdu, R. Duran, P.E. Bize, C. Sempoux, A. Denys; Lausanne/CH

P-320 Provision of interventional oncology services in the United Kingdom: a pilot study J. Zhong1, P. Atiiga1, D.J. Alcorn2, D. Kay2, R. Illing3, D.J. Breen4, N. Railton5, I.J. McCaﬀerty6, P.J. Haslam7, T.M. Wah1; 1Leeds/GB, 2Glasgow/GB, 3London/GB, 4Southampton/GB, 5Chelmsford/GB, 6Birmingham/GB, 7Newcastle-upon-Tyne/GB

P-321 Phase II study of hepatic arterial infusion chemotherapy with oxaliplatin and 5-ﬂuorouracil for advanced hilar cholangiocarcinoma X. Wang1, J. Hu1, G. Cao1, Y. Cui1, X. Li2, X. Ji1, X. Zhu1, J. Li1, C. Hao1, B. Xing1, S. Lin1; 1Beijing/CN, 2Duluth, MN/US

P-322 Eﬃcacy and safety of drug-eluting bead (DEB) TACE with microspheres < 150 μm in the treatment of hepatocellular carcinoma POSTERS T. Sattler, C. Bredt, N. Woehrle, J. Rieger, T.F. Jakobs; Munich/DE

P-323 Prospective study to evaluate safety of DEB-TACE with 100 μ beads in patients with non-resectable HCC J. Urbano1, L. LLanos Jiménez1, J. Echevarria2, J. Sanchez Corral1, C. Lanciego3, J.J. Ciampi Dopazo3, B. Peña Baranda2, M. González de Garay2, R. González Costero4, S. Mendez4, J.J. Muñoz Ruiz-Canela5, L. Lopez-Carreira6, J. Cuesta Pérez1, V. Nacarino Mejias7, J.R. Pulpeiro Ríos6, J. Peiró de las Heras7, A. García Suárez4; 1Madrid/ES, 2Bilbao/ES, 3Toledo/ES, 4Majadahonda/ES, 5Málaga/ES, 6Lugo/ES, 7Sevilla/ES

C RSE Posters 149

P-324 Irreversible electroporation of the liver: is there a threshold for the volume of tissue to be ablated? F. Burdío, A. Ivorra, P. Sanchez, A. Radosevic, Q. Castellvi; Barcelona/ES

P-325 Frankfurt FAST-study: randomized trial using lipiodol + TACE or lipiodol + EmboCept®S + TACE in the treatment of patients with hepatocellular carcinoma T.J. Vogl, M. Langenbach, T. Gruber-Rouh, N.-E.A. Nour-Eldin, N.N. Naguib; Frankfurt/DE

P-326 Hepatic arterial infusion of FOLFOX for unresectable liver metastases due to colorectal cancer after systemic chemotherapy failure T. Ihaya, S. Takasugi, T. Ogawa; Yonago/JP

P-327 Secondary resectability of ocular melanoma liver metastases following percutaneous hepatic perfusion M. Zeile1, F. Bonk1, G.A. Stavrou1, C.U. von Sedewitz1, P. Mohr2, M. Beumer1, K. Niehaus1, A. Stang1, K.J. Oldhafer1, R.D. Brüning1; 1Hamburg/DE, 2Buxtehude/DE

P-328 Clinical utility of lung radiofrequency ablation in patients with pulmonary metastases due to malignant uterus tumor Y. Sugino1, T. Yamanaka1, K. Nakajima1, N. Matsushita1, T. Hasegawa2, M. Fujimori1, H. Takaki3, J. Uraki1, A. Nakatsuka1, K. Yamakado3; 1Tsu, Mie/JP, 2Nagoya, Aichi/JP, 3Nishinomiya, Hyogo/JP

P-329 Validation of the ART and HAP scoring systems for

predicting response to retreatment with TACE in a POSTERS Dutch multicenter HCC population J.F. Kint1, R.B. Takkenberg1, A. Moelker2, M.C. Burgmans3, H.J. Klumpen1, E. Ghariq3, O.M. van Delden1; 1Amsterdam/ NL, 2Rotterdam/NL, 3Leiden/NL

P-330 Results of the MIRACLE I study of DEB-TACE with doxorubicin-loaded Embozene Tandem Microspheres for hepatocellular carcinoma G.M. Richter1, B.A. Radeleﬀ2, C. Stroszczynski3, P.L. Pereira4, T.K. Helmberger5, P.E. Huppert6; 1Stuttgart/DE, 2Heidelberg/DE, 3Regensburg/DE, 4Heilbronn/DE, 5Munich/DE, 6Darmstadt/DE 150 CIRSE 2016 Pocket Guide

P-331 Transarterial chemoembolisation of hepatocellular carcinoma with 70–150 μm (M1) doxorubicin-loaded beads: a retrospective single-centre analysis S. Mafeld, A. Al-Khatib, F. Colgan, H. Reeves, N. Moyse, R. Jackson, P. Littler; Newcastle upon Tyne/GB

P-332 Intra-arterial (IA) chemotherapy of locally advanced pancreatic head cancer P. Tarazov, A. Polikarpov, A. Pavlovskij, A. Kozlov; St. Petersburg/RU

P-333 Retrograde-outﬂow percutaneous isolated hepatic perfusion using cisplatin: results and drug-dose correlation to adverse events S. Murata, S. Onozawa, T. Ueda, F. Sugihara, H. Yamaguchi, D. Yasui, I. Miki, A. Sakamoto, T. Mine, S.-N. Kumita; Tokyo/JP

P-334 Microwave ablation of colon cancer pulmonary metastases A.J. Gonzalez Aguirre, E.N. Petre, H. Kodama, J.P. Erinjeri, S.B. Solomon, N.E. Kemeny, C.T. Sofocleous; New York, NY/US

P-335 Comparison between image quality and diagnostic performance of cone-beam computed tomography (CBCT) during drug-eluting bead transarterial chemoembolization and multidetector computed tomography for the detection of hepatocellular POSTERS carcinoma P. Lucatelli, R. Argiro’, C. Cirelli, S.G. Corradini, M. Bezzi, C. Catalano; Rome/IT

P-336 Percutaneous cryoablation of tumors in solitary kidneys: safety, renal function and oncologic outcomes C. Cicero1, A. Marzio1, B. De Concilio1, F. Stacul2, S. Siracusano2, L. Balestrieri3, M. Urbani3, A. Pinzani4, F. Laganà4, M. Ciaccia5, G. Casarrubea6, F. Pittarello7, P. Pellegrini8, A. Celia1, A. Guarise1; 1Bassano Del Grappa/ IT, 2Trieste/IT, 3Aviano/IT, 4Dolo/IT, 5Treviso/IT, 6Padova/IT, 7Piove Di Sacco/IT, 8Gorizia/IT

C RSE Posters 151

P-337 Embolotherapy for neuroendocrine tumor liver metastases: prognostic factors for hepatic progression-free survival and overall survival J.X. Chen1, S.C. Rose2, S.B. White3, G. El-Haddad4, N. Fidelman5, H. Yarmohammadi6, D.Y. Sze7, N. Kothary7, K. Stashek1, E.P. Wileyto1, R. Salem8, D.C. Metz1, M.C. Soulen1; 1Philadelphia, PA/US, 2San Diego, CA/US, 3Milwaukee, WI/US, 4Tampa, FL/US, 5San Francisco, CA/US, 6New York, NY/US, 7Palo Alto, CA/US, 8Chicago, IL/US

P-338 Small renal tumor percutaneous ablation versus nephrectomy: treatment and clinical outcomes P. Lourenco, N. Bilbey, B. Gong, B. Halkier; Vancouver, BC/CA

P-339 Chemoembolization for HCC: results of a national survey conducted in 2015 on practices in France A. Fohlen1, J.-P. Tasu2, H. Kobeiter3, J.-M. Bartoli4, J.-P. Pelage1, B. Guiu5; 1Caen/FR, 2Poitiers/FR, 3Créteil/FR, 4Marseille/FR, 5Montpellier/FR

P-340 Percutaneous transluminal forceps biopsy combined with percutaneous transhepatic biliary drainage in the management of patients with obstructive jaundice A. Fohlen, C. Bazille, M.-A. Jegonday, B. Dupont, J. Lubrano, J.-P. Pelage; Caen/FR

P-341 Transarterial chemoembolization of advanced hepatocellular carcinoma using degradable starch microspheres

T. Yamanishi; Kochi/JP POSTERS

P-342 HIFU for prostate cancer: a 9-year experience of 1150 patients V.A. Solovov, M.O. Vozdvizhenskiy, A.E. Orlov; Samara/RU

P-343 Safety of transarterial embolization using 40-μm drug- eluting spheres loaded with irinotecan for treating hepatic metastases from colorectal cancer: a prospective evaluation G.M. Varano1, G. Mauri1, R. Foà1, L. Monfardini2, G. Bonomo1, P. Della Vigna1, M. Zampino1, P. Ravenda1, F. Orsi1; 1Milan/IT, 2Brescia/IT 152 CIRSE 2016 Pocket Guide

P-344 Impact of diﬀerent embolic agents for TACE procedures on VEGF levels post-treatment P. Wiggermann1, K. Krüger2, C. Niessen1, L.P. Beyer1, E. Hohenstein2, C. Stroszczynski1, P.L. Pereira2; 1Regensburg/DE, 2Heilbronn/DE

P-345 Validation of the clinical scoring system SNACOR (tumour Size and Number, baseline Alpha-fetoprotein, Child-Pugh, and Objective radiological Response) after TACE of HCC R. Kloeckner, M.B. Pitton, A. Mähringer-Kunz, C. Düber, I. Schmidtmann, S. Koch, P.R. Galle, A. Weinmann; Mainz/DE

P-346 Relationship between pre-TACE angiographic ﬁndings and post-TACE lipiodol deposition pattern on CT scan: correlation with pathologic ﬁndings S. Li, S. Sun, S. Wang, Y. Guo, L. Lenhart; Iowa City, IA/US

P-347 Radiofrequency ablation of primary lung carcinoma: results of a prospective multicenter trial J. Palussière1, J.-Y. Gaubert2, C. Meunier3, O. Bonnefoy4, F. Laurent1, F. Chomy1, T. de Baère5; 1Bordeaux/FR, 2Marseille/FR, 3Rennes/FR, 4Pau/FR, 5Villejuif/FR

P-348 Cross-sectional and angiographic predictors for arterio-venous shunting in HCC S. Alzaabi, Z. AlSafran, N. Hamour, F. AlMolani, A. AlNammi, M. AlMuhaish; Dammam/SA POSTERS

P-349 Clinical outcome of RADPLAT for external auditory canal carcinomas: chronological comparison with surgery N. Tanaka, A. Kuhara, M. Koganemaru, M. Kusumoto, M. Nabeta, T. Abe; Kurume/JP

P-350 Transarterial chemoembolization with 40-μm drug-eluting beads for treatment of hepatocellular carcinoma G. Greco1, T. Cascella1, F.G. Greco1, G. Calareso1, M. Vaiani1, A. Casale1, A.V. Marchianò1, R. Lanocita1, C. Morosi1, R. Nani2, C. Spreaﬁco1; 1Milan/IT, 2Bergamo/IT

C RSE Posters 153

P-351 Size of drug-eluting beads does not inﬂuence OS in patients with colorectal liver metastases in a salvage setting. A retrospective analysis of 167 patients S. Pluntke1, C. Schmitt1, M. Stahl1, S. Held1, D. Strumberg2, R. Dappen1, J.-A. Koch1; 1Essen/DE, 2Herne/DE

P-352 Needle-based confocal laser endomicroscopy (nCLE) during chemoembolization P.P. Rao, I. Enescu, E. Boatta, J. Garnon, G. Tsoumakidou, G. Koch, J. Caudrelier, R.L. Cazzato, M.-A. Thenint, A. Gangi; Strasbourg/FR

P-353 Needle-based confocal laser endomicroscopy during cryoablation P.P. Rao, G. Koch, J. Garnon, G. Tsoumakidou, R.L. Cazzato, J. Caudrelier, M.-A. Thenint, A. Gangi; Strasbourg/FR

P-354 Assessment of the parenchymal blood volume by C-arm computed tomography for radioembolization dosimetry G. Grözinger, R. Syha, K. Nikolaou, C. la Fougère, D. Ketelsen; Tübingen/DE

P-355 Transrectal ultrasound-guided prostate ﬁducial marker placement for image-guided radiotherapy in prostate cancer: safety and eﬃcacy based on a single- centre experience C.M. Chu, E. Dai, D. Poon, W. Tsang, M. Kam; Hong Kong/HK

P-356 Detection of local tumor recurrence by parenchymal

blood volume (PBV) mapping using cone beam CT POSTERS (DynaCT) after transarterial chemoembolization of hepatocellular carcinoma J.D. Kim, N.R. Kim, H.Y. Han, H.J. Kim, S.Y. Choi; Daejeon/KR WITHDRAWN

P-357 Microwave ablation of hepatic lesions at challenging locations V.D. Vo Chieu, F. Wacker, H.-J. Raatschen, K.I. Ringe; Hannover/DE 154 CIRSE 2016 Pocket Guide

P-358 Accuracy evaluation of microwave ablation with the Covidien Emprint system in hepatocellular carcinoma: do expected volumes correlate with in vivo results S. Venkat1, T. Froud1, N. Salas2, A. Checkver1, G. Guerrero1, R. Lencioni1, G. Narayanan1; 1Miami, FL/US, 2Coral Gables, FL/US

P-359 Safety and eﬃcacy of the Hansen Medical 6-Fr Magellan catheter in robotically-assisted pelvic and visceral embolization: comparison between two catheter designs C. Del Giudice, O. Pellerin, G. Amouyal, C. Déan, M.R. Sapoval; Paris/FR

P-360 “Double-combined” treatment of intermediate-size HCC: preliminary results in 31 patients A. Vit, S. Cannizzaro, A. Pellegrin, V. Gavrilovic, P. Divis, M. Sponza; Udine/IT

P-361 Comparison of microwave vs. radiofrequency ablation of HCC when combined with DEB-TACE: progression- free and overall survival analysis R.J. Durrani, D.M. Biederman, J.S. Virk, E. Dayan, R. Patel, A. Fischman, F.S. Nowakowski, R.A. Lookstein, E. Kim; New York, NY/US

P-362 Evaluation of robot-assisted irreversible electroporation of malignant hepatic tumors: ﬁrst results POSTERS L.P. Beyer, C. Niessen, B. Pregler, C. Stroszczynski, P. Wiggermann; Regensburg/DE

P-363 Prospective evaluation of stereotactic percutaneous irreversible electroporation of malignant hepatic tumors L.P. Beyer, C. Niessen, B. Pregler, C. Stroszczynski, P. Wiggermann; Regensburg/DE

P-364 Impact of tumour size on long-term survival after irreversible electroporation of malignant hepatic tumours C. Niessen, L.P. Beyer, C. Stroszczynski, P. Wiggermann; Regensburg/DE

C RSE Posters 155

P-365 Laparoscopic ultrasound-guided radiofrequency ablation of hepatic tumors M.-C. Chern, C.-W. Lin, T.-J. Tsai; Taipei/TW

P-366 Surgical resection versus radiofrequency ablation plus drug-eluting bead transcatheter arterial chemoembolisation in the treatment of single large hepatocellular carcinoma A. Posa, R. Iezzi, G. Coppola, E.G.M. Antonuccio, A. Gasbarrini, L. Bonomo; Rome/IT

P-367 Single-step treatment with combined radiofrequency and embolization in hepatocellular carcinoma: 14-year prospective study J. Urbano, M. Cabrera-Gónzalez, A. Alonso-Burgos, L. Paul-Ferrer; Madrid/ES

P-368 Comparison of thermal ablation and partial nephrectomy for the treatment of renal cell carcinoma in the surveillance, epidemiology, and end results (SEER) database population O. Mironov, A. Jaberi, J.R. Kachura; Toronto, ON/CA

P-369 Toward personalized radioembolization with glass microspheres: an examination of new Yttrium-90 glasses with intrinsic radiopacity X.F. Zhang1, M. Bligh1, F. Heelan1, J. Fraser1, E. Tonkopi1, G. Mawko1, J. Clarke1, D. Liu2, R.J. Lewandowski3, S.C. Goodwin4, R. Abraham1, D. Boyd1, S. Kehoe1; 1Halifax, NS/CA, 2Vancouver, BC/CA, 3Chicago, IL/US, 4Orange, CA/US

P-370 Diﬀerences in patient characteristics and long- POSTERS term outcomes between European and Asian patients treated with radiofrequency ablation for hepatocellular carcinoma M.C. Burgmans1, C.W. Too2, M. Fiocco1, A. Kerbert1, J. Schaapman1, M. Coenraad1, A.R. van Erkel1, B.S. Tan2; 1Leiden/NL, 2Singapore/SG

P-371 Safety of Y90 radioembolization after prior hemihepatectomy M. Zimmermann, M. Liebl, M.F. Schulze-Hagen, F. Pedersoli, P. Isfort, C. Kuhl, P. Bruners; Aachen/DE 156 CIRSE 2016 Pocket Guide

P-372 The beneﬁts of a new method of chemoembolization for pancreatic cancer E. Khayrutdinov, A. Arablinskiy, V. Tsurkan; Moscow/RU

P-373 Repeated transarterial chemoembolization with degradable starch microspheres (DSMs-TACE) of unresectable hepatocellular carcinoma: a prospective pilot study F. Chegai, S. Merolla, A. Orlacchio; Rome/IT

P-374 Safety and eﬃcacy of percutaneous renal ablation using a high-power microwave system D.K. Filippiadis, G. Velonakis, A. Mazioti, S. Spiliopoulos, K. Malagari, A.D. Kelekis, N.L. Kelekis; Athens/GR

P-375 The relationships between baseline liver function and perfusion before and after yttrium-90 radioembolization E.J. Keller, N. Chatterjee, T. Carroll, R. Salem, A. Nemcek Jr., R.J. Lewandowski, J.D. Collins; Chicago, IL/US

P-376 Are lung microwave ablations really unpredictable? In vivo swine tumor-mimic model-based algorithm L. Tselikas, C. Teriitehau, J. Adam, K. Doassans, B. Ba, G. Gravel, T. de Baère, F. Deschamps; Villejuif/FR

P-377 CT-guided ablation of soft-tissue sarcoma lung metastases: safety and oncological outcomes in a comprehensive cancer centre POSTERS N.I. Fotiadis, T. Oliver, J. Suntharanathan, C. Benson, R. Jones, A. Miah; London/GB

P-378 Validation of the risk-prediction model STATE score and START strategy to guide TACE treatment in patients with hepatocellular carcinoma A. Mähringer-Kunz, M.B. Pitton, C. Düber, R. Kloeckner, I. Schmidtmann, S. Koch, P.R. Galle, A. Weinmann; Mainz/DE

P-379 Local recurrence rate of ultraselective transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) D. Abo, Y. Sakuhara, T. Soyama, R. Morita, K. Kudo; Sapporo/JP

C RSE Posters 157

P-380 Y-90 microsphere radioembolization (TARE) of unresectable HCC: how safe is it in case of portal vein thrombosis? F. Somma, R. D’Angelo, F. Fiore; Naples/IT

P-381 Role of radiofrequency ablation in ﬁbromatosis K.B. Gala, S.S. Kulkarni, N.S. Shetty, A.M. Polnaya, R.S. Chivate, V.N. Bakare, P. Patel, A. Puri, A. Gulia, S. Banavali; Mumbai/IN

P-382 Percutaneous thermal ablation therapies in treatment of hepatocellular carcinoma: short mid-term follow- up results I.H. Sever, I.N. Akpinar, R. Ergelen, F. Gunduz, M. Sucu, D. Tuney; Istanbul/TR

P-383 Histologic subtype is an independent predictor of local recurrence after ablation of primary lung adenocarcinoma E. Ziv, S. Gao, J.P. Erinjeri, H. Yarmohammadi, F.E. Boas, W. Shady, E.N. Petre, C.T. Sofocleous, S.B. Solomon; New York, NY/US

P-384 Eﬃcacy and safety of radiofrequency ablation of subcapsular hepatocellular carcinoma without creating artiﬁcial ascites: a single-center experience A.K. Yadav, R. Bansal, A. Gupta; Delhi/IN

P-385 Hybrid DynaCT-guided hook-wire localization of pulmonary lesions prior to surgical resection in the same hybrid operating theatre C.M. Chu, E. Dai, C. Ng, R. Lau, R. Wong, S.C.-H. Yu;

Hong Kong/HK POSTERS

P-386 Ambulatory percutaneous lung biopsy with early discharge and Heimlich valve management of iatrogenic pneumothorax A. Saini, A. Tavare, D. Creer, S. Hare; Barnet, Hertfordshire/GB

P-387 Bowel and abdominal organ displacement techniques for liver ablation procedures N. Kwok, R. Arellano; Boston, MA/US 158 CIRSE 2016 Pocket Guide

P-388 Combination of navigational radiofrequency ablation device, ultrahigh viscosity cement vertebral augmentation and stereotactic radiotherapy for the treatment of spine metastasis J.-B. Zerlauth, L. Schiappacasse, J. Bourhis, R. Meuli; Lausanne/CH

P-389 CT-guided ablation for lung malignancy: 8-year data and outcomes S.R. Virdee, N. Kibriya, J. Evans; Liverpool/GB

P-390 Safety and eﬃcacy of closure devices in patients with coagulation disorder who underwent DEB TACE B. De Fina, M.A. Perin, N. Wolosker, F. Nasser, B.B. Aﬀonso, F.L. Galastri, R.N. Cavalcante, J.M.D. Motta Leal Filho, L.G.M. Valle, A.A.P.D. Azevedo; São Paulo/BR

P-391 Transarterial chemoembolization (TACE) for hepatocellullar carcinoma after balloon-occluded retrograde transvenous obliteration (BRTO) J.H. Kim, Y.H. Kim, C.S. Kim, Y.H.D. Kim, S.H. Jeong, S.H. Kim; Daegu/KR

P-392 Pictorial review of suboptimal enhancement and failure of CT arterial portogram using a hybrid CT-angiography system A. Bangaragiri, T.A.J. Urlings, N.K.K. Venkatanara simha, S. Leong, A. Gogna, C.W. Too, A. Patel, J.M. Chan, C.G. Padre, H.G.R. Lo, F.G. Irani, B.S. Tan, K.-H. Tay, POSTERS K. Damodharan; Singapore/SG

P-393 Agitated saline sonography: a simple technique for intraprocedural feeder identiﬁcation during transcatheter arterial chemoembolization of hepatocellular carcinoma K.P. Bellam Premnath1, B. Ray2; 1Aluva/IN, 2Ernakulam/IN WITHDRAWN

P-394 Drainage outﬂow from hypervascular hepatocellular carcinoma: what you need to know and why it is important in transcatheter arterial chemoembolization (TACE) T. Minami1, O. Matsui1, S. Miyayama2, A. Kitao1, N. Terayama3, S. Kobayashi1, W. Koda1, K. Kozaka1, D. Inoue1, K. Yoshida1, N. Yoneda1, T. Matsubara1, T. Gabata1; 1Kanazawa/JP, 2Fukui/JP, 3Takaoka/JP Posters 159

P-395 Irreversible electroporation for medium-size pancreatic adenocarcinoma K.-W. Huang; Taipei/TW

P-396 Parenchymal blood volume (PBV) determined by C-arm computed tomography: "one-stop-shop" transarterial chemoembolization of hepatocellular carcinoma R. Syha, K. Nikolaou, D. Ketelsen; Tübingen/DE

P-397 Role of n-butyl cyanoacrylate (glue) in vascular and non-vascular procedures in interventional radiology K.B. Gala, S.S. Kulkarni, N.S. Shetty, A.M. Polnaya, R.S. Chivate, J. Aiya, V.N. Bakare, P. Patel, P. Kumar, A. Patil; Mumbai/IN

P-398 Role of lipiodol in vascular and non-vascular procedures in interventional radiology K.B. Gala, S.S. Kulkarni, N.S. Shetty, A.M. Polnaya, R.S. Chivate, P. Patel, V.N. Bakare, J. Aiya, P. Kumar; Mumbai/IN

P-399 Techniques to avoid complications during percutaneous cryoablation for renal cell carcinomas: all that we should know K. Michimoto, K. Shimizu, Y. Kameoka, J. Miki, K. Kishimoto, S. Sadaoka; Chiba/JP

P-400 Microvascular plug (MVP) deployment in the venous outﬂow to reduce the liver–lung shunt prior to radioembolization A. Masrani, J. Tasse, U.C. Turba, B. Arslan; Chicago, IL/US POSTERS P-401 Distal portal vein embolisation through a trans-splenic access using microvascular plug (MVP) to reduce a high hepatopulmonary shunt due to arterio-portal shunting and hepatofugal ﬂow A. Masrani, U.C. Turba, B. Arslan; Chicago, IL/US

P-402 Treatment of esophagotracheal and esophagoaortic ﬁstula in an esophageal cancer patient with vascular plug, glue, and aortic stent graft J.M. Lee1, J. Ohm2; 1Bucheon/KR, 2Daejeon/KR 160 CIRSE 2016 Pocket Guide

P-403 Successful treatment of growing hepatocellular carcinoma (HCC) supplied by portal blood (PB) with transcatheter arterial chemoembolization (TACE) via an arterio-portal shunt: a case report H. Tomimatsu, T. Taniguchi, N. Sakamoto, Y. Nakashima, T. Oda, M. Nishioka, S. Noguchi, T. Kadoba, S. Noma; Tenri/JP

P-404 Transarterial chemoembolization for treatment of ACTH-producing neuroendocrine liver metastases M.A. Shorikov, O.N. Sergeeva, D. Frantsev, V. Panov, B. Dolgushin; Moscow/RU

P-405 A potential pitfall in emergency TAE for ruptured hepatic lesion: extravasation from extra-hepatic feeding vessels in a patient with previously untreated hepatic lesion T.Nishiyama; Tokyo/JP WITHDRAWN

P-406 A rare complication of DEB-TACE: gastric ulcer caused by migration of the embolic agent through the adhesion between superﬁcial HCC and the stomach M. Hirata, R. Watanabe; Matsuyama Ehime/JP

P-407 Iatrogenic arterio-biliary ﬁstula caused by repetitive transcatheter arterial chemoembolization and arterial infusion chemotherapy: three case reports POSTERS R. Sato, T. Aramaki, E. Bekku, K. Yoza, M. Moriguchi; Shizuoka/JP

P-408 Use of the Hansen Medical Magellan vascular robot in trans-arterial chemoembolisation of liver tumours M. Scicchitano, J. Koukounaras, G.S. Goh, Y. Huynh; Melbourne, VIC/AU

P-409 Surgically assisted cryoablation with nerve protection for extra-abdominal desmoid tumors: case reports S. Grosﬁlley, P.E. Bize, A. Denys; Lausanne/CH

P-410 How far could we go to ablate lung tumors? J. Palussière, A. Crombe, V. Catena, X. Buy, F. Bonichon; Bordeaux/FR Posters 161

P-411 Successful embolization of massive life-threatening bleeding following transoral giant glomus jugulare tumor biopsy A. Tarkhanov, E. Grebenev, A. Dorofeev, M. Kartashov; Yekaterinburg/RU

P-412 Percutaneous cryoablation for stage T1b renal cell carcinoma in a patient with a horseshoe kidney H. Maeda, K. Shimizu, Y. Kameoka, K. Michimoto, T. Yanagisawa, K. Kishimoto, S. Sadaoka; Chiba/JP

Others

P-413 Embolizing lung radiofrequency ablation tracks J. Izaaryene, J.-M. Bartoli, V. Vidal, A. Jacquier, J.-Y. Gaubert; Marseille/FR

P-414 Transarterial chemoembolization utilizing an expandable-tip antireﬂux microcatheter: a multi- institution study of safety, feasibility, and early outcomes J. Titano1, A. Arepally2, T. Fischbeck3, M. Katz3, A. Kim4, S.C. Rose5, A. Fischman1; 1New York, NY/US, 2Atlanta, GA/ US, 3Los Angeles, CA/US, 4Washington, DC/US, 5San Diego, CA/US

P-415 Lung shunt fraction in radioembolization: antireﬂux microcatheter versus end-hole catheters J. Titano1, A. Arepally2, A. Pasciak3, A. Fischman1; 1New York, NY/US, 2Atlanta, GA/US, 3Knoxville, TN/US

P-416 IR fellows’ professional identities and values across

four American medical centers POSTERS E.J. Keller1, S.A. Resnick1, S.O. Trerotola2, K. Valji3, M.S. Johnson4, R.L. Vogelzang1; 1Chicago, IL/US, 2Philadelphia, PA/US, 3Seattle, WA/US, 4Indianapolis, IN/US

P-417 Medical students’ understanding of interventional radiology (IR): time for an undergraduate IR curriculum Z. Alsaﬁ, V. Bhrugubanda, S. Ramachandran, A. Alsaﬁ, M.S. Hamady; London/GB 162 CIRSE 2016 Pocket Guide

P-418 Following a zero tolerance approach to inadequate patient preparation for interventional radiology procedures: implementation and early experience R.D. White; Cardiﬀ/GB

P-419 A functional model for measuring competence in interventional radiology: a national society of radiology experience P. Valdes Solis1, M.D. Ferrer-Puchol2, T. Moreno Sánchez3, F. Galindo1, J.L. del Cura-Rodriguez4; 1Marbella/ES, 2Alzira/ES, 3Huelva/ES, 4Bilbao/ES

P-420 Limitations reported in current interventional radiology literature: a systematic review M. Kuang, W. Warnica, M. Wang, B. Davis, H.R. Khosravi, M. Midia; Hamilton, ON/CA

P-421 A survey of interventional radiology resources in Canada 2015 – ’State of the Nation’ S. Modi, H. Baydoun, A. Gotra, K. Muchantef, L.-M.N.J. Boucher, T. Cabrera, C. Torres, D.A. Valenti; Montreal, QC/CA

P-422 Comparison of percutaneous marking for small pulmonary lesions using the dye emulsion versus a short hook wire before video-assisted thoracoscopic surgery K. Sawada1, M. Yabuta2, Y. Ishizaka1, A. Okumura1, T. Koyama1; 1Okayama/JP, 2Tokyo/JP POSTERS

P-423 Radiofrequency ablation of benign thyroid nodules: a prospective multicenter study S.L. Jung, J.H. Baek, J.H. Lee, J.Y. Sung, K.S. Kim, D. Lee, J.-H. Kim, J. Sim, S.M. Baek, D.G. Na, Y.K. Shong; Seoul/KR

P-424 Radiofrequency ablation for benign thyroid nodules: indications, treatment, and results V.A. Solovov, A.A. Makhonin, M.O. Vozdvizhenskiy; Samara/RU

C RSE Posters 163

P-425 One-year follow-up in patients treated with ultrasound-guided percutaneous radiofrequency ablation of benign thyroid nodules: therapeutic eﬃcacy and safety of the technique P. Rabuﬃ, S. Vagnarelli, A. Bruni, D. Morosetti, A. Spada, A. Santonati, D. Bosco, C. Ambrogi; Rome/IT WITHDRAWN

P-426 Acute eﬀects of Shexiang Tongxin dropping pills in patients with coronary slow ﬂow phenomenon S. Wang1, L. Chu1, Z. Xu1, G. Li2, C. Cui2, J. Chen1, N. Huangfu1; 1Ningbo/CN, 2Xi’an/CN

P-427 Accurate and reliable wire position tracking without ﬂuoroscopy using a 3D navigation system for angiography in the left renal artery: a phantom model study T. Kariyasu, K. Kuroki, Y. Masuda, S. Katase, H. Tateishi, K. Soejima, Y. Hosoi, T. Ikezoe, J. Shudo, T. Iwamoto, T. Nitatori; Tokyo/JP

P-428 Pediatric PICCs: when to give up C. Kaufman, E. Reiner, D. Silin, B. Dillon; New Haven, CT/US

P-429 Comparison of pedal and intranodal lymphangiography for thoracic duct embolization (TDE) of traumatic chylous leaks G.J. Nadolski, Y. Dori, J. Johnstone, M. Itkin; Philadelphia, PA/US

P-430 Microwave radiometry thermometry for the non-

invasive diagnosis of arterial vascular disease in POSTERS patients with suspected critical limb ischemia: a feasibility study S. Spiliopoulos1, V. Theodosiadou2, P.M. Kitrou2, N. Barampoutis2, K.N. Katsanos3, P. Davlouros2, D. Alexopoulos2, E. Siores4, D. Karnabatidis2; 1Athens/GR, 2Patras/GR, 3London/GB, 4Bolton/GB

P-431 The implementation of the Exoseal vascular closure device for transpopliteal artery puncture Ö. Balli, V. Çakir, R. Pekçevik, S. Gür; İzmir/TR 164 CIRSE 2016 Pocket Guide

P-432 Interventional radiology (IR) procedural training using Thiel cadaver simulation models: trainee survey J. Anwar, H.M. McLeod, J. Robertson, R. Duncan, T. Wilkinson, M. Gueorguieva, R. Bhat, A. Barclay, A. Melzer, J.G. Houston; Dundee/GB

P-433 Diagnostic and interventional radiology in trauma to children: from head to toe J. Tisnado, G. Morano, M. Pasyk; Richmond, VA/US

P-434 CT-guided pulmonary nodule microcoil localization technique, misplacement errors, and complications: a pictorial essay S.R. Alharbi; Riyadh/SA

P-435 Novel imaging and interventional techniques of the lymphatic circulation M. Hsu, M. Itkin; Philadelphia, PA/US

P-436 Eﬃcacy and safety of minimally invasive treatment in patients with benign parathyroid lesions E.J. Ha1, J.H. Baek2; 1Suwon/KR, 2Seoul/KR

P-437 Comparison of diﬀerent percutaneous accesses for treatment of chylothorax A.S. Jo, B.S. Majdalany; Ann Arbor, MI/US

P-438 Ultrasound-guided muscle injection of botulinum toxin A in children: how we do it? POSTERS B. Connolly, R. Gnannt, D. Fehlings, W. Mubarak, D.A. Parra; Toronto, ON/CA

P-439 Anatomy, variants, and embryologic development of the colonic vasculature: implications for the practicing interventionalist C. Schlager, R.C. Gaba, A. Lipnik, R.P. Lokken, J.T. Bui, C.E. Ray, Jr.; Chicago, IL/US

P-440 Adrenal arterial embolisation: a case-based demonstration of essential anatomical and technical considerations P.S. Najran, D. Mullan, J. Bell; Manchester/GB

C RSE Posters 165

P-441 Arterial embolisation in priapism B. Dorobat, A.C. Carp, A. Dimitriade, Y. El Mekkaoui, G. Iana; Bucharest/RO

P-442 Perfused human Thiel-embalmed cadaveric hepatic model: hi-ﬁdelity teaching model for advanced interventional radiology simulation training H.M. McLeod, B. Cox, J. Robertson, R. Duncan, R. Eisma, M. Gueorguieva, R. Bhat, A. Barclay, A. Melzer, J.G. Houston; Dundee/GB

P-443 Landscape of medical errors in interventional radiology: entire pathway of care F.R. Rawf, C.D. Bicknell, A.W. Darzi, M.S. Hamady; London/GB

P-444 Thoracic duct embolization with ethylene vinyl alcohol copolymer (Onyx™) V.G. Helyar, N. Walker, T. Routledge, T. Sabharwal; London/GB

P-445 Selective retrograde embolization of the chyle duct branch for post-operative lymph leak A. Masrani, U.C. Turba, B. Arslan; Chicago, IL/US

P-446 Treatment of a huge post-gastrectomy arterioportal ﬁstula with coil embolization using ﬂow control with balloon remodeling M. Inagaki1, H. Kobayashi1, Y. Someya1, H. Nakai2, Y. Onishi1, R. Yamashita2; 1Otsu/JP, 2Kyoto/JP

P-447 Hypohepatia following living donor liver

transplantation: treatment by transcatheter POSTERS embolization using a simulated three-dimensional printing vascular model T. Kugiyama, M. Koganemaru, H. Horiuchi, A. Kuhara, M. Nabeta, N. Tanaka, R. Iwamoto, M. Kusumoto, T. Abe; Kurume/JP

P-448 Serum adrenal medullary hormones levels during percutaneous cryoablation for adrenal metastasis from renal cell carcinoma Y. Kameoka, K. Michimoto, K. Shimizu, J. Miki, K. Kishimoto, S. Sadaoka; Chiba/JP 166 CIRSE 2016 Pocket Guide

P-449 Tension hemothorax, a life-threatening complication of percutaneous transhepatic access: management and review of literature M. AbdalKader, L. Coubeau, J. Lerut, P.P. Goﬀette; Woluwe Saint Lambert/BE

P-450 Ultrasound-guided retrograde cannulation of the supraclavicular thoracic duct for treatment of chylothorax A.S. Jo, B.S. Majdalany; Ann Arbor, MI/US

P-451 Clinically successful Penumbra suction thrombectomy of bilateral pulmonary emboli non-responsive to anticoagulation A. Masrani, U.C. Turba, B. Arslan; Chicago, IL/US

P-452 A case of aorto-bilateral common iliac artery graft presenting with an arterio-enteric ﬁstula causing life- threatening lower GI bleeding treated with a covered stent S.R. Alharbi; Riyadh/SA

P-453 Collateral venous pathway: a pitfall of adrenal venous sampling (AVS) for accurate diagnosis and localization of aldosterone-producing adenoma K. Seiji, H. Ota, K. Omata, M. Nezu, Y. Ono, Y. Iwakura, R. Morimoto, M. Kudo, F. Satoh, K. Takase; Sendai, Miyagi/JP

POSTERS P-454 A rare case of cerebral air embolism caused by pulmonary arteriovenous malformation after removing a central venous catheter T. Kugiyama, M. Koganemaru, A. Kuhara, M. Nabeta, N. Tanaka, R. Iwamoto, M. Kusumoto, T. Abe; Kurume/JP

P-455 Percutaneous closure of a paravalvular leak (PVL) in a patient with hemolytic anemia and complicated diabetic foot M. Lewandowski1, A. Wojtarowicz1, M. Pelczarska1, R. Sabiniewicz2, J. Gorący1; 1Szczecin/PL, 2Gdansk/PL WITHDRAWN

C RSE Posters 167

Peripheral vascular disease intervention

P-456 Endovenous radiofrequency-powered thermal ablation of the marginal venous system W. Uller, W.A. Wohlgemuth; Regensburg/DE

P-457 Retrograde transpedal revascularization of below-the- knee arteries in patients with critical limb ischemia after an unsuccessful antegrade transfemoral approach J.P. Goltz, F. Broos, M. Planert, M. Horn, M. Wiedner, M. Kleemann, J. Barkhausen, E. Stahlberg; Lübeck/DE

P-458 Agitation thrombolysis and catheter-directed thrombolysis for patients with massive pulmonary embolism Y. Bi, X.-W. Han; Zhengzhou/CN

P-459 Closure devices for iatrogenic thoraco-cervical vascular injuries G. Makris, R. Patel, M.W. Little, J.A. Sutcliﬀe, A.K. Allouni, M. Bratby, R. Uberoi; Oxford/GB

P-460 Usefulness and complications of the Crosser system in heavily calciﬁed below-the-knee arteries of hemodialysis patients T. Sato; Hiroshima/JP

P-461 A novel perfusion angiography technique for the interventional treatment of peripheral vascular disease J. Hinrichs1, T. Murray2, M. Brehm1, M. Akin1, M. Wilhelmi1,

F. Wacker1, T. Rodt1; 1Hannover/DE, 2Dublin/IE POSTERS

P-462 Long-term patency of balloon-expandable covered kissing iliac stents at the aortic bifurcation for the treatment of atherosclerotic occlusive disease M. Ugas, R. Norby, J. Patrie, S. Sabri; Charlottesville, VA/US

P-463 A comparative study of percutaneous atherectomy for femoropopliteal arterial occlusive disease: an experience of 160 patients Y.Q. Gu; Beijing/CN WITHDRAWN 168 CIRSE 2016 Pocket Guide

P-464 Primary stenting of the superﬁcial femoral artery in intermittent claudication gives improved health- related quality of life, ABI, and walking distance compared with non-invasive treatment – 6 month results of a prospective randomized multicenter trial H. Lindgren1, P. Qvarfordt1, M. Åkesson2, S. Bergman3, A. Gottsäter2; 1Helsingborg/SE, 2Malmö/SE, 3Gothenburg/SE WITHDRAWN

P-465 Predictors of clinical outcome following endovascular treatment of infrapopliteal disease in patients with critical limb ischaemia L. Biasi, S. Patel, I. Paraskevopoulos, C. Gordon, C. Adkin, T. Lea, T. Donati, A. Diamantopoulos, K.N. Katsanos, H. Zayed; London/GB

P-466 Lumivascular case series: OCT-guided CTO crossing followed by OCT-guided atherectomy with 6-month MRA follow-up A. Desai1, M. Brodmann2; 1Redwood City, CA/US, 2Graz/AT

P-467 Transradial access for femoral artery intervention Z. Ruzsa1, R. Bellavics2, B. Nemes1, F. Kuti2, E.M. Végh1, K. Hüttl1, B. Merkely1; 1Budapest/HU, 2Kecskemét/HU

P-468 Beyond the acute ischemic stroke application of a neurovascular aspiration device: thrombotic and embolic complications in polidistrectual peripheral POSTERS vessels successfully managed with the Penumbra Max System R. Gandini, S. Merolla, S. Abrignani, E. Pampana, F. Chegai, M. Muto; Rome/IT

P-469 Usefulness of laser Doppler tissue ﬂowmeter monitoring during endovascular therapy for peripheral artery disease K. Takayama1, K. Myouchin1, K. Kichikawa2; 1Yao City/JP, 2Kashihara, Nara/JP

C RSE Posters 169

P-470 Impact of patient and lesion characteristics on DEB PTA of the femoro-popliteal artery: pooled analysis of three controlled randomised trials T. Albrecht1, A. Ukrow1, G. Tepe2, J. Ricke3, T. Zeller4, M. Werk1, U. Speck1; 1Berlin/DE, 2Rosenheim/DE, 3Magdeburg/DE, 4Bad Krozingen/DE WITHDRAWN

P-471 e-MISAGO: 1-year outcome data from the largest real world nitinol stent registry J. Ruef1, G. Schmid2, O. Andrés3, T. Fuss4, I. Kralj5, M. Wierzgon6; 1Frankfurt/DE, 2Neuss/DE, 3Girona/ES, 4Suhl/DE, 5Karlsruhe/DE, 6Trinec/CZ

P-472 Impact of lateral angiograms with a knee-joint bent after popliteal artery stenting M. Planert, E. Stahlberg, J. Loesaus, M. Horn, M. Kleemann, J. Barkhausen, J.P. Goltz; Lübeck/DE

P-473 Decreased limb survival in diabetic patients with critical limb ischemia compared with non-diabetic patients M. Spreen1, H. Gremmels2, M. Teraa2, R. Sprengers2, M. Verhaar2, R. Statius van Eps1, J.-P. de Vries3, W.P.T.M. Mali2, H. van Overhagen1; 1The Hague/NL, 2Utrecht/NL, 3Nieuwegein/NL

P-474 Elevated ankle brachial index is related to a high amputation rate and cardiovascular comorbidity in patients with critical limb ischemia M. Spreen1, H. Gremmels2, M. Teraa2, R. Sprengers2, M. Verhaar2, J. Wever1, J.A. Vos3, W.P.T.M. Mali2,

H. van Overhagen1; 1The Hague/NL, 2Utrecht/NL, POSTERS 3Nieuwegein/NL

P-475 Infra-popliteal bypass versus angioplasty in patients with critical limb ischaemia compared using propensity score analysis S. Patel, L. Biasi, I. Paraskevopoulos, J. Silickas, T. Lea, A. Diamantopoulos, K.N. Katsanos, H. Zayed; London/GB

P-476 A comparison of clinical outcomes for diabetic and non-diabetic patients following Misago Rx nitinol stent implantation in the e-MISAGO registry S. Müller-Hülsbeck1, K. Wahl2, I. Kralj3, L. Kindl4, U. Radtke5, L. Bagnaschino Barco6; 1Flensburg/DE, 2Bautzen/DE, 3Karlsruhe/DE, 4Most/CZ, 5Aachen/DE, 6Torrevieja/ES 170 CIRSE 2016 Pocket Guide

P-477 The impact of Misago Rx nitinol stenting on clinical outcomes for the treatment in the bypass grafts from the e-MISAGO registry O. Andres Navarro1, S. Thebault2, M. Wierzgon3, I. Kralj4, C. Paetzel5, M. Kaduk6; 1Girona/ES, 2Tarbes/FR, 3Trinec/CZ, 4Karlsruhe/DE, 5Weiden/DE, 6Döbeln/DE

P-478 Do drug-eluting stents really work? A comparison of bare metal and drug-eluting SFA stenting in a large UK tertiary referral centre G.H. Tse, J. Smith, D. Turner, S.D. Goode; Sheﬃeld/GB

P-479 Alternative techniques for treatment of complex below-the-knee arterial occlusions in diabetic patients with critical limb ischemia S. Merolla, D. Konda, S. Abrignani, F. Chegai, E. Pampana, R. Gandini; Rome/IT

P-480 An early single-centre experience with the Phoenix Atherectomy System in patients with heavily calciﬁed femoro-popliteal lesions R. Gandini, F. Chegai, S. Merolla, M. Stefanini, S. Abrignani, D. Konda, E. Pampana; Rome/IT

P-481 Performance of Luminor drug-eluting balloon for revascularization in chronic limb ischemia: a Spanish prospective multicenter registry V. Riambau; Barcelona/ES

POSTERS P-482 Color-coded ﬂuoroscopy in the determination of peri- interventional stenosis grading in peripheral artery disease in an angiographic suite: an in vitro phantom study of feasibility and reproducibility P. Ghibes, G. Grözinger, U. Grosse, P. Martirosian, F. Schick, K. Nikolaou, D. Ketelsen, R. Syha; Tübingen/DE

P-483 Eﬀectiveness of Supera® stent placement in femoropopliteal lesions in patients with a poor distal run-oﬀ T. Zander, R. Herrera, E. Afanador, M. Valdes, M. Maynar; Santa Cruz De Tenerife/ES

C RSE Posters 171

P-484 Preliminary angiographic and 6-month clinical results of the CONSEQUENT trial T. Albrecht1, D.R. Meyer1, S. Müller-Hülsbeck2, I. Ott3, U. Redlich4, J. Ricke4, M.W. Waliscewski1, T. Zeller5, G. Tepe6; 1Berlin/DE, 2Flensburg/DE, 3Munich/DE, 4Magdeburg/DE, 5Bad Krozingen/DE, 6Rosenheim/DE WITHDRAWN

P-485 Endovascular treatment of arterial access site injuries with N-butyl cyanoacrylate embolization K. Akkan, H. Ozer, M. Yazol, E.T. Ilgit, B. Önal; Ankara/TR

P-486 Percutaneous iliofemoral venous stenting to treat post-thrombotic syndrome: long-term outcomes from a single center experience C. Del Giudice1, G. Goudot1, L. Marzano2, P.Y. Laﬀy1, O. Pellerin1, G. Amouyal1, T. Mirault1, E. Messas1, M.R. Sapoval1; 1Paris/FR, 2Rome/IT

P-487 Oﬀ-label employment of StarClose vascular closure device for antegrade puncture of the femoral artery in lower extremity revascularization: two-year experience P. Scalise, A. Grigolini, S. Vitali, V. Iodice, L. Giorgi, R. Cioni, A. Lunardi; Pisa/IT

P-488 Analgesic management and sedation in patients undergoing PTA of lower limbs M. Santl Letonja, R. Grkovski; Murska Sobota/SI

P-489 The dual-layer micromesh design for the stenting of thrombotic or ulcerated carotid artery stenotic lesions

and peripheral aneurysms POSTERS K. Akkan1, K. Karaman2, E. Ersoz1, A.M. Dökdök3, E.T. Ilgit1, B. Önal1; 1Ankara/TR, 2Istanbul/TR, 3Kocaeli/TR

P-490 Effectiveness of drug-eluting balloon angioplasty versus plain balloon angioplasty for the treatment of in-stent re-stenosis in patients with superficial femoral artery stents M.A.K. Kabuli, M. Abbas, S.D. Goode, D. Kusumawidjaja; Sheffield/GB

P-491 Regional anaesthesia aiding peripheral vascular intervention in patients with ischaemic rest pain D. Vishwanath1, C. Murch2, G. Haldane2; 1Glasgow/GB, 2East Kilbride/GB 172 CIRSE 2016 Pocket Guide

P-492 Treatment of spontaneous dissection of the celiac artery O. Ikeda, Y. Tamura, S. Inoue, M. Eguchi, Y. Yamashita; Kumamoto/JP

P-493 Leaving nothing behind: systematic review of the paclitaxel-coated PTA ballon angioplasty in the femoropopliteal segment N.P.W. Eckardt, C. Klumb, U. Teichgräber, R. Aschenbach; Jena/DE

P-494 Deepen the knowledge “behind” retrograde punctures for critical limb ischemia intervention: anatomical considerations to achieve optimal retrograde puncture S. Inui1, M. Yamamoto1, K. Yamada1, M. Horikawa2, K. Tanaka1, T. Kaji1; 1Tokorozawa/JP, 2Portland, OR/US

P-495 CTO revascularization: step-by-step SAFARI technique using a snare J. Ferreira, P.F. Sousa; Vila Real/PT

P-496 Retrograde crural and popliteal access and its role in challenging peripheral arterial occlusions: a pictorial review A. Alfahad, D.R. Shaw; Leeds/GB

P-497 Direct percutaneous NBCA embolization of recurrent internal iliac artery aneurysm with common iliac POSTERS arterial balloon occlusion to alter hemodynamics of the involved branches Y. Ogawa, H. Nishimaki, K. Murakami, K. Chiba, Y. Sakurai, K. Fujiwara, T. Miyairi, Y. Nakajima; Kawasaki, Kanagawa/JP

P-498 A novel method for inferior epigastric artery false aneurysm embolisation with thrombin: a case report P.E. Smith; Melbourne, VIC/AU

P-499 Successful balloon-assisted n-butyl cyanoacrylate embolization of puncture site bleeding T. Ueda, S. Murata, F. Sugihara, D. Yasui, I. Miki, H. Saitou, S.-N. Kumita; Tokyo/JP

C RSE Posters 173

P-500 Inadvertent cannulation of the left subclavian artery during central line placement: endovascular repair with covered stent J.D. Vasani, M. Hamblin, R. Kane; Evanston, IL/US

P-501 Intraprocedural foot embolization during SFA recanalization for in-stent restenosis: plantar-to-pedal loop aspiration thrombectomy technique using the Penumbra Max catheter R. Gandini, S. Merolla, E. Pampana, F. Chegai, S. Abrignani; Rome/IT

P-502 Recanalization and percutaneous transluminal angioplasty of persistent sciatic artery occlusion S. Breznik, B. Polanec; Maribor/SI

P-503 Temporary aneurysm neck occlusion during thrombin injection J. Ferreira, P.F. Sousa; Vila Real/PT

P-504 Retrograde tibial angioplasty for critical limb ischaemia of forefoot amputation stump wound through dorsalis pedis artery after a failed USG- guided pedal artery cannulation S. Narasimhan; Bangalore/IN

Radiation safety

P-505 Prostate artery embolisation (PAE): radiation doses to patient and operator S. Mafeld, S. Findlay, F. Colgan, R. Padgett, K. Robson, T. Page, P. Littler, P.J. Haslam; Newcastle upon Tyne/GB POSTERS P-506 Usefulness assessment through application of house- made radiation protection devices in TACE J.S. Kim, J.H. Shin; Seoul/KR

P-507 Radiation dose structured reports: helping to improve patient care in interventional practices J.M. Fernandez-Soto, E. Vano, R.M. Sanchez, J.I. Ten; Madrid/ES 174 CIRSE 2016 Pocket Guide

P-508 Measurements, analysis & comparison with calculations of peak skin doses during common interventional radiology ﬂuoroscopy procedures R. Suri; San Antonio, TX/US

P-509 Advantages of using a realtime robotic tracking system for CT-guided percutaneous cryoablation of renal tumors in terms of success of treatment and radiation exposure S. Quarchioni, F. Arrigoni, F. Bruno, A. La Marra, S. Mariani, L. Zugaro, A. Barile, C. Masciocchi; L’Aquila/IT

P-510 CT angiography during long-term follow-up after endovascular aneurysm repair (EVAR): combined dose reduction techniques R.A. Rotzinger1, J. Kahn1, G. Böning1, P. Freyhardt1, D.M. Renz2, B. Hamm1, F. Streitparth1; 1Berlin/DE, 2Jena/DE

P-511 Using the LIGHTSABER to reduce patient radiation dose during ﬂuoroscopy M.K. Singh1, J.H. Shah2, M. Wallace-Severa1, A. Narkiewicz-Jodko1, R. Koﬀ1, A. Lee1, S. Braverman1, S. Hartzman1; 1Santa Barbara, CA/US, 2New York, NY/US

P-512 Occupational exposures to ionizing radiation from interventional cardiology: literature and practice review A. Maschera; Venezia/IT POSTERS Renal and visceral artery intervention

P-513 Iatrogenic renal vascular injuries: what is the role of the interventional radiologist? F. Corvino1, M. Silvestre1, F. Giurazza2, A. Cervo1, A. Corvino1, F. Maglione1; 1Naples/IT, 2Rome/IT

P-514 Iatrogenic bleeding: interventional radiology to the rescue A.K. Yadav, R. Bansal, A. Gupta; Delhi/IN

P-515 The usefulness of CO2 angiography in detecting active bleeding from the colonic diverticulum E. Sugihara, S. Kawamoto; Osaka/JP

C RSE Posters 175

P-516 Cryptogenic hemoptysis: eﬀectiveness of bronchial artery embolization using n-butyl cyanoacrylate C.J. Yoon, C.H. Jeon, H. Lee, Y.-J. Kim, S.W. An, Y.N. Woo; Seongnam/KR

P-517 Proximal splenic embolization in a polytrauma patient: our experience A. Nivolli, D. Ivaldi, M. Arnò, A. Barile, P. Gazzo; Pietra Ligure (Savona)/IT

P-518 Tumor localization with a hook wire and selective arterial embolization of renal tumor in a hybrid operating room at the same time as laparoscopic partial nephrectomy: a new approach in renal surgery L. Besnier, A. Bouvier, P. Bigot, P. Panayotopoulos, A.-R. Azzouzi, C. Aubé; Angers/FR

P-519 Evaluation of eﬀects of induced ischemia (arterial vs. venous) on the extension of coagulation necrosis of RFA in the liver, spleen, and kidneys A. Rasekhi, G. Shadmani, K. Kazemi, E. Zaree, A. Monabati; Shiraz/IR

P-520 Long-term results of percutaneous endovascular treatment in patients with mesenteric ischaemia: bypass postponement... or renouncement? T. Bulut1, R. Oosterhof-Berktas2, R. Geelkerken1, M. Brusse- Keizer1, E. Stassen1, J. Kolkman1; 1Enschede/NL, 2Enschede/ Groningen/NL

P-521 Stent angioplasty of transplant renal artery stenosis A. Massmann, C. Marchal, S. Seiler-Mussler, M. Janssen,

M. Stöckle, A. Buecker; Homburg/DE POSTERS

P-522 Short- and long-term outcomes of percutaneous interventions for transplant renal artery stenosis: a 10-year experience A. Macdonald, M.W. Little, P. Boardman, R. Patel, M. Bratby, A.J. Wigham, J. Phillips-Hughes, R. Uberoi, S. Anthony, C.R. Tapping; Oxford/GB 176 CIRSE 2016 Pocket Guide

P-523 Assessing the effect of baseline manual dexterity and playing computer-games on catheter-wire manipulation in interventional radiology-naïve medical students Z. Alsafi, Y. Hameed, P. Amin, S. Shamsad, A. Alsafi, M.S. Hamady; London/GB

P-524 Variables predicting active extravasation and contrast- induced nephropathy in conventional angiography for acute intra-abdominal bleeding Z. Haber, H.W. Charles, J. Weisstuch, S. Kovacs, A.R. Deipolyi; New York, NY/US

P-525 Percutaneous revascularization for renal artery stenosis: outcome of renal function and blood pressure J. Moreno Negrete, A. Sotomayor, M. Barrufet, F.M. Gómez, J. Guitart, P. Bermudez, M. Burrel; Barcelona/ES

P-526 Endovascular treatment of hepatic artery hemorrhage after pancreaticoduodenectomy and extended hepatectomy: what should we do to decrease mortality and complications? T. Hasegawa, H. Ota, T. Matsuura, T. Sato, K. Seiji, F. Motoi, J. Yamauchi, M. Unno, K. Takase; Sendai, Miyagi/JP

P-527 Endovascular intervention in high-grade renal trauma: POSTERS a single trauma center experience of the safety, eﬃcacy, and clinical outcomes J.W. Kim1, S.S. Byun1, J.H. Kim1, J.H. Shin2, G.-Y. Ko2; 1Incheon/KR, 2Seoul/KR

P-528 Endovascular treatment of visceral artery aneurysms (VAAs) and pseudoaneurysms (VAPAs) in 100 patients: feasibility, technical and clinical success, complications and clinical outcome of covered stenting P. Marra, M. Venturini, M. Colombo, R. Chiesa, A. Del Maschio, F. De Cobelli; Milan/IT

C RSE Posters 177

P-529 Endovascular management of renovascular hypertension in a paediatric population: a 12-year single-centre experience N. Thulasidasan, N. Karunanithy; London/GB

P-530 Spontaneous abdominal haemorrhage secondary to Sutton-Kadir syndrome: a case series E. Lake, N. Chalmers; Manchester/GB

P-531 Special considerations for embolization in patients with blunt renal trauma J.W. Kim1, J.H. Kim1, S.S. Byun1, D.I. Gwon2, G.-Y. Ko2; 1Incheon/KR, 2Seoul/KR

P-532 Coil embolization for renal aneurysm in a patient with Leriche syndrome: usefulness of the dual- microcatheter technique and triple-coaxial system Y. Furuta, M. Shimohira, T. Hashizume, T. Kawai, K. Suzuki, K. Ohta, Y. Sawada, K. Nakayama, H. Nishikawa, Y. Shibamoto; Nagoya/JP

P-533 Concomitant transarterial and transvenous coil embolization for a large aneurysmal-type renal arteriovenous ﬁstula K. Nakayama1, M. Shimohira1, T. Hashizume1, T. Kawai1, K. Ohta1, K. Suzuki1, Y. Sawada1, Y. Furuta2, Y. Shibamoto2; 1Nagoya/JP, 2Aichi/JP

P-534 Stent-assisted coil embolization with a jailed catheter and trans-cell techniques for a broad-necked saccular aneurysm of the proximal renal artery: a case report M. Inoue, M. Tamura, S. Nakatsuka, S. Oguro, M. Jinzaki;

Tokyo/JP POSTERS

P-535 Selective bilateral renal artery embolization with acrylic microsphere particles in focal segmental glomerulosclerosis N. Dogan, O.F. Nas, B. Canver, K. Ozturk, G. Gokalp; Bursa/TR

P-536 Embolization for spontaneous adrenal hemorrhage T. Gentsu, T. Okada, N. Katayama, R. Tani, E. Ueshima, Y. Koide, K. Sofue, M. Yamaguchi, K. Sugimoto; Kobe/JP 178 CIRSE 2016 Pocket Guide

P-537 Application of Y-stent-assisted coil embolisation technique in the treatment of broad-neck visceral artery aneurysms B. Barry, G. Parker, D. Robinson, S. Dubenec, C. Rogan; Sydney, NSW/AU

P-538 Stent-graft placement for hepatic artery pseudoaneurysm within one month after living donor liver transplantation U.R. Kang1, G.-C. Kim2, Y.H. Kim1, C.S. Kim1, S.H. Jeong1; 1Daegu/KR, 2Jung Gu, Daegu/KR

P-539 Early renal allograft venous thrombosis: is thrombolytic treatment eﬀective? A. Pastor, C. Nieto, J.M. Martinez, M. Pons; Palma De Mallorca/ES

P-540 Thrombolysis of a superior mesentery artery graft stent thrombosis using an AngioJet thrombectomy system H. Baydoun, A. Gotra, L.-M.N.J. Boucher, D.A. Valenti; Montreal, QC/CA

P-541 Renal artery entrapment by hypertrophic diaphragmatic crus in a 17-year-old athlete with hypertension: a case report and literature review Y. Someya1, R. Yamashita2, H. Kobayashi1, M. Inagaki1, Y. Onishi1; 1Otsu/JP, 2Kyoto/JP

POSTERS P-542 Endovascular treatment of an iatrogenic SMA pseudoaneurysm using a ﬂow-diverter stent K. Karaman, A.M. Dökdök, O. Karadeniz; Kocaeli/TR

P-543 Hybrid procedures for penetrating trauma combining emergency abdominal surgery and interventional radiology: 2 cases Y. Kawahara, S. Kijima, A. Ugajin, Y. Koyashiki, H. Fujii, H. Kanazawa, T. Sasaki, H. Nakamura, H. Sugimoto; Shimotuke-shi, Tochigi/JP

P-544 Recurrent aberrant aneurysm shortly after initial aneurysm embolization in cases of suspected segmental arterial mediolysis (SAM) T. Hasegawa, K. Seiji, H. Ota, T. Matsuura, K. Takase; Sendai, Miyagi/JP C RSE Posters 179

P-545 Retrograde stenting of the celiac trunk via the superior mesenteric artery F. Pedersoli, P. Isfort, M. Zimmermann, M.F. Schulze- Hagen, M. Liebl, P. Bruners, C. Kuhl; Aachen/DE

P-546 Emergency endovascular treatment for idiopathic dissection of the superior mesenteric artery (SMA): a report of two cases S. Kasuya, H. Kikuchi, T. Sonokawa, M. Tanami, R. Ishikawa, T. Nakatsuka, N. Kitamura, M. Odashima, T. Inaoka, J. Toda, H. Terada; Chiba/JP

P-547 Repermeabilization of the celiac trunk with stent allowing Whipple surgery in a patient considered unresectable due to celiac trunk stenosis C.J. Gonzalez Nieto, J.V. Méndez Montero, M. Leyva Vásquez-Caicedo, J.E. Armijo Astrain; Madrid/ES

P-548 Splenic artery embolisation for treatment of small-for- size liver remnant following resection M.A. Gelabert, J. Codina, S. López-Ben, M. Casellas, V. Cuba, A. Codina Barreras, S. Pedraza; Girona/ES

TIPS and portal vein intervention

P-549 Overnight balloon-occluded retrograde transvenous obliteration for gastric varices: value of the next-day CT H.-C. Kim, M. Lee, M. Kim; Seoul/KR

P-550 Factors predicting hypertrophy of the future liver remnant after preoperative percutaneous

transhepatic portal vein embolization with ethanol POSTERS Y. Sakuhara, D. Abo, T. Soyama, R. Morita, T. Kimura, K. Kudo; Sapporo/JP

P-551 Curative treatment option for hepatocellular carcinoma (HCC) patients beyond the Barcelona criteria: sequential embolization before hepatectomy P. Pajor, I. Dudás, A. Zsirka-Klein, D. Bárdos, L. Harsányi, P. Kupcsulik, O. Hahn; Budapest/HU 180 CIRSE 2016 Pocket Guide

P-552 Hepatocellular carcinoma with portal vein tumor thrombus and its treatment with transarterial chemoembolization combined with computed tomography-guided 125iodine implantation: a retrospective controlled study H.-T. Hu; Zhengzhou/CN

P-553 PV malignant thrombus percutaneous recanalization by endoportal RFA and stenting – the rationale, technique and early results M. Mizandari1, N. Habib2, T. Azrumelashvili1; 1Tbilisi/GE, 2London/GB

P-554 Endovascular treatment of symptomatic Budd–Chiari syndrome: in favor of early TIPS K.L.C. Rosenqvist1, R. Sheikhi1, L.-G. Eriksson1, R. Rajani2, F. Rorsman1, P. Sangfelt1, R. Nyman1; 1Uppsala/SE, 2Stockholm/SE

P-555 Impact of transjugular intrahepatic portosystemic shunting on liver transplantation: a single-center experience R. Gandini, F. Chegai, A. Lacché, S. Merolla, E. Pampana; Rome/IT

P-556 Transfemoral transcaval core-needle liver biopsy and portal pressure measurement: a single-center experience with the ﬁrst 100 cases C. Shabrang, J. Cho, D. Krausz, Y. Golowa, M. Jagust, POSTERS J. Cynamon; New York, NY/US

P-557 Polytetraﬂuoroethylene (e-PTFE)-covered transjugular intrahepatic portosystemic shunt (TIPS) after liver transplantation: a single-center experience L. Maruzzelli, M. D’Amico, I. Petridis, F. Tuzzolino, R. Miraglia, A. Luca; Palermo/IT

P-558 Transjugular portosystemic shunt (TIPS) in cirrhotic patients with portal vein thrombosis S. Lombardo Galera, J.J. Espejo Herrero, M.E. Perez Montilla, L.J. Zurera Tendero; Cordoba/ES

C RSE Posters 181

P-559 Portal vein stent placement with or without varix embolization for the management of jejunal variceal bleeding in patients with previous hepatopancreatobiliary surgery D.J. Shim, J.H. Shin, Y. Kim, K. Han, E.T. Kim, W.S. Choi, E. Jang; Seoul/KR

P-560 Parallel stent-technique for reduction of transjugular intrahepatic portosystemic stent-shunt in patients with hepatic encephalopathy and as bridging in acute liver failure: technical feasibility and clinical outcome in six patients T.L. Gockner1, K.-H. Weiss2, H.U. Kauczor2, B.A. Radeleﬀ2; 1Mainz/DE, 2Heidelberg/DE

P-561 Transsplenic approach for portal intervention in the presence of massive portal vein thrombosis and massive ascites D. Yasui, S. Murata, T. Ueda, H. Yamaguchi, F. Sugihara, I. Miki, H. Saitou, S.-I. Kumita; Tokyo/JP

P-562 Long-term outcomes of endovascular intervention for portal vein inﬂow disturbance after liver transplantation H.D. Jung; Anyang-si, Gyeonggi-do/KR

P-563 Portal vein embolisation: North Brisbane (Australia) experience K. Seow, N. Kienzle; Herston, QLD/AU

P-564 Ectopic varices: anatomical classiﬁcation, hemodynamic classiﬁcation, and management

by balloon-occluded retrograde and antegrade POSTERS transvenous obliteration (B-RTO and B-ATO) T. Matsubara, T. Minami, S. Kobayashi, W. Koda, K. Kozaka, T. Ogi, D. Inoue, A. Kitao, K. Yoshida, N. Yoneda, T. Gabata; Kanazawa/JP

P-565 Embolization of a coronary varix through recanalized paraumbilical vein in a cirrhotic patient C.H. Kang1, S.B. Yang2, H.J. Kim3, W.-H. Lee4, J.M. Lee5; 1Gangneung/KR, 2Gumi/KR, 3Daejeon/KR, 4Cheonan/KR, 5Bucheon/KR 182 CIRSE 2016 Pocket Guide

P-566 Vascular plug for partial TIPS occlusion L. Paul-Ferrer, A. Alonso-Burgos, M. Cabrera-Gónzalez, J. Urbano; Madrid/ES

P-567 Arterial embolization of a post-traumatic extrahepatic arterioportal ﬁstula P. Tarazov, A. Polikarpov; St. Petersburg/RU

P-568 Use of an Amplatzer vascular plug for the treatment of an aneurysmal intrahepatic portosystemic shunt in an adult F. Petrocelli, A. Utili, G. Salsano, G. Bovio, F. Camerano, C. Ferro; Genoa/IT

P-569 Severe cholangitis post-portal vein embolisation: lessons to be learned K. Seow, N. Kienzle; Herston, QLD/AU

P-570 Obliteration of mesocaval shunt with detachable coils and cyanoacrylate from the inlet to the outlet of the tract through a balloon catheter in a patient with hepatic encephalopathy J. Toda, T. Kimura, S. Kasuya, H. Terada, Y. Hirayama; Chiba/JP

P-571 Double balloon-occluded retrograde transvenous obliteration (BRTO) using a pull-through technique for the treatment of duodenal varices with two draining veins POSTERS Y. Koide, T. Okada, T. Gentsu, R. Tani, N. Katayama, E. Ueshima, K. Sofue, M. Yamaguchi, K. Sugimoto; Kobe/JP

P-572 Dual-access, antegrade and retrograde, embolization of large gastric fundal varices J.E. Armijo Astrain, M. Leyva Vásquez-Caicedo, C.J. Gonzalez Nieto, J.V. Méndez Montero; Madrid/ES

P-573 Direct intrahepatic portocaval shunt (DIPS) utilizing femoral access only for acute esophageal bleeding varices A. Masrani, J. Tasse, U.C. Turba, B. Arslan; Chicago, IL/US

C RSE Posters 183

P-574 Percutaneous treatment of a complex case of PD stone obstruction-induced pancreatitis complicated with diabetes, peripancreatic hematoma, and PV thrombosis M. Mizandari, T. Azrumelashvili; Tbilisi/GE

P-575 Interventional management of a diﬃcult case of recurrent umbilical caput bleeding V. Jain, A.H. Khandelwal, S.S. Baijal, D. Jain, A.K. Kapoor; Gurgaon/IN WITHDRAWN

P-576 Stent placement for portal vein stenosis E. Shibata, N. Okura, T. Hidemasa, J. Sato, K. Ohtomo; Tokyo/JP

P-577 Rheolytic mechanical thrombectomy for occluded TIPSS P. Kumar, S. Srinivasan; Liverpool/GB

P-578 Iatrogenic injury of the superior mesenteric vein A. Pastor, C. Nieto, M. Sastre, J. Pueyo, J.M. Martinez, B. Rodriguez; Palma De Mallorca/ES

P-579 Two cases of bleeding small intestinal varices successfully treated by balloon-occluded retrograde transvenous obliteration (B-RTO) using n-butyl-2- cyanoacrylate K. Masuda, S. Takenaga, H. Ashida, K. Enoki; Tokyo/JP

P-580 Portal stenting for post-operative portal thrombosis due to a kink at the portal trunk

Y. Kodama, Y. Sakurai, Y. Yoshino, Y. Ambo; Sapporo/JP POSTERS

P-581 A case of successful recanalization and stent placement for chronic portal vein obstruction after pylorus-preserving pancreatoduodenectomy H. Kondo1, Y. Tanahashi1, M. Osawa1, T. Yamamoto1, M. Inoue1, M. Yamamoto2, S. Onozawa1, S. Furui1; 1Tokyo/JP, 2Tokorozawa/JP 184 CIRSE 2016 Pocket Guide

P-582 Successful transjugular intrahepatic portosystemic shunts with embolization in the treatment of bleeding esophageal varices refractory to endoscopic management: anatomical change of esophageal varices after gastrectomy Y.J. Kang1, H.O. Kim2, N.Y. Yim2, B.C. Lee2, J.K. Kim2; 1Jeollanam-do/KR, 2Gwangju/KR

P-583 Transsplenic gastric fundal varices embolization and multiple splenic arteries embolization to manage untreatable gastric bleeding in a patient with chronic splenic vein occlusion R. Gandini, S. Merolla, E. Pampana, F. Chegai, S. Abrignani; Rome/IT

P-584 Transjugular thrombolysis followed by TIPS for an acute portal venous thrombosis Y. Takeuchi1, N. Hayashi1, Y. Ichijo1, H. Shirasu2, T. Nishimura1; 1Kyoto/JP, 2Fukuchiyama/JP

P-585 Complex endovascular treatment of a malignant portomesenteric vein occlusion T. Ključevšek; Ljubljana/SI

P-586 Venous graft thrombosis and perforation following modiﬁed Whipple procedure: endovascular management and review of literature M. AbdalKader, C. Bourdeaux, P.P. Goﬀette; Brussels/BE

POSTERS P-587 Two cases of rectal varices treated with balloon- occluded antegrade transvenous sclerotherapy N. Seino1, S. Sai1, N. Hosaka1, Y. Ohgiya1, R. Abe1, N. Mizobuchi1, M. Honda2, T. Gokan1, M. Hasegawa3; 1Shinagawa City/JP, 2Yokohama/JP, 3Koto City/JP

P-588 Successful trans-splenic recanalization of a completely occluded main portal vein in a pediatric liver transplant patient A.S. Jo, R. Srinivasa; Ann Arbor, MI/US

P-588a Portal biliopathy U.G. Rossi1, P. Torcia1, P. Rigamonti1, F. Petrocelli2, M. Cariati1; 1Milan/IT, 2Genoa/IT

C RSE Posters 185

Urinary tract intervention

P-589 Factors inﬂuencing success of percutaneous renal access by radiology for subsequent percutaneous nephrolithotomy M. Patel, D. Jilani, O. Ahmed, T.G. Van Ha, J.M. Lorenz, J.A. Leef; Chicago, IL/US

P-590 Percutaneous nephrostomy placement for urosepsis: is it that urgent? T.G. Tullius, M. Patel, J.A. Leef, J.M. Lorenz, T.G. Van Ha; Chicago, IL/US

P-591 Fluoroscopy-guided transurethral exchange of the double-J ureteral stent in women T.-S. Seo1, M.G. Song1, Y.H. Kim1, S.B. Cho1, H.H. Chung2, S.H. Lee2; 1Seoul/KR, 2Ansan/KR

P-592 Self-expanding stents for treating ureteral strictures and ﬁstulae J.R. Torrecilla García-Ripoll, J.M. Díaz Romero, M. Udaondo Cascante, A. Hermosín Peña, F.J. Trueba Arguiñarena, S. Martín Martín, J.R. Cortiñas González; Valladolid/ES

P-593 Endourologic treatment of ureteral stenosis in children: our experience M.E. Perez Montilla, S. Lombardo Galera, J.J. Espejo Herrero, L.J. Zurera Tendero; Cordoba/ES

P-594 Small renal masses and percutaneous biopsy: where are we?

A. Paladini, G. Pizzi, G. Vallati, D. Beomonte Zobel, POSTERS F.M. Danza; Rome/IT

P-595 Covered self-expanding metallic stents for recurrent ureteric stenosis in renal transplant patients A. Gotra1, H. Baydoun1, P. Delli Fraine1, A. Bessissow1, S. Modi2, M. Schmidt1, L.-M.N.J. Boucher1, D.A. Valenti1; 1Montreal, QC/CA, 2Southampton/GB

P-596 Prostate artery embolization with CO2 for giant prostatic hyperplasia I.M. Kably; Miami, FL/US 186 CIRSE 2016 Pocket Guide

P-597 Positive antegrade ureteric transluminal biopsy using a biliary biopsy forceps kit G. Aruede, P. Ignotus, C. Wetton, J. Donohue, A. Shaw; Kent/GB

P-598 Diﬃcult removal of a covered metallic ureteric stent in a renal transplant patient using a retrograde approach A. Gotra, H. Baydoun, M. Schmidt, P. Delli Fraine, A. Bessissow, L.-M.N.J. Boucher, D.A. Valenti; Montreal, QC/CA

P-599 Dedicated renal tract closure: a step towards single- step renal intervention S.D. Goode, F. Sakhinia, F. Lee; Sheﬃeld/GB

Venous intervention and IVC ﬁlters

P-600 Percutaneous embolization in pelvic congestive syndrome: long-term results M.D. Ferrer-Puchol, R. Ramiro Gandia, M. Leon Donoso, E. Esteban Hernández, P. Fariñas Alijo, G. Sempere-Campello; Alzira/ES

P-601 Outcome of endovascular treatment (BRTO/PTO) for visceral varices due to portal hypertension in one institute Y. Baba, T. Fuji, M. Ishikawa, K. Kajiwara, W. Fukumoto, K. Awai; Hiroshima/JP

POSTERS P-602 Embolization for erectile dysfunction due to venous leakage R. Aschenbach, U. Teichgräber, T. Franiel; Jena/DE

P-603 Intraplug coil delivery for fast closure of giant arteriovenous ﬁstula aneurysm in dialyzed patients: case series and literature review R. Gandini, F. Chegai, S. Merolla, D. Konda, E. Pampana; Rome/IT

P-604 Techniques of adrenal venous sampling in cases with double inferior vena cava K. Endo, S. Morita, S. Suzaki, H. Yamazaki, Y. Nishina, S. Sakai; Tokyo/JP

C RSE Posters 187

P-605 Investigation on proper locations and shapes of port-catheter implantation to prevent port-catheter dysfunction K. Matsunari, H. Fujisawa, T. Kushihashi; Kanagawa/JP

P-606 IVC ﬁlter retrieval rates and reasons for non-retrieval S. Sayeed, C.J. Hammond; Leeds/GB

P-607 Isolated pharmacomechanical thrombectomy in Paget–Schroetter syndrome J.M. Kärkkäinen1, T. Riekkinen1, E. Sihvo2, J. Turtiainen1, P. Saari1, K. Mäkinen1, H.I. Manninen1; 1Kuopio/FI, 2Jyväskylä/FI

P-608 A new technique for venous insuﬃciency treatment: vein sealing system O. Rodoplu; Bilecik/TR

P-609 Comparing early results for the treatment of acute and subacute iliofemoral deep vein thrombosis with rotational thrombectomy catheter and only medical treatment O. Rodoplu; Bilecik/TR

P-610 A comparison between Denali and Cook IVC filters: should a "difficult" filter retrieval alter practice? A. Baheti, D. Nicholson, J. Patrie, A. Uflacker, A.W. Park, S. Sabri, J.R. Stone, Z.J. Haskal, J.F. Angle, L. Wilkins; Charlottesville, VA/US WITHDRAWN

P-611 Geometric changes of the Crux inferior vena cava ﬁlter

within varying caval diameters POSTERS R. Sincic, V. Kumar, K. Lobo, J.M. Jeﬀerson, M.B. Conrad, S. Nanavati, D. McCoy, M. Saeed, S. Hetts, M. Wilson; San Francisco, CA/US

P-612 Caval penetration by retrievable and non-retrievable IVC ﬁlter: a retrospective study conducted in 3 community-based hospitals of North Chicago J.D. Vasani, M. Hamblin; Evanston, IL/US 188 CIRSE 2016 Pocket Guide

P-613 Retrievable inferior vena cava ﬁlters for pulmonary embolism prevention: long-term clinical and CT follow-up after retrieval A. Laborda, J.A. Guirola Ortíz, V. Mayoral Campos, C. Lahuerta, J. Bosch Melguizo, M.A. de Gregorio; Zaragoza/ES

P-614 The role that an IR department plays in association with PE mortality J.A. Guirola Ortíz1, A. Laborda1, V. Mayoral Campos1, C. Lahuerta1, W.T. Kuo2, M.A. de Gregorio1; 1Zaragoza/ES, 2Stanford, CA/US

P-615 Device-speciﬁc complication rates in retrievable inferior vena cava ﬁlters: a systematic review and meta-analysis M.F. Errea1, R.J. Lewandowski1, J. Karp1, R. Ryu2, K.R. Desai1; 1Chicago, IL/US, 2Aurora, CO/US

P-616 Endovascular treatment of iliofemoral deep vein thrombosis in pregnancy by using ultrasound-guided percutaneous aspiration thrombectomy M. Gedikoglu1, L. Oguzkurt2; 1Adana/TR, 2Istanbul/TR

P-617 Cardiac arrhythmias in children with peripherally inserted central catheters (PICCs) B. Connolly1, S. Dhillon2, O. Shearkhani1, R. Hamilton1; 1Toronto, ON/CA, 2Halifax, NS/CA

POSTERS P-618 Adrenal vein sampling with and without cone beam CT acquisitions: outcome in a low-volume center K.I. Ringe, F. Wacker, C. Terkamp, B.C. Meyer; Hannover/DE

P-619 Thrombolysis and endovascular treatment of acute iliofemoral DVT: a 5-year single-center retrospective experience S. Habib; Nottingham/GB

P-620 Carbon dioxide cavography for IVC ﬁlter retrieval: a safety and eﬃcacy study S.A. Gupta1, K.R. Desai1, S. Desai1, R. Ryu2, R.J. Lewandowski1; 1Chicago, IL/US, 2Aurora, CO/US

C RSE Posters 189

P-621 A multicenter evaluation of the Celect Platinum IVC ﬁlter R.G. McWilliams1, I. Wilson2, R. Allison2, T. Chan1, R. Lakshminarayan3, J.A. McCann-Brown4, G.J. Robinson3; 1Liverpool/GB, 2Southampton/GB, 3Hull/GB, 4West Lafayette, IN/US WITHDRAWN

P-622 Perforations associated with peripherally inserted central catheters (PICCs) in neonates B. Connolly1, A. Sertic2, K.-S. Lee1; 1Toronto, ON/CA, 2Dublin/IE

P-623 Sclerotherapy and vein gluing combined as a single procedure for saphenous veins J.C. Ragg; Berlin/DE

P-624 Outcome and histological analysis of explanted inferior vena cava ﬁlters T. Annweiler1, L. Bertoletti1, F.G. Barral2; 1Saint Priest En Jarez/FR, 2Saint-Etienne/FR

P-625 Establishing standard venous anatomy references for Angel Catheter insertion to guide the final position of the catheter filter M.R. Akhtar, J. Kyaw Tun, J. Saeed, J.-Y. Chun, O.S. Jaffer, N. Bunker, T. Fotheringham; London/GB

P-626 Two-year outcome after MOCA C. Teichert; Rostock/DE

P-627 Peripherally inserted central catheter in paediatric

population POSTERS A. Fohlen, F. Villedieu, J.J. Parienti, J.-P. Pelage; Caen/FR

P-628 Magnetic resonance venogram (MRV) using the blood-pool contrast agent gadofosveset trisodium versus gadolinium: comparison of image quality and vessel identiﬁcation and application to venous interventions H. Ferral, S. Regalado, M. Alonzo; Evanston, IL/US

P-629 Revisited diagnostic interventional endocrinology: IPSS, AVS, and ASVS N.Y. Yim, Y.J. Kang, H.O. Kim, B.C. Lee, H.D. Jung, J.K. Kim; Gwangju/KR 190 CIRSE 2016 Pocket Guide

P-630 The role of interventional radiology in venous blood sampling revisited G. Morano1, M. Pasyk1, J. Tisnado2, J. Tisnado1; 1Richmond, VA/US, 2New York, NY/US

P-631 Inadvertent puncture of central arteries during central venous catheterization: the spectrum of iatrogenic complications G. Morano, M. Pasyk, J. Tisnado; Richmond, VA/US

P-632 Understanding the radiology and biochemistry of adrenal venous sampling R. Chung; Singapore/SG

P-633 Superior vena cava syndrome: from the diagnosis to the treatment algorithm P. Torcia1, U.G. Rossi1, P. Rigamonti1, G. Mauri2, A.M. Ierardi3, G. Carraﬁello3, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT, 3Varese/IT

P-634 Interventional radiology in central venous stenosis in dialysis patients: why, when and how P. Torcia1, P. Rigamonti1, U.G. Rossi1, M. Gallieni1, G. Mauri2, A.M. Ierardi3, G. Carraﬁello3, M. Cariati1; 1Milan/IT, 2San Donato Milanese/IT, 3Varese/IT

P-635 Managing the dysfunctional central venous catheter V. Rachapalli1, N. Kundaragi1, D. Thiruchunapalli2, S. Inuganti2, S. Chappiidi3, M. Uthappa1; 1Bangalore/IN, POSTERS 2Chennai/IN, 3Hyderabad/IN

P-636 Pictorial essay of inferior vena cava ﬁlter complications T.B. Kinney, H. Aryafar, J. Minocha, A. Picel; San Diego, CA/US

P-637 Where is the vena cava? Depicting congenital vena cava anomalies A.I.S. Ferreira, M. Ramalho, J. Leitão, I. Távora; Lisbon/PT

P-638 The role of interventional management for lumbosacral radiculopathy due to epidural venous engorgement related to pelvic venous outﬂow impediment W. Hsu, T.-C. Tsai, L.-S. Lin, T.-C. Chang; Taipei/TW

C RSE Posters 191

P-639 Pulmonary embolism: what the past tells us for the future T. Heller; Rostock/DE

P-640 Aberrant drainage of the left testicular vein into the left subcostal vein and left renal vein presenting a challenge during varicocele embolization N.B. Mani, M.D. Darcy, A. Allaei; St. Louis, MO/US

P-641 Transvenous retrohepatic inferior vena cava sarcoma biopsy M. González Leyte, A. Alvarez Luque, M. Echenagusia Boyra, G. Rodriguez-Rosales, E. Calleja Cartón, J.M. Jimenez Perez; Madrid/ES

P-642 Innominate vein repair after central line misplacement L. Diaz Dorronsoro, R. Zaragozano Guillen; Zaragoza/ES

P-643 Emergency endovascular repair for iatrogenic common iliac vein injury during/after anterior lumbar interbody fusion S. Fuwa1, S. Hase2, T. Nakagawa2, J.-I. Nishimura2; 1Tokyo/JP, 2Kawasaki-city, Kanagawa/JP

P-644 Recanalising the SVC: time for new tools A. Alsaﬁ, R.H. Thomas, M.S. Hamady; London/GB

P-645 Interventional bullet retrieval from the right ventricle P. Kisza, A. Mojtahedi, S. Contractor; Newark, NJ/US

P-646 Successful endovascular treatment for severe multiple arteriovenous thrombosis caused by heparin-induced

thrombocytopenia POSTERS R. Usui, K. Idoguchi, M. Narita, S. Nakao, Y. Mizushima; Osaka/JP

P-647 Percutaneous treatment of IVC obstruction due to post-resection kinking associated with IVC thrombosis T.G. Van Ha, R. Navuluri, B.S. Funaki; Chicago, IL/US

P-648 Retrieval of an inverted Option® ﬁlter malpositioned in the renal vein O. Ahmed, A. Masrani, S. Madassery, J. Soni, J. Tasse, D. Heussner, C. Turba, B. Arslan; Chicago, IL/US 192 CIRSE 2016 Pocket Guide

P-649 Vena cava ﬁlter migration due to a pericatheter ﬁbrin sheath J.R. Fortuño, J. Guitart, A. Alguersuari, E. Criado Paredes, J.F. Falco-Fages; Sabadell/ES

P-650 Endovascular treatment of an iliac vein injury using stent graft S. Narasimhan; Bangalore/IN

P-651 Acute pulmonary embolism complicating upper extremity thrombolysis with CLEANER, a rotational thrombectomy device N.B. Mani, A.J. Gunn, R. Ramaswamy, M.D. Darcy; St. Louis, MO/US POSTERS

C RSE Posters 193 Barcelona, Spain terialASeptember 10-14 yBiliarCIRSE 2016y CORPORATE ACTIVITIES & EXHIBITION

Satellite Symposia Learning Centres IDEAS Training Village nousHands-on Workshop Sponsors V e Technical Exhibition Radiation Protection Pavilion cAortiSocieties c

PainPaPOSTERS POSTERS oNeur ELECTRONIC o yOnco

Satellite Symposia 195

Satellite Symposia

Saturday, September 10

13:00-14:00, Room 117 Abbott Vascular SY 401 New evidence for Supera in a broad spectrum of peripheral indications

Moderators: C.A. Binkert (Winterthur/CH), S. Müller-Hülsbeck (Flensburg/DE)

401.1 Does stent design matter? Results from a single operator registry M. Treitl (Munich/DE) 401.2 The challenge of chronic total occlusions – which stents are most eﬀective? Results from the SUPERFAST study K.N. Katsanos (London/GB) 401.3 Subintimal stenting in complex CLI lesions. Results from the SUPERSUB study L.M. Palena (Abano Terme/IT) 401.4 Supera in TASC C/D lesions – the Spanish experience E. Lonjedo (Valencia/ES) 196 CIRSE 2016 Pocket Guide

13:00-14:00, Room 112 Philips SY 402 Philips lunch symposium in partnership with BTG The next generation of image-guided therapy in interventional oncology. Guiding tomorrow’s innovations today

Moderator: J.-F.H. Geschwind (New Haven, CT/US)

402.1 Emboguide and CBCT during intra-arterial Y-90 treatment for primary and secondary liver malignancies H. Kobeiter (Créteil/FR) 402.2 Advances in embolisation therapy: live image guidance in combination with radiopaque beads E. Kim (New York, NY/US) 402.3 Increased eﬃciency in tumour diagnosis and ablation therapy: live image guidance for biopsies and cryoablations M.J.L. van Strijen (Nieuwegein/NL)

13:00-14:00, Auditorium 2 Surefire Medical SY 403 New frontiers in transarterial therapy: tumour penetration and response

Moderator: G. Maleux (Leuven/BE)

403.1 Challenges to drug delivery in transarterial liver therapy G. Maleux (Leuven/BE) 403.2 How Sureﬁre Infusion System improves drug delivery – new patient outcomes data from Europe & US F. Wolf (Vienna/AT) 403.3 Sureﬁre European experience – Belgium case series P.P. Goffette (Brussels/BE)

C RSE Satellite Symposia 197

16:15-16:55, Auditorium 2 Medtronic SY 609 New embolisation materials and treatment techniques for congenital heart disease and pelvic congestion syndrome

Moderator: R.A. Morgan (London/GB)

609.1 MVP microplugs in patients with congenital heart diseases Y. Boudjemline (Paris/FR) 609.2 Pelvic congestion syndrome: from coils to onyx, 15 years’ experience P. Nicolini (Lyon/FR)

17:30-17:50, Room 113 TVA Medical SY 709 Creating the endovascular arteriovenous ﬁstula (endoAVF) with the everlinQ™ endoAVF system

Moderator: R. de Graaf (Maastricht/NL)

709.1 Understanding the procedure and clinical data to date A.G. Schwindt (Münster/DE) 709.2 The European experience with the everlinQ™ endoAVF system R.-T. Hoffmann (Dresden/DE) 709.3 Panel discussion 198 CIRSE 2016 Pocket Guide

Sunday, September 11

08:00-08:20, Auditorium 2 GORE & Associates SY 801 Fit the anatomy rather than alter it!

Moderator: H. Rousseau (Toulouse/FR)

801.1 Importance of devices conformability to achieve optimal clinical outcomes M. Reijnen (Arnhem/NL)

Clinical cases demonstration: 801.2 All in one system – AAA and iliac branching M. Reijnen (Arnhem/NL) 801.3 Thoracic H. Rousseau (Toulouse/FR)

08:00-08:20, Room 134 Medtronic SY 802 Advances in procedural sedation – preventing respiratory compromise

Moderator: A. Gangi (Strasbourg/FR)

802.1 Does capnography monitoring add to patient safety in moderate to deep sedation? J.T.A. Knape (Utrecht/NL)

C RSE Satellite Symposia 199

11:30-12:30, Auditorium 2 Biotronik SY 1103 BIOTRONIK combination therapy. Stent, drug-coated balloon or both?

Chairman: G. Tepe (Rosenheim/DE) Moderator: R. Langhoff (Berlin/DE)

1103.1 Introduction & objectives G. Tepe (Rosenheim/DE) 1103.2 BIOFLEX PEACE All-comers registry with Pulsar stent 12m data – can we improve the outcomes of stent or drug-coated balloon alone? C. Nolte-Ernsting (Mülheim/DE) 1103.3 BIOLUX P-III All-comers registry 12m data using Passeo-18 Lux DCB M. Brodmann (Graz/AT) 1103.4 BIOLUX 4EVER trial 12m data – BIOTRONIK combi nation therapy: treatment rationale and clinical evidence K. Deloose (Dendermonde/BE) 1103.5 Panel discussion Panellists: J. Bao (Shanghai/CN), M. Brodmann (Graz/AT), K. Deloose (Dendermonde/BE), C. Nolte-Ernsting (Mülheim/DE) 1103.6 Take-home messages G. Tepe (Rosenheim/DE)

11:30-12:30, Auditorium 1 BTG SY 1104 See more. Reach further. Treat smarter. Illuminating the future of TACE

Moderator: M. Burrel (Barcelona/ES)

1104.1 Radiopaque bead – taking TACE to a new level T.F. Jakobs (Munich/DE) 1104.2 See the difference – the intra-procedural benefits of radiopaque beads visualised with image-guided therapy J.-F.H. Geschwind (New Haven, CT/US) 1104.3 Seeing is believing – early clinical findings with radiopaque bead G. Narayanan (Miami, FL/US) 200 CIRSE 2016 Pocket Guide

C RSE 201 202 CIRSE 2016 Pocket Guide

11:30-12:30, Room 117 Penumbra SY 1105 Expanding the horizon: Penumbra’s embolisation and thrombectomy technology

Moderators: J.F. Benenati (Miami, FL/US), L.P. Moramarco (Pavia/IT)

1105.1 Insights and advanced techniques for embolisation: Ruby and POD Packing Coil I.J. McCafferty (Birmingham/GB) 1105.2 The impact of new embolisation tools: change the paradigm of peripheral treatment with POD Packing Coil and Lantern microcatheter J.C. van den Berg (Lugano/CH) 1105.3 Endovascular mechanical thrombectomy for iliofemoral deep vein thrombosis: ﬁrst experiences with the Penumbra Indigo thrombectomy system M. Lichtenberg (Arnsberg/DE)

13:00-14:00, Auditorium 1 Boston Scientific SY 1201 The revolution of drug-eluting technology in peripheral arterial disease: from clinical evidence to health economic beneﬁt

Moderator: M.J. Lee (Dublin/IE)

1201.1 An overview of trials and breaking data from the RANGER™ drug-coated balloon clinical programme P. von Bilderling (Munich/DE) 1201.2 ELUVIA™ drug-eluting stent: from preclinical foun- dations to MAJESTIC FIM and IMPERIAL global trial S. Müller-Hülsbeck (Flensburg/DE) 1201.3 Drug-eluting technologies: patient outcome, health economics and the EMINENT trial Y. Gouëffic (Nantes/FR) 1201.4 Drug-eluting stents and drug-coated balloon – above and below the knee: an appraisal of clinical utility H. van Overhagen (The Hague/NL)

C RSE Satellite Symposia 203

13:00-14:00, Auditorium 2 Medtronic SY 1202 From bench to bedside: technology, evidence and treatment algorithms in peripheral arterial disease

Moderators: T.J. Cleveland (Sheffield/GB), F. Fanelli (Rome/IT)

1202.1 Opening and introduction F. Fanelli (Rome/IT) 1202.2 Mode of action of the IN.PACT DCB system: sustained drug, sustained beneﬁt F. Fanelli (Rome/IT) 1202.3 IN.PACT drug-coated balloons for treatment of chronic total occlusions in the SFA J.C. van den Berg (Lugano/CH) 1202.4 Gain lumen, maintain patency: the power of adjunctive therapy with directional atherectomy and DCB C. Nolte-Ernsting (Mülheim/DE) 1202.5 Beyond the SFA: using DCB in AV access K.N. Katsanos (London/GB) 1202.6 Close and take home messages T.J. Cleveland (Sheffield/GB) 204 CIRSE 2016 Pocket Guide

C RSE 205 206 CIRSE 2016 Pocket Guide

13:00-14:00, Room 117 Terumo Europe SY 1203 Generating clinical evidence in interventional oncology

Moderator: K. Malagari (Athens/GR)

1203.1 Introduction and objectives K. Malagari (Athens/GR) 1203.2 From bench top to clinical results: LifePearl in HCC T. de Baère (Villejuif/FR) 1203.3 Loco-regional treatments in HCC pre-transplant patients. LifePearl-100 patients experience F.V. Gomes (Faro/PT) 1203.4 Growing evidence with LifePearl-TACE in CRC. CIREL Registry highlights P.L. Pereira (Heilbronn/DE) 1203.5 New horizons in radioembolisation with QUIREM spheres M.G.E.H. Lam (Utrecht/NL) 1203.6 Take home messages K. Malagari (Athens/GR)

14:30-15:30, Room 117 Medtronic SY 1303 Thermosphere ablation: the easy way to become a superhero

Moderator: W. Prevoo (Amsterdam/NL)

1303.1 Liver F. Orsi (Milan/IT) 1303.2 Lung T.J. Vogl (Frankfurt/DE) 1303.3 Kidney G. Carrafiello (Milan/IT)

C RSE Satellite Symposia 207

14:30-15:30, Auditorium 2 Straub Medical AG SY 1304 Mechanical debulking in arterial and venous occlusions – an important step in the optimi- sation of endovascular therapy

Moderators: M. Bulvas (Prague/CZ), T. Heller (Rostock/DE)

1304.1 Change of paradigm in the treatment of acute and subacute vessel occlusion R. Loffroy (Dijon/FR) 1304.2 Mechanical debulking – is it an adjunctive treatment in the therapy of vessel occlusions? M. Bulvas (Prague/CZ) 1304.3 Oﬃce based dialysis access angioplasty/stenting/ thrombectomy under sonographic guidance D. Périard (Fribourg/CH) 1304.4 Mechanical debulking in bypass-occlusions – fast and eﬀective B. Migliara (Peschiera del Garda/IT) 1304.5 Recanalisation of venous occlusions with AspirexS followed by stenting M. Lichtenberg (Arnsberg/DE)

16:15-16:35, Room 114 Toshiba Medical Systems Europe SY 1404 Revolutionise intervention with Inﬁnix-4D-CT

Moderator: B. Guiu (Montpellier/FR)

1404.1 G.M. Kim (Seoul/KR) 208 CIRSE 2016 Pocket Guide

16:15-16:45, Room 112 C.R. Bard SY 1409 BARD innovations for tomorrow – arterial & venous endovascular interventions

Moderator: R. de Graaf (Maastricht/NL)

1409.1 Initial clinical experience with the Bard Venovo Venous Stent G.J. O’Sullivan (Galway/IE) 1409.2 Advancements in AV access maintenance: the Covera Vascular Covered Stent D. Rajan (Toronto, ON/CA)

16:15-17:00, Room 113 GE Healthcare SY 1410 New applications in planning and guidance of interventions with cone-beam CT

Moderator: T. de Baère (Villejuif/FR)

1410.1 Needle ASSIST and Stereo 3D: how to optimise workﬂow in interventional oncology F. Deschamps (Villejuif/FR) 1410.2 Improving the outcomes of prostate artery embolisation with computer-assisted analysis F.C. Carnevale (São Paulo/BR)

C RSE Satellite Symposia 209

Monday, September 12

07:40-08:20, Room 114 GORE & Associates SY 1601 Why, when and what patients will beneﬁt from TIPS? Introducing the new GORE TIPS Set and TIPS innovations

Moderator: G. Maleux (Leuven/BE)

1601.1 Real-time ultrasound guidance for portal vein targeting during TIPS creation. Effects on radiation exposure of patients and medical staff. Introducing the new GORE TIPS Set R. Miraglia (Palermo/IT) 1601.2 Introducing total patient care in portal hypertension: why, when, what patients will benefit from TIPS? Concept of an optimized TIPS service J. Trebicka (Bonn/DE)

08:00-08:20, Auditorium 2 Bolton Medical SY 1602 Proximal scallops in endovascular repair of thoracic and abdominal aorta

Moderators: M.A. Funovics (Vienna/AT), M.S. Hamady (London/GB)

1602.1 Advanced techniques to overcome short proximal landing zones in TEVAR J.C. van den Berg (Lugano/CH) 1602.2 Abdominal proximal scallop for challenging necks P.M. Amorin (Lisbon/PT) 210 CIRSE 2016 Pocket Guide

08:00-08:20, Room 113 PharmaCept SY 1603 DSM-TACE for a better ﬂexibility in liver cancer treatment

Moderator: A.H. Mahnken (Marburg/DE)

1603.1 Cisplatin – a powerful drug in DSM-TACE A.H. Mahnken (Marburg/DE) 1603.2 DSM-TACE in HCC: the time has come to collect prospective data – the HepaStar trial F. Collettini (Berlin/DE)

11:30-12:30, Auditorium 1 Cook Medical SY 1902 Drug elution in the SFA: leave the right thing behind Debating evidence to provide the answers

Moderator: M.D. Dake (Stanford, CA/US)

1902.1 Introduction to symposium M.D. Dake (Stanford, CA/US) 1902.2 Why and how to prepare the vessel? F. Fanelli (Rome/IT) 1902.3 Drug-eluting technologies: how to leave the right thing behind G.M. Richter (Stuttgart/DE) 1902.4 Understanding restenosis in the SFA R. Virmani (Gaithersburg, MD/US) 1902.5 What do we know about the combination DCB+BMS? C.I. Mena-Hurtado (New Haven, CT/US) 1902.6 Impact and cost of vessel re-occlusion and re-treatment K.N. Katsanos (London/GB)

C RSE Satellite Symposia 211

11:30-12:30, Room 117 Sirtex SY 1903 Building for the future with SIR-Spheres® Y-90 resin microspheres

Moderators: R. Cianni (Latina/IT), G. Maleux (Leuven/BE)

1903.1 Emerging evidence in HCC J. Ricke (Magdeburg/DE) 1903.2 SIRFLOX study results – recent update V. Heinemann (Munich/DE) 1903.3 Dosimetry & interesting cases P.M. Paprottka (Munich/DE) 1903.4 Panel discussion

11:30-12:30, Auditorium 2 Terumo Europe SY 1904 Pushing boundaries in the treatment of PAD

Moderator: A. Cremonesi (Cotignola/IT)

1904.1 Will Roadsaver expand the indication for CAS? A. Cremonesi (Cotignola/IT) 1904.2 The choice of permanent implants in fem-pop Y. Gouëffic (Nantes/FR) 1904.3 Best practices in managing critical limb ischaemia L.M. Palena (Abano Terme/IT) 1904.4 Radial access for the treatment of PAD A. Fischman (New York, NY/US) 212 CIRSE 2016 Pocket Guide

13:00-14:00, Auditorium 2 C.R. Bard SY 2001 Lutonix® Drug Coated Balloon evidence in SFA, BTK and AV

Moderator: F. Fanelli (Rome/IT)

2001.1 A study of downstream events of the two leading DCBs on the market R. Virmani (Gaithersburg, MD/US) 2001.2 Global SFA registry and optimal DCB outcomes from Levant 2 F. Fanelli (Rome/IT) 2001.3 Lutonix BTK randomised clinical trial and single centre experience in BTK A. Micari (Cotignola/IT) 2001.4 Lutonix AV retrospective clinical trial and single centre experience D. Karnabatidis (Patras/GR)

13:00-14:00, Auditorium 1 Cordis, a Cardinal Health Company SY 2002 New technologies to monitor your vascular patient

Moderator: J.A. Reekers (Amsterdam/NL)

2002.1 Introduction J.A. Reekers (Amsterdam/NL) 2002.2 The importance of monitoring vascular patients J.A.W. Teijink (Eindhoven/NL) 2002.3 New technologies to monitor vascular patients M.M.L. van den Houten (Eindhoven/NL) 2002.4 GPS and smartphone controlled exercise programmes S. Nawaz (Sheffield/GB) 2002.5 Future of tele-monitoring in PAD J.A. Reekers (Amsterdam/NL)

For healthcare professionals only. This event has been made possible through an educational support from Cordis Corporation.

C RSE Satellite Symposia 213

CIRSE 2016 CHARITY SPORTS EVENT Run for the Health of it! Saturday, September 10 at 19:00

Join us for the 3-km race and football cup: register on site or just come to cheer from the stands!

Changing rooms are available, and a delicious buﬀet will be provided from 19:45 until the end of the football cup.

The event supports Ärzte ohne Grenzen, part of the Médecins Sans Frontières.

See our news feeds or Congress News for more details!

CIRSE supports compliance with ethical standards. Therefore, CIRSE emphasises that the present invitation is directed to participants of CIRSE 2016, and recommends that participants who want to take part in the MSF Charity Evening bear any and all costs in this context (including donations) themselves.

Kindly note that participation in the MSF Charity Evening is NOT included in the CIRSE 2016 registration fee!

C RSE 214 CIRSE 2016 Pocket Guide

13:00-14:00, Room 117 Guerbet SY 2003 Conventional TACE: unique and undisputable standard-of-care for HCC stage B patients

Moderator: M.C. Soulen (Philadelphia, PA/US)

2003.1 cTACE eﬃcacy and safety based on 30 years of publications: from the mechanisms of actions to randomised clinical trials and treatment guidelines M.C. Soulen (Philadelphia, PA/US) 2003.2 An Asian insight into the cTACE technical evolution, Carm-CBCT and super-selective micro-catheterisation for a positive impact on the treatment response K. Osuga (Osaka/JP) 2003.3 cTACE treatment protocols, regimens and stand- ardisation for an optimal patient care T. de Baère (Villejuif/FR)

C RSE Satellite Symposia 215 216 CIRSE 2016 Pocket Guide

14:30-15:30, Room 117 Boston Scientific SY 2104 Clinical insights and practical solutions for intervention in HCC and mCRC with TANDEM™ small diameter uniform beads

Moderators: J.I. Bilbao (Pamplona/ES), T.K. Helmberger (Munich/DE)

2104.1 Design and technical aspects of TANDEM™ Microspheres: the science behind calibration and drug loading G.M. Richter (Stuttgart/DE) 2104.2 Post embolic syndrome in mCRC – insights into clinical causes: the importance of optimal embolisation technique F. Orsi (Milan/IT) 2104.3 Advanced and intensiﬁed microparticle chemoembolisation in liver tumours: breaking data from Miracle 1 trial G.M. Richter (Stuttgart/DE) 2104.4 Practical use of TANDEM™ Microspheres for DEB-TACE in HCC: a consensus view T.K. Helmberger (Munich/DE)

C RSE Satellite Symposia 217

14:30-15:30, Room 114 Shockwave Medical, Inc. SY 2105 Treating calciﬁed peripheral vascular arteries with the Shockwave Medical Lithoplasty® System

Moderator: T.J. Brinton (Stanford, CA/US)

2105.1 Introduction to the Shockwave Medical Lithoplasty System T.J. Brinton (Stanford, CA/US) 2105.2 Calciﬁcation in vascular disease F. Fanelli (Rome/IT) 2105.3 Early clinical experience and role of imaging in vascular calcium A. Holden (Auckland/NZ) 2105.4 Impact of Lithoplasty technology: DISRUPT PAD Study G. Tepe (Rosenheim/DE)

16:15-16:35, Room 114 Veryan Medical SY 2208 BioMimics 3D: a new generation swirling ﬂow fempop stent

2208.1 Outstanding results with a swirling flow stent T. Zeller (Bad Krozingen/DE) 2208.2 Why swirling flow and stent design are important P.A. Gaines (Sheffield/GB) 2208.3 A cost effectiveness analysis of SFA intervention B.C. Kearns (Sheffield/GB) 218 CIRSE 2016 Pocket Guide

Tuesday, September 13

13:00-14:00, Room 117 BTG SY 2801 European experiences with the EKOS™ system for arterial occlusion, deep vein thrombosis and pulmonary embolism treatment: share the best practice

Moderator: T. Heller (Rostock/DE)

2801.1 Rationale for use of EKOS™ in DVT patients, experience of large centre M. Treitl (Munich/DE) 2801.2 Arterial thrombosis patients beneﬁt from acoustic pulse thrombolysis treatment; clinical data and experience J.A. Vos (Nieuwegein/NL) 2801.3 Ultrasound-assisted thrombolysis for acute PE T. Heller (Rostock/DE)

13:00-14:00, Room 115 Medtronic SY 2802 Acute ischaemic stroke treatment: from clinical evidence to practice

Moderator: C. Molina (Barcelona/ES)

2802.1 A unique stroke organisation M. Ribo (Barcelona/ES) 2802.2 Acute ischaemic stroke treatment: best practice! V. Costalat (Montpellier/FR)

C RSE Satellite Symposia 219

13:00-14:00, Auditorium 2 Siemens Healthineers SY 2803 High-end imaging solutions for challenges in interventional work

Moderator: A. Holden (Auckland/NZ)

2803.1 Challenging questions in CLI intervention – how can imaging support? A. Holden (Auckland/NZ) 2803.2 Challenging kidney function – optimised workﬂow

for CO2 angiography U. Teichgräber (Jena/DE) 2803.3 MIYABI Angio-CT – joining forces to overcome challenging procedures D. Lacey (Des Moines, IA/US)

14:30-15:30, Room 117 Merit Medical SY 2904 Reach the unreachable with SwiftNINJA® Steerable Microcatheter!

Moderator: C.A. Binkert (Winterthur/CH)

2904.1 Why SwiftNINJA? The inventor’s perspective Y. Arai (Tokyo/JP) 2904.2 SwiftNINJA in PAE: technique and results M.R. Sapoval (Paris/FR) 2904.3 SwiftNINJA in liver cancer: technique and results B.C. Meyer (Hannover/DE) 220 CIRSE 2016 Pocket Guide

Learning Centres at CIRSE 2016

The Learning Centres at CIRSE 2016 will provide an excellent opportunity for all congress delegates to test the latest interventional devices, gain hands-on experience with new equipment and talk to industry representatives.

The following companies will provide Learning Centres at CIRSE 2016:

C.R. Bard Boston Scientiﬁc BTG Cook Medical Medtronic Merit Medical Penumbra Straub Medical Terumo Europe

Please note that CIRSE is not responsible for the information provided at the Learning Centres.

Learning Centre programmes (as per printing date)

C RSE Learning Centres 221

Boston Scientiﬁc

Boston Scientiﬁc has developed a dedicated Meet the Expert programme in the learning centre with a focus on the following areas:

HCC and mCRC treatment with Embozene TANDEM™ Drug Elutable Microspheres

Saturday, September 10, 13:00-14:00 B.A. Radeleff (Heidelberg/DE)

Sunday, September 11, 13:00-14:00 B.A. Radeleff (Heidelberg/DE)

Monday, September 12, 13:00-14:00 G.M. Richter (Stuttgart/DE)

Tuesday, September 13, 13:00-14:00 G.M. Richter (Stuttgart/DE)

UFE / Adenomyosis

Monday, September 12, 12:00-13:00 P.N.M. Lohle (Tilburg/NL)

Tuesday, September 13, 12:00-13:00 P.N.M. Lohle (Tilburg/NL)

Prostatic arterial embolisation

Saturday, September 10, 14:00-15:00 H. Rio Tinto (Nice/FR)

Sunday, September 11, 14:00-15:00 H. Rio Tinto (Nice/FR) 222 CIRSE 2016 Pocket Guide

Emborrhoid

Sunday, September 11, 10:00-11:00 V. Vidal (Marseille/FR)

Tuesday, September 13, 14:00-15:00 V. Vidal (Marseille/FR)

The science behind the drug delivery

Monday, September 12, 14:00-15:00 J. Diaz-Cartelle (Boston, MA/US), J. Kokate (Minneapolis, MN/US)

Why and when I use thrombectomy

Sunday, September 11, 12:00-13:00 S. Habib (Nottingham/GB)

Monday, September 12, 10:30-11:00 R. O’Neill (Nottingham/GB)

Why and when I use atherectomy

Monday, September 12, 11:00-12:00 K.N. Katsanos (London/GB)

Boston Scientiﬁc learning centre will remain open for delegates who would like to learn more about our broad range of high performance solutions in the vascular and oncology ﬁelds.

To learn more about our learning centre programme, please visit our booth.

All cited trademarks are the property of their respective owners. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for the use only in countries with applicable health authority product registrations. Indications, operating speciﬁcations and availability may vary by country. Check with local product representation and country-speciﬁc Information For Use for your country. This material is not approved for use or distribution in France.

C RSE Learning Centres 223

Cook Medical

The following presentations take place in the Cook Learning Centre, next to the Cook booth.

Saturday, September 10

11:30-noon Advance® Enforcer™ 35: a new focal force balloon for treating dysfunctional haemodialysis access ﬁstulae or grafts N. Karunanithy (London/GB), G. Rupp-Heim (Mutlangen/DE)

13:00-13:30 An expert’s techniques to cross chronic venous occlusions G.J. O’Sullivan (Galway/IE)

14:00-14:30 Enhancing the clinical value of your PICC practice: PICC placement, management of complications, and aftercare A. Fohlen (Caen/FR)

15:00-16:00 Cook venous workshop: ﬁlters, embolisation, PICCs, balloon angioplasty, and stenting Learning Centre physician faculty and Cook representatives

Sunday, September 11

09:30-10:00 Embolisation of varices following TIPSS procedures: techniques and options H. Mehrzad (Birmingham/GB)

11:00-11:30 CARTO: a new treatment for gastric varices and hepatic encephalopathy E.W. Lee (Los Angeles, CA/US) 224 CIRSE 2016 Pocket Guide

12:30-13:00 Biliary drainage beyond the usual: stones, leakage, and transhepatic feeding O.M. van Delden (Amsterdam/NL)

14:00-14:30 Transluminal biliary forceps biopsy: using results to reﬁne your technique A. Fohlen (Caen/FR)

15:30-17:00 Cook liver workshop: embolisation, drainage, biliary forceps biopsy, and liver access for TIPSS Learning Centre physician faculty and Cook representatives

Monday, September 12

09:30-10:00 Embolisation in the treatment of haemorrhoids: update on "emborrhoid" technique V. Vidal (Marseille/FR)

11:00-noon Zenith Alpha: why a system makes sense J. Palmero Da Cruz (Valencia/ES), E. Verhoeven (Nuremberg/DE), F. Verzini (Perugia/IT)

12:30-13:00 Vessel preparation before using drug-eluting devices: what is gained, when should it be done, and how should we do it? C. Hohl (Siegen/DE)

13:30-14:30 Learning pedal access L.M. Palena (Abano Terme/IT)

Tuesday, September 13

10:00-11:00 Vista physician education programme Cook Medical representatives

C RSE Learning Centres 225 Medtronic

MEET THE EXPERT One hour interactive peer-to-peer expert sessions. Limited to 15 people per session.

Aortic & peripheral vascular Pre-registration required: [email protected]

Saturday, September 10, 11:30 & Sunday, September 11, 14:30 Leveraging combination therapy of directional atherectomy and DCB in treatment of SFA complex lesions: a case driven workshop E. Blessing (Karlsbad/DE)

Sunday, September 11, 11:00 & Monday, September 12, 14:30 From evidence to practice. How I address complex femo- ropliteal lesions from recanalisation to treatment M. Treitl (Munich/DE)

Monday, September 12, 09:30 Management of endoleaks, when to treat and how? M. Treitl (Munich/DE)

Saturday, September 10, 14:30 Management of AVM, how to treat, diﬀerent embolisation materials? to be announced

Saturday, September 10, 13:30 Clinical use of cyanoacrylate for treating chronic venous insuﬃciency: procedure and data S. Ray (London/GB)

Advanced ablation solutions Pre-registration required: [email protected]

Sunday, September 11, 09:30 Lung thermal ablation R.F. Grasso (Rome/IT) 226 CIRSE 2016 Pocket Guide

Monday, September 12, 11:00 Liver thermal ablation B. Gonçalves (Porto/PT)

Tuesday, September 13, 11:00 Kidney thermal ablation J.M. Abadal (Madrid/ES)

Sunday, September 11, 16:00 EMPRINT™ procedure planning application M. Hemstreet (Boulder, CO/US)

Vertebral compression fractures Pre-registration required: [email protected]

Monday, September 12, 13:00 Understanding mortality beneﬁts of balloon kyphoplasty K.L. Ong (Philadelphia, PA/US)

Neurovascular Pre-registration required: [email protected]

Tuesday, September 13, 14:30 Acute ischaemic stroke treatment with Solitaire™ Revascularization Device: practical session V. Costalat (Montpellier/FR)

MEET THE PRODUCT Hands-on with demos and models focusing on:

• Ablation • DCB + atherectomy • Bone ablation • Endovenous • Embolisation • Neurovascular-AIS

Open from Saturday, September 10 to Tuesday, September 13, 09:00-18:00. No pre-registration required.

C RSE Learning Centres 227

Merit Medical

Why did I choose the radial approach? Insights from my practice

Moderator: A. Moelker (Rotterdam/NL)

From stick to haemostasis we will show the beneﬁts of radial access step by step in 4 diﬀerent stations:

1. Preparation and access: femoral vs. radial (using the femoral and radial stick model); 2. Navigation: wire and catheter choice and how to use it: femoral vs. radial pathway; 3. Radial procedure on our simulator, showing the challenges of radial approach (spasm, loops and tortuous anatomy) and how to overcome them; 4. Haemostasis: all the options for femoral (manual compression, closure devices and manual assist products) versus radial haemostasis products

Sunday, September 11, 11:00-12:15, 14:00-15:15 Monday, September 12, 11:00-12:15, 14:00-15:15 Tuesday, September 13, 11:00-12:15

RF ablation in spine: innovation and clinical evidence

Moderator: J.W. Jennings (St. Louis, MO/US)

Dr. Jennings will review demographics, current treatment algorithms and unique clinical requirements in treatment of spinal metastatic disease; the STAR Tumor Ablation System technology, his clinical experience and the STAR speciﬁc published clinical literature. Hands-on stations will provide attendees the opportunity to gain experience with the articu- lating STAR and StabiliT Systems used in spine ablation and cement augmentation including performing table top ablations, mixing and delivering cement.

Sunday, September 11, 16:00-17:30 Monday, September 12, 16:00-17:30

Please register at our booth no. 69 or via [email protected] 228 CIRSE 2016 Pocket Guide

Penumbra

Saturday, September 10

12:00-13:00 Learning Center sessions: Hands-on ﬂow model on embolisation and thrombectomy Penumbra

Sunday, September 11

14:00-15:00 Learning Center sessions: Hands-on ﬂow model on embolisation and thrombectomy Penumbra

Monday, September 12

10:30-11:20 Meet the Expert: Ruby Volume Coil & POD – Take a closer look at embolisation experience L.P. Moramarco (Pavia/IT) Meet the Expert: Hands-on ﬂow model F.M. Gómez (Valencia/ES)

13:30-14:20 Meet the Expert: Indigo System – A new thrombectomy tool for arterial, venous and pulmonary embolism clot removal J.F. Benenati (Miami, FL/US)

Tuesday, September 13

10:30-11:20 Meet the Expert: Optimising neurointerventional stroke care and evolution to the ADAPT technique Y. Kayan (Minneapolis, MN/US)

C RSE Learning Centres 229

13:30-14:20 Meet the Expert: CGuard™ EPS System – Our experience in treatment of carotid lesions: mechanical behavior and clinical results C. Wissgott (Heide/DE)

Straub Medical

Management of arterial and venous occlusive diseases with mechanical debulking

Topics: • Clinical and economic benefits of mechanical debulking • Indications, treatment specifics and success rates of Rotarex®S and Aspirex®S interventions • In-vitro demonstration of Rotarex®S and Aspirex®S catheters • Hands-on: experience the efficiency!

Please register at our booth no. 58. www.straubmedical.com 230 CIRSE 2016 Pocket Guide

IDEAS Training Village

Bolton Medical

1 to 1 Simulation sessions An hour slot fully dedicated to 1-2 physicians (possibly from the same team) to simulate the treatment of a thoracic or abdominal pathology with the Bolton Medical product. • Product presentation (TEVAR or EVAR) • Hands-on deployment • Case discussion • Case simulation

Upon participants’ discretion, a case can be downloaded and analysed prior to the case discussion. In order to view the cases, please refer to the Training Village programme on www.aorticideas.org.

Sunday, September 11 09:00-10:00 (1 slot) 14:00-17:00 (3 slots)

Monday, September 12 09:00-10:00 (1 slot) 14:00-17:00 (3 slots)

Tuesday, September 13 09:00-10:00 (1 slot) 14:00-17:00 (3 slots)

Small group Osirix course A sizing and planning course using Osirix, dedicated to a small group of 4 persons. Three diﬀerent courses will be given:

Pre-case planning course on TEVAR • Introduction to the software • Basic tools • ROIs • Measurements on MPR: lengths, angles, curved lengths • 3D volume rendering

Sunday, September 11 10:00-13:00

C RSE IDEAS Training Village 231

Pre-case planning course on EVAR • Introduction to the software • Basic tools • ROIs • Measurements on MPR: lengths, angles, curved lengths • 3D volume rendering

Monday, September 12 10:00-13:00

Advanced tips and tricks on Osirix • Use of 3D MPR on thoracic cases • Use of point ROI to deﬁne angles in EVAR • 3D volume rendering with segmentation • Calculation of volumes (automatic generation of ROIs) • Videos: ﬂythrough on 3D volume rendering • Videos: angiograms

Tuesday, September 13 10:00-12:00

How to participate: To register to the Bolton Medical activities organized at the IDEAS Training Village please refer to the Training Village programme on www.aorticideas.org.

Cordis, a Cardinal Health Company

Demonstration and simulated use of the low proﬁle AAA Stent Graft System Our AAA Stent Graft System experts will be available in the IDEAS Training Village to demonstrate the beneﬁts of this product on a simulator, along with presentations and demonstrations.

Sunday, September 11 09:00-12:00 | 13:30-18:00 Monday, September 12 09:00-12:00 | 13:30-18:00 Tuesday, September 13 09:00-12:00 | 13:30-18:00

How to participate: No need to register to get your personalized demonstrations. Our experts will welcome you during those hours.

In the US and Japan the AAA System is currently approved for investigational device use only. 232 CIRSE 2016 Pocket Guide

JOTEC

Endovascular treatment of aorto-iliac and isolated iliac aneurysms Hands-on demonstration on the E-liac and the E-tegra Stent Graft System.

Sunday, September 11 10:30-11:30 | 14:30-15:30 Monday, September 12 10:30-11:30 | 14:30-15:30 Tuesday, September 13 10:30-11:30 | 14:30-15:30

How to participate: Please enquire at the JOTEC booth.

MAQUET/GETINGE GROUP

The chimney endovascular technique in the treatment of juxtarenal aneurysms: "from alpha to omega"

Co-ordinators: K.P. Donas (Münster/DE), F. Azevedo (Münster/DE)

Sunday, September 11 13:00-15:30 Monday, September 12 13:00-15:30

How to participate: Pre-registration is advised as there is a limit on the number of participants. Kindly submit your request and/or questions to [email protected]. Participation is granted on a ﬁrst-come, ﬁrst-served basis. You will be informed of your participation status in due course.

C RSE IDEAS Training Village 233

Medtronic

Simulation Workshop – EVAR or TEVAR In this practical and interactive workshop, participants will be working in small groups on a Simbionix – 3D Systems simulator. An experienced therapy facilitator will support each simulation session and will lead the discussion about the procedure speciﬁc tips & tricks. Course participants will each have the opportunity to perform the procedural steps in a virtual environment. During each session, which will be approximatley 90mins the facilitator will introduce participants to Medtronic’s product oﬀerings in EVAR (Endurant) and TEVAR (Valiant captivia).

The workshop is aimed at physicians interested in learning more about the endovascular treatment options for patients with pathologies of the aorta.

Sunday, September 11 09:00-10:30 | 11:00-12:30 13:30-15:00 | 15:30-17:00

Monday, September 12 09:00-10:30 | 11:00-12:30 13:30-15:00 | 15:30-17:00

How to participate: Pre-registration is required for this course and spaces are limited to a maximum of 4 people per 90mins session who must also be registered for the CIRSE Congress. To attend a session, please send an email with your contact details indicating which date & time you prefer to attend to Michelle Veersteg at: [email protected]. Slots will be filled on a first-come first-served basis and may not be possible on the day. Medtronic will not cover any additional costs. 234 CIRSE 2016 Pocket Guide

Philips Volcano

IVUS-Guided EVAR/TEVAR Procedures • Procedural steps • Recorded case-examples • Hands-on on ﬂow model with real-time measurements

Learning objectives – To allow delegates to familiarise themselves with Philips Volcano Digital IVUS Technology in EVAR/TEVAR procedures – To provide hands-on experience on a ﬂow model and learn how IVUS-guidance can reduce contrast and radiation exposure in EVAR/TEVAR procedures – To improve technical and procedural expertise

Co-ordinators: D. Goodman and R. de Boer – Philips Volcano and with F. Fanelli (Rome/IT) on Sunday and Tuesday

Sunday, September 11 12:00-13:00 | 16:00-17:00 Monday, September 12 11:00-12:00 | 12:00-13:00 | 13:00-14:00 Tuesday, September 13 11:00-12:00 | 13:00-14:00

Phoenix Atherectomy System • Technical overview • Hands-on experience: preparation and operation of the system • Case examples

Learning objective To provide hands-on experience with the Philips Volcano Phoenix Atherectomy System for PAD.

Sunday, September 11 on demand Monday, September 12 on demand Tuesday, September 13 on demand

How to participate: Please enquire at the Philips Volcano booth no. 60.

Kindly note: A valid IDEAS or CIRSE Registration is required to be able to attend and/or pre-register for sessions in the IDEAS Training Village.

C RSE Cardiovascular and Interventional Radiological Society of Europe IDEAS Training Village 235 Dinner & Farewell Party CIRSE 2016 Tuesday, September 13 Doors open at 19:30

Join us at Can Travi Nou restaurant, an authentic Catalan farmhouse, for a three-course gala dinner followed by a party in its beautiful gardens!

Dinner tickets (cocktail reception, dinner, complimentary drinks, entertainment): EUR 75 each

Party only (doors open 22:00, includes free drinks and entertainment): EUR 25 each

Don’t miss out! Buy your tickets at the “Hotels | Social Events | City Information” desk, located in the registration area.

CIRSE supports compliance with ethical standards. Therefore, CIRSE emphasises that the present oﬀer (made by KUONI Congress Destination Management) is directed to participants of CIRSE 2016 and recommends that the participants who want to accept the present oﬀer shall bear any and all costs in this context themselves.

Kindly note that entrance to the CIRSE 2016 Party is NOT included in the CIRSE 2016 registration fee! 236 CIRSE 2016 Pocket Guide

Hands-on Workshop Sponsors

The A closer look at closure devices hands-on workshops are kindly supported by:

• Abbott Vascular • St. Jude Medical

The Embolisation: materials and tools hands-on workshops are kindly supported by:

• Boston Scientiﬁc • Cook Medical • GEM SRL • Medtronic • Penumbra • Siemens • Sirtex Medical Europe GmbH • St. Jude Medical • Terumo Interventional Systems

The Principles to practice: education and simulation skills training hands-on workshops are kindly supported by:

• 3D Systems, Simbionix Products • AngioDynamics • Bolton Medical • Boston Scientiﬁc • Cordis, Cardinal Health • Cook Medical • Mentice • Penumbra • St. Jude Medical • W.L. Gore & Associates

C RSE Hands-on Workshop Sponsors 237

The Tumour ablation: tips and tricks hands-on workshops are kindly supported by:

• Angiodynamics • Boston Scientiﬁc • CAScination AG • Galil Medical • GE Healthcare • HS Hospital Service SpA • IMACTIS • iSYS Medizintechnik GmbH • Medtronic • NeuWave Medical • Olympus Surgical Technologies Europe • RF Medical Co., Ltd. • Terumo Interventional Systems

The Varicose veins hands-on workshops are kindly supported by:

• Angiodynamics • Medtronic • Olympus Surgical Technologies Europe • RF Medical Co., Ltd. • Vascular Insights, LLC

For detailed information on the hands-on workshops, please refer to pages 20-31.

For further information about the industry partners, please refer to pages 248-297 of the Technical Exhibitors Guide.

If you are interested in obtaining product information outside of the hands-on workshop sessions, please visit the respective company booth in the exhibition area. 238 CIRSE 2016 Pocket Guide

C RSE 239 240 CIRSE 2016 Pocket Guide

C RSE 241 242 CIRSE 2016 Pocket Guide

Technical Exhibition (Alphabetical List)

Oﬃcial Name Booth#

Aachen Resonance 64 Abbott Vascular 9 ALN Implants Chirurgicaux 61 Andanza International 92 Andramed 77 AndraTec 94 Angiodroid 82 AngioDynamics 48 AprioMed 50 Argon Medical Devices 47 ArraVasc 90 Asahi Intecc 35 Avinger 75 Bard 51 Bentley / Joline 54 biolitec biomedical technology 39 Bioteque 18 Biotronik 57 Bluegrass Vascular Technologies 95 Bolton Medical 72 Boston Scientiﬁc 24 BTG 70 Cardionovum 23 CAScination 71 Contego Medical 2 Control Medical Technology 31 Cook Medical 52 Cordis 22 DAfMT 79 ECO Microwave 41 Edizioni Minerva Medica 67 Elastrat 11 Endovascular Today 20 Eurocor 93 GE Healthcare 83 GEM 68 Getinge Group 36 Gore & Associates 4

C RSE Technical Exhibition 243

Oﬃcial Name Booth#

Guerbet 55 Hansen Medical 62 HS Hospital Service 87 Hyprevention 16 Imactis 78 Imedicom 26 Interventional News / BIBA Medical 42 Invamed Health 29 iSYS Medizintechnik 40 iVascular 56 JJP Hospitalaria 1 Jotec 81 LINC 2017 3 Lombard Medical 84 MDL 88 Medcomp 65 Medtronic 7 Merit Medical 69 Mermaid Medical 89 Micro-Tech 32 MIM Software 25 Möller Medical 28 NeuWave Medical 80 Olympus Surgical Technologies Europe 45 OptiMed Medizinische Instrumente 33 Pajunk 44 Penumbra 91 Perouse Medical 12 PharmaCept 14 Philips 60 QualiMed 38 RenalGuard Solutions 15 RF Medical 27 ShockWave Medical 59 Siemens Healthcare 76 SIR 30 Sirtex Medical 8 St. Jude 63

Interested in searching exhibitors by product category? Use the CIRSE App! 244 CIRSE 2016 Pocket Guide

Oﬃcial Name Booth#

STARmed 46 Straub Medical 58 Sureﬁre Medical 53 Surgical Specialties 85 Tecres 86 Teleﬂex Medical 66 TeraRecon 6 Terumo 10 Tokai Medical 17 Toshiba Medical Systems Europe 43 TU Delft 37 TVA Medical 5 UreSil 73 Vascular Solutions 34 Veryan Medical 49 Vigeo 13 WCIO 19 Wisepress Medical Bookshop 21 Ziehm Imaging 74

C RSE Technical Exhibition 245

Technical Exhibition (Numerical List)

Oﬃcial Name Booth#

JJP Hospitalaria 1 Contego Medical 2 LINC 2017 3 Gore & Associates 4 TVA Medical 5 TeraRecon 6 Medtronic 7 Sirtex Medical 8 Abbott Vascular 9 Terumo 10 Elastrat 11 Perouse Medical 12 Vigeo 13 PharmaCept 14 RenalGuard Solutions 15 Hyprevention 16 Tokai Medical 17 Bioteque 18 WCIO 19 Endovascular Today 20 Wisepress Medical Bookshop 21 Cordis 22 Cardionovum 23 Boston Scientiﬁc 24 MIM Software 25 Imedicom 26 RF Medical 27 Möller Medical 28 Invamed Health 29 SIR 30 Control Medical Technology 31 Micro-Tech 32 OptiMed Medizinische Instrumente 33 Vascular Solutions 34 Asahi Intecc 35 Getinge Group 36 TU Delft 37 QualiMed 38

Interested in searching exhibitors by product category? Use the CIRSE App! 246 CIRSE 2016 Pocket Guide

Official Name Booth# biolitec biomedical technology 39 iSYS Medizintechnik 40 ECO Microwave 41 Interventional News / BIBA Medical 42 Toshiba Medical Systems Europe 43 Pajunk 44 Olympus Surgical Technologies Europe 45 STARmed 46 Argon Medical Devices 47 AngioDynamics 48 Veryan Medical 49 AprioMed 50 Bard 51 Cook Medical 52 Surefire Medical 53 Bentley / Joline 54 Guerbet 55 iVascular 56 Biotronik 57 Straub Medical 58 ShockWave Medical 59 Philips 60 ALN Implants Chirurgicaux 61 Hansen Medical 62 St. Jude 63 Aachen Resonance 64 Medcomp 65 Teleflex Medical 66 Edizioni Minerva Medica 67 GEM 68 Merit Medical 69 BTG 70 CAScination 71 Bolton Medical 72 UreSil 73 Ziehm Imaging 74 Avinger 75 Siemens Healthcare 76

C RSE Technical Exhibition 247

Oﬃcial Name Booth#

Andramed 77 Imactis 78 DAfMT 79 NeuWave Medical 80 Jotec 81 Angiodroid 82 GE Healthcare 83 Lombard Medical 84 Surgical Specialties 85 Tecres 86 HS Hospital Service 87 MDL 88 Mermaid Medical 89 ArraVasc 90 Penumbra 91 Andanza International 92 Eurocor 93 AndraTec 94 Bluegrass Vascular Technologies 95

Interested in searching exhibitors by product category? Use the CIRSE App! 248 CIRSE 2016 Pocket Guide

Technical Exhibitors Guide

Aachen Resonance 64 Pauwelstrasse 17 52074 Aachen GERMANY www.aachen-resonance.com

Aachen Resonance was founded as a spin-oﬀ company from the University of Aachen, Germany. It started as a R&D com pany, with its main focus on drug delivery. Now it is a complete manufacturing company with multiple production places in Europe and a commercial hub in Singapore to serve the Asian market. Continuous improvement of the product led to our latest devices ELUTAX "3", EMPEROR and ELUTAX SV. All three devices are drug eluting balloons with special indications to serve local market needs. We are the only company which has drug eluting balloons for large vessels over 12 mm and for intra-cranial indications.

Abbott Vascular 9 Park Lane, Culliganlaan 2B 1831 Diegem BELGIUM www.abbott.com

Abbott Vascular, a division of Abbott, is a global leader in cardiac and vascular care with market-leading products and an industry-leading pipeline. We are committed to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education. We oﬀer cutting-edge devices for coronary artery disease, peripheral vascular disease, carotid artery disease and structural heart disease.

ALN Implants Chirurgicaux 61 589 Chemin du Niel 83230 Bormes les Mimosas FRANCE www.aln2b.com

ALN is one of the leaders in its field with its ALN optional vena cava filter. This filter is well known in Europe for more than

C RSE Technical Exhibitors Guide 249

20 years and has long been present on inter national markets including the USA. Products: ALN Optional vena cava filter with Hook, ALN Optional vena cava filter without Hook, Retrieval systems of the ALN filter including the 2in1 device, CE Mark & FDA approved (2008), Proven effectiveness, Retrieval after long placements (over 40 months).

Andanza International 92 Zum Werrablick 4 37276 Meinhard GERMANY www.andanza.de

Andanza International is a German company and was founded in 2005. With the Premofix assortment, the company has developed a new range of unpretentious but inno vative products for puncture site aftercare. The Fast–Pressure- Systems are still a new product category for maintaining hemostasis. The products are meeting an internationally growing demand for increasing patient and user comfort at a low cost. It is unrivaled and easy to use: bandages, plaster strips and thick swabs to cover the puncture site become redundant, as do the side effects of these traditional solutions. Andanza International is a dynamic company, with a focus on puncture site aftercare. It is built on "Made in Germany" quality concepts. The Premofix assortment offers different products to increase patient safety either in addition to wound closure systems or as stand-alone solutions. Our goal is to supply simple and easy-to-use products which can also be applied by nursing staff. All of our products are non-invasive and therefore have a very low-risk profile. They are designed to be convenient for patients and nursing staff.

Andramed GmbH 77 Schiesswieslenstrasse 18 72766 Reutlingen GERMANY www.andramed.com

It is probably a combination of many factors that has made us successful since 2004: the good collaboration of a medium-sized family company; the site in the heart of Germany’s medical technology region around the University of Tübingen; our "typical Swabian" meticulousness and our 250 CIRSE 2016 Pocket Guide extremely high quality standards; our commitment to just a few, but therefore all the more high-quality niche products, and the collaboration with doctors to ﬁnd ever-better solutions. All this has contributed to our ﬁrst-class reputation and making us so well-known – as well as to our products being used worldwide.

AndraTec 94 Simmernerstrasse 70 56075 Koblenz GERMANY www.andratec.com

AndraTec is a leader in advanced interventional technologies. Our portfolio ranges from special guide wires and dedicated retrieval devices to new types of balloons, special stents and embolization material: Lokum Lunderquist & Alplatz, Exeter Snare & Micro Snare, AltoSa-PTA Balloon range, Optimus Stents & Covered Stents, Pillar BRD (Bifurcation Reconstructon Device), Pillow Large Lumen Occlusion Device.

Angiodroid Srl 82 Via Caselle, 76 40068 San Lazzaro di Savena (BO) ITALY www.angiodroid.com

Angiodroid S.r.l. is an innovative Italian company that projects and trades solutions for the medical market. Angiodroid The CO2 Injector is our main product. It is a carbon dioxide (CO2) injector for interventional radiology procedures and represents the perfect solution for the treatment of patients with diabetic diseases, renal failure or intolerance to iodinated contrast media. The use of CO2 in peripheral angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack of advanced technology which could support operators during the procedures. Angiodroid The CO2 Injector, whose main ﬁelds of application are interventional radiology & vascular surgery, is the perfect solution to all these problems and is the only injector: 100 % automatic, 100% safe, 100% digital, 100% user-friendly.

C RSE Technical Exhibitors Guide 251

AngioDynamics 48 Haaksbergweg 75 (Margriet Toren) 1101 BR Amsterdam Z-O THE NETHERLANDS www.angiodynamics.com

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics‘ diverse product lines include market-leading ablation systems, ﬂuid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

AprioMed AB 50 Virdings Allé 28 75450 Uppsala SWEDEN www.apriomed.com

AprioMed develops, manufactures, markets and sells innovative medical devices and related services within the field of interventional radiology. We aim to deliver, in close collaboration with healthcare practitioners, innovative tools to achieve optimal solutions for radiologists worldwide. AprioMed now introduces Gangi-SoftGuard® Coaxial Needle. Gangi-SoftGuard® combines the well-known technique of a coaxial biopsy needle with an all new spring-loaded blunt-tip stylet providing extra control and safety during soft tissue biopsy. AprioMed’s product range also includes Morrison Steerable Needle™. Being the first steerable needle enabling active guidance around objects within the body, Morrison Steerable Needle™ is the perfect tool for deep-seated targets. AprioMed is also the manufacturer of Bonopty® Bone Biopsy System, a coaxial bone biopsy system with eccentric drill. Using Bonopty®, it is possible to gain access even through thick, cortical bone as well as to sample somewhat sclerotic lesions. Visit the AprioMed booth to find out more about our products and get a live demonstration. 252 CIRSE 2016 Pocket Guide

Argon Medical Devices 47 Voie du Chariot, 3 1003 Lausanne SWITZERLAND www.argonmedical.eu.com

Argon Medical Devices welcomes you to booth 47 at Cirse 2016. Argon is a global manufacturer of specialty medical products oﬀering a broad range of single-use medical devices for interventional radiology, vascular surgery, interventional cardiology, and critical care procedures. Argon’s portfolio includes: CLEANER™ Thrombectomy Systems, Option™ ELITE IVC Filter, Atrieve™ Vascular Snare Kits, BioPince™ Full Core Biopsy Instrument, TLAB® Transjugular Biopsy Instrument and SKATER™ Drainage Systems, in addition to many other products for your interventional needs. Our products are sold globally through our sales teams and specialist distributors. CIRSE 2016 sees the European launch of Argon’s Option™ ELITE IVC Filter new indication for delivery via popliteal access. This unique feature will enable physicians to combine Option™ ELITE and CLEANER™, the only wall- contacting rotational thrombectomy device indicated for use in peripheral vasculature, for a uniquely eﬀective approach to treat DVT and prevent PE through a single access site. The Argon team will be delighted to meet you at stand 47 for presentations and hands-on sessions of our complete range of products. We are looking forward to your visit!

ArraVasc 90 Unit 2 Ballybrit Business Park Galway IRELAND www.arravasc.com

ArraVasc Ltd. is an ISO13485 accredited medical device company, headquartered in Galway, Ireland, that is developing and manufacturing percutaneous transluminal angioplasty balloon catheters for peripheral vascular disease. Our Pirouette family of PTA catheters features novel low-proﬁle balloon-forming technology, FineForm™, and is available across a wide matrix of balloon lengths 20mm to 300mm, diameters 1.25mm to 12.0mm, and catheter lengths 450mm to 1500mm. Pirouette is supplied to our strategic distribution partners across all key global markets.

C RSE Technical Exhibitors Guide 253

ArraVasc has developed a number of innovative access technologies, including: • World-class balloon design and manufacturing technologies, over-the-wire and rapid-exchange, across .014", .018" and .035" platforms, with low profile and wide pressure ranges • Innovative catheter design and assembly • Novel low-profile ‘peel away’ split sheath technology which supports the most accurate stent placement for coronary or peripheral applications • Thin wall balloon technology – allowing clinicians to complete even more procedures in 4F • Low profile, High Pressure balloons – for AV Fistula and other difficult-to-treat lesions • Innovative R&D pipeline including scoring balloon design. Please call by CIRSE booth number 90 and meet the ArraVasc team.

Asahi Intecc Co., Ltd 35 Strawinskylaan 967, WTC Tower D-9th ﬂoor 1077 XX Amsterdam THE NETHERLANDS www.asahi-intecc.co.jp

Asahi Intecc develops and supplies high-quality medical products using an integrated in-house production system that covers everything from the selection and treatment of raw materials to the manufacturing of final products. In the peripheral field, Asahi Intecc offers a selection of guide wires that incorporate technological innovations resulting from more than twenty years of researching and developing guide wires for coronary interventions. These innovations ensure optimal torque transmission from the proximal to the distal end and better control for intraluminal tracking. For femoropopliteal (SFA) interventions, the wire line-up consists of the 0.018” Gladius18, Halberd18, GaiaPV,Treasure 12, Treasure Floppy and Astato 30, while for infrapopliteal (BK) interventions the 0.014" wires Gladius14, Halberd14, Regalia XS 1.0, Astato XS 20 and Astato XS 40 are available. In the field of IR, Asahi Intecc recently introduced Masters Parkway, a new series of microcatheters with a high flow rate and a large inner lumen for high-volume injection and smooth delivery of embolic materials. For increased ease of use, a version with a pre-loaded guide wire that is prepared with just one flush injection is also available. For more information and product demonstrations, please visit our booth! (Booth No. 35). 254 CIRSE 2016 Pocket Guide

Avinger 75 400 Chesapeake Dr. CA 94063 Redwood City UNITED STATES www.avinger.com

Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter- based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the ﬁrst-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

Bard Peripheral Vascular 51 C.R. Bard Forest House, Tolgate Forest Business Park Brighton Road RH11 9BP Crawley UNITED KINGDOM www.bardpv.com

Bard Peripheral Vascular, Inc. has a tradition of vascular innovation with a focus on improving the quality of patients’ lives. It provides a range of interventional and surgical medical devices for the treatment of peripheral vascular, venous, dialysis access, biliary and tracheobroncheal disease. Featured interventional products include the Lutonix® Paclitaxel Coated PTA Balloon Catheter, the LifeStent® Vascular Stent Systems - available in lengths up to 250mm, Lifestream™ Balloon Expandable Vascular Covered Stentgraft, VascuTrak™ PTA Dilatation Catheter, Ultraverse® 014, 018 and 035 PTA Dilatation Catheters, Rival® PTA Dilatation Catheter and a range of unique tools for crossing chronic total occlusions with the Crosser® CTO Recanalization Catheter and Seeker® Crossing Support Catheter.

C RSE Technical Exhibitors Guide 255

Bentley / Joline 54 Lotzenäcker 25 72379 Hechingen GERMANY www.bentley-innomed.com

Bentley offers innovative solutions for minimal-invasive coronary and peripheral vascular therapies and aims for the best solutions to help patients. Our core competence is the development of covered and uncovered stents. The first products of our BeGraft and BeSmooth range constitute the ambitious beginning of an extensive product pipeline. Joline has built on a long tradition in the development and production of medical devices under the highest quality standards. Advanced production technology and medical expertise ensure consistency and reliability. All Joline products have been developed and produced exclusively in Germany. Excellent global customer relations are essential for our success. biolitec biomedical technology GmbH 39 Otto-Schott-Straße 15 07745 Jena GERMANY www.biolitec.de biolitec® is a worldwide leader in laser applications and is the only medical technology provider with the relevant expertise (photo-sensitizers, lasers, and optical fibers) in the area of photodynamic therapy (PDT). In addition to laser-assisted treatment of cancerous diseases with the medication Foscan®, biolitec® researches and markets minimally-invasive laser procedures. ELVeS Radial™ (endo laser vein system) is the most frequently used laser system worldwide for treating venous insufficiency. In connection with the LEONARDO® Dual 200 W laser, the innovative XCAVATOR® enables the gentle treatment of benign prostatic hyperplasia (BPH) in urology. The new LEONARDO® diode from biolitec® is the first universal medical laser to feature a combination of two wavelengths (980 nm and 1470 nm) and be used across disciplines. The biolitec® segment also includes laser applications in the areas of proctology, ENT, gynecology, thoracic surgery, and pneumology. Further information can be found at www.biolitec.de. 256 CIRSE 2016 Pocket Guide

Bioteque Corporation 18 5F-6, No.23, Sec.1, Chang-An E. Rd. 104 Taipei TAIWAN www.bioteq.com.tw

Bioteque Corporation currently operates two manufacturing plants in Taiwan and one manufacturing plant in the Philippines. The Bataan facility was established in 2013 by Bioteque Corporation. The facility employs approximately 300 people. The area (size) of the facility is 34,288 total square meters. Product categories manufactured are mainly Bloodline and Respiratory Care products. We provide solutions in many critical applications such as nephrology and dialysis, cardiovascular catheters, endourology, interventional radiology – just about every ﬁeld that exists. Manufacturing processes associated with full range of TPU (Thermoplastic polyurethane) catheters and full range of endovascular, endourology, interventional radiology products are manufactured by the Taiwan facilities. All our facilities are accredited with ISO 13485 and compliant with FDA, GMP and Quality System Regulations. In pursuit of extensive and everlasting growth, we are supplying quality products including: Pigtail Drainage Catheter / Double Pigtail Ureteral Stent / PCN kits for Nephrostomy, Hemodialysis Bloodline / AV Fistula Needles, IV Infusion Bags, Double Lumen Dialysis Catheter, CVC catheter, CAPD solution system. Our facility is ISO13485, CE-0434 accredited and passed FDA establishment audit. For more information, please visit our website www.bioteq.com. tw. Bioteque is continuously dedicated to develop innovative products and provide total solutions for all its customers.

Biotronik 57 Ackerstrasse 6 8180 Bülach SWITZERLAND www.biotronik.com

A global leader in cardio- and endovascular medical tech no- logy, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pace- maker in 1963, BIOTRONIK has engineered many innovations, C RSE Technical Exhibitors Guide 257 including Magmaris, the first clincally-proven bioresorbable magensium scaffold; BIOTRONIK Home Monitoring®; Pulsar, the world’s first 4 F compatible stent for treating long lesions; Orsiro, the industry’s first hybrid drug-eluting stent; and the world’s first implantable cardioverter defibrillators and heart failure therapy devices with ProMRI® technology.

Bluegrass Vascular Inc. 95 18618 Tuscany Stone TX 78258 San Antonio UNITED STATES www.bluegrassvascular.com

Bluegrass Vascular Technologies is focused on innovating lifesaving devices and methods for vascular access procedures. Its Surfacer® Inside-Out® Access Catheter System is indicated for obtaining central venous access to facilitate catheter insertion into the central venous system via a novel Inside-Out approach.

Bolton Medical 72 Plaza de Europa, nº 21-23 8908 L‘Hospitalet de Llobregat SPAIN www.boltonmedical.com

Bolton Medical is a subsidiary of the WerfenLife Company. WerfenLife is a global company that manufactures and distributes medical diagnostic solutions and medical devices worldwide. Bolton Medical’s vision is to become the leading provider of endovascular solutions for aortic disease. Headquartered in the US, Bolton Medical improves the quality and safety in patient care by developing, manufacturing, and distributing innovative, high quality products and technology solely focused on the aorta. Visit www.boltonmedical.com for more information.

Interested in searching exhibitors by product category?

USE THE CIRSE APP! C RSE 258 CIRSE 2016 Pocket Guide Technical Exhibitors Guide 259

Boston Scientiﬁc International 24 2 rue René Caudron 78961 Saint Quentin en Yvelines Cedex FRANCE www.bostonscientiﬁc.eu

Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 25,000 employees and revenue of $7.477 billion in 2015. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.eu and connect on Twitter (@bostonsci) and Facebook.

BTG 70 Lakeview, Riverside Way Watchmoor Park GU15 3YL Camberley UNITED KINGDOM www.btg-im.com

At BTG we are focused on bringing to market innovative products in specialist areas of medicine to better serve doctors and patients. Our growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer tumours, advanced emphysema, severe blood clots and varicose veins, while our Specialty Pharmaceuticals portfolio oﬀers antidotes that alleviate toxicity and treat rare conditions. Healthcare is constantly evolving – so BTG never stands still. Inspired by a deep understanding of our customers’ needs, we’re working to meaningfully improve the lives of patients and their healthcare experience. Our com- petitive advantage is our dedication to ﬁnding smart, often unconventional solutions to complex medical problems. Many of our products combine medicines, device technology and new techniques in order to deliver more targeted treatments. We also invest in the clinical evidence to help demonstrate the value of our products to doctors, patients, and healthcare systems. Doing what’s right for patients is what gets us to work in the morning. It’s part of our DNA. By staying true to this principle and our values, we’ve earned a strong reputation for the quality of our products and our commitment to 260 CIRSE 2016 Pocket Guide innovation. Whether developed in our own labs or in partnership with clinicians, academics and other companies, we believe passionately that medical innovation has the power to improve human health. For more information, please visit www.btg-im.com.

Cardionovum 23 Am Bonner Bogen 2 53227 Bonn GERMANY www.cardionovum.de

Cardionovum GmbH is a leading company in innovative coronary and peripheral drug coating technologies improving clinical outcomes and quality of life. LEGFLOW® drug coated balloon for peripheral artery disease treatment as well as APERTO® Drug coated balloon for hemodialysis shunt treatment and RESTORE® for coronary artery disease treatment are the latest innovations with highest patient safety guarantee.

CAScination AG 71 Steigerhubelstrasse 3 3008 Bern SWITZERLAND www.cascination.com

Swiss Precision for your ablation treatments: CAScination provides CAS-One IR, a navigation system for ablation treatments. CAS-One IR enhances control over your ablation workflow: 1. Ablation planning and simulation In the planning phase, CAS-One IR provides comprehensive software tools to plan single and multiple access trajectories and optimal needle placement/spacing to achieve complete tumor ablation. The expected ablation volume, displayed in multi-planar renderings and in 3D, enables risk and margin assessment before the treatment. 2. Navigated needle placement In-plane and off-plane needle insertion is carried out with precise, frameless stereotactic support. By using CAScination‘s aiming device, any kind of needle can be efficiently navigated. The navigation technology enables needle placement in one shot, avoiding additional punctures and radiation to the operator.

C RSE Technical Exhibitors Guide 261

3. Ablation control and documentation CAScination‘s PhotoFinish treatment veriﬁcation is based on image fusion between the initial contrast scan and subsequent control images. Photoﬁnish allows for quantitative assessment of targeting accuracy and ablation coverage. CAS-One IR is a dedicated navigation system for CT-guided interventional procedures providing intuitive support for complex treatments. Join us during CIRSE to see a live demonstration of this exciting technology!

Contego Medical 2 3921 Sunset Ridge Road Suite 102 NC 27607 Raleigh UNITED STATES www.contegomedical.com

Contego Medical, LLC is a medical device company dedicated to the development of novel embolic protection devices for cardiovascular and peripheral vascular procedures. The company’s integrated embolic protection (IEP) platform, which combines embolic protection and treatment into one device, is designed to simplify catheter-based procedures and improve patient outcomes. Contego Medical’s portfolio is poised to transform cardiovascular and endovascular interventions by making existing procedures safer without increasing complexity or compromising performance. The company is focused on three initial products: The Paladin® Carotid Post-Dilation Balloon System, the ﬁrst and only angioplasty balloon with IEP Technology aimed at reducing stroke risk (CE Mark), The Vanguard® Percutaneous Transluminal Angioplasty Catheter with Integrated Embolic Protection for occlusive SFA treatment, and the Corguard® Coronary Stent System. Contego Medical is based in Raleigh, North Carolina in the United States. 262 CIRSE 2016 Pocket Guide

Control Medical Technology 31 2500 South State Street Suite D257 UT 84115 Salt Lake City UNITED STATES www.controlmedtech.com

Thrombectomy needs vary based on the size, location, and age of thrombus. Certain procedures benefit from continuous high-thrombectomy force. Other procedures only need quick spot, or touch-up, thrombectomy. Yet in other situations, pulsed thrombectomy to rapidly cycle between full and no power is required. Basic syringes lack this versatility. Typically, syringes only fill 30ml at a time requiring repeated attachment, stopcock manipulation, filling, detachment, drainage, and re-attachment to catheters. Slow, messy, risky, and inefficient. Electromechanical systems may deliver more force and volume than basic syringes, but add complexity and cost to the procedure with limited tactile feel and control. The ASPIRE Mechanical Thrombectomy System includes a high-performance mechanical aspirator with over-the-wire and rapid-exchange catheters for arterial and venous procedures. The ASPIRE delivers new control during thrombectomy allowing users to instantly start, stop, increase, decrease, maintain, and pulse thrombectomy force with the power of their hand. Squeezing the handles starts thrombectomy force and releasing the handles stops it. The dual valves and a drain bag combine to create a closed fluid system to eliminate repeated syringe-catheter detachments and drainage. Users may connect the ASPIRE Mechanical Thrombectomy driver to any catheter and aspirate with improved speed, volume, and control.

Cook Medical 52 O’Halloran Road, National Technology Park Limerick IRELAND www.cookmedical.eu

A global pioneer in medical breakthroughs, Cook Medical is committed to creating eﬀective solutions that beneﬁt millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs

C RSE Technical Exhibitors Guide 263 and ethical business practices ﬁrst, Cook is a family-owned company that has created more than 10,000 jobs worldwide. For more information, visit www.cookmedical.eu.

Cordis 22 Regus Pegasus Airport Center Pegasuslaan 5 1831 Diegem BELGIUM www.cordis.com/emea

Cordis, a Cardinal Health company, is a worldwide leader in developing and marketing innovative solutions and devices for cardiovascular disease management. Cordis is committed to delivering the right combination of solutions, products, services and evidence to treat millions of patients who suﬀer from vascular disease.

Deutsche Akademie für Mikrotherapie (DAfMT) 79 Leipziger Strasse 44 39120 Magdeburg GERMANY www.dafmt.de

The Deutsche Akademie für Mikrotherapie (DAfMT) oﬀers academic teaching in practical courses and workshops. Our philosophy is based on a disease-centred approach, with physicians of various specialties gathering to teach con- ceptual interdisciplinary thinking in addition to practical skills in microtherapy. Scholars will be guided to develop treatment algorithms including microtherapeutic techniques, and they will additionally undergo training using phantoms and animal models to learn essential practical skills. The DAfMT also renders speciﬁc services for preclinical science and development in microtherapeutic techniques and the according tools.

Interested in searching exhibitors by product category?

USE THE CIRSE APP! C RSE 264 CIRSE 2016 Pocket Guide

ECO Microwave 41 10F Bldg. 2, No. 305 North Jiangdong Rd 210037 Nanjing CHINA www.njecomed.com

We are the leading manufacturer for Microwave Ablation system and Microwave Varicose Vein systems in China since the year 2002. We are developing the latest technologies in Microwave. Our system is CE-approved, and the FDA certiﬁcate is also under process.

Edizioni Minerva Medica 67 C. So Bramante 83-85 10126 Turin ITALY www.minervamedica.it

Since 1909, Edizioni Minerva Medica publishes specialist journals and books which are distributed worldwide, among them the Journal of Cardiovascular Surgery and the book series European Vascular Course. The Journal of Cardiovascular Surgery is indexed by Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus and the latest Impact Factor available is 1.632.

Elastrat 11 43 Ave de Châtelaine 1203 Geneva SWITZERLAND www.elastrat.ch

Elastrat sàrl. is a worldwide leader in the development and realization of anatomical human vascular phantoms. Based in Geneva, Switzerland, our flow models contain various pathologies such as aneurysms, stenoses and loops. We manufacture head, thoracic, heart, abdominal and peri pheral models. The models work with a small pump in a closed water circuit and are appropriate for education, hands-on trainings, R&D purposes to enhance new intervention technologies, product development and procedure improvements. As they are transparent to light they are suitable for use with video and photographic monitoring. Elastrat’s phantoms offer C RSE Technical Exhibitors Guide 265 quality hands-on training experience. We also supply custom- made phantoms of patients’ specific pathologies with STL files received from clients. All our models train in a most realistic medical environment. Elastrat’s in-vitro models are compatible with all imaging technologies such as angiographies with contrast liquid, CI, IRM and, provided the appropriate circulating fluid is used, trans-cranial Doppler techniques. Elastrat maintains close working relationships with renowned medical centers such as the GRAC (groupe de recherches en anatomie clinique) University of Geneva and HUG Geneva Hospitals. You will find Elastrat at booth 11.

Endovascular Today Europe 20 1008 Upper Gulph Road, Suite 200 PA 19087 Wayne UNITED STATES www.evtoday.com

Endovascular Today Europe is the premier publication for all specialists engaged in endovascular therapies. Published seven times a year with a weekly online e-news, each issue of Endovascular Today Europe features timely articles on new techniques, clinical trial results, case studies, and advances in technology for endovascular practitioners. Endovascular Today Europe is distributed to 9,200 endo vascular specialists in Europe.

Eurocor Gmbh 93 In den Dauen 6a 53117 Bonn GERMANY www.eurocor.de

Eurocor is a European Science Technology Corporation specializing in research, development and manufacturing of cardiovascular and endovascular products. Eurocor provides physicians with innovative endovascular devices, manufactured in Europe. Products are indicated for minimally invasive peripheral interventions and comply with biological and biomechanical principles to offer highly flexible, adaptable solutions. Research and development, close clinicial collaboration, quality standard philosophy and global scientific alliances lead to optimization of clinically effective technology. Eurocor’s drug-coated PTA balloon FREEWAY™ has been developed to potentially overcome the 266 CIRSE 2016 Pocket Guide high incidence of restenosis after interventions in peripheral artery disease. FREEWAY DCBs are available in two versions: FREEWAY 035 designed for the treatment of femoropopliteal arteries, FREEWAY 014 designed for the treatment of infrapopliteal arteries (BTK). Both provide state-of-the-art outstanding crossability, trackability, pushability and ease of use. The coating makes the difference – FREEWAY uses a special homogenous 1:1 shellac/paclitaxel coating. When the balloon is expanded the antiproliferative drug paclitaxel is released to inhibit the proliferation of smooth muscle cells by disturbing microtubule formation. Paclitaxel is applied to the surface of the balloon in a final concentration of 3 μg/mm². Eurocor GmbH is a wholly owned subsidiary of Opto Eurocor Healthcare Limited and is part of the Opto Circuits Group.

GE Healthcare 83 283 rue de la miniere 78533 Buc FRANCE www.gehealthcare.co.uk

GE Healthcare provides medical technologies and services to help solve the challenges facing healthcare providers around the world. From medical imaging, software, patient monitoring and diagnostics, to biopharmaceutical manufacturing technologies, GE Healthcare solutions are designed to help healthcare professionals deliver better, more efficient and more effective outcomes for more patients. GE Interventional image guided systems: The Discovery IGS 740 and the Innova IGS 540 angiography interventional solutions and the LOGIQ E9 (with XDclear) ultrasound system help clinicians plan, guide and assess interventional oncology procedures precisely and efficiently: flight plan for Liver software automatically highlights liver tumor feeders and helps to guide embolization procedures quickly and precisely, needle ASSIST* allows clinicians to precisely assess the positioning of the needle, based on the reconstructed 3D needle obtained from 2 fluoroscopic images and displayed on oblique CBCT cross sections, volume Navigation Image Fusion with Active Tracker technology allows for the auto registration of live ultrasound with CBCT, MRI and CT.

* Needle ASSIST solution includes TrackVision 2 and requires AW workstation with Volume Viewer, Volume Viewer Interventional. These applications are sold separately.

C RSE Technical Exhibitors Guide 267

GEM 68 Via dei Campi 2 PO BOX 427 55049 Viareggio ITALY www.gemitaly.it

GEM srl is an Italian ﬁrm established in 1994, producing surgical glues (under the GLUBRAN brand) and distributing all over the world: • GLUBRAN 2 (Ref. G-NB-2; G-NB2-50; G-NB2S-25) for Surgical and Endovascular use • GLUBRAN TISS (Ref. G-NBOC; G-NBOC-25) for skin application GEM srl also produces and distributes the application devices suitable for the use of these glues: • Dispensing Tips (Ref. G-DT) suitable for all the types of vials of glues • Catheters for Laparoscopy (Ref. G2-LPC; G2-LPC-RIG) for laparoscopic surgeries • Drop Control Devices (Ref. G2-DCD-210-8T) for open surgeries • Spray Devices in 5 models (Ref. G2-NBT; G2-NBT-SMALL; G2-NBT-RIG; G2-NBT-SHORT; G2-NBT-SM-SHORT) suitable for open, laparoscopic, thoracoscopic and bariatric surgeries • Application devices dedicated to the closure of vascular accesses, Glubran 2 Seal Device Ref. G2-SL 5/6; G2-SL 7/8 • 1 ml luer lock syringes Ref. G-LLS in polypropylene All the above listed application devices are technically studied on purpose for GEM’s glues. All GLUBRAN products are CE marked.

Getinge Group 36 Kehler Strasse 31 76437 Rastatt GERMANY www.maquet.com

Getinge Group is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. Getinge’s offering is mainly targeted at care providers, care givers and care receivers. The offering to hospitals is organized in three areas: Enable, Treat and Care. This allows Getinge to identify customer issues at an early stage, promote clinical 268 CIRSE 2016 Pocket Guide and economic benefits and follow and support the customer decision process. Getinge’s unique offering mirrors the hospital’s organization and value chain, and the solutions are used before, during and after the patients’ hospital stay. Passion for life is Getinge’s brand promise. The company is built on a genuine compassion for people’s health and well-being. Based on first-hand experience and close partner- ships, Getinge provides innovative healthcare solutions that improve every-day life for people, today and tomorrow.

Gore & Associates 4 AZ 86004 Flagstaﬀ UNITED STATES www.goremedical.com/eu

At Gore Medical, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. "100 Best Companies to Work For" lists since the rankings debuted in 1984. For several years now, we have also been voted one of the best work- places in Europe and have been ranked on top workplace lists in France, Germany, Great Britain, Italy and Sweden. For more information, visit goremedical.com/eu.

Guerbet 55 BP 57400 95943 Roissy CdG Cedex FRANCE www.guerbet.com

Guerbet is a pioneer in the contrast agent ﬁeld with nearly 90 years of experience, and is the only pharmaceutical group dedicated to medical imaging worldwide. It oﬀers a comprehensive range of X-Ray, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve the diagnosis and treatment of patients. To discover new products and ensure future growth, Guerbet invests C RSE Technical Exhibitors Guide 269 heavily in R&D, spending around 9% of its sales each year. Guerbet (GBT) is listed on Euronext Paris (Segment B – Mid Caps) and generated revenue of € 489M in 2015.

Hansen Medical 62 800 East Middleﬁeld Road CA 94043 Mountain View UNITED STATES www.hansenmedical.com

Hansen Medical®‘s Magellan™ Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan Robotic System is designed to deliver predictability, control and catheter stability to endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan Robotic System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedures globally. The Magellan Robotic System oﬀers several important features including: • Provides predictability, control and catheter stability as a physician navigates a patient‘s peripheral vasculature and then provides a conduit for manual treatment of vascular disease with standard therapeutic devices • Is designed to enable more predictable procedure times and increased case throughput, potentially allowing hospitals to improve utilization within their vascular business line • Employs an open architecture designed to allow for the subsequent use of many therapeutic devices on the market today • Is designed to potentially reduce physician radiation exposure and fatigue by allowing the physician to navigate procedures while seated comfortably at a remote workstation away from the radiation ﬁeld and without wearing heavy lead as required in conventional endovascular procedures • The Magellan 6Fr Robotic Catheter allows for independent robotic control of two separate bend sites on a single catheter, as well as robotic manipulation of standard guide wires.

Interested in searching exhibitors by product category?

USE THE CIRSE APP! C RSE 270 CIRSE 2016 Pocket Guide

HS Hospital Service SPA 87 Via Zosimo 13 00178 Rome ITALY www.hshospitalservice.com

HS Hospital Service SpA is a leading player in the interventional oncology market, from RF and MW tumor ablation systems to soft tissue and bone marrow biopsy needles, catheters, drug infusion devices and all sorts of products for surgery, interventional radiology and critical care. In the field of health technologies, success may only be achieved through excellence. We are committed to delivering excellence all the way from product design and manufacturing to post-sale customer care. We transfer know-how and expertise from industrial research to the clinical field and back. Everyday we work side by side with physicians and interact with all stakeholders in interventional oncology to better understand and fulfill their needs and requirements, so as to deliver to the market top-level devices, with optimum performance, minimum invasiveness and unmatched usability. Let us show you our new products and projects and let us share with you information, ideas, plans and strategies for the future. Come and visit us at booth number 87!

Hyprevention 16 PTIB – Hopital Yavier Arnozan Avenue due Haut Leveque 33604 Pessac FRANCE www.hyprevention.com

Founded in 2010 by Cécile Vienney (CEO) and three ortho- pedic surgeons, Hyprevention is a French company that develops, manufactures and sells implantable medical devices to address unmet clinical needs. It is certified ISO 13485: 2003 since January 2014, and CMDCAS since January 2015. Hyprevention received CE mark approval for its first product, Y-STRUT®, indicated for percutaneous internal fixation for impending pathological fracture of proximal femur.

C RSE Technical Exhibitors Guide 271

Imactis 78 5 avenue du Grand Sablon 38700 La Tronche FRANCE www.imactis.com

Imactis is specialized in computer-assisted interventional radiology. Imactis develops and markets innovative solutions to assist interventional radiologists during minimally invasive needle procedures. The objective is to increase accuracy and safety, facilitate complex procedures, reduce the length of procedures, decrease the number of controls and improve patient treatment.

Imedicom Co., Ltd 26 #612, 172 LS-ro 15807 Gunpo REP. OF KOREA www.imedicom.co.kr

Imedicom co., Ltd is a medical device company manufacturing balloon kyphoplasty systems, video-guided catheters for epiduroscopy, surgical power tools and saw blades. 1. The Balloon Kyphoplasty System by Imedicom is intended to be used as conventional bone tamps for the reduction of vertebral compression fractures (VCFs) Approved: CE, FDA, CFDA, ANVISA. 2. The epidural catheter and video-guided catheter is a product for patients with chronic back pain. As a minimal invasive surgery, these products are a good alternative for discogenic pain or spinal adhesion. Approved: CE, FDA(pending).

Interventional News / BIBA 42 526 Fulham Road SW6 5NR London UNITED KINGDOM www.interventionalnews.com

Interventional News is an editorially independent, expertly curated news provider that brings you the news, as it happens. With a brand new website, fortnightly newsletters, social media presence, and an app with worldwide reader- ship, we also have a quarterly print edition for subscribers in Europe and North America. Published by BIBA Medical, 272 CIRSE 2016 Pocket Guide

Interventional News is steered by renowned editors-in-chief, Professor Andy Adam and Dr. Brian Stainken, and reaches over 12,000 interventionalists. Interventional News contains the latest news, summaries of cutting-edge research and spot- lights controversies in interventional radiology. We publish expert analysis, conference coverage and key updates on the latest products and medical device industry. Have you visited us yet? Free subscription at www.interventionalnews.com.

Invamed Health Inc. 29 Mutlukent Mah.19.Sok. Hekimköy Sitesi No:10 Çankaya 06810 Ankara TURKEY http://invamed.net

Invamed Health Inc. is a manufacturer company under vascular surgery. Our products are: venablock (sealing system in varicose), veinoff (small segment of varicose), Filler (treatment to puerperal aneurism), hemoff (treatment hemoreid), angioblock (vascular closer), Mantis (thrombectomy device), inca (vena cava filter), dovi (aspiration chateter), Extender (DEB). iSYS Medizintechnik GmbH 40 Bergwerksweg 21 6370 Kitzbühel AUSTRIA www.isys.co.at

The core competence of iSYS Medizintechnik GmbH is the development, production and distribution of computer-aided assistance and navigation systems for the real-time positioning of instruments directly within the gantry of the imaging device, e.g. our iSYS Navi+ System. Furthermore iFIX, a unique universal immobilization and positioning platform, is in the portfolio of iSYS.

C RSE Technical Exhibitors Guide 273 iVascular 56 Camí de Can Ubach 11 08620 Sant Vicenç dels Horts SPAIN www.ivascular.es iVascular is a fast-growing company based in Barcelona with the aim of developing advanced and innovative medical devices for the treatment of disorders of the cardiovascular system. Our staﬀ has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognized experience in the development of medical devices and implants. iVascular possesses and develops its own technologies through a vertically integrated project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the ﬁnal device or implant. iVascular is present in more than 30 countries with a portfolio of coronary and peripheral products including drug eluting balloons, drug eluting stents, nitinol self-expandable stents, CoCr balloon-expandable stents, aspiration thrombus extrac- tor and angioplasty balloons.

JJP Hospitalaria S.L. 1 Av. Republica Argentina N°22 Bis 3°C 41011 Seville SPAIN www.jjphospitalaria.com

Maxio is an image-guided, physician controlled stereotactic accessory to a Computed Tomography system, intended for the stereotactic spatial positioning and orientation of an end effector and instrument guide to assist in manual advance- ment of one or more instruments such as rigid straight needles and probes during CT guided percutaneous procedures or organs and anatomical structures in the thorax, abdomen and pelvis. JJP Hospitalaria SL is a multinational company based in Sevilla (Spain) and with presence in Spain and Latin America since 1997 as the exclusive distributor of Maxio and other powerful tools for interventional radiologists and with the target of finding the most technological advances in the field of Health. Perfint Healthcare, a company based in Chennai (India), is the manufacturer of Maxio. Their mission and purpose is to bring innovative advances to the field of image guided therapies, working together with physicians and trying to improve the quality of life of patients. 274 CIRSE 2016 Pocket Guide

Jotec GmbH 81 Lotzenäcker 23 72379 Hechingen GERMANY www.jotec.com

Jotec provides Vascular and Cardiac Surgeons, Radiologists and Cardiologists with solutions for vascular disease. According to the highest standards of innovation and quality, Jotec develops, manufactures and markets medical devices for peripheral and aortic vascular disease. The product portfolio comprises surgical grafts as well as endovascular implants and accessories. Continuous product improvements and new developments aim to oﬀer best possible solutions for both – patient and physician.

Linc 2017 3 Sonnenleite 3 91336 Heroldsbach GERMANY www.leipzig-interventional-course.com

The Leipzig Interventional Course is committed to advancing the scientific and clinical evaluation and treatment of patients with complex vascular disease through an interdisciplinary discussion of novel endovascular techniques. Linc is a comprehensive and international live course designed to foster collaboration between colleagues of differing specialities and to promote the understanding and development of endovascular therapies that can be incorporated into daily clinical practice. The involvement of leading interventional centers from Europe and North America as live transmission sites, as well as the presence of interventional experts as guest operators in our cathlabs and operating rooms will provide a broad coverage of different interventional approaches and techniques. The organisers of the course and the members of the faculty would like to welcome you to the Leipzig Interventional Course 2017.

C RSE Technical Exhibitors Guide 275

Lombard Medical 84 4 Trident Park OX11 7HJ Didcot UNITED KINGDOM www.lombardmedical.com

Lombard Medical, Inc. is a leading global, innovative company that is expanding the EVAR treatable population with our portfolio of patient focused technologies and customer support. Aorfix is an established endovascular stent graft specifically designed for flexibility and conformity in difficult to treat AAA anatomies, including aortic neck angulation up to 90 degrees. Our latest Altura endograft system’s revolutionary 14F ultra low profile design offers extraordinary advantages including no cannulation, unique seal and repositionability for a simple and predictable solution for treatment of more standard AAA anatomies. Aorfix: Aorfix is an established endovascular stent graft specifically designed for flexibility and conformity in difficult to treat AAA anatomies, including aortic neck angulation up to 90 degrees. The new intelliflex™ Low Profile delivery system offers an integrated exchange sheath and intuitive step by step deployment for precise and controlled delivery. Altura: The 14F ultra low profile Altura endograft system has a revolutionary bilateral aortic stent design. Altura offers extraordinary advantages including no cannulation, unique seal and repositionability for a simple and predictable EVAR procedure. A broad range of patients may be treated with a complement of 6 pieces of inventory.

MDL 88 Via Tavani 1/a 23014 Delebio ITALY www.mdlsrl.com

Based in Northern Italy, MDL, has been on the forefront of innovation since 1993. Already an established leader in the production of biopsy needles, it continues to innovate by developing new and custom-made technologies for the following procedures: Histological Biopsy, Cytological Biopsy, Bone Marrow Biopsy, Bone Biopsy, Senology, Percutaneous Drainages, Radiology, Anesthesia. MDL‘s in-house production capabilities allow medical professionals to work hand in hand with technicians to develop, modify and innovate, providing state-of-the-art, custom solutions both quickly and efficiently, 276 CIRSE 2016 Pocket Guide for any specialized medical use. MDL is in the unique position to guarantee the devices’ performance, maintenance and further developments through its effective quality management system. The entire design, production and distribution process meets the standard UNI CEI EN ISO 13485:2012 and UNI EN ISO 9001-2008. The devices also bear the CE Mark released as per Annex II of European Council Directive 93/42 CEE. The product‘s production certification guarantees that each device has undergone a comprehensive and accurate inspection at each phase of production. This attention to detail and the stringent approval process ensures the highest quality product. MDL is placed nationally and internationally through a dedicated and exclusive sales network of regional and international distributors.

Medcomp 65 1499 Delp Drive PA 19438 Harleysville UNITED STATES www.medcompnet.com

Medcomp is a major supplier of Venous Access Systems. This year, Medcomp is proud to introduce you to the next generation of ECG PICC placement with the C3 Wave. The C3 Wave is an easy-to-use, app-based wireless ECG system designed to free up clinicians’ hands by removing excess wires and allowing more focus on patient care. As well as showcasing our new C3 Wave Medcomp will also be exhibiting: Hemodialysis Catheters, cuffed and uncuffed. This will include its series of Split Tipped designs. Rounding off the dialysis line will be DuraLock-C, Trisodium Citrate antibacterial-anticoagulant catheter locking solution. For drug/chemotherapy administration, CT-Power Injectable PICC lines and Ports will be demonstrated. Rated at 300psi, these venous access devices allow contrast delivery to 5cc/second, facilitating superior contrast enhanced CT studies. Also the new direct micropuncture ports will be shown Neonatal micropuncture access will be showcased as well. Significant features include: a .010“ mini-mandrel wire, a mini-sheath/dilator, and a 1.9 French neonatal line.

C RSE Technical Exhibitors Guide 277

Medtronic 7 710 Medtronic Parkway MN 55432 Minneapolis UNITED STATES www.medtronic.com

As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges – such as rising costs, aging populations and the burden of chronic disease – faced by families and healthcare systems today. But no one can do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Founded in 1949 as a medical repair company, we‘re now among the world‘s largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 155 countries. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.

Merit Medical 69 Amerikalaan 42 6199 AE Maastricht Airport THE NETHERLANDS www.meritemea.com

Founded in 1987, Merit Medical Systems is a worldwide leader in the development, manufacturing, and distribution of quality medical devices used in interventional and diagnostic procedures, from access to closure. With a global workforce and cutting-edge manufacturing facilities equipped with the most advanced technology, Merit Medical consistently delivers quality products that are backed by excellent customer service and professional expertise. We look forward to CIRSE 2016 and the opportunity to showcase our portfolio of high-performance embolotherapy and oncology products, including HepaSphere™ Microspheres, approved for use with Doxorubicin and Irinotecan in TACE, and Embosphere® Microspheres, indicated for use in Uterine Fibroids and Prostatic Artery Embolisation. We will be hosting a symposium on the steerable microcatheter SwiftNINJA®, a unique straight tip catheter that articulates up to 180 degrees in opposing directions to rapidly select the most challenging vascular ostium. Please join us Tuesday, Sept. 13, 14:30-15:30, 278 CIRSE 2016 Pocket Guide room 117 to learn more about the technique and results in using this innovative product. We will also show the beneﬁts of the radial access at 4 diﬀerent stations in our Learning Centre workshops. The Merit Medical team will be delighted to meet you at our booth no. 69 and present our diverse product portfolio.

Mermaid Medical Group 89 Frydensbergvej 25 3660 Stenløse DENMARK www.mermaidmedical.dk

Mermaid Medical Group is a private and independently owned company, headquartered in Copenhagen, Denmark. Within our areas of business we strive to be the preferred partner for both producers of medical devices as well as end- users in the healthcare sector. Mermaid Medical Group is the exclusive distributor for several world-leading producers of medical devices. Our global sales force works out of 10 sales oﬃces in Europe, USA and Asia. We supply medical devices to hospitals and other end-users. Our focus area is interventional radiology, ultrasound intervention in particular along with niche products for cardiology. Such a product is the D-Clot Thrombectory Cathether System which unique properties open up for eﬀective treatment of thrombosis and chronic occlusions.

Micro-Tech 32 No. 10 Gaoke 3rd Road Hi-Tech Induestrial Development Zone 210032 Nanjing CHINA www.micro-tech.com.cn

Micro-Tech is a medical device manufacturer focusing on minimally invasive surgical products. Micro-Tech specializes in research and development, manufacturing (including OEM/ ODM services), marketing and sales of single-use products. As one of the leaders in the minimally invasive surgical ﬁeld, Micro-Tech products include Pulmonary, Interventional Radiology and GI Endoscopy products and most of the products are CE marked.

C RSE Technical Exhibitors Guide 279

MIM Software Inc. 25 25800 Science Park Drive Suite 180 OH 44122 Cleveland UNITED STATES www.mimsoftware.com

MIM offers innovative and clinically relevant solutions for Y90 microsphere therapies with MIM SurePlan Y90. A complete, multi-department solution is offered that ties together IR, Nuclear Medicine, and Radiation Oncology. Save significant time with atlas based segmentation of the liver, rigidly or deformably fuse MR or Diagnostic CT for tumor definition, calculate lung shunt %, and calculate dose on post-procedure Bremsstrahlung SPECT/CT or PET/CT-PET/MR. DVH display, isodose curves, and structured reporting are all included.

Möller Medical GmbH 28 Wasserkuppenstrasse 29-31 36043 Fulda GERMANY www.moeller-medical.com

Möller Medical is a German medical device manufacturer who belongs to the medimondi group. medimondi group is part of Centrotec Sustainable AG and covers all corporate activities concerning medical devices and engineering plastics. Möller Medical manufactures components and highly sensitive medical devices. Our product portfolio consist of own brands (interventional radiology, urology, neurosurgery, aesthetics, blood banks) and OEM business (human cannulae, nano- coatings, HPLC hardware, peristaltic pumps). Our product line BiopC is based upon decades of experience in developing and manufacturing all kinds of cannulae and needles for human medicine as well as in the ﬁeld of intensive care. Creating high quality products with the utmost respect for patient’s well- being has been an unspoken mission statement ever since the foundation of the company 60 years ago. This guideline directly inﬂuenced the development of the BiopC product range and will remain a determining factor for continuous development of the product portfolio. 280 CIRSE 2016 Pocket Guide

NeuWave Medical 80 3529 Anderson Street WI 53704 Madison UNITED STATES www.neuwave.com

NeuWave Medical®, founded by physicians and scientists, created the first intelligent ablation system and the only system that has it all. The versatile probe portfolio with multi- probe synchronized energy delivery allows physicians to tailor ablations with 1, 2 or 3 probes. In addition, the 17 gauge Precision™ PR probe is the only probe available with distal energy control. The unique computer controlled system now includes Ablation Confirmation™ software, offering the only integrated in-procedure confirmation to evaluate the technical success of your procedure. Build your ablation program with the first intelligent ablation system and the only system that has it all.

Olympus Surgical Technologies Europe 45 Olympus Winter & Ibe GmbH Kuehnstrasse 61 22045 Hamburg GERMANY www.olympus-oste.eu

Olympus develops solutions for healthcare professionals that help to improve outcomes and enhance quality of life for their patients. By enabling less invasive treatments and innovative diagnostic procedure, Olympus is transforming the future of healthcare. At our booth we are going to present the Celon RFITT method - the unique radiofrequency bipolar and multipolar technology for treating varicose veins and tumor ablation. The method was developed by Celon, a German company that is now a part of Olympus as the worldwide competence center for new medical radiofrequency technologies. We will be happy to provide you with more information about our devices for the RFITT procedure at our booth.

C RSE Technical Exhibitors Guide 281

Optimed Medizinische Instrumente GmbH 33 Ferdinand-Porsche-Str. 11 76275 Ettlingen GERMANY www.opti-med.de

Optimed is specialized in manufacturing and developing medical products for minimally invasive therapy. As a constant innovation leader with headquarters in Germany, we commit ourselves to the highest quality standards. Our products are the optimal combination of unique designs and high-technology processes. Our 2016 highlight products are: sinus-Obliquus, a dedicated stent to treat symptomatic obstructions of the iliac veins such as May-Thurner Syndrome. The innovative oblique part allows a placement directly at the venous bifurcation and the hybrid design with three different design elements perfectly meets all expectations for a dedicated venous stent. The sinus-Venous raises the standards of stent design to a new level. Due to its unique power diamonds and the segmental ring design the stent delivers an outstanding performance with high radial force and perfect vessel adaption even in complex anatomical conditions of the iliofemoral veins. CO2-Angioset: CO2 is the alternative to iodine-based contrast media. It is ideally suited for use in diagnostics, interventional radiology and vascular surgery. Patients with renal insufficiency, hyperthyroidism, or with an intolerance to contrast-media can be treated with CO2. Its use is as straight forward as conventional DSA. To get more information, find us at booth #33 in Barcelona or visit our homepage www.opti-med.de.

Pajunk GmbH Medizintechnologie 44 Karl-Hall-Strasse 1 78187 Geisingen GERMANY www.pajunk.com

Pajunk® was established in 1965 in Geisingen, southern Germany. Since then Pajunk® continuously invests in its employees, manufacturing facilities and research and development, which has helped maintain the growth of an already established product range. Our manufacturing plant in Germany produces high quality medical products throughout our product portfolio, which includes Regional Anaesthesia, Interventional Pain, Laparoscopic Surgery, Biopsy and Dental. Pajunk® oﬀers a wide range of dispos- 282 CIRSE 2016 Pocket Guide able cannulas for extraction of soft tissue such as prostate, kidney, liver and a variety of soft tumours. The cannula system is characterised by their ﬁnish, precision & geometry. Bone marrow biopsy products are also available. Pajunk® complies with the following standard – ISO EN 13485.

Penumbra 91 Am Borsigturm 44 13507 Berlin GERMANY www.penumbrainc.com

Penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with signiﬁcant unmet clinical needs. We design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at signiﬁcant overall cost savings to the healthcare system. Today we have sales operations in North America, Europe, Australia and Asia.

Perouse Medical 12 Route Du Manoir 60173 Ivry le Temple FRANCE www.perousemedical.com

Perouse Medical, cardiovascular and long-term vascular access specialist within the Vygon group, is a benchmark company in the international medical devices market. The multi-disciplinary research and development teams and a unique technology portfolio enable Perouse Medical to make all its technological expertise available to the practitioners and to the medical industry. Perouse Medical Cardiovascular Division is developing a full range of technically sophisticated cardiovascular implants dedicated to replacing or treating failing arteries and veins. This division also specializes in innovating mini-invasive techniques. It designs and manufactures devices for coronarography and angioplasty procedures (inﬂation devices, haemostatic valves…) and is a key player in the Imaging ﬁeld with its range of consumables (syringes, connection lines…) for CT, MRI and angiography injectors.

C RSE Technical Exhibitors Guide 283

PharmaCept GmbH 14 Bessemerstrasse 82 12103 Berlin GERMANY www.pharmacept.com

PharmaCept stands for a successful development of niche products and instructions in the area of cancer treatment with a special focus on research in Interventional Oncology. The main pillar of our company’s development is in the field of chemoembolization therapy. On the basis of the Barcelona guidelines for the treatment of primary liver cell carcinoma, chemoembolization has become an integral part of the treatment of this illness. Increasing experience has shown that the use of permanent vascular occlusion materials promotes the development of new blood vessels which sustain tumor growth. As well as stimulating growth, permanent vascular occlusion also exacerbates pain. With EmboCept® S, our biodegradable starch microspheres, these side effects can be considerably reduced. New clinical studies will now further scientifically explore the already known advantages of short- term vessel-blockage and unlimited combination with drugs, e.g. our future Cisplatin powder with the use of our emboli- zate EmboCept® S.

Philips 60 Veenpluis 6 5684 PC Best THE NETHERLANDS www.philips.com/newscenter

Philips Volcano, a Philips business, is a global leader in physiology and intravascular imaging for coronary and peripheral applications. The business also oﬀers a suite of peripheral therapeutic devices. This is part of Philips’ industry leading solutions to decide, guide and conﬁrm the right therapy for each patient in real-time during image-guided therapies. Founded in cardiovascular care and expanding into other specialties, Philips is focused on improving patient and economic outcomes. Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips lever- ages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a 284 CIRSE 2016 Pocket Guide leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

QualiMed 38 Boschstrasse 16 21423 Winsen GERMANY www.qualimed.de

QualiMed is a leader in the design, development, production, and sales of innovative medical devices for cardiology, peripheral vascular, non-vascular, and surgical interventionists and the patients they treat. QualiMed is continually focused on enhancing its team of medical device professionals who are interested in working in the fast-paced ever-changing environment. Qualimed specializes in medical device implants with a primary focus on implantable mechanical devices, catheter based technologies, drug device combination products, and biodegradable and bioabsorable implants. The company has vast expertise in taking products from any point in the development process from Ideation through manufacturing and sales. For more information, please contact us on +49 4171 6578 0 or email us at [email protected].

RenalGuard Solutions Inc. 15 459 Fortune Boulevard CT 01757 Milford UNITED STATES www.renalguard.com

RenalGuard® protects at-risk patients from kidney damage caused by iodinated contrast, as demonstrated by studies comparing it to standard hydration. RenalGuard has been found to reduce the incidence of AKI after TAVI, the need for dialysis, and the long-term impact of CI-AKI. RenalGuard is limited to investigational use in the US.

C RSE Technical Exhibitors Guide 285

RF Medical Co., Ltd. 27 #505 World Meridian 60-24 Gasan-dong, Geumcheon-gu 153-781 Seoul REP. OF KOREA www.rfa.co.kr

As a manufacturer, RF Medical is dedicated to popularizing radio frequency ablation treatments since 2003. Our extensive product range spans from tumor ablation to varicose vein treatments. Our sophisticated technology has allowed us to spread our business to more than 40 countries and our proven quality has granted us a strong reputation on the market. As always, RF Medical strives with all its capabilities to create a healthier world by continuous investment in research and development.

Shockwave Medical, Inc. 59 48501 Warm Springs Blvd Suite 108 CA 94539 Fremont UNITED STATES www.shockwavemedical.com

Shockwave Medical is working to change the standard of care for advanced cardiovascular disease by specifically targeting a major obstacle to effective treatment: calcified plaque. Our proprietary Lithoplasty® Technology integrates the calcium disrupting power of lithotripsy with the familiarity and simplicity of balloon-based interventional devices. Built on a traditional balloon catheter platform, Lithoplasty Devices use the intermittent pulsatile mechanical energy of lithotripsy to disrupt calcium while minimizing soft tissue injury and an integrated balloon to dilate lesions, restoring blood flow. Reshape interventional therapy with the power of Lithoplasty® Technology for the treatment of calcified plaque. To experience the power of Lithoplasty Technology for the treatment of calcified, stenotic peripheral arteries join us at CIRSE for the Shockwave Medical Symposium on Monday, September 12, 2016 at 14:30-15:30 in Room 114. For more information visit www.shockwavemedical.com. 286 CIRSE 2016 Pocket Guide Technical Exhibitors Guide 287

Siemens Healthcare GmbH 76 Henkestr. 127 91052 Erlangen GERMANY www.healthcare.siemens.com

Siemens Healthcare is one of the world’s largest suppliers of technology to the healthcare industry and a leader in medical imaging, laboratory diagnostics and healthcare IT. All supported by a comprehensive portfolio of clinical consulting, training, and services available across the globe and tailored to customers’ needs. In ﬁscal 2014, Siemens Healthcare had around 43,000 employees worldwide and posted a revenue worth 11.7 billion euros, and proﬁts of more than 2 billion euros. Further information is available on the Internet at http://www.healthcare.siemens.com/.

Sirtex Medical Europe GmbH 8 Joseph-Schumpeter-Allee 33 53227 Bonn GERMANY www.sirtex.com

Sirtex Medical is actively engaged in the field of liver-directed therapies for cancer patients. The innovative technology of Sirtex, SIR-Spheres® Y-90 resin microspheres (microscopic Yttrium-90 resin beads), is a medical device used in interventional oncology to deliver Selective Internal Radiation Therapy (SIRT), also known as radioembolisation, to the liver. This treatment for inoperable liver cancer delivers high doses of radiation directly to the site of tumours whilst conserving normal liver parenchyma. SIR-Spheres® Y-90 resin microspheres were approved in 2002 for use in the treatment of a variety of unresectable liver tumours as well as in hepatocellular carcinoma. Approximately 61,000 doses have been supplied worldwide at more than 950 medical centres in over 40 countries. The SIRFLOX study: The SIRFLOX study evaluated the efficacy and safety of adding SIR-Spheres® Y-90 resin microspheres to a current first-line systemic chemotherapy in patients with non-resectable colorectal liver metastases. SIRFLOX is with more than 500 recruited patients the largest randomised interventional radiology study ever conducted in oncology. This study has now been published in the Journal of Clinical Oncology, the most widely read prestigious official journal of the ASCO. Please visit us at our exhibition booth. 288 CIRSE 2016 Pocket Guide

Society of Interventional Radiology (SIR) 30 3975 Fair Ridge Drive, Ste 400 North 22033 Fairfax, VA UNITED STATES www.sirweb.org

Come by, say hello and see what’s new! Stay current on Up and Coming Events; take home a NEW IR Quarterly and much more.

STARmed Co Ltd. 46 #1401, B-dong, 158, Haneulmaeul-ro, ILsandong-gu, 10355 Gyeonggi-do REP. OF KOREA www.starmed4u.com

STARmed Co., Ltd. is a young and fast growing company from South Korea, specializing in Radiofrequency technology. Passionately working on the best possible RF treatment, STARmed has collaborated with a number of Key Opinion Leaders in developing the most innovative Electrodes and leading-edge RF Technology speciﬁc to certain tumour types and clinical applications, in liver, lung, kidney, myoma, bone, etc. Currently, STARmed is proud to be the world leader in thermal ablation of benign thyroid nodules through Radiofrequency. In addition to R&D and manufacturing, STARmed devotes its time and resources to Professional Education through Master Classes, Hands-on Workshops and Proctorship for Doctors keen on such minimally in vasive procedures. STARmed strives to be your best partner in Radiofrequency Ablation.

St. Jude Medical Coordination Center 63 Davincilaan 11 Box F1 1935 Zaventem BELGIUM www.sjm.com

St. Jude Medical is a leading global medical device manufacturer and is dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The company does this by developing cost-eﬀective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has ﬁve major areas of focus that include heart failure, atrial C RSE Technical Exhibitors Guide 289

ﬁbrillation, neuromodulation, traditional cardiac rhythm management, and cardiovascular diseases. For more information, please visit sjm.com.

Straub Medical AG 58 Straubstr. 12 7323 Wangs SWITZERLAND www.straubmedical.com

Straub Medical AG is an internationally leading enterprise in the field of treating vascular disease. We aim to be the first brand to come to a physician’s mind when a patient presents with vascular occlusion. We manufacture the Straub Endovascular System with its Rotarex®S and Aspirex®S catheter families. A range of endovascular tools, including the Capturex® peri-interventional filter catheter, adds to our portfolio. Our Swiss-made products are of highest quality and precision. Our innovative minimally-invasive technologies contribute to improving the outcomes of endovascular interventions worldwide.

Sureﬁre Medical, Inc. 53 6272 W. 91st Avenue CO 80030 Westminster UNITED STATES www.sureﬁremedical.com

Surefire Medical is inventing the future for cancer care with advanced treatment technology. We are pioneers, developing liver cancer infusion systems that overcome the limitations of traditional tools and delivery methods. Clinical discoveries paired with new, precise technology arm physicians to target tumors with superior accuracy, control and protection. Our Colorado-based team of physicians, engineers and re searchers are united in a mission to progress cancer care and offer new hope to patients. Learn more: www.surefiremedical.com.

Interested in searching exhibitors by product category?

USE THE CIRSE APP! C RSE 290 CIRSE 2016 Pocket Guide

Surgical Specialties 85 50 Braintree Hill Oﬃce Park Suite 101 MA 02184 Braintree UNITED STATES www.surgicalspecialties.com

The BioSentry™ tract sealant system is the ﬁrst biopsy sealant system of its kind and represents a major advance in the prevention of lung biopsy-related pneumothorax. The BioSentry™ system deploys a self-expanding hydrogel plug into the pleural space following biopsy. The plug expands, creating an airtight seal that closes the pleural puncture, reducing the risk of pneumothorax by more than 50%.

Tecres SPA 86 via A. Doria 6 37066 Sommacampagna ITALY www.tecres.it

Tecres is a leading developer and manufacturer of bone cements and acrylic resins with over thirty years of ex perience in orthopaedics and in minimal invasive spine surgery. We sell our products in more than seventy countries all over the world. Mendec Spine HV System is the unique all-in- one closed mixing device specifically developed for the preparation of our high density acrylic resin which comes preloaded inside the mixing cartridge. Mendec Spine is our acrylic resin specifically developed for the filling of vertebral cavities. It comes with a complete kit for vertebroplasty procedures as Mendec Spine Kit.

Teleﬂex Medical Europe Ltd 66 IDA Business and Technology Park Garrycastle, Dublin Road Co Wetmeath Athlone IRELAND www.teleﬂex.com

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields C RSE Technical Exhibitors Guide 291 of vascular and interventional access, surgical, anaesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com. Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose. Teleflex offers a wide array of technolo- gically advanced products for minimally invasive interventional applications. Our products are designed to enhance performance in interventional access and peripheral vascular procedures. The OnControl® Powered Bone Access System uses a patented handheld driver technology to provide interventional radiologists a faster, more reliable solution for accessing dense and hard-to-reach bone lesions. The ARROW- Clark™ VectorFlow™ Catheter is a tunneled hemodialysis catheter with symmetrical tip designed to reduce loss of lock solution, give sustained high flows, minimize recirculation and reduce the risk of platelet damage resulting from shear stress.

TeraRecon 6 Walther-von-Cronberg-Platz 16 60594 Frankfurt GERMANY www.terarecon.com

TeraRecon is the largest independent, vendor-neutral medical image viewing solution provider with a focus on advanced image processing innovation. The TeraRecon solutions advance accessibility, performance, clinical functionality and the medical imaging workﬂow throughout many areas of the healthcare ecosystem. We provide world class advanced visualization 3D post-processing tools, as well as a spectrum of enterprise medical image viewing, diagnostic interpretation, image sharing, interoperability and collaboration solutions. TeraRecon is a privately-held company with its world headquarters in Foster City, California, and major oﬃces in Tokyo, Japan; Frankfurt, Germany; and Acton, MA. 292 CIRSE 2016 Pocket Guide

Terumo Europe N.V. 10 Interleuvenlaan 40 3001 Leuven BELGIUM www.terumo-europe.com

Founded in Tokyo in 1921, Terumo is a multinational company with more than 90 years’ experience in developing best-in-class medical devices. At Terumo Interventional Systems, we constantly work to refine and perfect our products so that interventionalists can do more. Our exceptional tools and educational programs empower physicians with the confidence they need to perform ever-more challenging procedures and spark progress. For peripheral interventions, Terumo solutions include a dedicated self-expanding stent Misago®, PTA balloon catheters Metacross® – 0.035" OTW and RX design and Senri® – 0.018" RX design, an OTW PTA balloon catheter Tercross® – 0.014", a Carotid Artery Stent, Roadsaver®, a double layer micromesh stent, as well as a broad choice of guidewires, angio-, support-catheters and other access materials. In interventional oncology, Terumo offers interventional radiologists a complete toolkit to treat patients suffering from cancer. Terumo offers a large selection of access devices like Progreat® microcatheter and Occlusafe® ballon occlusion catheter; a complete range of loco-regional therapies including LifePearl® drug-elutable microspheres; as well as Azur embolic coils. During CIRSE 2016, Terumo will present QuiremSpheres, the next generation radioembolic microspheres, which will further enhance the interventional Oncologist’s toolkit.

Tokai Medical 17 1485, Srayashiki, Taraga 4860808 Kasugai, Aichi JAPAN www.tokaimedpro.co.jp/en

Tokai Medical Products started its business with the ardent desire to save the life of the founder‘s daughter. Now we have spread our wings around the world to save as many lives as possible all over the world.

C RSE Technical Exhibitors Guide 293

Toshiba Medical Systems Europe 43 Zilverstraat 1 2718 RP Zoetermeer THE NETHERLANDS www.toshiba-medical.eu/eu/

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Visit Toshiba Medical Systems Corporation’s website at http://www.toshibamedicalsystems.com.

TU Delft – Minimally Invasive Surgery and 37 Interventional Techniques Lab Department of Biomechanical Engineering Mekelweg 2 2628 CD Delft THE NETHERLANDS www.misit.nl, www.tudelft.nl

A fascination for science, design and engineering is the common denominator driving the 4700 employees of TU Delft. Delft University of Technology is not only the oldest, but also the largest university of technology of the Netherlands. TU Delft cooperates with many other educational and research institutions, both in the Netherlands and abroad. The high quality of our research and teaching is renowned. The Minimally Invasive Surgery and Interventional Techniques Lab (MISIT) is part of the department of Biomechanical Engineering. MISIT conducts research on tissue-instrument- human interaction with the goal to improve diagnostic and therapeutic performance during minimally invasive interventions. Our focus is on the mechanical interaction with instruments and on the design of new instruments. Our vision is to develop medical technology that is designed for the environment of its intended use. Among other instruments, we design and develop steerable needles intended for use in interventional radiology. The tip of these needles can be actively steered, with the goal to increase possible route options within the organ and lowering the amount of punctures needed per procedure. In addition, these needles should be able to correct for unwanted needle deﬂections during insertion, to improve needle placement accuracy. 294 CIRSE 2016 Pocket Guide

TVA Medical 5 7000 Bee Cave Rd. TX 78746 Austin UNITED STATES www.tvamedical.com

TVA Medical, Inc., headquartered in Austin, Texas, is developing minimally invasive therapies for end-stage renal disease, peripheral vascular disease and other potential applications. More information is available at www.TVAMedical.com.

UreSil, LLC 73 5418 West Touhy Ave IL 60077 Skokie UNITED STATES www.uresil.com

UreSil, LLC manufactures and distributes cutting-edge medical devices that serve the needs of the Interventional Radiologist. These include the innovative Origin™ series of drainage catheters and a full line of drainage catheters including General Purpose, Nephrostomy, Biliary, Bariatric, Large Bore, Nephro-Ureteral and Miniaturized Catheters. Uresil LLC is also the proprietary manufacture of the Tru-Close suction drainage system and the Thora-Vent®. The Thora-Vent is designed to manage and resolve a simple pneumothorax without the need for a chest tube. All manufacturing is performed in a state-of-the-art 35,000 square foot facility in Skokie, Illinois. UreSil utilizes a network of over one hundred local sales representatives globally to promote and support its products and is constantly and actively innovating new solutions for healthcare worldwide.

Vascular Solutions, Inc. 34 6464 Sycamore Court N MN 55369 Minneapolis UNITED STATES www.vasc.com

Driven by clinical needs and supported by innovative thinking, Vascular Solutions oﬀers a rapidly growing product line that spans both coronary and peripheral vascular treatments. Cardiologists, radiologists, electrophysiologists and vein specialists worldwide rely on the quality and proven clinical eﬀectiveness of our products. C RSE Technical Exhibitors Guide 295

Veryan Medical Ltd 49 Unit 15 City Business Centre Brighton Road RH13 5BB Horsham UNITED KINGDOM www.veryanmed.com

Veryan was formed in 2003 as the result of a technology spin- out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three-dimensional Nitinol stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro of Imperial College London on the link between vessel geometry, blood flow mechanics and vascular disease. BioMimics 3D – The Swirling Flow Stent - generates swirling flow, raising wall shear to limit intimal hyperplasia. It showed significantly better performance than straight control stents in the randomised fempop Mimics Study. Veryan is nearing completion of enrolment of its MIMICS-2 IDE study in the US and Japan and has begun its MIMICS-3D Registry which will study a minimum of 500 patients across Europe. Veryan benefits from a highly experienced Board of Directors and the Company’s management team has built an outstanding development group, supported by a world class Scientific Advisory Board. The Company’s head office is in Horsham, West Sussex, UK, and the research and development facility is in Galway, Ireland. Veryan has a direct sales force in Germany and has agreements across Europe with distributor partners.

Vigeo srl 13 Via Dell’Alpino 2 46031 Bagnolos S. Vito (MN) ITALY www.vigeosrl.it

Vigeo has for more than 10 years been a specialist in the development, manufacture and sale of minimally invasive single-use instruments. Our core competence lies in the implementation of new ideas and solutions, taking into account the speciﬁc needs of treating doctors. Our product portfolio oﬀers a broad and innovative range of minimally invasive disposable instruments in the following areas: breast care & diagnostics – wire and clip marking (new: Relock Premium Soft), soft tissue and bone marrow biopsy (new: CTCORE), prenatal diagnostics, cyst drainage, pulmonary interventions, vertebroplasty (new: V-SPIN). 296 CIRSE 2016 Pocket Guide

WCIO 19 2025 M Street NW, Suite 800 WA 20036 Washington UNITED STATES www.io-central.org

WCIO is a global community whose mission is to establish, nurture and support Interventional Oncology (IO) as the 4th pillar of cancer therapy alongside medical, surgical, and radiation oncology worldwide. Through IO Central and WCIO Annual Conference, professionals can engage 24/7, 365 days a year. WCIO is the leading interventional oncology conference, bringing together medical experts from around the world for a multidisciplinary approach. Featuring state-of-the-art lectures on innovative IO topics, tumor boards highlight- ing real-world techniques, cutting-edge best practices, and bench-to-bedside program content, WCIO raises the bar on IO and complex biology. Session topics span private practice, hospital, and institutional settings. Medical students, residents and fellows, advanced practice providers, IO experts, and less experienced operators alike can participate in a truly dynamic learning and networking experience. New this year is an interactive session with the opportunity to challenge conference faculty. Additionally, through IO University, WCIO features the most comprehensive on-demand education for IO professionals. With access to an in-depth IO curriculum, best practices, and industry advances, IO University will build your skills while oﬀering the opportunity to earn CME credits online. Please visit www.io-central.org for the latest interventional oncology news and conference updates.

Wisepress Medical Bookshop 21 25 High Path, Merton Abbey SW19 2JL London UNITED KINGDOM www.wisepress.com

Wisepress.com, Europe’s leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientiﬁc bookshop online with great oﬀers. Follow us on Twitter for the latest news @WisepressBooks.

C RSE Technical Exhibitors Guide 297

Ziehm Imaging 74 Donaustrasse 31 90451 Nürnberg GERMANY www.ziehm.com

Founded in 1972, Ziehm Imaging has stood for the development, manufacturing and worldwide marketing of mobile X-ray-based imaging solutions for more than 40 years. Employing more than 400 people worldwide, the company is the recognized innovation leader in the mobile C-arm industry and a market leader in Germany and other European countries. The Nuremberg-based manufacturer has received several awards for its ground-breaking technologies and achievements, including the Frost & Sullivan Award (various years), the iF Design Award 2011, the Top100 award for innovative mid-size companies 2012, the Stevie Awards 2013, 2014 and 2015, the German Stevie Award and the IAIR Global Awards 2014 as "Best Company for Innovation & Leadership", Mid-size companies 2012, the Stevie Awards 2013 and 2014 and the IAIR Global Awards 2014 as “Best Company for Innovation & Leadership”. For more information, please visit: www.ziehm.com. 298 CIRSE 2016 Pocket Guide

The Radiation Protection Pavilion: Can you handle the risk?

CIRSE’s Radiation Protection Subcommittee proudly presents the third Radiation Protection Pavilion – an interactive awareness campaign for radiation protection and dose management. The initiative’s prime focus is to raise awareness for the speciﬁc health risks interventional radiologists are facing due to high levels of occupational exposure to radiation. The Radiation Protection Pavilion provides real value for CIRSE members by oﬀering tangible services and practical advice. Visit the Pavilion and…

… get a free eye check-up: CIRSE is oﬀering complimentary ophthalmological check-ups (vision testing and lens opacity screening) to members. Book an appointment at the registration counter in the Pavilion.

… get expert advice: Learn about the health hazards linked to high levels of occupational exposure to radiation – consult our best-practice guides and information materials, or take a seat and listen to a brief talk hosted by our Subcommittee or industry partners (see mini-talk programme on your CIRSE app).

… explore state-of-the-art protective technologies: Discuss the latest products for protection and dose management with select industry partners, who will be on hand to address any questions you may have.

… train and test yourself: Train and test your radiation pro tection skills right in the Pavilion – a radiation protection simulator will be on hand, as well as various virtual environ- ments for you to try out. Don’t forget to test your knowledge afterwards with our electronic quiz, which you can ﬁll out via the CIRSE app.

Find out more about this initiative in the CIRSE app or on our website: www.cirse.org/rpp

C RSE Radiation Protection Pavilion 299

Technical Exhibition RPP (Alphabetical List)

Oﬃcial Name Booth#

3D Systems Healthcare RPP4 Amray RPP10 Bayer Medical Care RPP1 BTG RPP6 Esprimed RPP8 EuroSafe Imaging RPP11 GE Healthcare RPP9 Mavig RPP3 MDT RPP5 Mentice RPP2 Radpad – Worldwide Innovations & Technologies RPP7

Technical Exhibition RPP (Numerical List)

Oﬃcial Name Booth#

Bayer Medical Care RPP1 Mentice RPP2 Mavig RPP3 3D Systems Healthcare RPP4 MDT RPP5 BTG RPP6 Radpad – Worldwide Innovations & Technologies RPP7 Esprimed RPP8 GE Healthcare RPP9 Amray RPP10 EuroSafe Imaging RPP11 300 CIRSE 2016 Pocket Guide

3D Systems Healthcare RPP4 5381 South Alkire Circle CO 80127 Littleton UNITED STATES www.3dsystems.com

3D Systems Healthcare advances precision medicine through the development of targeted products and treatment plans from training and planning to the operating room. Our ANGIO Mentor™ endovascular training simulator was designed to meet the needs of various specialties such as interventional cardiology, electrophysiology, interventional radiology, vascular surgery and neuroradiology. Training on the system enhances skills and allows practice of all aspects of interventional techniques, including complication management. The system is offered in several configurations, including the ANGIO Mentor Suite designated for team training, and the ANGIO Mentor Flex ultra-portable system. The ever-expanding library of modules includes 24 endovascular procedures with over 140 cases, including Endovascular Basic Skills, Peripheral Interventions, Peripheral Embolization, Aortic Interven- tions, Transradial and Transfemoral Coronary Interventions, Structural Heart Diseases, Electrophysiology and Neuro- vascular Interventions. We offer a selection of fine detailed anatomical printed models in various materials and the option to print patient-specific printed models derived from your patient’s scans. These are used by training programs, medical device companies, and physicians planning an upcoming procedure. The innovative PROcedure Rehearsal Studio™ software allows clinicians to create a personalized virtual or 3D printed anatomical model based on a patient’s CT for the purpose of simulating, analyzing and evaluating surgical treatment options.

Amray RPP10 Unit 9-11 Greenhills Industrial Village Greenhills Industrial Village Louth, Drogheda IRELAND www.amray.eu

AmRay is a leading supplier of personal radiation protection and infrastructural radiation shielding. Having been in the business of radiation protection for 31 years, there is little we have not seen. Please call by our stand where our expert team would be delighted to discuss and advise you on your needs. C RSE Radiation Protection Pavilion 301

Bayer Medical Care RPP1 Müllerstrasse 178 13353 Berlin GERMANY www.bayer.de

As a true life science company, Bayer understands where treatment starts: With an early and precise diagnosis. Radiologists have a unique ability to provide clear direction during moments of uncertainty in a patient’s clinical journey. That’s why, for more than 100 years, we have created high-quality imaging products, tools and services to strengthen conﬁdence on the path to better health, Bayer oﬀers the full range of products and services to ensure Radiologists can achieve high quality contrast enhanced imaging and safety.

BTG RPP6 Lakeview, Riverside Way Watchmoor Park GU15 3YL Camberley UNITED KINGDOM www.btg-im.com

At BTG we are focused on bringing to market innovative products in specialist areas of medicine to better serve doctors and patients. Our growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer tumours, advanced emphysema, severe blood clots and varicose veins, while our Specialty Pharmaceuticals portfolio oﬀers antidotes that alleviate toxicity and treat rare conditions. Healthcare is constantly evolving – so BTG never stands still. Inspired by a deep understanding of our customers’ needs, we’re working to meaningfully improve the lives of patients and their healthcare experience. Our com- petitive advantage is our dedication to ﬁnding smart, often unconventional solutions to complex medical problems. Many of our products combine medicines, device technology and new techniques in order to deliver more targeted treatments. We also invest in the clinical evidence to help demonstrate the value of our products to doctors, patients, and healthcare systems. Doing what’s right for patients is what gets us to work in the mor ning. It’s part of our DNA. By staying true to this principle and our values, we’ve earned a strong reputation for the quality of our products and our commitment to innovation. Whether developed in our own labs or in partner- 302 CIRSE 2016 Pocket Guide ship with clinicians, academics and other companies, we believe passionately that medical innovation has the power to improve human health. For more information, please visit www.btg-im.com.

Esprimed RPP8 1, Mail du Pr. Georges Mathé 94800 Villejuif FRANCE www.esprimed.net

Esprimed is a medical physics company developing innovative solutions for patient and staﬀ radiation protection. During CIRSE 2016 we will showcase em.dose (quick calculation of skin dose map and peak skin dose) and em.sim, a serious game for operational radiation protection.

EuroSafe Imaging RPP11 Neutorgasse 9 1010 Vienna AUSTRIA www.eurosafeimaging.org, www.myESR.org

EuroSafe Imaging is the European Society of Radiology’s ﬂagship campaign to promote quality and safety in medical imaging. The mission of EuroSafe Imaging is to support and strengthen medical radiation protection across Europe following a holistic, inclusive approach. EuroSafe Imaging has issued the ‘EuroSafe Imaging Call for Action’, a 12-point action plan to achieve EuroSafe Imaging’s objectives of promoting appropriateness in radiological imaging, maintaining radiation doses within diagnostic reference levels, using the ALARA principle, promoting the use of up-to-date equipment, empowering patients, and joining forces with various stakeholders. Visit the EuroSafe Imaging booth (No. RPP11) to learn about our quality and safety initiatives and support us by becoming a EuroSafe Imaging Star.

C RSE Radiation Protection Pavilion 303

GE Healthcare RPP9 283 rue de la miniere 78533 Buc FRANCE www.gehealthcare.co.uk

GE Dose Management in Interventional Radiology Deliver the right dose: With a comprehensive integrated solution that enables radiation dose and contrast parameters optimization and standardization. DoseWatch is a web- based dose management solution that captures, tracks, and reports radiation and contrast dose directly from the medical device. DoseWatch is a multi-modality and vendor agnostic solution. It can help you optimize dose levels by helping to detect possible causes of excess radiation, so you can produce focused diagnostic images with lower exposure. Enterprise- wide dose management solustion: Automatic multi-modality & multi-vendor dose tracking DoseWatch can automatically receive and store dosimetric information from imaging systems from a variety of vendors, including: CT-scanners, Contrast Data Management, Interventional Radiology (IR) Systems, Cardio-Vascular (CV) Systems, Mammography Systems, Radiography Systems, Surgical/Mobile C-Arms, Nuclear Medicine. Dose Excellence Program GE Healthcare oﬀers a customized Dose Excellence Program with professionals such as a Clinical Applications Specialist to provide onsite DoseWatch training and optimization services. The Clinical Applications Specialist will work directly with the user(s) to review historical dose data, outline and review all protocols currently set up, identify opportunities to standardize and adjust protocols, identify opportunities to better use dose saving features and review ALARA principles.

Mavig RPP3 Stahlgruberring 5 81829 Munich GERMANY www.mavig.com

MAVIG GmbH, founded in 1921, designs and manufactures X-Ray protection clothing and accessories, as well as ceiling- and table-mounted equipment. In the course of time our products have achieved a worldwide reputation for highest quality and performance. MAVIG is certified following EN ISO 13485:2012 and complies with all newest European and US 304 CIRSE 2016 Pocket Guide standards. Most of our products are developed and tested by our own R&D department in Munich. Also the entire production of radiation protection and suspension systems is located in our head office in Munich, Germany. Each part, each production step and each finished item are subject to the meticulous inspection of our quality management. Our products always comply with the latest requirements of the industry. MAVIG is market leader in its business fields. Quality "Made in Germany" is acknowledged worldwide.

MDT RPP5 Bukkumweg 26 5081CT Hilvarenbeek THE NETHERLANDS www.mdt.nl

MDT X-Ray is a Pan European Medical company that specializes in "made to measure" personal X-Ray Protection apparel within the highest quality standards known to industry. The level of ﬁnishing is unequalled, cost of ownership very low and delivery time the shortest in the industry.

Mentice RPP2 Odinsgatan 10 41103 Gothenburg SWEDEN www.mentice.com

Mentice is world leader in endovascular training solutions covering neurovascular, cardiovascular and peripheral vascular disciplines. Mentice’s expertise is represented in clinically relevant medical endovascular scenarios through high ﬁdelity simulation. This realistic training permits transfer of skills and knowledge in a reproducible, safe and measurable way, beneﬁting clinical teams and patients.

C RSE Radiation Protection Pavilion 305

Radpad – Worldwide Innovations & Technologies RPP7 14740 w. 101st Terrace KS 66215 Lenexa UNITED STATES www.radpad.com

RADPAD® products allow medical facilities to comply with the ALARA (As Low As Reasonably Achievable) standard of the radiation protection industry. After the primary develop- mental work was completed, WIT’s focus turned to manufacturing and commercialization of the products. Product marketing and sales essentially began in the U.S. in 1998. In 2002, WIT expanded its medical market focus internationally by initiating sales in Canada and Japan. In 2007 and 2009, RADPAD® radiation protection products were introduced into the European and Middle East markets, respectively. Our products have been independently tested, studied, and proven to be eﬀective in reducing radiation exposure. In 2010, WIT obtained ISO 13485 and CE mark for all products to conﬁrm and enhance its commitment to quality products and customer service. 306 CIRSE 2016 Pocket Guide

Technical Exhibition Societies (Alphabetical List)

Oﬃcial Name Booth#

BSIR S11 CIRSE S7 DFIR S3 ECIO 2017 | GEST Europe 2017 S14 ESR S6 ICIR S5 IESIR S8 IROS | OEGIR | DeGIR S9 PAIRS S1 SERVEI S12 SIDI S13 SRSCVIR S2 SSVIR S4 TSIR S10

Technical Exhibition Societies (Numerical List)

Oﬃcial Name Booth#

PAIRS S1 SRSCVIR S2 DFIR S3 SSVIR S4 ICIR S5 ESR S6 CIRSE S7 IESIR S8 IROS | OEGIR | DeGIR S9 TSIR S10 BSIR S11 SERVEI S12 SIDI S13 ECIO 2017 | GEST Europe 2017 S14

C RSE Societies 307

BSIR – British Society of Interventional Radiology S11 63 Lincoln’s Inn Fields WC2A 3JW London UNITED KINGDOM www.bsir.org

BSIR: A specialist medical society supporting its members in the promotion of scientiﬁc education and research in Inter- ventional Radiology: The Future of Image Guided Surgery.

CIRSE – Cardiovascular and Interventional S7 Radiological Society of Europe Neutorgasse 9 1010 Vienna AUSTRIA www.cirse.org

CIRSE is a non-profit, educational and scientific association which comprises over 7,000 members, and aims to improve patient care through the support of teaching, science, research and clinical practice in the field of cardiovascular and interventional radiology. CIRSE facilitates learning throughout the year with state-of-the-art meetings, educational workshops and grants, and scientific, advocacy and patient safety initiatives.

DFIR – Danish Society of Interventional Radiology – S3 Dansk Forening for Interventionel Radiologi Att. Poul Erik Andersen, Department of Radiology, Odense University Hospital, Sdr. Boulevard DK-5000 Odense C DENMARK www.dﬁr.dk

The Danish Society of Interventional Radiology (DFIR) was established in 1996. The society is the main pillar in IR education in Denmark by organising annual national scientiﬁc and educational meetings which have been arranged during the last 14 years. We have an educational programme for IR and a Danish syllabus but there is no oﬃcial sub-specialisation of IR in Denmark. 308 CIRSE 2016 Pocket Guide

Out of about 80 members of DFIR, six are EBIR holders and four are CIRSE Fellows. DFIR has been a group member of CIRSE since 2007. We have served on the Executive Commit- tee, Scientiﬁc Programme Committee, Rules Committee, the Membership Committee, and on the Vascular Division of the Foundation Advisory Council. Further, we have members of the EBIR Council and EBIR examinations. We have been the local host for ESIR (embolisation) in Odense and for CIRSE 2008 in Copenhagen, and will be again for CIRSE 2017. We have acted in CIRSE as congress co-organisers, programme planners, faculty members, lecture presenters and moderators, and reviewers for CVIR for many years.

DeGIR – German Society of Interventional Radiology S9 c/o Deutsche Röntgengesellschaft Ernst-Reuter-Platz 10 10587 Berlin GERMANY www.degir.de

DeGIR is the German society for interventional radiology and minimally invasive therapy (www.degir.de). Founded in 2008, it is a society of now more than 1,300 members and is strongly related to the German Roentgen Society (DRG). DeGIR has a permanent office located in Berlin. The society runs an elaborate national registry of interventional procedures, collecting data from 170,000 interventions documented by 295 Institutes in 2015. DeGIR established a qualification initiative in interventional procedures similar to EBIR which is divided into 6 different modules including vascular recanalization techniques, embolization, nonvascular interventions and neurointerventions. Qualification requires both a written and oral exam and a sufficient practical experience. To date, more than 1,000 certificates of personal qualification in interventional radio logy have been issued. A network of training facilities is also offered to its members. For further information, please contact the society directly at [email protected].

C RSE Societies 309

ECIO 2017 – European Conference S14 on Interventional Oncology Featuring a comprehensive scientific programme, world- renowned faculty and a first-rate technical exhibition, ECIO explores the latest developments and best practices in minimally invasive, image-guided cancer treatment. As the interventional oncologist is playing an increasingly colla- borative role alongside oncologists and surgeons in cancer treatment, this annual event puts great emphasis on multidisciplinary discussion, with joint sessions, Multidisciplinary Tumour Boards and an initiative to encourage registrants to bring their non-radiologist colleague at no extra cost. ECIO 2017 will be held in Bilbao, Spain from April 23-26. To find out more, visit our booth or www.ecio.org.

ESR – European Society of Radiology S6 Neutorgasse 9 1010 Vienna AUSTRIA www.myESR.org

Founded in 2005, by merging the European Congress of Radiology (ECR) and the European Association of Radiology (EAR), the European Society of Radiology (ESR) is an apoliti- cal, non-profit organisation dedicated to strengthening and unifying European radiology. With more than 63,600 members across the globe, it has grown to become the largest radiological society in the world and hosts one of the biggest and most innovative scientific meetings in Europe, the European Congress of Radiology, in Vienna each year (more than 25,000 participants at ECR 2016). The Society works closely with national radiological societies across Europe and further afield, while establishing relationships with major international organisations from other related fields. It also monitors developments on the EU level which could have an impact on research and practice in radiology, with the best interests of the patient as its overriding goal. The mission of the European Society of Radiology is to serve the healthcare needs of the general public by supporting scientific research, education and training while constantly striving to improve the quality of radiological practice. 310 CIRSE 2016 Pocket Guide

GEST Europe 2017 S14 The Global Embolization Symposium and Technologies (Europe) offers a biennial platform where interventionists can discover the very latest in embolisation, from tools to techniques. An expansive technical exhibition offers delegates an opportunity to discover new and existing embolics, contrasts and catheters, while a carefully selected scientific programme sees world-renowned experts introduce their latest findings, best practice data and new applications. GEST Europe 2017 will be held in Florence, Italy, from May 31-June 3. Visit us at Booth S14!

ICIR – Italian College of Interventional Radiology S5 Via della Signora n.2 20122 Milan ITALY www.sirm.org

The Italian College of Interventional Radiology is a section of the main Italian Society of Radiology named Italian Society of Medical Radiology (S.I.R.M.).

IESIR – Italian-European Society S8 of Interventional Radiology Neutorgasse 9 1010 Vienna AUSTRIA www.iesir.org

The Italian-European Society of Interventional Radiology (IESIR) was founded in 2015 as an independent society. Its objective is to develop and promote the clinical work of interventional radiologists in Italy and in Europe as well as supporting scientiﬁc activities, representing the interests of Italian IRs, actively contributing to the creation of guidelines and reports, and strengthening connections to the European IR community.

C RSE Societies 311

IROS 2017 S9 Neutorgasse 9 1010 Vienna AUSTRIA www.irosonline.org

IROS 2017 – the annual meeting of the Austrian, German and Swiss Societies of Interventional Radiology – will take place in Berlin, Germany, from January 12-14. In addition to lectures and workshops, delegates will have the possibility to participate in live procedure demonstrations, Satellite Symposia and intensive courses tailored to the daily needs of interventional radiologists. For further information, please visit our booth or our website at www.irosonline.org.

ÖGIR – Austrian Society of Interventional Radiology S9 Neutorgasse 9 1010 Vienna AUSTRIA www.oegir.at

ÖGIR is the Austrian Society of Interventional Radiology and Minimally Invasive Therapy (www.oegir.at). Founded in 2007, the society now has over 200 members. ÖGIR has a permanent office located in Vienna and organises the IROS annual meeting together with the German Society of Interventional Radiology (DeGIR) and the Swiss Society of Interventional Radiology (SSVIR). In 2012, ÖGIR, in cooperation with DeGIR, introduced a qualification initiative in interventional pro cedures similar to EBIR, which is divided into 6 different modules including vascular recanalisation techniques, embolisation, non-vascular interventions and neurointerventions. For more information, please visit www.oegir.at or email [email protected]. 312 CIRSE 2016 Pocket Guide

PAIRS – Pan Arab Interventional Radiology Society S1 424 Abdel Aziz Street, 2nd ﬂoor, Suite 204, Blue Building Beirut LEBANON www.pairsweb.org

The Pan Arab Interventional Radiology Society (PAIRS) was established in 2006, based in Beirut and aims to spread the knowledge about interventional radiology in the Arab world and region. PAIRS aims to educate patients and other medical professionals in our region about interventional radiology and new high tech, cutting edge alternatives to patients. PAIRS also aims to educate interventional radiologists about updates in the specialty through multiple educational activities in addition to its annual scientiﬁc meeting.

SERVEI – Secretaria Española de Radiología S12 Vascular E Intervencionista Calle Alcalá 135, 1ª planta 28009 Madrid SPAIN http://servei.org

The Spanish Society of Vascular and Interventional Radiology (SERVEI) is a non-profit medical-scientific association founded in 1987, with the aim of promoting training, development, research, knowledge sharing and diffusion of vascular and interventional radiology (VIR). VIR is a subspecialty of radiology for the diagnosis and treatment of many diseases by minimally invasive procedures and guided by imaging techniques (fluoroscopy, CT, ultrasound and MRI). They are less aggressive and have lower morbidity and mortality rates than conventional surgery treatments, allowing patients a quick recovery with shorter hospital stay. It includes treatments for vascular disease, non-vascular, musculoskeletal procedures and cancer treatments. Their role is particularly important in many emergency situations where other specialties have no treatment options. SERVEI holds a National Congress every two years and multiple courses and training sessions.

C RSE Societies 313

SIDI – Sociedad Iberoamericana de Intervencionismo S13 C/ Domingo Miral s/n 50009 Zaragoza SPAIN www.intervencionismosidi.org

SIDI is the scientific society that brings together the Spanish- speaking interventional specialists of North, Central and South American countries, Spain and Portugal. The objectives and policies of the Society are aimed at updating and con tinuing education of interventional medical specialists in Latin America. An annual congress is organised in different countries, which reviews current issues through lectures, workshops, free papers and hands-on sessions, with guest professors from around the world. The Society also has links with other friendly societies, such as the CIRSE and SERVEI. SIDI has a Board of Directors which is responsible for carrying out the various guidelines issued by the Assembly of Members, according to the Statutes, also has various advisory committees, including the Scientific Committee which is responsible for organising the congress annually. Medical specialists in interventional work who work in these Spanish- speaking countries are eligible to apply for membership, and may be associated with an application, which will be evaluated by the Board. Our magazine Interventionism is available online and is the only scientific magazine on interventional radiology and invasive procedures in the Spanish language.

SRSCVIR – CardioVascular and Interventional S2 Radiology Subsection of Singapore Radiological Society 14 Robinson Road #13-00 Far East Finance Building Singapore 048545 Singapore SINGAPORE www.srs.org.sg

The CardioVascular and Interventional Radiology (CVIR) Subsection of the Singapore Radiological Society (SRS) was formed in the year 2000 with slightly more than 10 foun- ding members. In tandem with the growth of interventional radiology (IR) services in Singapore, our Subsection membership increased 5 fold in 15 years to just over 50 members currently. All our public and private hospitals have state-of- the-art angiographic equipment and the full spectrum of IR service is available here. On the education front, our Sub- 314 CIRSE 2016 Pocket Guide section meets regularly to share interesting and morbidity/ mortality cases in order to to learn from each other. We also regularly invite overseas experts to speak at our meetings. The highlight of our education calendar is the annual workshop – WIRES (Workshop in Interventional Radiology Education Singapore) usually organised in the middle of the year. The workshop is conducted over a weekend where overseas and local experts share their expertise in one or two IR themes. Concurrent sessions designed for IR nurses and techs are also included in the WIRES program.

SSVIR – Seldinger Society of Vascular and S4 Interventional Radiology SSVIR c/o Michael Åkesson Västra Lärkvägen 3 23642 Höllviken SWEDEN www.seldinger.se

Seldinger Society was established 1994 as a platform for radiologists interested in vascular and interventional radiology in Sweden. The goal of the society is to support research and development in this area. Join SSVIR Annual Meetings each spring for its interesting scientiﬁc programme, experience exchange and discussions about innovations within interventional radiology. SSVIR is a part of Swedish Society of Radiology and a member of CIRSE.

C RSE Societies 315

TSIR – Turkish Society of Interventional Radiology S10 Hoşdere Caddesi Çankaya Evleri F Blok Daire 2 Çankaya Ankara TURKEY www.tgrd.org.tr

The Turkish Society of Interventional Radiology (TSIR) was established in 2000. Its offices were located first in Istanbul and are now in the capital city, Ankara. As of June 2014, the society had 573 members including 300 interventional radiologists and 90 radiology residents. Interventional radiology has not yet become a governmentally recognised subspecialty of radiology in Turkey. For interventional radiology, the routine residency programme has a three- to ten-month rotation, and after completion most radiologists are capable of performing basic interventions. Therefore, education on interventional radiology has become the most important mission of the society. The society arranges courses and annual national meetings in the field of interventional radiology. The mission of TSIR is to contribute to the education and training of radiologists who perform all kinds of interventional procedures and to pursue research and development on this field. Our 11th Annual Scientific Meeting was held in Antalya Titanic Hotel Convention Center on March 10-13, 2016. A total of 508 attendees, including interventional radiology doctors, technicians, nurses and industry members, participated in this meeting. The 12th meeting will be organised in Antalya Sueno Deluxe & Hotel Convention Center on March 9-12, 2017. 316 CIRSE 2016 Pocket Guide

C RSE Imprint 317

Imprint

CIRSE Central Oﬃce Neutorgasse 9 1010 Vienna, Austria

Phone: +43 1 904 2003 Fax: +43 1 904 2003 30 E-mail: [email protected] Web: www.cirse.org

The CIRSE 2016 Pocket Guide In case of any enquiries or comments, please contact us at [email protected]

GraphX by L O O P . E N T E R P R I S E S media www.loop-enterprises.com 318 CIRSE 2016 Pocket Guide

Mezzanine 2 Meeting Room

Room M211

Room M212

Room M216

Room M217

Room M218 Room M219 Room M220 Room M221

C RSE Meeting Room First Floor Lecture Room / Hands-on Workshop Room

Room 125

Room 124

Room 123 Room 130

Room 122

Room 121

Room 132 Room 120

Room 119 Room 133

Room 118 Room 134

down to Ä Speaker Centre

Room 117 Room 116 Room 115 Room 114 Room 113 Room 112 Room 111 Learning Centre Entrance Level Lecture Room

Future Meetings

IDEAS Simulator Gallery Training Village Society Booths S1-S13

RP P10RPP11 RPP9 85 84 RPP1 Radiation 94 Penumbra Auditorium 2 Auditorium 1 RPP8 88 81 Protection 86 83 RPP2 Pavilion RPP7 93 90 89 87 82 80

Eye-Check Room 91 Cash RPP3 RPP5RPP4 RPP6 92 Bar 75 78 67 66 68 74 79 77 Merit BTG 63 Medical 73 Straub 64 65 69 70 71 72 76 Poster Area Members‘ 49 54 44 43 Lounge C.R. 48 Cook Medical Bard 45 42

62 61 60 59 58 57 55 56 53 52 51 50 47 46 41 Lounge of the Exhibition Hall European 32 6 5 23 38 37 Trainee 33 32 31 Forum 39 Medtronic 9 Boston 30 36 Terumo Scientific 40 29 22 Internet 24 34 35 47 8 10 11 12 13 14 25 26 27 28 Area 1 95 15 16 17 18 19 20 21

down to Kuoni Cloakroom Hospitality Desks

Entrance Hall down to Students‘ Lounge

Registration up to Speaker Centre

ECIO 2017, GEST Europe 2017 S14

Hotels Hotel AC Barcelona Forum Ä Ä Hilton Diagonal Mar Barcelona Princess Diagonal Zero Entrance Entrance terialA Biliary nousV Aortic PainP a oNeuro yOnco